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Abstract 
Objective: Efforts are being made to identify dementia with Lewy bodies (DLB), the 
second commonest cause of neurodegenerative dementia after Alzheimer's disease 
(AD), in the Mild Cognitive Impairment (MCI) phase, during which intervention on the 
disease processes would likely be most successful. Few studies have targeted this 
group and the cognitive profile of MCI with Lewy bodies (MCI-LB) is therefore 
unclear. The present study aims to elucidate the neuropsychology of MCI-LB relative 
to MCI due to AD (MCI-AD) and healthy controls. 
 
Methods: In addition to age-matched controls (n = 31), participants with MCI and 
symptoms suggestive of LB disease were recruited from local clinics. Baseline 
assessment of all subjects included clinical examination, imaging (123iodine-
metaiodobenzylguanidine [MIBG], dopamine transporter imaging [DaTscan]), and 
comprehensive neuropsychological assessments. Simple and Choice Reaction Time 
(SRT and CRT) and a Continuous Performance Test-AX (CPT-AX) were also 
administered to measure intraindividual variability (IIV) in attention using ex-Gaussian 
modelling of reaction times. MCI patients were diagnosed firstly following National 
Institute on Aging-Alzheimer’s Association (NIA-AA) criteria for MCI. Participants with 
demonstrable cognitive impairment but no clinical symptoms or biomarkers for DLB 
were considered MCI-AD (n = 18). Within MCI-LB (n = 44), individuals with two or 
more consensus criteria for the diagnostic features or biomarkers of DLB (McKeith et 
al., 2017) were considered "Probable" MCI-LB (n = 30). White matter integrity was 
quantified using diffusion tensor imaging (DTI) and tract-based spatial statistics. 
 
Results: While both groups are impaired relative to controls, MCI-LB Probable 
performed worse than MCI-AD on processing speed (Digit Symbol Substitution Test 
[DSST, p = .011]), executive function (Verbal Fluency [FAS], p = .027) and 
visuospatial function (pareidolia task, p = .010; Visual Patterns Test, p = .019) tests. 
In contrast, MCI-AD scored significantly lower than MCI-LB Probable on tests of 
verbal learning and memory (Rey Auditory Verbal Learning Test short, p = .047, and 
long delay, p = .025, and retroactive interference, p = .029). DSST was the best 
predictor of group allocation using a stepwise discriminant analysis, F(2,76) = 36.89, 
p < .001, and 92.6% of MCI-LB Probable scored at or below the 16th percentile of 
control DSST scores. Using hierarchical linear regression, a control-informed 
processing speed composite fully explained group-associated variance in the 
visuospatial composite, RAVLT learning and RAVLT short delay recall. In contrast, 
FAS explained only 25.0% of group variance in the visuospatial composite and is not 
significantly correlated with RAVLT short delay (p = .132). MCI-LB Probable showed 
increased IIV using ex-Gaussian tau in CRT (p = .021, d = 1.12) and CPT-AX (p 
= .007, d =0.80) relative to controls, while MCI-AD differed significantly from controls 
in SRT tau (p = .002, d = 0.93). No difference between groups was found in white 
mater integrity, although the DSST showed substantial correlation with fractional 
anisotropy in the sample as a whole. 
 
Conclusions: The present study succeeded in demonstrating that the cognitive 
dysfunction typical of advanced DLB and AD is observable in the MCI phase of 
clinically-defined MCI-LB and MCI-AD, respectively. MCI-LB showed visuospatial, 
attentional and processing speed impairments. Processing speed emerged as 
particularly important to MCI-LB neuropsychology, suggesting a processing speed, 
rather than executive, mediated model of decline in MCI-LB. MCI-AD, in contrast, 
shows verbal learning and memory impairment. Future work should pursue this 
promising evidence of subtle, aetiologically-specific differences in cognition in MCI. 
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Chapter One: Introduction to Lewy body disease 
 
1.1 Introduction 
 
The prevalence of dementia, defined as “a progressive cognitive decline of 
sufficient magnitude to interfere with normal social or occupational functions, or with 
usual daily activities” (McKeith et al., 2017, p. 2), is anticipated to reach 131 million 
worldwide by 2050 (Prince, Comas-Herrera, Knapp, Guerchet, & Karagiannidou, 
2016). In 2016, this was estimated to equate to a worldwide cost of 818 billion USD 
(Prince et al., 2016). Indeed, dementia poses a critical economic, medical and 
scientific challenge to society. Dementia with Lewy bodies (DLB) is the second most 
common cause of dementia following Alzheimer’s disease (AD) (Donaghy & McKeith, 
2014; Perry et al., 1990). A recent review by Vann Jones and O'Brien (2014) found 
DLB represented 7.5% and 4.2% of diagnosed dementias in secondary care and 
community studies, respectively. However, epidemiological studies are limited and it 
is believed that 50% of DLB remains undiagnosed (Palmqvist, Hansson, Minthon, & 
Londos, 2009), making accurate estimation problematic, although Vann Jones and 
O'Brien (2014) note that use of the (then most recent) 2005 revised Third DLB 
International Consensus Criteria was successful in significantly increasing the 
proportion of DLB diagnoses. Brain bank studies report much higher rates of Lewy 
body (LB) disease, with DLB occurring in up to a quarter of such cases (McKeith et 
al., 2017).  
 
1.2 Clinical diagnosis of DLB 
 
Clinical diagnosis of DLB is challenging. Recently, the DLB Consortium has 
published updated recommendations on clinical and pathological diagnosis of the 
disease, which reflect levels of uncertainty in such diagnoses (McKeith et al., 2017). 
The revised consensus criteria stipulates that a diagnosis of “probable DLB” requires 
cognitive impairment plus two or more “core clinical features” or one “core clinical 
feature” with one positive indicative biomarker (McKeith et al., 2017, see Table 1 on 
p. 2). Core features are: recurrent and detailed visual hallucinations, one or more 
cardinal features of spontaneous parkinsonism, REM sleep behaviour disorder, and 
pronounced fluctuations in attention and arousal. The update retained a list of 
features supportive of DLB (such as severe neuroleptic sensitivity, repeated falls or 
syncope, severe autonomic dysfunction, non-visual hallucinations, and other  
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Table 1. Revised clinical and biomarker criteria for the diagnosis of dementia with Lewy 
bodies (adapted from McKeith et al., 2017). 
 
 
 
 
 
 
 
 
 
Clinical Features 
Core Fluctuating cognition with pronounced variations in 
attention and alertness 
Recurrent visual hallucinations that are typically well 
formed and detailed 
REM sleep behaviour disorder, which may precede 
cognitive decline 
One or more spontaneous cardinal features of 
parkinsonism: these are bradykinesia (defined as 
slowness of movement and decrement in amplitude or 
speed), rest tremor, or rigidity 
Supportive Severe sensitivity to antipsychotic agents 
Postural instability 
Repeated falls 
Syncope or other transient episodes of 
unresponsiveness 
Severe autonomic dysfunction (e.g. constipation, 
orthostatic hypotension, urinary incontinence) 
Hypersomnia 
Hyposmia 
Hallucinations in other modalities 
Systematized delusions 
Apathy, anxiety, and depression 
 
 
 
 
 
Biomarkers 
Indicative Reduced dopamine transporter uptake in basal ganglia 
demonstrated by SPECT or PET. 
Abnormal (low uptake) 123iodine-MIBG myocardial 
scintigraphy. 
Polysomnographic confirmation of REM sleep without 
atonia. 
Supportive Relative preservation of medial temporal lobe structures 
on CT/MRI scan. 
Generalized low uptake on SPECT/PET perfusion/ 
metabolism scan with reduced occipital activity ± the 
cingulate island sign on FDG-PET imaging. 
Prominent posterior slow-wave activity on EEG with 
periodic fluctuations in the pre-alpha/ theta range. 
 
psychiatric symptoms), but these are not used formally in diagnosis. Alternatively, 
“possible DLB” can be used for patients with dementia demonstrating only one 
feature of DLB, either a core clinical feature or indicative biomarker. A possible DLB 
diagnosis is more uncertain: patients are equally likely to be diagnosed with probable 
DLB or non-DLB dementia at follow up (O'Brien et al., 2009). 
1.3 DLB pathophysiology 
 
LB disease is characterised by the presence of intracellular aggregates of 
ubiquinated alpha-synuclein, Lewy bodies and Lewy neurites. Alpha-synuclein is a 
140 amino acid protein concentrated within the presynaptic terminals of 
dopaminergic neurons where it is thought to maintain synaptic vesicles required for 
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neurotransmission (Cheng, Vivacqua, & Yu, 2011; Engelender, 2008; Forno, 1996). 
While LB disease is associated with loss of dopaminergic neurons, dopamine itself 
may also bind to alpha-synuclein to facilitate the formation of Lewy body protofibrils 
(Eriksen, Dawson, Dickson, & Petrucelli, 2003; Overk & Masliah, 2014). At autopsy, 
20-35% of dementia patients will have Lewy bodies in the neocortex, while they are 
not typically found in the brains of healthy late-life adults (Hansen et al., 1990; Perry 
et al., 1990).  Wakisaka et al. (2003), however, showed that Lewy body presence is 
associated with advancing age in a community-based study while clinic-based 
estimates show even higher proportions of Lewy bodies regardless of the extent of 
cognitive impairment.  
Neuropathologically, DLB is characterised by the loss of dopaminergic 
neurons of the substantia nigra and cholinergic neurons of the nucleus basalis (Mayo 
& Bordelon, 2014). Overall, it is generally accepted that the areas particularly 
vulnerable to Lewy body pathology are brainstem nuclei, such as the substantia nigra 
and the dorsal motor nucleus of the vagal nerve, the olfactory bulb and peripheral 
autonomic nervous system (Donaghy & McKeith, 2014). Staging based on the Braak 
system of Parkinson’s disease (PD) neuropathology was initially developed with a 
brainstem to cortex progression (Braak et al., 2003). However, this has not proved 
reliable in DLB, with studies showing many DLB cases as unclassifiable using this 
staging model (Beach et al., 2009; Zaccai, Brayne, McKeith, Matthews, & Ince, 
2008). More recent evidence points to the presence of alpha-synuclein pathology in 
the peripheral nervous system, even in early, mild cases of LB disease (Beach et al., 
2010; Wang, Gibbons, Lafo, & Freeman, 2013). Thus, the pathology of alpha-
synucleinopathy in DLB is not currently well understood nor predictable; this is in 
contrast to AD, which has a highly predictable progression, beginning in the 
transentorhinal cortex.  
 
1.4 Lewy body (LB) dementias and diagnostic overlap 
 
LB disease manifests clinically as a spectrum of phenotypes: PD, PD 
dementia (PDD), and DLB (Aarsland, 2016; Sengupta et al., 2015). The latter two 
syndromes are referred to as the Lewy body dementias (LBDs) and are believed to 
differ clinically due to different loci of early degeneration (Aarsland, 2016).  
DLB is diagnosed when dementia presents either before or concurrently with 
motor symptoms, while PDD refers to dementia presenting in the context of well-
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established PD. This distinction has been arbitrarily set at one year of PD before 
cognitive decline for PDD and DLB is diagnosed if features of PD are present within a 
year or later than the cognitive decline (‘the one year rule’) (McKeith et al., 2017; 
Petrova, Mehrabian-Spasova, Aarsland, Raycheva, & Traykov, 2015). PD increases 
one’s risk of developing dementia and over three quarters of PD patients that survive 
for 10 years or more will develop PDD (Aarsland, Zaccai, & Brayne, 2005; 
Kramberger et al., 2015; Mosimann et al., 2004), with a cumulative frequency of 83% 
in 20-year PD survivors (Hely, Reid, Adena, Halliday, & Morris, 2008). While cohort 
studies suggest cognitive impairment in PD is not solely a late-stage issue, it is not 
always detected in patients nor reported as a presenting condition, suggestive of the 
problematic diagnostics of synucleinopathies (Aarsland, 2016; Aarsland et al., 2008; 
reviewed in Goldman, Williams-Gray, Barker, Duda, & Galvin, 2014a). 
Indeed, there is appreciable overlap in the clinical presentation of DLB and 
PDD, including physical symptoms such as orthostatic dizziness, increased 
salivation, hyposmia, constipation and parkinsonism (Donaghy, O'Brien, & Thomas, 
2014).  In cases of early, pronounced cognitive impairment, it can be unclear whether 
a PDD or DLB diagnosis is more appropriate (Aarsland, 2016). Mosimann et al. 
(2004), for example, found no difference between the patient groups in terms of 
Unified PD Rating Scale (UPDRS) motor scores, dementia duration, or impairment in 
activities of daily living. In both DLB and PDD, REM Behaviour Sleep Disorder (RBD) 
and fluctuations of attention are commonly reported, and both categories of patients 
may respond well to cholinergic therapy (Burn & McKeith, 2003; Thomas et al., 
2006). The third report of the DLB Consortium in 2005 concluded that, “no major 
differences between DLB and PDD have been found in any variable examined 
including cognitive profile, attentional performance, neuropsychiatric features, sleep 
disorders, autonomic dysfunction, type and severity of parkinsonism, neuroleptic 
sensitivity, and responsiveness to cholinesterase inhibitors” (McKeith et al., 2005, p. 
1865). Post-mortem diagnosis is unhelpful in differentiating PDD and DLB (Mayo & 
Bordelon, 2014). As such, there is controversy regarding the validity of the temporal 
distinction between the conditions, and whether there are indeed any variables that 
differ significantly. In light of the current emphasis on early diagnosis, in which 
symptoms such as parkinsonism and cognitive impairment will be especially mild, 
Donaghy and McKeith (2014) argue that  “the distinction between DLB and PDD is 
unlikely to be useful or practicable at this stage and a general classification of 
‘prodromal LB disease’ may be more appropriate.” This perspective is adopted in 
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Chapter 2, in which a structured review of the literature includes not only MCI due to 
LB disease but also early PD and MCI-PD in order to best capture the populations 
relevant to DLB. 
 
1.5 Risk factors and genetics 
Males are at a higher risk for DLB than females (Nelson et al., 2010), though 
other evidence does not confirm this (Vann Jones & O'Brien, 2014) or suggests only 
a slight male predominance (McKeith, Fairbairn, Perry, Thompson, & Perry, 1992). 
DLB often appears at an older age of onset (60 to 90 years) than AD with early 
reported symptoms including disturbed sleep, anxiety, hallucinations, constipation 
and parkinsonism, usually bilateral symmetric limb rigidity or bradykinesia (Mayo & 
Bordelon, 2014). Hypertension and hyperlipidaemia have been identified as potential 
risk factors (Gardner, Valcour, & Yaffe, 2013).  
A recent comprehensive study by Guerreiro et al. (2018) investigated genetic 
variability in DLB. Results implicated three primary genes. Firstly, apolipoprotein ɛ4 
(APOE ɛ4), well-established as the main genetic risk factor for AD, was found to have 
the strongest association with DLB (Guerreiro et al., 2018). The second strongest 
association occurred at the SNCA locus, which encodes the alpha-synuclein protein 
(Guerreiro et al., 2018). Moreover, Guerreiro et al. (2018) replicated their group’s 
earlier findings that different SNCA haplotypes are associated with increased DLB 
and PD risk (Bras et al., 2014). The authors tentatively suggest that this differential 
gene expression may be responsible for the different localization of pathology in the 
two conditions (Bras et al., 2014; Guerreiro et al., 2018; Halliday, Hely, Reid, & 
Morris, 2008). An effect size similar to that of APOE was found with GBA. GBA 
showed the only significant association with DLB risk in a genome-wide burden-
based analysis (Guerreiro et al., 2018). GBA1, the most common currently identified 
PD-associated gene, is estimated at 3.5% versus 2.9% in PDD and 0.4% in the 
general population (Mata et al., 2008). Overall, Guerreiro et al. (2018) quantify DLB’s 
heritability at 36%.  
 
1.6 Prevalence and prognosis 
Although, as discussed above, there is a dearth of well-designed 
epidemiological studies, LB dementia is generally accepted to be responsible for 
15% of dementia cases with PDD and DLB contributing about equally to that figure 
(Aarsland, 2016), although brain bank reports are higher. A recent study of the 
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prevalence of LB dementia in two regions of England suggests that both DLB and 
PDD are under-diagnosed (Kane et al., 2018). Specifically, significantly fewer 
dementia cases were reported as DLB in East Anglia (3.3%) than in the North East 
(5.6%), the latter of which is a hub of LB dementia research and medical training, 
though those local diagnostic rates remain lower than expected (Kane et al., 2018). 
The percentage of total clinical dementia cases due to DLB was lower than figures 
prevously reported by both meta-analyses (4.2-7.5%; Vann Jones & O'Brien, 2014) 
and neuropathological studies (15-20%; Aarsland, Ballard, McKeith, Perry, & Larsen, 
2001; Jellinger & Attems, 2011). Kane et al. (2018) similarly found lower prevalence 
of PDD in their case study than had previously been reported in systematic review 
(3.6% of all dementia cases; Aarsland et al., 2005). 
Various studies report a more aggressive disease course in LBDs than AD in 
terms of mortality (Collerton, Burn, McKeith, & O'Brien, 2003), hospitalisation rate 
(Mueller et al., 2018), cognition (Olichney et al., 1998) and resource requirements 
(Boström et al., 2009; Williams, Xiong, Morris, & Galvin, 2006). A recent study by 
Price et al. (2017), one of the largest clinical cohorts of DLB published to date, 
showed significantly faster decline from first presentation to death in DLB versus AD. 
This relationship was independent of age, sex, physical comorbidities and 
antipsychotic use (Price et al., 2017). However, a systematic review by (Breitve et al., 
2014) did not support faster rates of cognitive decline.  
 
1.7 Imaging and biomarkers in DLB 
Lewy bodies were first described pathologically by Fritz Heinrich Lewy in 1912 
in the brainstem of PD patients (Lewy, 1912). Advances in in vivo imaging technology 
since have shed further light on brain status and cognitive correlates in DLB. 
Biomarkers that are used in dementia/ cognitive decline investigations either identify 
tissue pathology (biochemical) or tissue damage (i.e. consequential neuronal 
injury)(Albert et al., 2011). The addition of biomarkers to the Consortium Consensus 
criteria aims to aid clinicians in assigning diagnostic certainty (probable or possible) 
to a DLB diagnosis. The imaging biomarkers are validated for use in later disease 
states, however, and their utility early in the disease process is less clear.  
In the current DLB diagnostic criteria biomarkers are termed “indicative” or 
“supportive” (McKeith et al., 2017). Indicative biomarkers in DLB are: reduced 
dopamine transporter (DaTSCAN) uptake in basal ganglia using single-photon 
emission computed tomography (SPECT) or positron emission tomography (PET), 
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reduced uptake in 123iodine-metaiodobenzylguanidine (MIBG) myocardial 
scintigraphy, and confirmation of REM sleep without atonia (REM sleep behaviour 
disorder) by polysomnography. Indicative biomarkers cannot diagnose probable DLB 
in isolation. However, if one or more is present in combination with one or more core 
clinical features a probable DLB diagnosis is given. Possible DLB is diagnosed if 
there are one or more positive indicative biomarkers only.  
Supportive biomarkers are those that can assist in evaluation of a patient and 
are associated with DLB, but lack diagnostic specificity (McKeith et al., 2017). They 
include: preservation of medial temporal lobe (particularly hippocampus) on 
computed tomography (CT) or magnetic resonance imaging (MRI); generalized low 
uptake, reduced occipital activity, or the posterior cingulate island sign on SPECT/ 
PET perfusion or metabolism; prominent posterior slow-wave activity with fluctuations 
on electroencephalogram (EEG); amyloid-beta (Aβ) PET imaging; and other 
biomarkers such as cerebrospinal fluid (CSF), blood or genetic screens. In particular, 
using fluorodeoxyglucose positron tomography (FDG-PET), reduced perfusion may 
be observed in the occipital lobe and the primary visual cortex, with one study 
reporting a 61% decrease in occipital metabolism (Mosconi et al., 2008). 
The most commonly-used imaging and biomarkers techniques in the 
investigation of suspected LB disease, and utilised in the study entitled 123I-MIBG 
Scintigraphy Utility as a Biomarker for Prodromal Dementia with Lewy Bodies 
(SUPErB; see Chapter 3), are briefly presented below. 
 
Dopamine Transporter Imaging 
As discussed, LB diseases are associated with a loss of dopaminergic 
transporters associated with nigrostriatal degeneration (Piggott et al., 1999). 
Dopamine transporter imaging (DaTscan) utilizes a dopamine transporter radioligand 
to assess loss of these neurons. It is licensed for use in the differentiation of AD and 
DLB and listed in the National Institute for Health and Clinical Excellence’s (NICE) 
guidelines for use in doubtful DLB cases. Along with MIBG and EEG, DaTscan 
imaging is now included in the consensus diagnostic criteria as a indicative 
biomarker of DLB for its diagnostic accuracy in advanced DLB (McKeith et al., 2017). 
However, both DLB and PDD are associated with low DaTSCAN uptake within the 
basal ganglia and, as such, it cannot differentiate between DLB, PDD or PD (Walker, 
2007). DaTSCAN has high sensitivity (78%) and specificity (90%) for the 
differentiation of probable DLB from AD (McKeith et al., 2007; Papathanasiou, 
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Boutsiadis, Dickson, & Bomanji, 2012). In MCI with LB disease (MCI-LB), Thomas et 
al. (2018) reported lower sensitivity (54.2%) but high specificity (90.0% in detecting 
clinically-diagnosed possible or probable MCI-LB. 
 
MIBG myocardial scintigraphy 
Recent studies indicate that the cardiac sympathetic plexus may show LB 
disease pathology very early in the disease process, possibly prior to cerebral 
involvement or clinical symptoms (Orimo, Takahashi, et al., 2007; Orimo, Uchihara, 
et al., 2007). MIBG imaging is used to identify this alpha-synuclein pathology in the 
nervous system by showing reduced cardiac MIBG uptake. It has shown potential for 
greater specificity in discriminating DLB from AD and frontotemporal dementia than 
DaTscan (Tiraboschi et al., 2016), as well as for identifying prodromal DLB (Fujishiro 
et al., 2013; Yoon, Lee, Yong, Moon, & Lee, 2014). Komatsu et al. (2018) recently 
reported follow up results of sensitivity/ specificity values of 0.77/0.94 in 
distinguishing probable DLB versus probable AD. This is an improvement in 
sensitivity from their baseline report of 68.9%, regardless of using an automated or 
visual assessment (Yoshita et al., 2015). Sensitivity and specificity were higher 
(77.4% and 93.8%, respectively) when considering only mild dementia (MMSE ≥ 22) 
(Yoshita et al., 2015). 
 
Amyloid imaging 
In AD, amyloid positron emission tomography (PET) is used to detect the 
presence of amyloid pathology in vivo. Amyloid-positive DLB patients may indicate 
concomitant AD pathology, while “pure” DLB cases will be associated with an 
average lower abnormal cortical uptake (Aarsland, 2016). The presence of amyloid 
deposition in DLB requires direct investigation using PET imaging, as it has not been 
shown to correlate with clinical or neuropsychological measures (Donaghy, Firbank, 
et al., 2018). Findings by Donaghy, Firbank, et al. (2018) suggest that there is little 
evidence of an AD-like clinical profile in amyloid-positive DLB patients, but AD-like 
medial temporal lobe abnormalities are more likely in those patients. 
 
MRI Imaging 
Using MRI, DLB typically shows generalized cortical atrophy and preserved 
hippocampal volume (Barber, Ballard, McKeith, Gholkar, & O’brien, 2000; Barber et 
al., 1999; Chow et al., 2012). AD, conversely, is strongly associated with 
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hippocampal atrophy (Albert et al., 2011; Whitwell et al., 2007). However, atrophy 
may also be observed in DLB cases, likely due to comorbid AD pathology (Nedelska 
et al., 2015). As such, MRI hippocampal imaging is listed as a supportive positive 
biomarker for DLB. 
 
Electroencephalogram  
Non-invasive EEG recordings are used to quantify changes in electro-cortical 
activity in a variety of conditions including neurodegenerative dementias. Alterations 
are believed to reflect neuronal/ synaptic dysfunction. EEG has shown DLB to be 
associated with abnormalities relative to both healthy controls and AD (Bonanni et 
al., 2008; Roks, Korf, Van der Flier, Scheltens, & Stam, 2007). At resting state, 
increases in posterior slow-wave activity are observed and shown to relate to clinical 
phenotype such as the severity of cognitive fluctuations (Bonanni et al., 2008; 
Walker, Ayre, Cummings, Wesnes, McKeith, O’Brien, et al., 2000). In terms of early 
diagnosis, such alterations may be visible in the Mild Cognitive Impairment (MCI) 
stage (Bonanni et al., 2015) and may thus serve as an early biomarker. 
 
CSF biomarkers 
Decreased CSF Aβ, which in AD is believed to reflect the increased deposition 
occurring in the brain, and increased tau levels are not observed in DLB (Aarsland, 
2016). However, there is evidence that the proportion of biomarkers in the CSF may 
delineate dementia subtypes. For example, a relative decrease in CSF Aβ-42 and 
increase in tau may distinguish between DLB and PD (Kaerst et al., 2014). Increased 
tau may be associated with decreased longevity in DLB patients (reviewed in Mayo & 
Bordelon, 2014).The recent consensus reports notes that understanding of the 
interactions between Aβ, alpha-synuclein and tau is increasingly important (Guo et 
al., 2013; McKeith et al., 2017). 
 
Mixed pathologies 
Findings in LBD generally reflects a divergence from AD in most biomarkers, 
although mixed-pathology cases may display greater overlap (Aarsland, 2016; 
Compta et al., 2011; Kehagia, Barker, & Robbins, 2012). While the preceding 
sections attempt to summarize the typical pattern of DLB, LB pathology will not occur 
in isolation. Coexisting pathologies, especially Aβ and hyperphosphorylated tau 
(typically associated with AD) and cerebrovascular disease, are present in a large 
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proportion of synucleinopathy patients (Kehagia et al., 2012). These abnormalities 
exert their own influence on cognition and function, while also further promoting LB 
pathology and disrupting downstream activities (Irwin, Lee, & Trojanowski, 2013; 
Sengupta et al., 2015). In particular, DLB has been shown to be associated with 
greater amounts of co-occurring amyloid and tau pathology than PDD (Jellinger & 
Attems, 2011). For example, a systematic review of amyloid imaging in LBD revealed 
that 68% of DLB cases were positive for amyloid using Pittsburgh Compound B (PIB) 
(Petrou et al., 2015). In contrast, half this number of PDD patients (34%) and only 5% 
of PD patients in the Mild Cognitive Impairment (MCI) stage were PIB positive 
(Petrou et al., 2015). Tarawneh and Galvin (2007) report that 80% of individuals with 
a DLB diagnosis show AD neuropathology sufficient for a mixed dementia diagnosis. 
The phenomenon of multiple pathologies in many people with dementia makes 
attempts to delineate a clear, etiologically-orientated neuropsychological profile 
challenging. In particular, the role of tau and the possible synergistic interactions of 
concurrent AD and DLB pathology require elucidation in future work. 
 
1.8 Mild Cognitive Impairment 
Dementia syndrome was long believed to represent widespread and advanced 
pathology (Donaghy & McKeith, 2014). However, there is increasing evidence that 
synaptic dysfunction occurs in the prefibrillar oligomeric stage and that the actual 
amount of cortical LB pathology does not necessarily correlate with clinical dementia 
severity (Donaghy & McKeith, 2014; Paleologou et al., 2009). It follows that the 
current criteria for DLB is likely only fulfilled after the underlying disease processes 
are too advanced to intervene with dementia. Accordingly, there is great interest in 
early and specific MCI diagnosis. Such would (1) create an essential window of 
opportunity for intervention potential pharmacological intervention, including 
identification of suitable clinical trial participants, and (2) improve disease 
management in the clinical setting (Donaghy & McKeith, 2014). For example, earlier 
identification of DLB would allow patients to access treatment for other related 
symptoms of the condition (e.g. motor, dysautonomia and other non-psychiatric 
symptoms) (Pink, O’Brien, Robinson, & Longson, 2018). Similarly, the cognitive 
fluctuations characteristic of DLB are often misdiagnosed as delirium and 
inappropriately treated with antipsychotics, despite the severe neuroleptic intolerance 
experienced by up to 50% of DLB (McKeith et al., 1992) and clinicians are cautioned 
against their use in DLB (McKeith et al., 2017). 
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Figure 1. Trajectory of decline in Alzheimer’s disease (Forlenza, et al., 2010). 
 
The concept of Mild Cognitive Impairment (MCI) was introduced in the 1990s 
by Flicker et al. (1991) and Petersen (1995) and is characterized by impaired 
cognitive abilities that are less severe than in dementia yet more pronounced than 
expected in normal ageing (Arnáiz & Almkvist, 2003; Donaghy & McKeith, 2014). 
MCI is generally conceptualized as an intermediate stage preceding dementia, in 
which activities of daily living are preserved (Albert et al., 2011). Dementia, on the 
other hand, is associated with significant functional declines and an inability to live 
independently (Aarsland, 2016). Figure 1 illustrates the trajectory of such a decline in 
the context of AD.  
The original criteria for the identification of MCI, which is often still used, was 
based on neuropsychological assessment and subsequent classification by MCI 
subtype (Flicker, Ferris, & Reisberg, 1991; Petersen et al., 1999). Subtypes were 
used to reflect MCI heterogeneity and firstly differentiated based on an amnestic or 
non-amnestic manifestation, depending on the degree of memory dysfunction 
(Donaghy & McKeith, 2014). As defined, the amnestic subtype associated with a high 
rate of progression to AD, while non-amnestic MCI patients with deficits in other 
domains were more likely to convert to DLB, vascular or frontotemporal dementias 
(Ferman et al., 2011). The amnestic and nonamnestic MCI subtypes are further 
differentiated based on whether other domains are impacted, i.e. single or multiple 
domain (Petersen et al., 2001). However, what constitutes a “deficit” in a given 
domain differs, in both this amnestic/ nonamnestic MCI classification system as well 
as later-evolved clinical approaches.   
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While development of the concept of MCI supported a proliferation of studies 
targeting the prodromal stages of dementia since the 1990s, most of the focus has 
been in MCI later diagnosed as AD (MCI-AD) and prodromal AD (pAD). To date, 
analogous MCI due to LB disease (MCI-LB) criteria have not been standardized and 
validated. The Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5; 
American Psychiatric Association, 2013)(DSM-5) has proposed ‘mild neurocognitive 
disorder due to Lewy bodies’ (roughly equivalent to MCI-LB). Absent from these 
criteria, however, are biomarkers or symptoms to assist in differentiation from pAD. 
DLB core and suggestive features, like visual hallucinations, REM Behaviour Sleep 
Disorder, and autonomic dysfunction, have been shown to be effective in accurate 
early discrimination between pAD and pDLB (Blanc et al., 2015; Donaghy, O'Brien, & 
Thomas, 2015; Thomas, Blanc, Donaghy, & Bousiges, 2015). Although preliminary 
and requiring replication, this work suggests that LB disease in the pre-dementia, 
MCI stage can be identified clinically. Clinical diagnosis of MCI-LB is also 
advantageous in allowing consideration of the cognitive profile of the diagnostic 
group. A neuropsychological approach has alternatively been used in the context of 
PD with MCI (PD-MCI) by the Movement Disorder Society (MDS). MDS criteria 
diagnosis PD-MCI at either Level 1 or 2, measuring cognition ideally in five domains 
by at least two tasks each. This is intended to capture the breadth of each domain 
and identify all impaired individuals (relative to normative data). However, the use of 
such a large battery of tests will also increase the likelihood of reaching significance 
on at least one measure and the inclusion of false positives. Furthermore, the use of 
such neuropsychological criteria precludes consideration of cognitive function in 
more detail. Significant impairments are guaranteed between groups at the level 
stipulated by the criteria (typically between 1 and 2 SDs). While it would be 
reasonable to hypothesize that neuropsychological impairment in MCI-LB will occur 
in the domain impacted in advanced DLB (i.e. executive functions, visuospatial 
ability), this remains an assumption that requires empirical support. 
Taken together, there is therefore a clear unmet need to understand the 
neuropsychological profile which is associated with MCI-LB. Criteria should utilize the 
emergent evidence of reliable biomarkers of early DLB. To this end, MCI-LB can be 
clinically diagnosed using the symptoms and biomarkers from the consensus criteria 
for DLB in conjunction with the National Institute on Aging-Alzheimer’s Association 
(NIA-AA) research criteria for mild cognitive impairment (Albert et al., 2011), as 
operationalised successfully in Donaghy, O'Brien, Colloby, et al. (2015) and Blanc et 
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al. (2015). Of course, the criteria may not be purely clinical: cut-offs using global 
scores can aid in omitting dementia and cognitively normal cases, while allowing for 
potential heterogeneous neuropsychological presentation. 
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Chapter Two: The neuropsychology of MCI-LB 
 
2.1 Rationale for a review of the neuropsychological profile of MCI-LB 
 
In addition to the prominent clinical features that can interfere with 
psychological processes, such as visual hallucinations and cognitive fluctuations, 
cognitive impairment per se is a hallmark of LBD. While DLB in particular has 
experienced increased visibility the past decade, there remains a paucity of research 
on the neuropsychology of DLB when compared to the AD evidence base. In a meta-
analytic review, Collerton et al. (2003) found only 21 controlled-comparison studies of 
the cognitive performance of patients with DLB, for example. To the author’s 
knowledge, no more recent structured reviews have been published. More recent 
narrative reviews, moreover, have typically contrasted cognition in DLB with PD or 
AD and do not include controls (Aarsland, 2016; Gross, Siderowf, & Hurtig, 2008; 
Metzler-Baddeley, 2007). While AD is associated with an amnestic cognitive profile, 
advanced PDD and DLB typically show similar impairments of the executive function, 
visuospatial and memory domains (Aarsland, 2016). However, some differences 
between LBD groups have been reported. In particular, DLB may perform more 
poorly than PDD on tasks with high executive or attentional demands (Downes et al., 
1998; Gnanalingham, Byrne, Thornton, Sambrook, & Bannister, 1997; Mondon et al., 
2007).  
As concluded in Chapter One, there is increasing interest in the MCI phase of 
disease, which precedes dementia. Cognitive impairment is observable in MCI, but 
individuals are generally able to function independently. The neurocognitive profile of 
clinically-diagnosed MCI-LB is unclear, although it is anticipated to be related to that 
of advanced DLB. In MCI that will progress to DLB and PDD, memory and language 
are believed to be less impaired than in prodromal AD, in line with advanced AD’s 
amnestic cognitive profile. MCI-LB individuals, who are more likely to convert to DLB, 
are expected to show impairments in the executive, attentional, and visuospatial 
domains (Aarsland, 2016). A recent longitudinal study of 266 patients by Breitve et al. 
(2018) suggests that MCI-LB patients experience a steeper cognitive decline than 
MCI-AD, but only on one task (Trail Making Test A [Trails A]) from a battery of 
neuropsychological tests. Higher executive function scores at baseline were 
associated with slower overall decline to severe dementia or death; however, this did 
not differ by aetiology, in contrast to previous studies showing executive impairment 
conferring greater risk of decline in AD (Buccione et al., 2007; Marra, Silveri, & 
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Gainotti, 2000). Neuropsychological profiles in MCI can range broadly, are subject to 
disease progression, and could be impacted by mixed pathologies (Goldman et al., 
2014a; Mosimann et al., 2004). Methodological issues, including disregard of 
cognitive models (see Chapter 6), the use of a wide range of tasks across different 
studies, questionable validity and reliability of such tasks, use of nonspecific MCI 
classification, and the still-evolving MCI diagnostic criteria, likely also add to 
contradictions in the MCI literature (Rasquin, Lodder, Visser, Lousberg, & Verhey, 
2005; Smith & Bondi, 2013).  
As presented in Chapter One, PDD and DLB are differentially diagnosed 
based on the timeline of cognitive impairment onset. However, PD cohort studies 
suggest cognitive impairment is not solely a late-stage issue and may not always be 
detected or reported at presentation (reviewed in Aarsland et al., 2008; Goldman, 
Weis, Stebbins, Bernard, & Goetz, 2012). Thus, validity of this approach of 
differentiating PDD and DLB diagnoses remains debated. Based on the 
neuropathological and phenotypic overlap of PDD and DLB and the dearth of MCI-
LB-specific research, understanding of the neuropsychological profile of MCI-LB 
should be informed by research in earliest PD and PD-MCI. To this end, a systematic 
review was performed by the author in MCI-DLB, earliest PD, and PD-MCI in order to 
gain a broader understanding of cognition in early synucleinopathies. Relevant 
findings are discussed below.  
 
2.2 Methods: semi-structured review 
 
The semi-structured review targeted studies in early LBD. In addition to 
prodromal DLB, the primary target of the present study, PD-MCI and “early PD” were 
of interest to the review. As discussed previously, there is considerable overlap 
between conditions. Inclusion of both “early PD” and “PD-MCI” studies allowed fuller 
consideration of earliest presentations of PD. PD-MCI studies tend to utilize MDS 
diagnostic criteria for MCI, which is based on neuropsychological performance. Thus, 
evaluation of the cognitive profiles of MDS-defined PD-MCI patients guarantees 
deficits of a certain magnitude based on the a priori determined diagnostic criteria. 
While “early PD” is clearly a vaguer patient category, its inclusion in the review 
serves to capture recently-diagnosed, de novo, and earliest disease-stage PD 
patients, and is less likely to be impacted by the circularity of MDS-MCI criteria. 
These patients are typical of first clinical presentation. Although it must be done 
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cautiously, comparison of early PD with PD-MCI also offers insight into disease 
temporal progression. 
The outcome of interest was cognitive impairment, measured using 
standardised tests and organized by the author into domains. The key terms of the 
database search were “Lewy bodies,” “neuropsychology,” and “MCI” or “early.” 
Synonyms were created for each term and exploded with medical subject headings 
in the databases where appropriate to capture relevant papers. Databases searched 
were Medline (from 1946), Embase (from 1988), Psychinfo (from 1987), PubMed, 
ProQuest, Scopus (from 1987) and ScienceDirect (from 1987). Results were limited 
to human studies in peer-reviewed English language journals. Reviews, meta-
analyses, abstracts, case studies, commentaries, discussion papers, editorials and 
conference proceedings were excluded. As the focus of the review was on the 
neuropsychological pattern in early LBD articles that were primarily imaging or eye 
tracking studies were removed. Articles with titles related to animal testing (‘rodents,’ 
‘rats,’ ‘mouse,’ ‘monkey’) were excluded using separate key terms. References were 
exported to EndNote. The author performed the initial title screen for relevant articles 
after duplicates were removed both by using EndNote’s duplicate search function 
and during the title review. After the initial title screen, titles and abstracts were 
reviewed by two reviewers independently (the author, Bethany Little). A review of the 
full text occurred if it was not clear from the title or abstract whether the study met the 
review criteria described below. Any conflicts between reviewers were flagged for re-
review, which resulted in agreement for inclusion versus exclusion.  
 
Inclusion and exclusion criteria 
Studies were included if they measured at least one domain of cognition using 
an established neuropsychological task. Tasks and outcome measures were 
considered established if they were published in at least ten peer-reviewed journal 
articles. Composite scores of standardised tasks were accepted, for example the 
“Power of Attention” in Peraza et al. (2017) and “Working Memory Index” in Yu et al. 
(2012). Articles were excluded if they only measured cognition globally (for e.g. Mini-
Mental State Exam [MMSE; Tombaugh , 1992], Montreal Cognitive Assessment 
[MoCA; Nasreddine, 2005]), used only subtests from such global measures as a 
proxy for domain scores, or only provided domain-level composite score data. 
However, authors were contacted for the individual test scores whenever possible. 
Measures of intelligence were not included. 
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Studies were included if a group of healthy controls (HCs) was tested for 
comparison. However, only three studies in MCI-LB remained after applying other 
inclusion and exclusion criteria; therefore, although two of these three studies utilized 
MCI subtypes as comparison groups (see below), they were retained for qualitative 
review. Studies that considered the prevalence of deficits based on published 
normative data rather than a control group were excluded. Where studies included 
both HCs and a second clinical group, only comparisons with the HC groups were 
extracted. Only the baseline data were extracted in the case of longitudinal studies. 
Studies were excluded if PD diagnostic criteria was unclear, insufficient or not based 
on clinical assessment. Studies that used unspecified MCI classification criteria, MCI 
subtypes, or ten or fewer patient participants were excluded.  
 
Data review, extraction and synthesis 
From each study, the following variables for each established cognitive 
outcome measure were extracted: first author, year of publication, country of 
publication, participant numbers, participant age means and standard deviations 
(SD), PD diagnostic criteria, MCI criteria (where applicable), disease duration, and 
outcome measure mean and SD (see Appendix A). The direction of effect sizes (ES) 
was reversed as appropriate to reflect deficits as negative ES, for example number of 
errors. Data was entered into an Excel ES calculator that is freely distributed online 
by the Centre for Evaluation and Monitoring (CEM; Coe, R, retrieved from 
http://www.cem.org/effect-size-calculator). The calculator produces a bias-corrected 
ES and 95% confidence interval to estimate the difference between the two means in 
terms of the pooled estimate of SD. It is bias-corrected based on a factor provided by 
Hedges and Olkin (1985). ES and confidence intervals were plotted by domain 
(verbal learning and memory, visuospatial learning and memory, working memory, 
and executive function) and organized by number of participants. Separate graphs 
were constructed for closer comparison of equivalent tasks (see Appendix B). When 
there were at least five studies using the same task in a patient group, summary ES 
and 95% total confidence intervals were calculated using Cochrane Reviews’ Review 
Manager (RevMan; The Nordic Cochrane Centre, 2014) fixed effect model and 
inverse variance. Due to different testing parameters and scoring across studies (i.e. 
z-scores), the summary ES were calculated as the standardized mean difference to 
avoid overestimation of the overall difference. RevMan calculates standardized mean 
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difference ES as Hedges’ adjusted g, which is very similar to Cohen's d, but includes 
an adjustment for small sample bias (Deeks & Higgins, 2010). 
 
2.3 Results 
 
Early and MCI due to PD 
Due to the high number of studies yielded, results in PD-MCI and early PD 
were considered quantitatively, summarized in Table 2. These analyses emphasize 
that there are significant deficits in PD-MCI and early-PD relative to HCs. Overall, the 
highest proportion of deficits was observed in the visuospatial domain, which was 
particularly poor in PD-MCI (measured by figure copying tasks). One of the largest 
differences between PD-MCI and controls was in Benton’s Judgement of Line 
Orientation task (JOLO; Benton, Hamsher, Varney, & Spreen, 1983), while the effect 
in early PD was small. JOLO, unlike many other visuospatial tasks, requires minimal 
motor skill and is free of practice effects (Montse, Pere, Carme, Francesc, & 
Eduardo, 2001). Such tasks may be particularly useful in tracking cognitive decline in 
the progression of both PD and DLB. Similarly, in the verbal domain, studies in PD-
MCI reported verbal learning and memory deficits more frequently than those in 
early-PD. About three quarters of the outcome variables in EF and verbal domains 
showed significant impairment, as opposed to only half of working memory variables. 
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Table 2 Summary of impairments in early Parkinson’s disease (PD) and Parkinson’s disease with Mild Cognition Impairment (PD-MCI) across 
neuropsychological domains. 
Group Number 
of papers 
retained 
Patient group Control group Domain Proportion of studies 
with at least one 
impaired variable 
relative to controls 
Proportion of 
outcome variables 
impaired relative to 
controls 
n Age 
Mean 
(SD) 
Disease 
duration 
Mean (SD) 
n Age 
Mean 
(SD) 
Early-PD 10 568 64.3 (6.0) 21.3 (6.9) 564 64.1 (5.8) Executive function 88.9% (8/9) 61% (22/36) 
WM/Attention 77.8% (7/9) 47% (14/30) 
Visuospatial L&M 100% (5/5) 76% (13/17) 
Visuospatial WM 33.3% (1/3) 75% (1/6) 
Verbal L&M 100.0% (6/6) 64% (16/25) 
PD-MCI 13 530 65.0 (3.9) 54.0 (36.0) 840 64.4 (2.8) Executive function 100% (13/13) 89% (39/44 
WM/Attention 88.9% (8/9) 68% (21/31) 
Visuospatial L&M 88.9% (8/9) 91% (30/33) 
Visuospatial WM 75.0% (3/4) 67% (4/6) 
Verbal L&M 100% (11/11) 88% (30/34) 
Both 
groups 
combined 
23 1098 64.7 (4.2) 39.8 (27.0) 1404 64.3 (3.5) Executive function 95.5% (21/22) 76% (61/80) 
WM/Attention 83.3% (15/18) 57% (35/61) 
Visuospatial L&M 92.9% (13/14) 86% (43/50) 
Visuospatial WM 57.1% (4/7) 42% (5/12) 
Verbal L&M 100.0% (17/17) 78% (46/59) 
SD = standard deviation; PD = Parkinson’s Disease; MCI = Mild Cognitive Impairment; WM = working memory, L&M = learning and 
memory. 
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PD-MCI-associated deficits in figure copying were more pronounced than in 
recall, although both had large effect sizes. Conversely, visuospatial recognition is 
much less impaired (Song, Kim, Jeong, Song, & Lee, 2008) and was not shown to be 
impaired in early-PD (Elgh et al., 2009). Recognition memory for word list stimuli 
seems similarly intact in PD-MCI, in contrast to deficits in both immediate and 
delayed recall conditions. This pattern of dysfunction in both the visuospatial and 
verbal domains in PD-MCI suggests impaired retrieval and relatively intact encoding 
and storage mechanisms (Shin, Park, Park, Seol, & Kwon, 2006). This supports the 
established retrieval deficit hypothesis of memory impairment in PD (Tröster & Fields, 
1995; Whittington, Podd, & Kan, 2000) which argues that the cause of memory 
impairment is inability to retrieve material on demand rather than encoding or 
retention ability (Mahurin, Feher, Nance, Levy, & Pirozzolo, 1993). However, there 
has been increasing scrutiny of this hypothesis and evidence of recognition 
impairment in some PD patients without dementia (Higginson, Wheelock, Carroll, & 
Sigvardt, 2005; Whittington et al., 2000). Whittington (2000) found impairment in 
recognition in PD participants without dementia, but not in newly diagnosed PD 
patients, and Bronnick, Alves, Aarsland, Tysnes, and Larsen (2011) found that early-
PD patients performed poorly on free recall, cued recall and recognition memory. 
Bronnick et al. (2011) attribute this impairment to encoding failure due to poor 
executive function, rather than to impaired retrieval. Indeed, PD participants used 
fewer semantic clustering strategies to enhance their recall, and both strategy and 
executive function explained significant variance in learning. Earlier, Gershberg and 
Shimamura (1995) and Hirst and Volpe (1988) had demonstrated that frontal lobe 
lesion patients were unable to capitalize on the potential semantic organization 
present in word lists. My review similarly shows PD is associated with larger 
executive function deficits in semantic than phonemic verbal fluency.  
Thus, it is likely that the prominent executive function impairments in early-PD 
at least partly explain poorer performance on tasks of greater complexity, regardless 
of domain. For example, early-PD patients with shorter disease durations 
demonstrated intact working memory capacity but performance declines if updating 
or set-shifting components are added (e.g., Digit Backwards and Trails B). PD-MCI 
conversely, show impairment in both purer working memory tasks and the executive-
weighted variants. PD-MCI and early-PD groups were of similar ages but PD-MCI, as 
expected, report longer disease duration than early-PD (approximately 54 months 
versus 21 months). The divergence between groups could thus be taken as a proxy 
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for advancement of PD, and much of the review’s interpretation of the 
neuropsychological results proceeded under this assumption. Therefore, increased 
executive dysfunction as early-PD progresses to PD-MCI may explain why working 
memory capacity is more compromised in PD-MCI than early-PD. Similarly, 
impairment was found on only 41% of visuospatial working memory measures 
despite a high proportion of visuospatial learning and memory tasks showing deficits 
in early-PD and PD-MCI. Why then is visuoconstructional ability impaired but not 
visuospatial working memory? Figure copying such as the Rey-Osterrieth complex 
figure (ROCF) is a complex task that requires executive functions such as sustained 
attention, planning and organization (Shin et al., 2006), in addition to the visuospatial 
perception and processing that is required in visuospatial working memory tasks like 
Corsi blocks. Methodologically, this emphasizes the importance of locating the 
executive processes within tasks with face validity in other domains. However, even 
simple working memory tasks such as Digits Forward could be argued to be 
influenced by executive control (“chunking”, for example.). This issue could thus 
relate more to the debate regarding multicomponent versus unitary models of 
working memory (Cowan, 1999; Engle, Tuholski, Laughlin, & Conway, 1999) than to 
a salient difference in the patient population.  
Taken together, PD-MCI and early-PD show deficits in visuospatial, executive 
and verbal tasks. However, these results should be interpreted with caution due to 
issues of circularity. Hierarchical linear regression modelling can be pursued in future 
studies to help determine the potential mediating role of executive function. 
 
MCI-LB 
The search strategy did not yield any studies in MCI-LB that met full inclusion 
criteria, notably use of control group. The three studies measuring cognition in MCI-
LB compared function with MCI-AD.  One study had only nine participants (Jicha et 
al., 2010). All three studies measured cognition globally using MMSE and found no 
significant difference between MCI-LB and MCI-AD. Domain-level function was 
assessed in all as executive function, working memory/ attention and verbal learning 
and memory. Cagnin, Bussè, Gardini, et al. (2015) also assessed visuospatial 
function. The studies together provide 43 outcome measures from 22 tasks across 5 
total domains. Only eleven of the extracted outcome variables in MCI-LB showed 
significant differences between groups after bias-correction. Yoon, Kim, Moon, Yong, 
and Hong (2015) only showed impairment in executive function (Stroop Colour test; 
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ES: -0.73). Cagnin, Bussè, Gardini, et al. (2015) reported poorer performance in MCI-
LB in working memory (Trail Making Test A), visuospatial and visuoconstructive 
ability [Visual Object and Space Perception Battery (VOSP; Warrington & James, 
1991), ROCF copy], and executive function (Verbal Fluency, Digit Span Backwards). 
Magnitude of these deficits ranged from medium (-0.57, Object Decision Visuospatial 
Test of VOSP) to large (-0.97, Digit Span Backwards). Jicha et al. (2010) also 
reported a phonemic Verbal Fluency impairment, but this failed to remain significant 
after bias correction, likely due to small sample size. The remaining nine outcome 
measures of Jicha et al. (2010), including semantic Verbal Fluency, did not differ 
significantly between groups.  
These findings from the semi-structured review thus provide only limited, and 
at times contradictory evidence, for differentiation between MCI-LB and MCI-AD 
based on a small number of studies. Two studies (Cagnin, Bussè, Gardini, et al., 
2015; Yoon et al., 2015) show worse performance in MCI-LB in some, but not all, 
tasks of visuospatial, working memory, and executive function. Half of the variables 
extracted across the three papers differ between groups, but most came from one 
study (Cagnin et al., 2015). The findings of Cagnin, Bussè, Gardini, et al. (2015) are 
further surprising given high global cognitive scores (MMSE) as an inclusion criterion. 
Their retrospective design may have introduced selection bias or an overestimation 
of deficits. The findings and other evidence of impairment in DLB are discussed 
further by domain below. 
 
Executive function and attention 
Deficits in these domains are common in neurodegenerative dementias overall 
and, along with visuospatial ability, are the most typically impaired domains in 
advanced LBD (Collerton et al., 2003). All three of the retained MCI-LB studies in the 
review provide evidence for executive dysfunction at the MCI stage. It was the only 
domain significantly impacted in Yoon et al. (2015), with a medium-large effect size, 
and Cagnin, Bussè, Gardini, et al. (2015) report poorer performance than MCI-AD in 
Verbal Fluency and Digit Span Backwards with large effect sizes. However, the 
executive measures in Jicha et al. (2010) did not reach significance with bias-
correction. These findings are in line with other work (not retained through the search 
strategy) demonstrating attentional and executive impairments in the MCI phase of 
DLB as well (Kemp et al., 2017; Molano et al., 2009; Sadiq, Whitfield, & Walker, 
2015). Prominent executive function impairments also emerged within the retained 
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PD literature, both in PD-MCI and “early PD.” Early PD patients perform poorly on 
tasks with executive weighting, regardless of which domain they appear to target 
(working memory, processing speed, visuospatial and verbal learning), and despite 
general intact performance on simpler tasks in those domains (Trail Making Test A, 
Rey Auditory Verbal Learning Test [RAVLT]).  
Indeed, executive and attentional dysfunction may have specific relevancy to 
LBD (Ballard et al., 2002). Attentional difficulties observed in DLB, PD and PDD are 
similar and more pronounced than in AD (Baddeley, Baddeley, Bucks, & Wilcock, 
2001; Ballard et al., 2002), and may thus be expected to be demonstrable in the MCI 
phase. Both PD and DLB have been argued as “dysexecutive syndromes” (p. 81, 
Kehagia, 2013), with executive dysfunction likely one of the earliest-occurring 
cognitive symptoms (Collerton et al., 2003; Foltynie, Brayne, Robbins, & Barker, 
2004; Muslimović, Post, Speelman, & Schmand, 2005). Kehagia et al. (2012), in a 
review of their laboratory’s findings over two decades, concludes that executive 
deficits in the MCI stage are present in 50% of PD patients and are comparable to 
those observed in frontal lobe-damaged patients. These deficits are associated with 
impaired activities of daily living and goal-directed behaviour, which can have 
important consequences for patient quality of life and caregiver burden (Bronnick et 
al., 2006; Lee, McKeith, Mosimann, Ghosh‐Nodyal, & Thomas, 2013). Executive and 
attentional impairment is also implicated in the aetiology of LBD cognitive fluctuations 
and hallucinations (Firbank et al., 2016; Shine, Halliday, Naismith, & Lewis, 2011).  
Donaghy, Taylor, et al. (2018) recently published study on the LewyPro study, 
a forerunner and pilot to SUPErB with similar patient classifications. This showed 
MCI-LB performed significantly worse than MCI-AD in attention and visuospatial 
function (Donaghy, Taylor, et al., 2018), in line with the divergent profiles of the 
advanced dementias (Metzler-Baddeley, 2007). One commonly-used measure of 
executive function is FAS, and Donaghy, Taylor, et al. (2018) demonstrate that MCI-
LB performs worse on both the category and letter fluency variants relative to MCI-
AD. FAS, however, also depends on intact verbal function (Shao, Janse, Visser, & 
Meyer, 2014). Donaghy, Taylor, et al. (2018) notes that because MCI-LB performed 
no worse on measures of language function than MCI-AD (ACE-R, Graded Naming 
Test), the difference in FAS performance can be said to be strictly related to 
executive dysfunction in MCI-LB, rather than any verbal ability that might be required 
by the test, such as confrontational naming.  
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Visuospatial domain 
Of the three retained MCI-LB studies in the review, only Cagnin, Bussè, 
Gardini, et al. (2015) assessed visuospatial ability, with small to medium effect sizes 
on visuoconstructive and visuoperceptual tasks. Larger magnitudes of deficit might 
have been expected, given that visuospatial difficulty is a well-documented feature of 
impairment in DLB (McKeith et al., 1996). Tiraboschi et al. (2006), for example, found 
visuospatial dysfunction to be present in 74% of neuropathologically-confirmed DLB 
cases and lack of impairment to be the best negative predictor of DLB at autopsy. 
Such dysfunction is also suggested to occur early in disease and to precede memory 
impairment (Alescio-Lautier et al., 2007; Hort et al., 2007) and associated with 
greater frequency of visual hallucinations in both PDD and DLB (Sanchez‐Castaneda 
et al., 2010). Visuospatial impairment has been shown to predict greater functional 
decline in DLB, for example as measured by nursing home admission rate, falls 
incidence and quality of life (Aarsland, Larsen, Tandberg, & Laake, 2000; Kudo, 
Imamura, Sato, & Endo, 2009). Hamilton et al. (2008) used autopsy-verified DLB 
cases to demonstrate that steeper cognitive decline and more severe visual 
hallucinations was predicted by baseline visuoconstructive skills using the WISC-R 
Block Design and Clock Drawing Test-Copy. Visuospatial function has also been 
linked to decreased activities of daily living at follow-up in DLB, but not in AD (Wood, 
Neumiller, Setter, & Dobbins, 2010). As opposed to executive and attentional 
domains, visuospatial declines are less typical in normal aging, suggesting that the 
large deficits seen in LBD are more directly linked to the disease process (Klencklen, 
Després, & Dufour, 2012). These findings of early and substantial visuospatial 
difficulties in DLB suggest that deficits in this domain may be the most apparent at 
the MCI stage (McKeith et al., 1996). Results from the structured review indicate the 
visuospatial ability is particularly poor in PD-MCI, but less so in early PD, which may 
be said to represent an earlier disease state. It thus remains unclear whether 
visuospatial deficits will be the most salient cognitive deficit in MCI-LB as in 
established DLB. Results from the LewyPro study, in which MCI-LB Probable showed 
lower scores on the ACE-Visuospatial subtest and an angle discrimination test, 
indicate that deficits are indeed present (Donaghy, Taylor, et al., 2018). 
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Verbal Memory and Learning 
While Cagnin, Bussè, Gardini, et al. (2015) and Yoon et al. (2015) show 
deficits in MCI-LB versus MCI-AD in the domains of working memory, executive 
function and visuospatial function, MCI-LBs performed significantly better than MCI-
AD on verbal learning and memory tasks in all three studies. Verbal learning and 
memory appears preserved in MCI-LB relative to MCI-AD, in line with the 
pronounced memory encoding deficits of AD (Lange et al., 2002; Martin, Brouwers, 
Cox, & Fedio, 1985). However, without the use of HCs, it cannot be concluded 
whether the verbal domain is intact or simply less impaired compared with MCI-AD. 
Results in PD from the structured review stress the relevancy of verbal impairment to 
early PD. Patients performed significantly worse than controls in 78% of the verbal 
domain variables, with PD-MCI showing a higher proportion than early-PD. Each 
study that tested verbal learning and memory reported at least one significant 
difference between groups. However, 7 of the 17 studies reporting a deficit in one 
outcome measure also reported at least one other without a significant difference, 
highlighting the potential equivocality in using large neuropsychological batteries. 
Recognition in both the visuospatial and verbal domains in PD-MCI seems intact, 
while recall is not. As discussed above, this suggests impaired retrieval and relatively 
intact encoding and storage mechanisms, supporting the established retrieval deficit 
hypothesis of memory impairment in PD. 
Thus, evidence from the review is equivocal. The MCI-LB studies do not 
indicate poor verbal performance, while there is substantial evidence within the early 
PD/ PD-MCI literature. Similar to the three retained MCI-LB studies, Donaghy, Taylor, 
et al. (2018) found MCI-LB performance to exceed MCI-AD in memory. However, 
40% of the MCI-LB group scored greater than 2 SD below the mean in RAVLT 
delayed recall. Indeed, Ferman et al. (2013); Yoon et al. (2015) and Kemp et al. 
(2017) note that a substantial proportion of DLB cases will have an amnestic MCI 
profile, despite non-amnestic MCI being more likely to convert to DLB (Ferman et al., 
2013). Some studies have shown that DLB patients may demonstrate early memory 
and language deficits. Auning et al. (2011), for example, used caregiver report to 
argue that memory impairment was the most common presenting symptom of DLB 
(57%); that it is much more reported in AD (99% caregiver report) perhaps lends 
credence to this methodology. However, caregiver reporting is notoriously influenced 
by bias, especially in retrospective accounts (Caviness et al., 2007; Noe et al., 2004). 
Noe et al. (2004), for example, found objective measurement in PDD conflicted with 
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subjective reports by caregivers of memory impairment as the earliest symptom. The 
use of control groups in the present study is therefore based on the need to clarify 
how MCI patients objectively perform relative to age-matched controls, as well as the 
differential profiles of MCI-LB and MCI-AD. 
As discussed above, PD participants may fail to capitalize on their semantic 
knowledge or use of semantic clustering strategies as frequently. These are 
essentially executive functions, but may present as verbal memory dysfunction 
without careful consideration of task demands. The present study aims to consider 
whether domain-general executive functions can explain any measurable memory 
impairment. 
 
2.4 Importance of clinical characterization of patient groups 
As mentioned above, early PD and PD-MCI could be interpreted as 
representing earlier and later forms of PD with advancing cognitive impairment. 
However, a crucial limitation to this interpretation is the potential for circularity due to 
the neuropsychological characterisation of MCI.1 In the PD-MCI group, all but one 
study (Anderson, Simpson, Channon, Samuel, & Brown, 2013) defined groups on 
neuropsychological criteria. Most followed MDS criteria, developed in order to 
provide clarity in the diagnosis of MCI, which is an understandable endeavour given 
the complicated overlap between LBDs. However, these criteria also ensure 
significant impairments are observed between groups. For example, one of largest 
overall differences found in the present study was in Benton’s JOLO, with PD-MCI 
performing on average more than two SDs worse than HCs, and a more moderate 
deficit in early-PD (g=-0.36). This could represent real divergence between early-PD 
and PD-MCI, the latter of which have longer disease durations and are more likely to 
develop dementia than a cognitively intact early PD patient (Janvin, Larsen, 
Aarsland, & Hugdahl, 2006). Indeed, many of the standardized mean differences 
computed in the present review are between 1 and 2 SDs. However, this is perhaps 
more assuredly evidence of circularity rather than a demonstration of PD-associated 
impairment. 
                                                          
1 MCI is frequently diagnosed based on neuropsychological cut-offs relative to normative data. For example, 
PD-MCI criteria by Litvan et al. (2012) stipulates impairment of 1-2 SDs in two tests in a single domain or one 
test in two domains. However, MCI-LB can be diagnosed clinically following consensus criteria guidelines. These 
criteria do include a cut-off for global function (MMSE, for example), but do not depend on neuropsychological 
cut-offs by domain. When using clinical criteria, a more nuanced investigation of cognitive impairment in MCI-
LB may be possible. 
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Methodological decisions regarding what level of deficit constitutes 
“impairment” also has critical implications to a study’s results. Dalrymple-Alford et al. 
(2011), for example, found that while only 14% of a PD sample was considered PD-
MCI when defined as two SDs below normative scores in at least two tests in a 
domain, this number increases to 89% if considered at 1 SD or more. In the latter 
scenario, 70% of clinically-defined HCs were also identified as MCI. Similarly, 
Brooks, Iverson, Holdnack, and Feldman (2008) found 30.8% of healthy older adults 
meet Petersen et al.’s (2001) criterion for MCI. These findings pointedly question the 
utility of such a cut-off. MDS criteria stipulates that cognition should ideally be 
measured in five domains by at least two tasks. This is intended to capture the 
breadth of each domain and identify all impaired individuals, but also increases the 
likelihood of reaching significance on at least one measure. Few studies correct for 
multiple comparisons. Such a large amount of neuropsychological testing can also 
become unwieldy to report in entirety and encourages selection biases in presenting 
only significant results. Thus, choosing a battery poses a problem: decreasing the 
breadth may omit relevant individuals, but increased breadth often leads to 
contradictory findings within domains. The use of composite domain scores may help 
to overcome this methodological challenge (Crane et al., 2012; Gibbons et al., 2012)  
but a neuropsychological definition of MCI in research remains problematic. 
Alternatively, defining MCI clinically (e.g. by measuring independent function and 
daily activities, input from family members, neurological examination, or biomarker 
tests) achieves a less biased sample of participants when investigating 
neuropsychological impairment. 
 
2.5 Overall aims of the PhD 
While advances in neuroimaging and other methods of identifying biomarkers 
in vivo are greatly accelerating diagnostics in the MCI stage, neuropsychological 
measurement remains a critical tool in neurodegeneration research and clinical 
practice (Smith & Bondi, 2013). The criteria for defining MCI-LB clinically has only 
recently been established and its associated cognitive phenotype is unclear. 
Moreover, the previous work that suggests MCI-LB will consistently show a 
dysexecutive profile is troubled by the use of a wide range of tasks across different 
studies, questionable validity and reliability of such tasks, and the use of inconsistent 
MCI diagnostics (Rasquin et al., 2005; Smith & Bondi, 2013). This PhD therefore 
firstly aims to define the neuropsychological profile of clinically defined MCI-LB 
28 
 
relative to both healthy controls and MCI-AD. The following chapters will attempt to 
clarify neuropsychological function using these clearly and clinically-defined MCI 
groups. Secondly, the PhD will use a cognitive psychological framework to consider 
whether domain-general resources are responsible for the higher-order deficits 
commonly associated with DLB, particularly visuospatial dysfunction. Because of the 
large comprehensive battery utilised in the study, Principal Components Analysis 
(PCA) will be employed as data reduction technique before moving into these 
multivariate analyses. There is a dearth of data in this novel MCI-LB population; 
therefore, few specific hypotheses are offered. However, given the existing literature 
in DLB, it is hypothesized that MCI-LB will be associated with deficits in visuospatial 
function, executive function and attention, relative to both controls and MCI-AD. MCI-
AD, conversely, is expected to demonstrate a mildly amnestic profile with impaired 
verbal learning and memory skills. Following these initial empirical chapters, a 
cognitive psychological approach and advanced modelling techniques will be 
employed to expand on the initial findings in greater detail. Introduced in detail in 
Chapters 6-8, these research questions include whether there is a hierarchy of 
deficits in MCI-LB and if intraindividual variability in reaction time performance differs 
between groups. Finally, an exploratory chapter (Chapter 9) will tentatively consider 
how the neuropsychological processes that emerge in the earlier chapters may relate 
to the MCI-LB phenotype more broadly, using measures of severity of cognitive 
fluctuations (a major clinical symptom) and white matter integrity in the brain. 
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Chapter Three: Description of the SUPErB study cohort 
 
3.1 Introduction to SUPErB 
 
Chapter one and two presented background literature on DLB and current 
understanding of the neuropsychology of MCI-LB. The structured literature review 
highlighted the minimal existing empirical evidence in MCI-LB and reviewed findings 
in other forms of early LB disease (MCI-PD and early PD). In addition to the lack of 
existing studies in the population, the issue of circularity when defining MCI-LB based 
on neuropsychological cut-offs was introduced. Clinical identification of MCI-LB is 
possible following consensus criteria guidelines. While these criteria benefit from use 
of thresholds of global function to ensure participants are sufficiently cognitively intact 
to warrant an MCI diagnosis, they do not depend on neuropsychological cut-offs by 
domain. Therefore, use of clinical criteria can allow for a more nuanced investigation 
of cognitive impairment in MCI-LB. The123I-MIBG Scintigraphy Utility as a Biomarker 
for Prodromal Dementia with Lewy Bodies (SUPErB) study was designed to address 
these and other issues in MCI-LB. The current chapter aims to outline the SUPErB 
study, including recruitment, biomarker testing, and the diagnostic process, and 
present the overall aims of the present PhD. The cohort will be described in the 
present chapter terms of clinical and biomarker presentation, global cognitive scores, 
and demographics. Subsequent chapters will contain detailed information on the 
empirical results of the neuropsychological testing. 
 
MCI-LB Possible patients 
MCI-LB will be diagnosed following the most recent consensus criteria on DLB 
(McKeith et al., 2017) in conjunction with NIA-AA clinical diagnosis of MCI (Albert et 
al., 2011), as described further in section 3.4.3. In this scenario, two MCI-LB 
diagnostic categories are created. MCI-LB Possible requires clinical MCI criteria are 
met and the presence of one core clinical symptom of DLB or one positive indicative 
biomarkers (DaTSCAN or MIBG). MCI-LB Probable is a stricter diagnosis, requiring 
two clinical symptoms or one clinical symptom and a positive biomarker. Therefore, 
the MCI-LB Probable group, by definition, will be more assuredly showing cognitive 
decline due to LB disease. As discussed above (section 1.7.7), neuropathological 
research shows that at autopsy many dementia patients show concomitant brain 
pathologies typical of AD and DLB. For example, studies such as the Alzheimer’s 
Disease Neuroimaging Initiative (ADNI) report that only a quarter of clinical AD cases 
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have pure AD brain pathology at autopsy (Cairns et al., 2015). Mixed-pathology 
individuals are particularly difficult to diagnosis clinically (Merdes et al., 2003), and 
would be likely to be included in the MCI-LB Possible group, rather than MCI-AD or 
MCI-LB Probable, due to positive biomarker results. For example, a patient with 
amnestic cognition and absent DLB clinical symptoms, like hallucinations and 
parkinsonism, may show abnormal MIBG or DaTSCAN results suggesting latent LB 
disease. This would lead to a diagnosis of MCI-LB Possible in the present study. In 
contrast, a MCI-LB Probable diagnosis requires more evidence that decline is due to 
purer LB disease. As such, basic information on the clinical profile of MCI-LB 
Possible will be presented in the current chapter, but the neuropsychological 
comparisons in the subsequent chapters will focus primarily on MCI-LB Probable. 
This allows greater confidence that scores in the MCI-LB Probable group relate to LB 
pathology specifically and that inferences can be more safely drawn when comparing 
the group to MCI-AD and controls. 
 
MCI-AD and controls 
The present study also utilises control and MCI-AD groups. The control group 
was recruited to be matched to the MCI patients overall on age and sex. Healthy 
controls have normal cognitive function and undergo all imaging and 
neuropsychological components of the study. This allows for optimal comparison with 
the MCI group rather than depending on normative data. Neuropsychological tasks 
can be subject to biases such as order effects. Moreover, many of the tasks have 
subtle differences in administration. For example, the RAVLT is regularly 
administered with Long Delay recall conditions of between 15 and 30 minutes. The 
use of a control group avoids a number of potential confounding factors and permits 
a clearer understanding of the profile of deficits in the MCI groups. 
The recruitment strategy for MCI participants in SUPErB aimed to infuse the 
patient sample with those likely to have LB disease. Nevertheless, a number of 
participants were anticipated to receive an MCI-AD diagnosis after baseline 
assessment. The MCI-AD participants were diagnosed following exclusion of LB-
symptoms or biomarkers, as well as positive identification of a NIA-AA defined MCI 
profile that is consistent with AD. As such, MCI-AD participants were not recruited 
specifically as MCI due to AD per se: they are likely to progress to AD, but also may 
have some LB features.  
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Substantial neocortical LB burden in the context of established clinical and 
pathological AD has been argued to characterise a Lewy body variant of AD 
(McKeith et al., 2005). At post-mortem examination, many DLB cases will show 
concurrent AD pathology (Ballard et al., 2006). It is unclear how mixed pathologies 
may impact the phenotype, in terms of cognition and clinical features. Amyloid 
deposition in DLB, for example, has been correlated with fewer core clinical features 
(Tiraboschi et al., 2014) and greater cerebral atrophy and cognitive impairment 
(Nedelska et al., 2015; Nelson et al., 2009). However, recent work by Donaghy, 
Firbank, et al. (2018) failed to find differences in neuropsychological or 
neuropsychiatric profile, fluctuations or parkinsonism between amyloid-positive and 
amyloid-negative DLB cases using PET imaging. The phenomenon of multiple 
pathologies in many people with dementia makes attempts to delineate a clear, 
etiologically-orientated neuropsychological profile challenging. In particular, the role 
of tau and the possible synergistic interactions of concurrent AD and DLB pathology 
require elucidation in future studies. 
In terms of the implications for the present study, the reality of mixed 
pathologies suggests that any significant differences that emerge between MCI 
groups are particularly notable: given that the MCI-AD group is slightly “Lewy” (in that 
they were initially approached for reports of features of LB disease), any impairments 
relative to MCI-LB should be of an even greater magnitude in “purer” MCI-AD. 
Comparison with the MCI-AD group therefore offers insight into how these 
pathologies differ in the MCI stage. 
 
3.2  Methods 
 
Recruitment and inclusion/ exclusion criteria 
MCI patients were recruited in two primary ways. Firstly, volunteers from a 
previous study in MCI-LB by the same group were contacted in anticipation of their 
annual follow-up and invited to move into the SUPErB study if desired. This study, 
LewyPro, was a pilot study with equivalent entry criteria although with a less-detailed 
set of assessments for early DLB. Secondly, patients were recruited through 
consultants in regional National Health Service (NHS) trust old age psychiatry, 
neurology and memory services and through case-note searching by staff from the 
North-East Local Research Network of the Dementias & Neurodegenerative 
Diseases Research Network (NE-DeNDRoN). These patients with MCI and at least 
one symptom suggestive of DLB are approached through their consultant via a letter 
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with information about the study and an agreement form for the Newcastle research 
team to contact them. 
Control participants were recruited from a voluntary database of individuals 
interested in participating in research, which is maintained and searched by staff from 
NE-DeNDRoN. Eligible carers of the MCI group were also informed of the study if 
they expressed interest in participating in research.  
 
Inclusion screening criteria 
Prior to assessments, participants must be at least sixty years of age, 
medically/ pharmacologically stable, willing and able to give informed written consent 
to participate in the study, and not have a record MMSE score of less than 20. 
Participants were excluded in cases of clinical evidence of dementia, including a 
Clinical Dementia Rating over 0.5, history or evidence from neurological examination 
of clinical stroke or major cerebrovascular disease on brain imaging, a Parkinson’s 
disease diagnosis according to the Movement Disorder Society (Postuma et al., 
2015) over a year before cognitive decline, diagnosis of a movement disorder or 
other serious neurological condition, or severe mental illness (current major 
depression, bipolar disorder, schizophrenia). Women within a year of menopause 
were excluded. In order to permit MIBG imaging, participants with class II or worse 
heart disease according to the New York Heart Association classification or a history 
of myocardial infarction within the past 12 months were excluded. In order to permit 
SPECT and CT, participants must have been able to lie flat with sufficient comfort for 
thirty minutes and tolerate the enclosed MRI scanner (i.e. no claustrophobia). 
Pharmacologically, participants must not have been taking prescription of tricyclic 
antidepressants, tramadol or labetalol. Additional inclusion/ exclusion criteria is 
outlined below by group (patients and controls). 
 
MCI inclusion and exclusion criteria 
Following assessment, all MCI patient participants must firstly meet diagnosis 
for MCI regardless of aetiology following criteria by NIA-AA workgroups (Albert et al., 
2011). Other patient inclusion criteria are an MMSE score over 20, and 
independence in activities of daily living (see Table 3). The latter inclusion criteria is 
especially crucial as an important delineating characteristic between diagnoses of 
MCI and dementia. It was asked that a spouse, close relative or established carer 
33 
 
accompany the subject to study visits and to act as an informant (minimum contact 
twice weekly). However, if no suitable person was available, participants could  
 
Table 3 Summary of criteria for Mild Cognitive Impairment diagnoses for MCI with Lewy body 
disease (MCI-LB; Probable or Possible) and MCI due to Alzheimer’s disease in the SUPErB 
study. 
MCI criteria for all patients 
o NIA-AA workgroup criteria for MCI (Albert et al., 2011) 
o MMSE > 20 
o Intact activities of daily living 
o No dementia 
o No Parkinson’s disease diagnosed more than a year before cognitive decline 
o Medical and pharmacological stability 
MCI subtype criteria: 
MCI-LB Probable MCI-LB Possible MCI-AD 
Either: 
o Two positive symptoms of 
DLB (visual hallucinations, 
cognitive fluctuations, REM 
Behaviour Sleep Disorder, 
parkinsonism), or 
o One symptom and one 
positive biomarker of Lewy 
body disease (abnormal 
FP-CIT or MIBG) 
 
o One positive symptom or 
one biomarker indicative of 
Lewy body disease. 
o NIA-AA MCI decline 
characteristic of 
Alzheimer’s disease 
o No symptoms or 
biomarkers indicative of 
Lewy body disease 
 
 
complete the study without the carer assessments being completed. Patients must 
not have dementia. 
 
Control exclusion and inclusion criteria 
Healthy control subjects were free of memory complaints or concerns by 
others, not on anti-dementia or anti-Parkinson’s disease drugs and, following 
assessment, had MMSE scores equal or above 26. They had no evidence of any 
movement disorder at screening or assessment and normal MRI scans. 
 
MCI diagnosis 
Patients were diagnosed by a consensus panel of expert Old Age 
Psychiatrists (Professor Alan Thomas, Dr Paul Donaghy, and Dr John-Paul Taylor). 
Firstly, NIA-AA MCI diagnosis (Albert et al., 2011) was confirmed. Secondly, the two 
primary clinicians (Professor Thomas and Dr Donaghy) reviewed each participant’s 
clinical data individually to determine the presence of the four core clinical features of 
DLB (cognitive fluctuations, visual hallucinations, RBD, spontaneous cardinal 
features of parkinsonism), according to 2017 consensus criteria (McKeith et al., 
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2017). These decisions were made blind to imaging results. In cases where the 
primary two clinicians did not agree, the third clinician (Dr Taylor) made the final 
decision. Procedures for imaging assessments are described separately below.  
These six diagnostic features (fluctuations, visual hallucinations, RBD, 
parkinsonism, and abnormal FP-CIT SPECT or MIBG) were used to classify 
participants as MCI-LB Probable (NIA-AA MCI plus one or more clinical features or 
one clinical feature and one positive biomarker),  MCI-LB Possible (NIA-AA MCI plus 
one or clinical features or one positive biomarker), MCI-AD (NIA-AA MCI without any 
DLB features, with decline characteristic of AD, and absence of symptoms of other 
aetiologies), and controls.  
 
Design and procedure 
SUPErB is a large, multiple day study that includes neuropsychological 
evaluations, carer questionnaires, numerous imaging and biomarker studies, and 
clinical evaluations. Participants completed a thorough baseline neuropsychological 
and clinical evaluation, as well as blood sampling, imaging (MRI, DaTSCAN, MIBG, 
EEG), and autonomic readings across five or more study days. All potential subjects 
who agree to enter the study were first seen in their own home or, if they preferred, at 
a dedicated NHS research unit, in the presence of their carer or family member. The 
researcher (author) explained the aims, structure, demands and risk of the study. 
Following any questions that may arise, capacity to give consent was reaffirmed by 
the author before the participant provided their written consent. Throughout testing 
days, participants were asked if they would like any breaks between tasks to avoid 
fatigue, and participants were reminded that they can cease testing and/ or withdraw 
from the study at any time without restriction.  
Neuropsychological pen and paper tasks were typically administered at the 
participant’s home on the first visit. Computerised tests were given in a quiet clinical 
room at the final visit. Participants were given verbal instructions by the researcher 
and understanding of the task demands were confirmed before each test was 
administered. Where the participant was unable to understand how to complete the 
task, the task was omitted. Administration of these pen-and-paper and computerised 
tasks took place over the course of two separate study days, and supplementary 
testing to complete outstanding tasks was sometimes necessary due to time 
constraints and participant fatigue. In total, completion of the tests took between 3 
and 4.5 hours. 
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No financial incentives or remuneration were provided in exchange for 
participation in this study, but taxi transportation to and from the study sites and 
meals on testing days were provided as appropriate. Informed written consent was 
collected by the author at the first visit, typically at the participants’ homes. Ethical 
approval was obtained for the patient cohort by the NHS Research Ethics Committee 
including an amendment to recruit the control group. Since study subjects do not 
have dementia they had capacity to give consent. This was formally checked during 
the consent process following Good Clinical Practice and Mental Capacity training 
completed by the author. To preserve anonymity and confidentiality, any data leaving 
the site identified participants by a unique study identification code only, approved by 
the Research Ethics committee. The study complies with the 1998 Data Protection 
Act.  All study records and Investigator Site Files were kept in a locked filing cabinet 
with restricted access. 
SUPErB is a five-year longitudinal study. After this baseline year, participants 
are invited to return to the campus (or home visits when requested) for yearly follow-
ups consisting of the neuropsychological evaluation, carer questionnaires and repeat 
biomarker testing for some participants (pending funding and appropriateness). This 
continues for four follow-up visits or until a participant converts to a dementia 
diagnosis. The primary aim of SUPErB is to prospectively evaluate the diagnostic 
utility of MIBG in predicting conversion to dementia over the course of five years, 
while this PhD focusses on the cross-sectional baseline data in order to clarify the 
neuropsychological profile of this novel patient group. 
I (the author) selected the neuropsychological battery with the support of my 
supervisors. Programming of the computerised tasks was adapted for the study by 
myself with guidance from Dr Michael Firbank, Dr Rachel Moss and Dr Andreas 
Finkelmeyer. I personally took consent and medical history for all participants and 
administered, scored, and analysed all of the neuropsychological tests, except in a 
few, rare occasions in which illness or double-booking necessitated administration of 
the tasks by another trained researcher. The groups were created based on clinical 
and imaging assessments completed and interpreted by other members of the 
SUPErB team. These are described further below.  
 
Materials 
 
Demographics and other background variables 
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Participant sex, date of birth, age, years of education, highest qualification 
attained were collected. Questionnaires and clinical assessments are described 
below. 
 
National Adult Reading Test (NART; Nelson, 1982) 
Premorbid intelligence was estimated using the National Adult Reading Test 
(NART) (Nelson, 1982), which consists of 50 words of irregular pronunciation 
presented on paper and read aloud by participants. Pronunciation is checked for 
correctness by the researcher using phonetic spellings. Premorbid IQ is then 
estimated by the following formula: Predicted Full-Scale IQ = 128 - 0.83 x NART error 
score (S.E. est. = 7.6). 
 
Geriatric Depression Scale – Short Form (GDS-15; Sheikh & Yesavage, 1986) 
Depressive symptomology was evaluated by the Geriatric Depression Scale – 
Short Form (GDS-15; Sheikh & Yesavage, 1986), a self-report measure specific for 
use in older populations with good reported reliability (0.81; Almeida & Almeida, 
1999; current study Cronbach’s α = .934) and validity (de Craen, Heeren, & 
Gussekloo, 2003). Questions pertain specifically to mood over the past week. 
 
MDS-Unified Parkinson’s Disease Rating Scale (Goetz et al., 2008) 
The UPDRS’ motor subsection was used to assess motor impairment in 
patients. Total score is calculated by summing scores for the five measures (rigidity, 
tremor at rest, bradykinesia, action tremor, facial expression). 
 
Lawton Instrumental Activities of Daily Living Scale (IADL; Lawton & Brody, 
1969) 
IADL assesses an older person’s hypothetical ability to complete tasks related 
to daily functions, whether or not they are regularly performed by the person and 
separate from physical disability. The eight tasks queried are: using a telephone, 
shopping, food preparation, housekeeping, laundry, mode of transportation, 
responsibility for own medications, and ability to handle finances. Scores range from 
0 (highest functional impairment) to 8 (full functional capacity).  
 
Neuropsychiatric Inventory with Caregiver Distress Scale (NPI-D; Cummings et 
al., 1994) 
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Informants (carers; if available) complete the NPI-D with the researcher in 
order to assess behavioural symptoms typical of dementia syndrome. The inventory 
consists of twelve domains assessed for presence, severity and frequency over the 
past month: hallucinations, delusions, agitation/ aggression, depression/ dysphoria, 
anxiety, elation/ euphoria, apathy/ indifference, disinhibition, irritability/ lability, 
aberrant motor behaviour, sleep, and appetite/ eating disorders. Higher scores 
indicate greater neuropsychiatric impairment. Because the NPI-D does not include 
measures of fluctuations, which are particularly relevant to DLB, two fluctuation 
scales were administered separately. 
 
Clinical Assessment of Fluctuations Scale (CAF; Walker, Ayre, Cummings, 
Wesnes, McKeith, O'Brien, et al., 2000) 
Informants complete the CAF together with a trained clinician. The scale 
consists of two portions relating to the (1) frequency and (2) duration of fluctuating 
cognition/ consciousness over the month prior to assessment. Scoring of each 
subscale is between zero and four and an overall total is computed by multiplying the 
two subscales. Scores can range from 0 (no fluctuations) to 16 (severe fluctuations). 
Limitations to the scale have been suggested based on its dependency on clinician 
ability and the qualitative nature of several questions (Lee, Taylor, & Thomas, 2012). 
Due to the fluctuations characterising the condition, DLB patients are expected to 
score higher than AD patients on this scale (O’Brien et al., 2014). 
 
Dementia Cognitive Fluctuations Scale (DCFS; Lee et al., 2014) 
The DCFS is completed by an informant to quantify fluctuations using four 
scales: variation in function, daytime sleepiness, daytime lethargy and overall level of 
consciousness. These subscales have been shown to be successful in differentiating 
DLB from AD (Lee et al., 2014).  
 
North East Visual Hallucinations Interview (NEVHI; Mosimann et al., 2008) 
The NEVHI is an informant-based semi-structured interview to screen for 
hallucinations. The emotions, cognitions and behaviours associated with the 
hallucinations, if present, are also assessed (Mosimann et al., 2008). 
 
Clinical Dementia Rating Scale (CDR; Hughes, Berg, Danziger, Coben, & Martin, 
1982) 
38 
 
The CDR is completed by a clinician to determine the patient’s overall level of 
functional impairment due to dementia across six domains: memory, orientation, 
judgement and problem solving, community affairs, home and hobbies, and personal 
care. A total score is computed using an algorithm in which 0.5 is consistent with MCI 
or dementia (Morris, 1993). A score of zero indicates absence of dementia. Scores of 
1-3 is in line with a dementia diagnosis. The CDR, like CAF, is dependent on clinician 
skill as other sources of impairment, such as physical disability, must be ruled out.  
 
Hoehn and Yahr Scale (Hoehn & Yahr, 1998) 
The Hoehn and Motor Scale is a widely used measure original developed in 
PD to assess motor severity. It relates to both unilateral/ bilateral involvement and 
compromised balance/ gait. Parkinsonian motor impairment can be ranked in severity 
from unilateral (stage 1), bilateral without balance difficulties (stage 2), bilateral with 
postural instability (stage 3), loss of physical independence (stage 4), and wheelchair 
or bed-bound without assistance (stage 5) (Goetz et al., 2004). 
 
Global cognitive assessment 
Global cognitive function is assessed using Addenbrooke’s Cognitive 
Examination-Revised (ACE-R; Mioshi , Dawson, Mitchell, Arnold, & Hodges, 2006) 
and the MMSE, which is extracted from the ACE-R. MMSE is the one of the most 
frequently used generally cognitive assessment tools and is well validated in various 
patient groups including MCI (Aarsland, 2016). 
 
MIBG imaging 
MIBG cardiac imaging was carried out within the medical physics department 
of the Royal Victoria Infirmary NHS hospital in Newcastle upon Tyne. Subjects are 
firstly administered medication to block thyroid uptake of any free iodine following 
standard clinical protocol. After the absorption period of the thyroid block, subjects 
receive a single intravenous bolus of 111 MBq (3mCi) of 123I-MIBG followed by a 
saline flush. Planar images in anterior view are then obtained at 20 minutes post-
injection (early image) and 240 post-injection (delayed image). SPECT chest imaging 
uses a dual-headed gamma camera and low energy, high resolution collimator. 
Images were analysed using established methods of regions of interest (ROI; 
polygonal) manually drawn over the entire heart, including the left ventricular cavity. 
A rectangular ROI is also set on the upper mediastinum. Heart to mediastinum (H/M) 
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ratios are computed for both early and delayed images. MIBG uptake is quantified as 
the fraction of mean count per pixel in the heart ROI over mean count per pixel in the 
upper mediastinum. Throughout the MIBG procedure and prior to discharge, subjects 
are observed for any signs of adverse reactions, excessive inflammation at the 
injection site or surrounding tissue.  
From the MIBG scans, heart-to-mediastinum ratio (HMR) values were 
measured by two researchers and averaged. Any cases of more than 10% 
disagreement in values were reviewed by the researchers towards consensus 
ratings. The optimum threshold for normality was computed by adapting previous 
values obtained in a multicentre study (2.10; Yoshita et al., 2006) to the cameras 
used in the present study using a phantom calibration method and the control group 
for normalization. Two control participants were excluded from this calculation due to 
abnormal scans. The threshold was determined to be <1.86 as abnormal.  
 
DaTscan 
123I-FP-CIT SPECT is likewise administered from the outpatient medical 
physics department following standard clinical procedure. Intravenously, thyroid-
blocking medication is administered followed by the 185 MBq of 123I-FP-CIT. 
Approximately 4 hours after injection, multiple views of the head over around a 360-
degree orbit are acquired using a dual-headed gamma camera. Imaging itself lasts 
about 30 minutes. Subsequently, image reconstruction produces transverse sections 
with an axial resolution under 10mm full width at half maximum. Each FP-CIT SPECT 
image was evaluated using the Benamer scale and a panel of five experienced 
clinicians (Dr Paul Donaghy, Professor Alan Thomas, Ms Gemma Roberts, Dr 
George Petrides, and Dr James Lloyd) to avoid the potential bias of a single rater 
(Benamer range 0-3; Benamer et al., 2000; Colloby et al., 2008). Panel members met 
in person to discuss uncertain cases, defined as a 3:2 split (or 3:1:1; 2:2:1, or 
2:1:1:1). Where there was full consensus or 4 panellists in agreement this was taken 
as the final rating. Final Benamer rating for each participant was normal (0) or 
abnormal (0-1) for the purpose of diagnosis.  
 
3.3 Cohort profile 
 
Patient groups 
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Seventy-five MCI participants were recruited over the course of 23 months. 
Thirty-two control participants were recruited so that groups remained comparable for 
age and gender. After consent and baseline study assessments, fourteen 
participants (including one control) were withdrawn from the study prior to completion  
 
Figure 2 Flow chart showing the recruitment, withdrawal and ultimate allocation of SUPErB 
study volunteers to the four groups. 
 
for reasons of medical delay (n = 3), voluntary removal (n = 5), dementia/ advanced 
impairment (n = 5), and insufficient impairment (n = 1). See Figure 2 and Appendix C 
for complete information on removed participants. This resulted in a final groups of 
31 controls, 44 MCI-LB patients and 18 MCI-AD patients. The MCI-LB group was 
further diagnosed as 14 MCI-LB Possible and 30 MCI-LB Probable individuals. 
 
Demographics 
Demographic data by participant group is presented in Table 4 on page 42. 
Overall, patients ranged in age from 60 to 89 and subgroups remained matched by 
age. The MCI-LB groups, however, have a predominance of males and lower scores 
of premorbid IQ estimates relative to controls and MCI-AD. The mean premorbid IQ 
estimates for controls and MCI-AD groups are quite high overall. MCI groups did not 
differ on CDR or IADL, indicating any impact on independent function was very 
limited and in line with MCI. There was no difference in NPI-D scores. Global 
cognitive status (MMSE and ACE-R scores) did not differ between patient subtypes. 
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As expected, control global cognitive scores were in the normal range and 
significantly higher than each MCI subtype. MCI-LB Probable patients scored 
significantly higher (M = 5.27, SD = 3.91) than controls (M = 1.32, SD = 1.82) on 
GDS self-reports of depression, but MCI-AD and MCI-LB groups were not statistically 
different. 
Biomarker Results 
Eighteen of 28 MCI-LB Probable and 4 of 14 MCI-LB Possible participants 
who received MIBG imaging had abnormal scans. Seventeen of the 30 MCI-LB 
Probable group had abnormal panel-rated DaTSCAN.  In total, thirteen of the 30 
MCI-LB Probable participants had both abnormal MIBG and DaTSCAN. No MCI-AD 
participants had abnormal DaTSCAN or MIBG scans. Nine of the 14 MCI-LB 
Possible participants had a biomarker indicative of LB disease. 
 
Core symptoms and related scales 
In MCI-LB Probable, RBD and cognitive fluctuations were the most common 
consensus symptoms (66.67% of group for both). No participants were positive for 
neuroleptic sensitivity, which was originally included when planning the study in 
diagnostic criteria but removed when 2017 criteria were published. MCI-LB Probable 
participants had the following numbers of core symptoms: n = 1 with four symptoms, 
n = 6 with three symptoms, n = 12 with two symptoms, and n = 11 with one symptom 
and at least one abnormal biomarker. Five of the 14 MCI-LB Possible group were 
diagnosed based on cognitive fluctuations as a core symptom, rather than a positive 
biomarker. The participants were interviewed to determine that fluctuations were 
consistent with LB disease rather than AD. The difference between controls and MCI-
LB Probable in mean CAF and UPDRS scores did not reach significance, but MCI-LB 
Probable have significantly higher scores on DCFS (p = .006) and NEVHI (p = .004) 
than controls. 
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Table 4 Demographics (means, and standard deviations in brackets) of the dementia groups 
(LBD and AD) and age-matched controls. Note: the ‘MCI Post Hoc’ column shows the results 
of analyses comparing the MCI-AD and MCI-LB groups only. 
 Controls  
(n = 31) 
MCI-LB 
Probable  
(n = 30) 
MCI-LB 
Possible  
(n = 14) 
MCI-AD  
(n = 18) 
All group 
comparison 
MCI-LB 
Probable vs 
MCI-AD 
Age (years) 73.84 
(7.29) 
74.73 
(7.00) 
75.93 
(7.34) 
76.89 
(8.50) 
F(3,89) = 0.72, 
p = .542 
t(46)=0.95,  
p = .346 
Age range 61-89 60-87 61-87 62-89   
Gender 
(female, 
male) 
8, 23 7, 23 4, 10 10, 8 Χ2(2) = 6.18,  
p = .045 
Χ2(1) = 5.11,  
p = .024 
NART IQ 114.57 
(8.27) 
106.60 
(10.10) 
104.71 
(10.98) 
112.61 
(9.00) 
F(3,88) = 5.53, 
p = .002 
Control > MCI-
LB Possible, p 
= .010, & MCI-
LB Probable, p 
=.008 
t(46)=2.08,  
p = .043 
Hoehn and 
Yahr Stage1 
All stage 0 18 stage 0, 5 
stage 1, 4  
stage 2, 1  
stage 3, 2 
missing 
13 stage 0, 1 
stage 1 
All stage 0   
CDR2  0.45 
(0.15) 
0.50 
(0.00) 
0.53 
(0.12) 
 t(45)=1.84,  
p = .072 
UPDRS3 5.42 
(4.42) 
24.37 
(15.15) 
17.36 
(10.13) 
16.94 
(10.76) 
F(3,89) = 15.75, 
p < .001 
Control < MCI-
LB Probable, p 
< .001, MCI-LB 
Possible, p 
=.005, & MCI-
AD, p = .003 
t(46)=-1.82,  
p = .076 
IADL4  12.32 
(3.71) 
12.86 
(4.66) 
12.20 
(4.23) 
 t(38)=-0.09,  
p = .926 
Fluctuations 
(%) 
 66.67% 7.14% 16.7%*   
Visual 
Hallucination
s (%) 
 16.67% 0% 0%   
Parkinsonis
m (%) 
 40% 14.29% 0.0%   
RBD5 (%)  66.67% 14.29% 0.0%   
Neuroleptic 
sensitivity 
(%) 
 0.0% 0.0% 0.0%   
Abnormal 
FP-CIT 
SPECT6 (%; 
panel rating) 
6.5% 56.67% 35.71% 0.0%   
Abnormal 
MIBG7 (%) 
6.5% 64.29% 28.57% 0.0%   
Mean total 
core features 
0.00 
(0.00) 
1.90 
(0.84) 
0.36 
(0.50) 
0.17 
(0.38) 
  
Positive 
biomarkers 
only (%; 
MCI-LB only) 
 0% 64.29%    
ACE-R8 92.74 
(4.41) 
83.20 
(8.81) 
79.43 
(9.78) 
83.00 
(8.28) 
F(3,89) = 13.61, 
p < .001 
t(46)=-0.08,  
p = .938 
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Controls > MCI-
LB Probable, 
MCI-LB 
Possible, & 
MCI-AD, all ps 
< .001 
MMSE9 28.42 
(1.18) 
26.33 
(2.62) 
26.36 
(2.41) 
26.78 
(1.93) 
F(3,89) = 6.36, 
p = .001, 
Controls > MCI-
LB Probable, p 
= .001, MCI-LB 
Possible, p 
= .013, & MCI-
AD, p = .042 
t(46)=0.63,  
p = .535 
GDS10 1.32 
(1.82) 
5.27 
(3.91) 
3.67 
(2.69) 
3.56 
(3.11) 
F(3,89) = 8.88, 
p < .001 
Controls < MCI-
LB Probable, p 
< .001 
t(46)=-1.58,  
p = .121 
NPI-D11  16.04 
(12.35) 
12.64 
(13.83) 
14.67 
(11.21) 
F(2,51) = 0.34, 
p = .717 
t(38)=-0.35,  
p = .727 
NEVHI12 0.10 
(0.54) 
3.23 
(4.55) 
1.54 
(2.70) 
0.47 
(1.33) 
F(3,87) = 6.73, 
p < .001 
MCI-LB 
Probable > 
Controls, p 
< .001 
t(36.9)=-3.10, 
p = .004 
CAF13  4.26 
(4.18) 
1.64 
(2.27) 
2.47 
(3.27) 
 t(40)=-1.43,  
p = .159 
DCFS14  9.07 
(3.45) 
8.00 
(3.49) 
6.13 
(2.53) 
 t(40)=-2.89,  
p = .006 
*Participants with only cognitive fluctuations are evaluated for fluctuations consistent 
with AD in order to obtain a MCI-AD diagnosis.  
1 Hoehn and Yahr Stage = Stages 0 (asymptomatic), 1 (unilateral movement only), 2 
(bilateral involvement without impairment of balance), 3 (mild to moderate 
involvement, some postural instability), 4 (severe disability), 5 (wheelchair or 
bedridden unless aided).  
2 CDR = the Clinical Dementia Rating  
3 MDS-UPDRS = Unified Parkinson’s Disease Rating Scale (motor subsection)  (Postuma 
et al., 2015)  
Geriatric Depression Scale  
4 IADL = Instrumental Activities of Daily Living (New Score)  
5 RBD = Rapid Eye Movement Sleep Behaviour Disorder  
6 FP-CIT SPECT = 123I-N-3-fluoropropyl-2beta-carbomethoxy-3beta-4-iodophenyl 
tropane (FP-CIT) single-photon emission computed tomography  (SPECT) 
7 MIBG = metaiodobenzylguanidine  
8 ACE-R = Addenbrooke’s Cognitive Examination -Revised 
9 MMSE = Mini Mental State Examination (Folstein et al., 1975)  
10 GDS = Geriatric Depression Scale  
11 NPI-D = Neuropsychiatric Inventory (Cummings et al., 1994)  
12 NEVHI = North-East Visual Hallucinations Interview 
13 CAF = Clinical Assessment of Fluctuations  
14 DCFS = the Dementia Cognitive Fluctuation Scale (Lee et al., 2014) 
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3.4 Discussion 
In the present study, 62 patients were recruited based on suspected LB 
disease and were clinically diagnosed by Old Age Psychiatrists to have MCI following 
NIA-AA criteria. The MCI-AD and control groups did not show any symptoms or 
biomarkers suggestive of LB disease, except for two control participants with 
abnormal MIBG. Those control volunteers had normal clinical presentation, intact 
cognition and no other evidence of LB disease. All other controls also displayed 
intact global cognitive scores, in line with normal ageing. Of the 44 MCI-LB diagnosis, 
30 were found to have two or more core clinical symptoms of DLB or one core 
symptoms and on positive biomarker. About one third of the MCI-LB Probable group 
only displayed one of the four clinical features of DLB used in diagnosis. Thus, these 
participants would have been only given a Possible MCI-LB diagnosis without the 
use of biomarkers to aid diagnosis. Clinical diagnosis of even advanced DLB is often 
challenging: even with the expertise of specialised clinicians, the core symptoms are 
problematic to assess. Both visual hallucinations and parkinsonism are observed in 
other neurologic and psychiatric conditions, and may be subtle in early 
manifestations (Walker & Walker, 2009). Fluctuations, for example, can occur over 
the course of minutes, hours, or much longer periods that may not be reliably 
detected during clinical assessment or through informant report (McKeith, 2007). My 
findings therefore emphasize the importance of the addition of biomarkers to the 
most recent consensus guidelines (McKeith et al., 2017).  
Demographically, the results are generally in line with expectations for the 
subgroups. Subgroups did not differ significantly in age or measures of self-reported 
depression. All MCI subtypes show worse motor impairment as measured by UPDRS 
than controls. UPDRS has previously been demonstrated to measure motor 
impairment severity independent of cognitive function (Ballard et al., 1997). As such, 
future chapters will consider how psychomotor function contributes to performance 
on cognitive tasks between groups. Motor function using UPDRS will be considered 
alongside scores on tasks that are particularly motor-dependent. UPDRS scores did 
not differ significantly between MCI-AD and MCI-LB, but the raw difference is quite 
high. This lack of significance is likely attributable to low powering due to the small 
number of MCI-AD participants and the non-specific contribution to UPDRS rating 
scores associated with ageing and age-related diseases. 
High estimates of premorbid IQ were demonstrated in both controls and MCI-
AD, relative to the MCI-LB groups, however. This is unsurprising as often healthy 
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control groups consist of individuals engaged with research and familiar with 
university settings, thus making it likely that they are more highly educated. The 
NART was originally standardized based on data from individuals 20 to 70 years of 
age (Nelson & Willison, 1991). Although reading ability is thought to be largely stable 
(Nelson & Willison, 1991), it is possible the older age of the patient groups partly 
explains the low scores. We also found a predominance of men in the clinically 
diagnosed MCI-LB groups. Previous meta-analyses (Vann Jones & O'Brien, 2014) 
and epidemiological studies (Savica et al., 2013; Yue et al., 2016) have not reported 
DLB to be more prevalent among men. However, Kane et al. (2018), in a clinical 
study analysis using a large sample size (n = 4,504 dementia diagnoses) and two 
service locations, did find a significant association between male gender and DLB 
prevalence. This has also been demonstrated in neuropathological work (Klatka, 
Louis, & Schiffer, 1996). 
In conclusion, the SUPErB study has created four groups based on clinical 
diagnoses with the aid of biomarkers. The control group’s global cognitive, clinical 
and biomarker profiles are in line with expectations of normal healthy ageing. In the 
subsequent chapters, their data will be useful in comparing MCI patients’ 
performance on neuropsychological tasks. The MCI subtypes show equivalence on 
demographic factors such as age and activities of living that might confound 
neuropsychological interpretation. However, differences in estimates of intelligence 
and gender distribution between groups warrant further consideration. 
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Chapter Four: Neuropsychological profile of MCI-LB in the SUPErB 
study 
 
4.1 Introduction 
Review of the literature suggests that despite similar global cognitive capacity, 
MCI-AD and MCI-LB display different neuropsychological profiles. It is unclear, 
however, whether the groups can be reliably discriminated or if the most salient 
impairments of the advanced dementia stage are manifest at this MCI stage. For 
example, only eleven of the extracted outcome variables in MCI-LB showed 
significant difference from MCI-AD after bias-correction. Donaghy, Taylor, et al. 
(2018) conducted a post-hoc discriminant analysis of the four variables that were 
significantly different between MCI-LB and MCI-AD (ACE-R fluency and visuospatial, 
digit vigilance time and angle task result). The low sensitivity (64%) and specificity of 
(68%) led the authors to conclude that “the heterogeneity of cognitive impairment 
observed in MCI-LB and MCI-AD was reflected in the poor discriminant ability... 
Thus, though a pattern of prominent executive and visuospatial dysfunction is 
supportive of a diagnosis of MCI-LB it is not sufficient to warrant a diagnosis of MCI-
LB in isolation” (p. 5). The importance of clinical assessment, over 
neuropsychological evaluation, in MCI-LB diagnosis is therefore stressed. However, 
neuropsychological measurement remains a critical tool in neurodegeneration 
research and clinical practice (Smith & Bondi, 2013). The inclusion of HCs and more 
nuanced cognitive modelling may advance the predictive ability of 
neuropsychological testing. 
4.2 Methods 
Materials 
The study aims to firstly clarify the broad neuropsychological profile of the 
emergent diagnostic category of MCI-LB, as well as MCI-AD, using a battery of 
standard tasks. More experimental tasks are also utilized and are mostly addressed 
in chapters 5 and 6. The present chapter presents the battery of individual tasks that 
will be compared between groups. In chapter 4, these tasks will be used to create 
data-driven composite scores using principal components analysis (PCA) for use in 
MRI analyses and hierarchical linear modelling in order to consider the mediating role 
of domain-general resources like processing speed and executive function. The tasks 
are described below, organized by the domain they are intended to target (Table 5): 
visuospatial, executive function, verbal memory, psychomotor speed and working  
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Table 5 Tasks administered in SUPErB, organized a priori by domain. 
Domain Tasks 
Global Cognitive Measure Addenbrooke’s Cognitive Examination-Revised (ACE-R) 
Mini-Mental State Examination (MMSE) 
Visuospatial Corsi blocks 
Visual Patterns Task 
Modified Taylor Complex Figure (MTCF) 
Pareidolia Test 
Verbal Learning and Memory Rey Auditory Verbal Learning (Rey, 1964): 
Graded Naming Test 
Executive Function Trail Making Task B 
Digit Span backwards 
Stroop C-W 
Verbal Fluency (FAS) 
Processing Speed DSST 
Symbol Copy 
Error Check 
Trail Making Task A 
Simple reaction time  
Choice reaction time 
Working Memory Capacity Digit Span forward 
 
memory capacity. In addition to the global cognitive measures (ACE-R and MMSE, 
discussed in Chapter Two), fifteen other neuropsychological tasks were administered 
(eight pen and paper, three computerized). Two additional computerised, 
experimental tasks (Continual Performance Test and Metacognition Test) were 
administered and are discussed in later chapters. 
 
Visuospatial function 
Corsi Blocks 
This touchscreen, computerised version of the classic Corsi blocks task (Corsi, 
1972) quantifies the capacity of spatial sequential working memory. Participants must 
mimic the order in which some of blue squares presented on the screen are 
illuminated. The task ends after three consecutive trial failures. 
 
Visual Patterns Task (VPT; Della Sala , Gray, Baddeley & Wilson, 1997) 
This computerised adaptation of the task developed by Della Sala et al. (1997) 
presents participants with a square matrix pattern in which some of the cells are filled 
in black for 2000ms. This stimuli matrix is then removed (3000ms interstimulus 
interval [ISI]) and participants must reproduce the pattern in a blank grid of the same 
size by clicking on the squares that were black using a standard external mouse. 
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There is no time limit to respond and responses can be changed until the participant 
clicks the “enter” key and moves onto the next stimulus.  
Stimuli begin as a 2x2 matrix with 2 black squares (targets), increasing to 3x2 
(3 targets), 3x3 (4 targets), 4x3 (5 and 6 targets), 4x4 (7 and 8 targets), 5x4 (9 and 
10 targets), 5x5 (11 and 12 targets), and 6x5 (13, 14 and 15 targets). There are three 
stimuli in the 2- and 3-target levels. Beginning at 4 targets, 6 stimuli are presented, 3 
that are “high verbal coding” and 3 that are “low verbal coding” conditions. Brown, 
Forbes, and McConnell (2006) explicitly acknowledged the possibility of verbal 
coding within the VPT and separated the stimuli into subsets of High and Low 
verbalization patterns. A subset of these two sets of stimuli are used within this task. 
In the few cases in which participants did not feel comfortable using the external 
computer mouse to complete this task, they were instructed to touch the squares on 
the screen to indicate their selections. The author then used the mouse to match 
their touch responses and verbally confirmed that it was as they desired before 
moving on. Necessity of this approach was recorded and analysed for potential 
confounding effects. The VPT intends to capture short-term static visual memory, 
without the spatio-sequential demands of tests like Corsi blocks. 
 
Modified Taylor Complex Figure (MTCF) 
The MTCF was completed by only 82 participants as it was added to the 
testing battery after testing had begun. Time taken to complete the copy and recall 
conditions were recorded for 49 and 43 participants respectively. A second rater 
(Calum Hamilton) marked 19 participants’ drawings, blind to diagnostic group, to 
confirm reliability of the rating scales. Intra-class correlation coefficients were 
acceptable for both copy (0.96) and recall (0.95) conditions. The MTCF was used in 
the present study as it has previously been shown to be comparable to the more-
commonly used ROCF in terms of resistance to verbal encoding and accuracy in 
assessing visuospatial memory (Hubley & Tremblay, 2002); moreover, the MTCF 
may be easier to copy for older adults (Hubley, 2010). This was deemed appropriate 
to avoid fatigue or floor effects in a population of mildly cognitively impaired older 
adults. 
 
Pareidolia Task 
This is a 40-item neuropsychological test which evokes and measures visual 
illusions similar to visual hallucinations observed in patients with dementia with Lewy 
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bodies and Parkinson’s disease (Yokoi et al., 2014). Participants are asked to report 
whether a face is visible within the images, after completing three practice trials. 
Within the set of forty images, eight contain faces. Participants are scored on the 
number of correct answers, misses and false alarms (pareidolias). Example stimuli 
with and without a face are shown in Figure 3.  
 
 
Figure 3 Pareidolia test example stimuli with a face present (L) and absent (R). 
  
Verbal Learning and Memory 
 
Graded Naming Test 
A measure of semantic memory in which participants must name 30 black and 
white drawings. Participants may take their time to answer and proceed and return to 
previous items. In cases of certain incorrect responses, the experimenter offered 
verbal responses or pointed when appropriate to reorient the participant. 
 
RAVLT (Rey, 1964) 
A test of verbal learning with two lists of 15 words presented verbally across 7 
trials. Memory of list A is evaluated with both immediate (5 consecutive trials), short-
term delayed recall, and longer-term (approximately 20 minutes) delayed recall. List 
B is presented immediately recalled once. Following the longer delay condition, 
recognition of the two lists and distractor words follow. Because the most delayed 
recall condition is dependent on how well List A was first learned, the percentage 
recalled of the maximum score from the first five conditions is calculated. Retroactive 
interference is calculated by subtracting the fifth trial of list A (T5) from the short delay 
(T6) score, quantifying how subsequent learning impairs recall of previously-learned 
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target material (Postman & Underwood, 1973). Proactive interference is calculated 
by subtracting the first A trial (T1) from the first/ only B trial (B) and thus represents 
the detriment due to prior learning in recalling “subsequently presented target 
material (Postman & Underwood, 1973).” Interference scores thus involve an 
executive component that will be discussed further. Due to the number of potential  
 
Table 6 RAVLT outcome measures and descriptions. 
RAVLT Outcome Measure Description 
Max T1:T5 The sum of scores from first five free recall trials (Trials 1 to 5)/ 
“learning - episodic memory” 
“Learning” The score of Trial 5 minus the score of Trial 1 
Short Delay Number of words freely recalled from list A after presentation of list 
B. 
Long Delay Number of words freely recalled 25 minutes after Short Delay recall 
trial. 
Percent Remembered at 
Long Delay (from max 
T1:T5) 
The percentage of a participant’s maximum words recalled in trials 1 
to 5 that are remembered at the Long Delay free recall trial. ([Long 
Delay/ Max T1:T5]*100) 
Retroactive Interference (T6-
T5) 
The difference between the number of List A words freely recalled at 
Short Delay and trial 5. 
Proactive Interference (B-
T1)* 
The difference between the number of List B words freely recalled 
minus the number of List A words recalled at trial 1. 
Recognition False B* The number of List B words falsely identified as being from List A in 
the delayed recognition trial. 
 
 
outcome variables of the RAVLT, the ones that will be analysed in the present study 
are presented in Table 6. 
 
Executive Function 
 
Trail Making Task B (Trails B) 
Trails B is a pen and paper task that assesses both attention and task switching. In 
Trails B, there are both numbers and consecutive letters presented within circles 
arranged on a page, unlike Trails A which includes only numbers. Participants must 
draw a line between the circles in ascending order, alternating between number and 
letter. The researcher interrupts in cases of mistakes and directs the participant to 
continue from the last correct circle. Time to completion is scored and interference 
scores are also calculated. Interference is frequently reported using Ratio (Trails B/ 
Trails A) or Difference (Trails B-Trails A) (Arbuthnott & Frank, 2000; Giovagnoli et al., 
1996). The Ratio interference score has been argued to be a more accurate 
assessment of executive function impairment. For example, a ratio score greater than 
3 was associated set-switching impairment, but Difference was not (Arbuthnott and 
51 
 
Frank, 2000). Typically, Trails B administration is meant to be curtailed if the 
participant takes longer than five minutes to complete. The present study allowed 
participants to take as long as was needed, and use of a ratio or difference 
interference score allows quantification of executive function impairment even in very 
slow completers. 
 
Digit Span backwards 
Digit span is a measure of working memory that requires participants to recall 
strings of verbally-presented digits both forwards and backwards.  In the backwards 
condition, the lowest level is two numbers up to 8 numbers. The maximum scores are 
14 for each condition (forwards and backwards) and a cumulative maximum of 28. 
The test ends when the participant does not correctly answer at least one of the two 
stimuli for a level. In cognitive models, the backwards condition places greater 
demands on the central executive or executive function than digit span forwards, 
which is a more pure measure of phonological loop capacity. 
 
Verbal Fluency (FAS) 
Participants are asked to generate as many unique words as possible 
beginning with F, A and S within sixty seconds. They are instructed to avoid proper 
nouns. Running totals were taken every fifteen seconds and a total score computed. 
 
Stroop Test 
This test consisted of two conditions: colour (C) and colour-word (CW). Both 
use a one-page piece of paper with columns of block-letter words: BLUE, GREEN, 
RED and BROWN. The font is coloured so that each word has an incongruous colour 
font (RED in green ink, for example). In C, participants must go down the column 
reading allowed the printed words as quickly as possible. In CW, the written word 
must be ignored and the colour of the ink said aloud. CW thus requires the 
participant to inhibit the reading of the word and attend to the colour ink. Following 
the method of Golden (1978), participants are given 45 seconds to complete each 
version as quickly as possible. The number of correct words or colours is recorded. 
Interference scores are also calculated, in various ways. In the present study, two 
methods were used. Firstly, the classical method subtracts the CW from the C score 
(C-CW; Hammes, 1978). Secondly, a ratio interference effect is calculated to correct 
for colour-naming speed (C-CW/C).  
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Processing speed 
 
Digit Symbol Substitution Test (DSST) 
DSST is a pen and paper task in which participants reference a number-
symbol key to write the correct symbol below a list of 96 randomly ordered numbers 
presented in a grid as quickly as possible within 90 seconds. The number of correct 
symbols drawn is recorded. A Coding time variable is be derived as the time per item 
in completing the DSST-original (90 seconds) minus the time per item in Symbol 
Copy (90 seconds), reversed so that a higher score indicates a faster mental coding 
speed. Early work by Salthouse (1992) demonstrated that controlling for performance 
on a simple speed test removed 95% of the age-related variance in DSST. However, 
the DSST clearly necessitates other resources including graphomotor and perceptual 
speed, as well as potential executive function and memory components  (Joy, 
Kaplan, & Fein, 2004; Van der Elst, van Boxtel, van Breukelen, & Jolles, 2006). 
 
Symbol Copy 
An adaptation of DSST, Symbol Copy, was first included on the Weschler 
Intelligence Scales (WAIS)-RI (Kaplan, Fein, Morris, & Delis, 1991). Participants must 
simply copy each symbol in the grid into an empty box directly below it as fast as 
possible in 90 seconds. The test intends to isolate DSST’s graphomotor component 
(Joy, Fein, Kaplan, & Freedman, 2000). A small meta-analysis by Joy and Fein 
(2001) reported that Symbol Copy, like DSST, has a strong negative relationship with 
age that becomes significantly stronger beginning at age 50. 
 
Error Check 
Another DSST variant, Error Check was first developed by Joy et al. (2000) to 
capture the coding processes involved in DSST without graphomotor demands. Error 
Check involves scanning a completed DSST for errors in relation to the key above 
and marking any with a pencil slash as quickly as possible in 90 seconds. 
 
Trail Making Task A 
Participants must draw lines between 25 numbered circles in ascending order 
as quickly as possible without making a mistake. Time to completion is scored. 
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Simple and Choice reaction time (SRT and CRT, respectively) 
These two computerised tests measure speed of reaction to a stimuli. In SRT, 
the participant must depress an external, handheld button as quickly as possible 
upon presentation of a white X on a black screen. In CRT, the white stimulus 
presented is an arrow pointing either to the left of the right. The participant holds one 
external button in each hand and must depress the correct button (left if arrow points 
left, for example) as quickly as possible. The inter-stimulus interval in both tasks 
varies and the stimulus disappears upon button press. Each task lasts about 150 
seconds total. Mean reaction time is calculated as the primary outcome measure. In 
CRT, only the reaction times of the correct button presses are included. Participants 
receive training on use of the response module. If physical limitations or discomfort 
made use of the external buttons impossible, the test was discontinued to avoid 
participant distress and the influence of motor disability on test performance. These 
two tasks are addressed in more detail in chapter five. 
 
Working memory capacity 
 
Digit Span forward 
In the forward condition of Digit Span, two sets of between three and nine 
digits are read aloud to participants. Each level (3 digits, 4 digits, so on) scores 0, 1 
or 2 points depending on how many of the two sets were correctly recalled by the 
participant. As with Digit Span backwards, the test ends when the participant does 
not correctly recall at least one of each span level. 
 
Treatment of data 
Data was analysed using the Statistical Package for the Social Sciences, V. 
21 (SPSS , IBM Corp, 2013). Variables (in this and subsequent chapters) were 
assessed for outliers and normality. Data exceeding Z=+/- 3.0 were considered for 
potential exclusion. Outliers can have substantial (Osborne & Overbay, 2004), 
deleterious effects on statistical analyses by increasing error variance and reducing 
statistical power. Multivariate analyses (performed in Chapters 6-9) also require that 
assumptions of sphericity and normality be met, and outliers can problematize such 
assumptions if they are not distributed randomly (Osborne, 2012). Transformations 
and removal of outliers remains debated in statistical literature, but conscientious 
data cleaning is generally assumed to improve generalizability of results (Osborne, 
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2012). In the case of mean differences between groups (t-tests and analysis of 
variance [ANOVAS]), Osborne (2012) demonstrates tendency for increased accuracy 
with removal of extreme scores and little evidence that Type I error risk increases. As 
only 1% of subjects should be 3 or more SDs from the mean, this initial screen prior 
to visual inspection is a useful means of identifying potential outliers (Osborne & 
Overbay, 2004).  
Normality was assessed firstly visually through the use of histograms and 
secondly using measures of skewness and kurtosis in questionable instances, 
following suggestions from Osborne (2012). In cases of relative normality to the 
distribution (through visual inspection), 6 data observations above or below 3.0 SDs 
were removed. As suggested by Tabachnick and Fidell (2007) and Howell (2007), 
moderate skewness was adjusted using square root transformations and substantial 
skewness with Logarithmic base 10 transformation. In both cases, negative skews 
required use of a constant, square root of (K-X) for example. Transformations were 
performed on 12 variables, as shown in Appendix D, to achieve acceptable skew and 
kurtosis values. Other variables were reversed as appropriate so that increasing 
scores always indicate better performance. Neuropsychological outcome measures 
are limited to variables representative of the constructs and suitable to the target 
population in order to facilitate meaningful interpretation and remove redundancy. 
Given that MCI-LB is an emergent diagnostic category, neuropsychological 
data was firstly measured by individual outcome measure, presented below by 
domain. Univariate independent-samples t-tests were run between MCI-LB Probable 
and MCI-AD, the primary comparison of interest, to determine differences in 
neuropsychological function. One-way ANOVAs were then run between all four 
participant groups (controls, MCI-AD, MCI-LB Probable and MCI-LB Possible) to 
evaluate cognitive profile of MCI groups relative to controls. The MCI groups did not 
differ by age, but did differ by gender and NART IQ. However, analysis of covariance 
(ANCOVA) was not utilized in order to retain statistical power. Moreover, use of 
ANCOVA should be limited to situations in which the intrinsic properties of the 
population do not include the potential covariate (Miller & Chapman, 2001). That is, 
group allocation is not purely random and may be associated with greater likelihood 
of male gender and low education level in the case of MCI-LB. Forest plots were 
constructed to visually demonstrate the cognitive profile of MCI-AD and MCI-LB 
Probable relative to controls. The direction of effect sizes was reversed as 
appropriate to reflect deficits as negative effect size, for example number of errors. 
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Data was entered into an Excel effect size calculator that is freely distributed online 
by the Centre for Evaluation and Monitoring (CEM; Coe, R, retrieved from 
http://www.cem.org/effect-size-calculator). The calculator produces a bias-corrected 
ES and 95% confidence interval to estimate the difference between the two means in 
terms of the pooled estimate of SD. It is bias-corrected based on a factor provided by 
Hedges and Olkin (1985). Effect sizes and confidence intervals were plotted by 
domain (verbal learning and memory, visuospatial learning and memory, working 
memory, and executive function) and organized highest to lowest effect size for MCI-
LB Probable versus controls. Separate graphs were constructed for closer 
comparison of performance by domain.  
 
Percentiles 
The present study aimed to quantify the magnitude of difference between MCI 
groups and controls while recognizing that inter-individual variation in performance 
can be great. Thus, performance is presented in terms of effect sizes and 
significance testing as well as percentile standing based on the control data. Data 
from the control group was used to generate percentile ranking and percentage of 
each MCI group scoring at or below the 5th and 16th percentiles, which capture 
scores 1.5 and 1.0 SDs below control means, respectively. These two cut-offs are 
often used in psychometric criteria for MCI, and performance below the 5th percentile 
of controls has been considered by both clinicians and researchers as a clinically 
significant level of cognitive impairment, indicating unusually low scores (Gauthier et 
al., 2006; Litvan et al., 2012; Porter et al., 2006). Following recommendations of 
Crawford, Garthwaite, and Slick (2009), the percentage of scores that fall below the 
score of interest includes half of those obtaining the precise cut-off score.  
 
Stepwise discrimination analysis 
Following means significance testing of each individual task outcome 
measure, any variables showing significant differences between MCI-AD and MCI-LB 
probable will be entered into a stepwise discrimination analysis to determine the 
maximal differentiation between groups. Firstly, these tasks would be used to predict 
group membership including controls and, secondly, only with the MCI participants. 
The first analysis allows us to understand how the groups cluster within the overall 
neuropsychological space of the battery. The second is based on a more clinical/ 
56 
 
applied perspective to consider whether and how MCI-LB Probable can be separated 
from MCI-AD based on neuropsychological scores. 
Discriminant analysis is similar to regression analysis by creating a model that 
predicts group membership (control, MCI-LB [probable or probable and possible], 
MCI-AD) based on linear combinations of the predictors. A stepwise approach retains 
the variables that maximally separate the groups and discards variables which do not 
provide the best discrimination between groups in a step-by-step process. At each 
step, the variable that would best discriminant the groups is added and each is re-
evaluated with each subsequent addition. In SPSS, the model starts without any 
predictors and then iteratively adds the predictor with the largest F to Enter value 
above a minimum threshold (3.84; value for removal 2.71 or lower). The final model 
provides two or more functions. The first function is the most powerful “differentiating 
dimension” and “maximizes the difference between the values of the dependent 
variable. The second function maximizes the difference between the values of the 
dependent variable while controlling the first function. A weighted discriminant score 
is then calculated from the two or more functions for each participant that determines 
which group they should be assigned based on the model. Centroids are computed 
that are the mean discriminant score for each group. The model is evaluated on the 
null hypothesis that the centroids of the groups are equal, and this can be graphically 
represented. Prior to running the discriminant analysis, variables are re-checked for 
outliers and Shapiro-Wilk test is used to test assumption of normality. 
 
4.3 Results 
4.3.1 Neuropsychological results by theoretical domain 
 
All four groups were compared on task-level performance. The results of each 
task outcome measure are summarised below by cognitive domain. Descriptive 
statistics and between-group comparisons can be found in Appendix E. 
 
Verbal Learning and Memory 
As expected in the verbal domain, at least one MCI group performed more 
poorly than controls on every outcome variable except for RAVLT Proactive 
interference and the Graded Naming Test. MCI-AD performed significantly worse 
than MCI-LB Probable on short-term free recall on the RAVLT, with a medium effect 
size (g = 0.60). At the long delay recall (25 minutes), the two MCI subgroups did not 
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differ significantly. However, if quantified as the percentage recalled from their 
maximum during the learning period, MCI-AD participants recalled significantly fewer 
of at the long delay (M=38.23%, SD=35.67%) than MCI-LB (M=65.02%, 
SD=37.61%), to a large effect size (g = 0.73). The percentage recalled by MCI-LB 
Probable did not differ significantly from controls (M=71.59%, SD=19.52%). 
Retroactive interference (A6-A5) scores also differed significantly between MCI-AD 
(M=-3.72, SD=1.90) and MCI-LB Probable (M=-2.13, SD=2.60), t(46)=-2.25, p 
= .029, g = 0.70, and MCI-AD’s poorer performance versus controls was on trend, p 
=.056. Retroactive interference indicates recall at first presentation of a second list is 
impaired following the task of recalling the first list. MCI-LB Probable or Possible and 
MCI-AD performed significantly worse than controls on 6 of the 10 tasks. Statistically, 
homogeneity of variances was not confirmed for ACE Language or RAVLT Percent 
Remember at Long Delay, suggesting the significant results on these tasks must be 
interpreted cautiously. 
 
Visuospatial Learning and Memory 
In the visuospatial domain, MCI-LB Probable (M=8.08, SD=3.59) scored 
significantly worse on VPT High than MCI-AD (M=10.80, SD=2.93), p=.019, and 
controls (M=13.38, SD=3.26), p<.001. However, the effect size of this difference is 
small (g = 0.28). In the Low condition of the VPT, the difference between MCI-LB 
Probable and MCI-AD was on trend (p=.065). MCI-LB possible versus controls did 
reach significance (p = .043), with MCI-LB Possible scoring significantly lower on the 
VPT Low semantic condition (M=4.83, SD=2.69) than MCI-AD (M=8.13, SD=2.64). 
The MCI-LB Probable group also performed worse on the Pareidolia task outcome 
measures with a large effect size (g = 0.79); however, these variables are severely 
skewed in their distribution with notable ceiling/ floor effects (depending on the 
variable). Attempts at transformation were unsuccessful. As such, results of the 
comparisons are problematic to interpret. This test’s format is likely more suitable to 
categorical cut-offs based on performance. The six other measures of visuospatial 
ability did not reveal differences between MCI-LB and MCI-AD. MCI-LB Probable or 
Possible performed significantly worse than controls on all of the ten measures. In 
contrast, MCI-AD was only significantly worse than controls on three variables 
(MTCF Recall, MTCF Percent Recall and VPT High). As in the verbal domain, 
several variables did not meet homogeneity of variance assumption (ACE 
Visuospatial, VPT Ratio, Pareidolia, MTCF Copy). 
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Executive function and working memory 
In the executive domain, two tasks showed significant differences between 
MCI-AD and MCI-LB. Firstly, MCI-LB Probable produced significant fewer words in 
FAS (M=30.10, SD=15.47) than both MCI-AD (M=39.89, SD=12.22, p=.027) and 
controls (M=43.77, SD=9.84, p<.001). The significant difference between MCI-LB 
Probable and MCI-AD was large (g = 0.70). Secondly, MCI-LB has significantly lower 
Stroop interference scores using the classical formula (C-CW; Hammes, 1971) with 
the largest effect size of all of the neuropsychological comparisons (g = 1.20). 
However, when Ratio approach is used, which corrects for speed of reading, the 
effect disappears. The other seven outcome measures did not show a significant 
difference between MCI-LB Probable and MCI-AD. In comparison to controls, MCI-
LB Probable scored significantly lower on all variables except for Stroop Classical 
Interference and Digit Span Forwards (ps>.05), the latter of which is a working 
memory capacity task. MCI-AD scores were significantly lower than controls on three 
of the ten variables (Stroop CW, Stroop Ratio Interference, and Trails B). 
Homogeneity was not met via Levene’s statistic (<.05) by FAS, Trails B and Trails 
Difference. 
 
Processing Speed 
MCI-LB Probable performed significantly worse than MCI-AD on three of the 
seven processing speed measures, all related to the DSST and all with large effect 
sizes: DSST (p=.011, g = 0.83), Error Check (p=.002, g =1.09), and DSST Coding 
Time (p=.013, g = 0.83). Relative to controls, MCI-LB performance was significantly 
slower on all tasks, while MCI-AD was only impaired on three (DSST, Symbol Copy 
and DSST Coding Time). Performance on Stroop was also poorer in MCI-LB 
Probable than MCI-AD in the C (word) condition, p=.015, with a large effect size 
(0.94). Homogeneity of variance was not met by Trails A or SRT, neither of which 
showed significant differences between MCI-AD and MCI-LB Probable. 
 
MCI-LB Possible comparisons 
In several instances the difference in mean performance between MCI-LB 
Possible and controls was significant while it was not for MCI-LB probable and 
controls. For example, MCI-LB Possible scored significantly lower than controls on 
ACE Language, p = .002 (controls versus MCI-LB Probable on trend, p = .080), 
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RAVLT Percent Recalled at Long delay, p = .024 (controls versus MCI-LB Probable, 
p .847, significant difference with MCI-AD t-test), and MTCF % Retained, p = .005 
(controls versus s, p = .118; MCI-AD also lower scores than controls, p = .004).  
 
4.3.2 Forest plots of effect sizes: MCI-LB Probable and MCI-AD 
The primary comparison of interest in the present chapter is between MCI-AD 
and MCI-LB Probable, a diagnostic category with at least two clinical symptoms or 
biomarkers indicative of Lewy body disease, and thus more likely to be associated 
with LB disease than MCI-LB Possible, which requires only one symptom or 
biomarker for diagnosis. Forest plots of the effect sizes of comparisons of MCI-LB 
Probable and MCI-AD with controls are presented in figures 4-7 on the following 
pages. In the verbal domain, MCI-AD’s prominent memory impairments relative to 
controls are clearly shown by the consistently large effect sizes. MCI-LB Probable 
versus controls is less consistently significant in the verbal domain, and significant 
differences are rarely more severe than one SD below controls. In contrast, the 
processing speed domain shows a predominance of deficits in MCI-LB, with very 
large effect sizes. DSST reveals the largest impairment in MCI-LB relative to controls 
in any of the domains (g = -1.99). While processing speed and verbal learning and 
memory show clear divergence between groups, the visuospatial and executive 
function domain profiles are less clear. In visuospatial, there is clear divergence on 
pariedolias, with a large effect size in MCI-LB Probable and a nonsignificant 
comparison with MCI-AD relative to controls; however, this interpretation is limited by 
the severe ceiling effects of the variable. MCI-AD appears often similarly impaired to 
MCI-LB Probable, for example in MTCF, Trails and Digit Span Backwards.  
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Figure 4 Bias-corrected effect sizes and confidence intervals of the difference in scores by MCI subtypes (MCI with Lewy bodies and MCI with 
Alzheimer’s disease) versus controls on tasks targeting the verbal domain. Asterisks (*) indicate significance at the p < .05 level. 
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Figure 5 Bias-corrected effect sizes and confidence intervals of the difference in scores by MCI subtypes (MCI with Lewy bodies and MCI with 
Alzheimer’s disease) versus controls on tasks targeting the visuospatial domain. Asterisks (*) indicate significance at the p < .05 level. 
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Figure 6 Bias-corrected effect sizes and confidence intervals of the difference in scores by MCI subtypes (MCI with Lewy bodies and MCI with 
Alzheimer’s disease) versus controls on tasks targeting the executive function. Asterisks (*) indicate significance at the p < .05 level. 
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Figure 7 Bias-corrected effect sizes and confidence intervals of the difference in scores by MCI subtypes (MCI with Lewy bodies and MCI with 
Alzheimer’s disease) versus controls on tasks quantifying processing speed. Asterisks (*) indicate significance at the p < .05 level. 
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4.3.3 Percentiles 
 
Tables 7 and 8 show neuropsychological outcome measures expressed as the 
percentage of the patient group (MCI-LB Probable and MCI-AD) performing at or 
below the 5th and 16th percentile cut-off scores, calculated using the control data as 
reference. 
For the tests reported, almost all produced at least one outcome measure on 
which about 25–60% of the MCI-AD patient sample performed at or below 1 S.D. of 
controls (16th percentile). Particularly high proportion of MCI-AD were impaired at the 
16th percentile level on RAVLT Short Delay (77.8%) and MTCF Percent Retained 
(75.0%). In contrast, only 38.5% of MCI-LB Probable was impaired at this level 
relative to controls. At the 5th percentile level, percentages of MCI-AD impaired were 
lower (5-33%), but particularly high proportions are observed in RAVLT Max T1:T5 
(61.1%) and RAVLT Short Delay (66.7%), RAVLT Long Delay (50.0%), and RAVLT 
Percent Remembered at Long Delay (50.0%). 
In the MCI-LB Probable group, particularly high proportions perform at or 
below the 16th percentile on processing speed measures (85.7% on Trails B, 81.5% 
on Trails Difference, 92.6% DSST, and 81.5% on Symbol Copy and Coding Time). In 
the visuospatial domain, 75.0% of MCI-LB Probable were at the 16th percentile on 
VPT High, but other tasks in this domain were considerably more modest (58.3% or 
lower). Smaller proportions of MCI-LB Probable were at the 5th percentile in the 
verbal domain (3.3-40.0%) and tasks such as Graded Naming Test (3.5%), Digit 
Span Forwards (3.3%) and Backwards (0.0%), MTCF Percent Retained (3.9%).  
Substantial differences emerge in certain tasks by percentile. At the 5th 
percentile of controls, 50.0% of MCI-AD are impaired on RAVLT Long Delay versus 
only 20.7% of MCI-LB Probable. False recognition of List B also differs greatly, with 
only 3.5% of MCI-LB Probable impaired and 20.0% of MCI-AD impaired. In 
visuospatial tasks, much higher percentages of MCI-LB Probable versus MCI-AD 
occur at the 5th percentile on ACE Visuospatial (35.0% versus 13.9%), MTCF Copy 
(30.8% versus 14.3%), VPT High (66.7% versus 20.0%), VPT Low (43.8% versus 
10.0%), VPT Ratio (29.2% versus 6.7%), and Pareidolias (34.6% versus 0.0%). 
Verbal fluency (FAS), which differs significantly between groups, have 46.7% of MCI-
LB performing at or below the 5th percentile of controls in contrast to only 11.8% in 
MCI-AD. However, on MTCF Recall, almost half of MCI-AD are at the 5th percentile 
or lower than controls, and only 15.4% of MCI-LB Probable performing this poorly.  
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Table 7 5th percentile standing of MCI-Probable and MCI-AD patients (% of group). 
 MCI-LB 
Probable 
MCI-AD 
ACE-R Total 53.3 55.6 
MMSE 46.7 33.3 
ACE-Language 26.7 16.7 
RAVLT    
Max T1:T5 33.3 61.1 
“Learning” 16.7 27.8 
Short Delay 40.0 66.7 
Long Delay 20.7 50.0 
Percent Remembered at 
Long Delay (from max 
T1:T5) 
20.9 50.0 
Percent Forgetting 21.4 43.8 
Retroactive Interference 
(A6-A5) 
3.3 5.6 
Proactive Interference 
(B-A1) 
3.3 5.6 
Recognition False B 3.5 20.0 
Graded Naming Test 3.5 11.1 
ACE-Visuospatial 35.0 13.9 
Corsi blocks 39.3 22.2 
MTCF    
Copy 30.8 14.3 
Recall 15.4 41.7 
% Retained 3.9 41.7 
Visual Patterns   
High 66.7 20.0 
Low 43.8 10.0 
Ratio 29.2 6.7 
Pareidola: pareidolias 34.6 0.0 
Verbal Fluency (FAS) 46.7 22.2 
Stroop   
C 40.0 11.8 
CW 37.5 12.5 
Ratio Interference 6.3 18.8 
Trail Making Test   
A 36.7 22.2 
B 42.9 33.3 
Difference 37.0 33.3 
Ratio 22.2 16.7 
Digit Span    
Forwards 3.3 0.0 
Backwards 0.0 11.1 
DSST   
Original 37.0 16.7 
Symbol Copy 48.2 33.3 
Error Check 45.0 6.7 
Coding Time 37.0 5.6 
Reaction Time   
Simple 10.7 11.1 
Choice 25.0 5.9 
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Table 8 16th percentile standing of MCI-Probable and MCI-AD patients (% of group). 
 MCI-LB 
Probable 
MCI-AD 
ACE-R Total 61.7 58.3 
MMSE 56.7 55.6 
ACE-Language 50.0 33.3 
RAVLT    
Max T1:T5 50.0 61.1 
“Learning” 45.0 61.1 
Short Delay 58.3 77.8 
Long Delay 43.1 62.5 
Percent Remembered at 
Long Delay (from max 
T1:T5) 
27.6 53.1 
Percent Forgetting 28.6 53.1 
Retroactive Interference 
(A6-A5) 
20.0 47.2 
Proactive Interference 
(B-A1) 
36.7 11.1 
Recognition False B 51.7 46.7 
Graded Naming Test 31.0 38.9 
ACE-Visuospatial 65.0 58.3 
Corsi blocks 48.2 36.1 
MTCF    
Copy 42.3 28.6 
Recall 42.3 66.7 
% Retained 38.5 75.0 
Visual Patterns   
High 75.0 46.7 
Low 58.3 33.3 
Ratio 33.3 20 
Pareidola: pareidolias 53.9 29.4 
Verbal Fluency (FAS) 53.3 27.8 
Stroop   
C 56.0 23.5 
CW 70.8 56.3 
Ratio Interference 33.3 50.0 
Trail Making Test   
A 56.7 33.3 
B 85.7 66.7 
Difference 81.5 66.7 
Ratio 22.2 27.8 
Digit Span    
Forwards 20.0 16.7 
Backwards 40.0 38.9 
DSST   
Original 92.6 72.2 
Symbol Copy 81.5 66.7 
Error Check 65.0 20.0 
Coding Time 81.5 50.0 
Reaction Time   
Simple 46.4 27.8 
Choice 35.7 29.4 
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Twenty percent or more of MCI-LB Probable versus MCI-AD participant 
numbers are at the 5th percentile on various executive (Stroop CW) and processing 
speed (Stroop C, DSST, Error Check, Coding Time) measures. CRT similarly shows 
25.0% of MCI-LB Probable at the 5th percentile level and only 5.9% of MCI-AD. When 
looking at the higher percentiles rankings, only 7.4% of MCI-LB Probable participants 
score above the 16th percentile of controls. In contrast 27.8% of MCI-AD score above 
that cut-off. 
 
4.3.4 Discriminant analyses 
 
Table 9 Tasks showing significant differences (p < .05) between MCI-LB Probable and MCI-
AD groups, with redundant/ interrelated measures removed. 
Domain Outcome Variables 
Verbal Learning and Memory RAVLT Short Delay 
RAVLT Percent Maximum Recall at Long Delay 
RAVLT Retroactive Interference 
Visuospatial Learning and Memory VPT High 
Pareidolia 
Executive Function FAS 
Stroop C 
Stroop Classical Interference 
Processing Speed DSST 
Error Check 
Coding Time 
 
Two post-hoc stepwise discriminant analyses were next run using the 
individual neuropsychological outcome variables that showed a significant difference 
between MCI-AD and MCI-LB Probable (Table 9) to determine which measures best 
discriminate between the groups. However, Coding Time, while significantly different 
between MCI-AD and MCI-LB probable, was not entered due to the high bivariate 
correlation with DSST (r = .922, p < .001), from which it is partially derived. Pareidolia 
was likewise omitted due to the substantial floor effect. Error Check was omitted due 
to substantial missing data. Missing data points were replaced using an expectation-
maximization approach following Little’s Missing Completely at Random Test (MCAR) 
test (see Chapter 4 for full details). Absence of multicollinearity was confirmed and 
assumptions of normality were checked using the Shapiro-Wilk statistic. RAVLT Max 
Recall at Long Delay, RAVLT Retroactive Interference and VPT Ratio failed this 
assumption; however, inspection of the Q-Q plots and histograms determined near 
normality was present and enabled continuation of the discriminant analysis. 
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Table 10 Test of Equality of group means from stepwise discriminant analysis predicting 
group membership (controls, MCI-LB Probable, MCI-AD). 
 Wilks’ Lambda F df1 df2 p-value 
DSST 0.51 36.89 2 76 <.001 
VPT High 0.65 20.21 2 76 <.001 
RAVLT Short Delay 0.70 16.24 2 76 <.001 
RAVLT % Recalled at Long Delay 0.85 6.74 2 76 .002 
RAVLT Retroactive Interference 0.91 3.57 2 76 .033 
FAS 0.81 9.09 2 76 <.001 
Stroop C 0.74 13.60 2 76 <.001 
Stroop Classical Interference 0.87 5.75 2 76 .005 
 
Table 11 Wilks’ Lambda of stepwise discriminant function analysis to predict group 
membership (controls, MCI-LB Probable or MCI-AD. 
Test of Functions Wilks’ Lambda Chi-square df p-value 
1 through 2 0.42 66.15 4 <.001 
2 0.85 12.75 1 <.001 
 
MCI-LB Probable, MCI-AD and Control Discrimination 
Firstly, the stepwise discriminant analysis was run with all control subjects, 
predicting group membership as control, MCI-AD or MCI-LB Probable. The highest F 
value of the eight predictor variables was DSST, F(2,76) = 36.89, p < .001, followed 
by VPT High, F(2,76) = 20.21, p < .001. The analysis resulted in two steps showing 
the best predictors for group membership were DSST and RAVLT Short Delay (Table 
10). The other six variables were not entered into the model. The two models were 
both significant (ps < .001) and Wilks Lambdas of 0.42 and 0.85, respectively. Box’s 
M was not significant (p = .545), indicating that the data do not differ significantly from 
multivariate normal and the analysis can proceed. The eigenvalue for the first 
function (loaded only by DSST) was substantially higher than the second, suggesting 
it may be sufficient in differentiating 84.8% group variance. However, as seen in  
Table 11, both functions are significant, suggesting that function 2 may contribute 
more discriminant value above and beyond function 1. Only DSST and RAVLT Short 
Delay were retained in the model. Function 1 (-3.81 + .09[DSST] +.09[RAVLT Short 
Delay] is highly correlated with DSST (0.967). Function 2 (0.31[RAVLT Short Delay] - 
0.06[DSST]) relates to verbal memory, with RAVLT Short delay loading at 0.84.  
Graphical representation of participants by the two discrimination functions 
clearly shows separation between the control group and the MCI groups (Figure 8). 
However, there substantial overlap of the MCI subtypes around the two group 
centroids. The Prior Probabilities table (Table 12), indicates the probability of random 
allocation to a group. The likelihood was 22.8% for MCI-AD, 38.0% for MCI-LB  
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Table 12 Probability of group membership by chance. 
Figure 8 Participants (controls, MCI-LB Probable MCI-AD) plotted 
according to weighted composite scores on the two functions to predict 
group. 
Table 13 Classification result showing the correct classification 
percentages. 
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Probable, and 39.2% for controls for each group. In contrast, using the predictive 
function of the four variables, 75.9% of original grouped cases are correctly 
classified. This model is most successful in classifying Controls (87.1%), with 76.7% 
of MCI-LB cases also correctly classified. MCI-AD was only correctly classified at 
55.6% (see Table 13). The lower n in the MCI-AD group likely contributed to this low 
classification rate; however, as demonstrated graphically, MCI-AD participants range 
substantially especially along the y-axis of function 2 (RAVLT Short Delay). Literature 
suggests that a useful model should provide at least 25% improvement than random 
calculation. This occurred for all three of the groups. As such, this model appears 
substantially improved from random.  
 
Three and four group stepwise discriminant analysis without aberrant controls 
The above stepwise discriminant analyses were re-run with the removal of four 
controls with positive biomarkers associated with Lewy body disease: SUP124MM 
and SUP133SF (abnormal panel-rated DaTSCAN), SUP160VB and SUP161ED 
(abnormal MIBG). This resulted in n = 75 and was pursued to rule-out the potential 
effects of underlying LB pathology on the cognitive results. As with the original 
approach, Box’s M test was not significant and four steps were produced. The final 
models likewise retained DSST and RAVLT Short Delay in line with the findings with 
all controls. The classification results were 5.5%, 3.3% and 1.8% higher for MCI-AD, 
MCI-LB Probable and controls, respectively. Given the identical pattern of variable 
loadings, the results using all of the control subjects were carried forward into the 
analyses in later chapters.  
 
Sensitivity and Specificity between MCI-AD and MCI-LB Probable only 
Separately, the sensitivity and specificity of all eight variables for MCI-LB Probable 
were computed using receiver operating characteristic (ROC) analyses (Table 14). 
All of the ROC were significant at p < .05. Area under the ROC curve (where an area 
of 1 represents a “perfect” test in terms of sensitivity and specificity) were low for all 
outcome variables although DSST had the highest area (.729). Coordinates of the 
ROC curve were evaluated to determine cut-offs that maximized sensitivity while 
maintaining specificity at 50% or above when possible. Sensitivity of the pareidolia 
test was particularly poor. While sensitivity was highest for Stroop C (a psychomotor 
speed measure), specificities of all tests were low (50.0-66.7%).  
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Table 14 Prior probabilities, sensitivity and specificities (with cross-validation/ “leave-one-out” 
method) of the eight variables with significant difference in mean performance between MCI-
AD and MCI-LB Probable. 
Domain Outcome 
Variables 
Sensitivity Specificity Cut-Off 
Score 
Area under 
the curve 
p-
value 
Verbal Learning 
and Memory 
RAVLT Short 
Delay 
70.0% 55.6% 3.5 
(above) 
.684 .034 
RAVLT Percent 
Maximum 
Recall at Long 
Delay 
70.0% 66.7% 55.1 
(above) 
.704 .019 
RAVLT 
Retroactive 
Interference 
70.0% 61.1% -3.5 
(above) 
.693 .027 
Visuospatial 
Learning and 
Memory 
VPT High 70.0% 50.0% 9.3 
(below) 
.698 .023 
Pareidolia 
(pareidolias) 
61.5% 64.7% 39.5 
(below) 
.683 .044 
Executive 
Function 
FAS 73.3% 66.7% 38 
(below) 
.693 .027 
Stroop C 83.3% 55.6% 81.5 
(below) 
.722 .011 
Stroop Classical 
Interference 
73.3% 50.0% -52.5 
(below) 
.715 .013 
Processing 
Speed 
DSST 73.3% 50.0% 31.5 
(below) 
.729 .009 
Coding Time 73.3% 50.0% -0.4 
(below)s 
.594 .282 
 
Therefore, a stepwise discriminant analysis was run with only the MCI-AD and 
MCI-LB Probable data to determine a maximally-discriminant and specific formula for 
group determination. Again, the eight outcome variables with significant differences 
between the two groups were entered as predictors of binary group membership 
(MCI-AD, n = 18, or MCI-LB Probable, n = 30), except for Pareidolia, Coding Time 
and Error Check. All variables were significant in tests of quality of group means and 
Box’s M test was not significant (p = .700). The model resulted in entry of the same 
variables in two steps: DSST, F(1,46) = 7.98, p = .007 and RAVLT Short Delay, 
F(1,46) = 8.42, p = .001. The analysis results in the discrimination formula: -1.83+ 
0.11(DSST) - 0.22(RAVLT Short Delay). The function is most highly correlated with 
DSST (0.68) followed by RAVLT Short Delay (-0.49). The model correctly classified 
72.9% of all cases. The classification results showed the model to have 86.7% 
sensitivity but only 50% specificity for correctly classifying clinically-defined MCI-LB 
Probable. 
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4.4 Discussion 
 
The present chapter aimed to profile neuropsychological test performance in 
clinically-diagnosed MCI-LB (both Probable and Possible) and MCI-AD relative to 
healthy age-matched controls, primarily through the use of univariate analyses of the 
outcome measures from the test battery. While poorer performance relative to 
controls was anticipated, the use of forest plots, percentiles and discriminant 
analyses help to clarify the profiles of impairments in the two MCI diagnostic groups. 
From this cross-sectional work, clear differences between the MCI subtypes emerge 
that suggest that both conditions are associated with patterns of domain-level deficits 
in MCI as in their advanced dementia stages.  
 
MCI-AD show worse impairments in verbal learning and memory 
Both MCI-LB Probable and MCI-AD showed impairments relative to controls in 
the verbal domain. Both were impaired on RAVLT’s maximum recalled during 
learning trials, short delay, long delay, and percent recalled at long delay. Scores on 
the learning trials of word list tasks like the RAVLT have been previously shown to be 
very sensitive to earliest impairments in AD (Fox, Olin, Erblich, Ippen, & Schneider, 
1998). Fox et al. (1998) suggest this sensitivity relates to AD-specific pathology in the 
medial temporal lobe. MCI-AD also showed worse retroactive interference scores 
relative to controls and larger overall effect sizes in their impairments relative to 
controls. Performance by MCI-LB Probable, if significantly worse, was rarely more 
than one SD below control means. Overall, MCI-AD emerges with consistent 
impairments in the verbal learning and memory domain relative to controls, with 
medium and large effect sizes. In comparison to MCI-LB Probable, MCI-AD performs 
significantly poorer on three tests of verbal memory. Firstly, to a moderate effect size, 
MCI-AD patients remember significantly fewer words overall after short delay. The 
retention period is rather brief (the time it takes to administer the single List B 
immediate recall trial), but still relates to incidental long term memory rather than 
short term memory, as working memory is engaged and refreshed in completing the 
List B trial. Therefore, this significant finding points to impaired long term verbal 
memory in the MCI stage of AD.  
However, through the use of percentiles (section 4.3.3), my results show that a 
substantial proportion of MCI-LB Probable individuals (40%) perform at or below the 
5th percentile of control levels on the RAVLT verbal short term memory recall task. 
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This is in line with the findings on the same measure in Donaghy, Taylor, et al. 
(2018), and substantiates the conclusions by Ferman (2013), Kemp et al. (2017) and 
Yoon et al. (2015) that many DLB cases will show amnestic profiles in the MCI stage. 
However, only 20% of MCI-LB Probable perform at such a low level relative to 
controls on the long delay verbal memory test. By raw count of words recalled, the 
MCI groups did not differ significantly. That is, MCI-AD had significantly worse verbal 
memory in the long delay condition than MCI-LB Probable, but only when quantified 
as the proportion of an individual’s maximum words recalled during the “learning” 
(first five immediate recall) trials. MCI-LB Probable group was also impaired on 
ACE’s Language measure and recognition of List B at long delay, while MCI-AD was 
not. This points to impaired storage or recall ability in MCI-LB, rather than to 
encoding deficits per se. Under this interpretation, the results could suggest that the 
prominent retrieval deficit hypothesis of PD (Bronnick et al., 2011) may likewise apply 
to MCI-LB. This theory identifies memory impairments in PD as localized to retrieval 
deficits rather than impaired learning and encoding. It also now recognises a 
mediating role of executive dysfunction and poor semantic strategy use in verbal 
learning and memory (Bronnick et al., 2011). My review (Chapter 2) did suggest 
learning and encoding failures were reported frequently in MCI-LB, as in PD. 
Moreover, my results demonstrate executive function and semantic naming (Graded 
Naming Test) impairments in MCI-LB. As such, these could be considered as a 
potential mediators of verbal memory impairment in MCI-LB in future work, following 
the protocol of Bronnick et al. (2011). Bronnick et al. (2011) utilised the California 
Verbal Learning Test-2, a list-learning test highly similar to RAVLT, in PD to compute 
measures of recall, encoding, retention and recognition, as well as semantic 
clustering learning strategy use and executive function. 
Methodologically, the finding also suggests the importance of using of 
adjusted scores in memory recall tasks when attempting to target long term episodic 
memory, particularly in clinical conditions where amnesia or hippocampal damage is 
suspected. Such measures of proportion recalled at long delay have previously been 
related to AD-status (Estévez‐González, Kulisevsky, Boltes, Otermín, & García‐Sá
nchez, 2003; Gomar, Conejero-Goldberg, Davies, Goldberg, & Initiative, 2014; 
Moradi et al., 2015). Indeed, an amnestic profile is the most salient cognitive feature 
of AD and early delayed recall impairment using the RAVLT may suggest 
development of this aetiology of dementia (Estévez‐González et al., 2003; Tierney et 
al., 1996). Neurobiologically, this is consistent with higher pathological burden in the 
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hippocampus or other temporal structures (Helmstaedter & Elger, 1996; Ricci, Graef, 
Blundo, & Miller, 2012).  
The short delay trial is an uncued, free recall condition, occurring after 
immediate free recall of the second list (List B), a distractor task. Through the use of 
a distractor task, the RAVLT, like various other memory tasks, is also able to quantify 
two measures of interference. Proactive Interference captures how prior learning can 
impair memory of subsequently-presented material (Postman & Underwood, 1973). 
In contrast to Proactive Interference, Retroactive Interference relates to how delayed 
recall will be negatively impacted by learning new material afterwards. Retroactive 
Interference is therefore typically assessed immediately following the intervening 
“distractor” task. Interference in general has been suggested as related to executive 
function and memory consolidation. Participants are not informed that they will be 
asked about the first list of words again. In order to perform well on the second list, 
they much refocus their attention on the new list of words, through the use of 
executive processes such as updating. If participants are unable to complete these 
executive tasks, this would be reflected in a poorer Proactive Interference score with 
fewer list B words remember in the single free recall condition. Empirical support for 
executive function’s primary role in interference effects stems largely from work in 
patients with frontal lobe damage showing increased proactive (Gershberg & 
Shimamura, 1995; Smith & Jonides, 1999; Van der Linden, Bruyer, Roland, & Schils, 
1993) and retroactive interference (Blusewicz, Kramer, & Delmonico, 1996; Luria, 
1980), which also correlates with measures of executive function. 
Instead, in the present study, MCI-LB and MCI-AD did not differ significantly in 
Proactive Interference scores, only Short Delay recall. This suggests that the 
subsequent poorer recall of List A words is likely unrelated to poor executive function. 
While there was no evidence of exaggerated proactive interference, MCI-AD had 
significantly lower scores of Retroactive Interference. Retroactive interference has 
previously been argued to be more strongly dependent on executive skills than 
Proactive Interference, by specifically requiring shifting to previously-learned stimuli 
(Torres, Flashman, O'Leary, & Andreasen, 2001). Indeed, MCI-AD perform worse 
than controls on Stroop CW and Ratio Interference, as well as Trails B and Trails 
Ratio Interference. These outcome measures relate to inhibition and set-shifting, 
respectively. Thus, it cannot be ruled out that the significantly poorer Retroactive 
Interference are not partly due to executive dysfunction. As an alternative, 
interference has also been posited as indicative of memory consolidation and storage 
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failure, due to poor medial temporal lobe integrity (Torres et al., 2001). Retroactive 
Interference scores are dependent on the Short Delay performance (T6-T5), which 
was significantly lower than both controls and MCI-LB Probable. Thus the poor long 
term verbal memory in MCI-AD may be responsible for the derived retroactive 
interference scores. The subsequent chapter aims to elucidate these outstanding 
questions through linear regression to consider how executive function may predict 
verbal abilities such as these outcome measures.  
 
Executive Function  
In executive function, results are mixed. The magnitudes of effect size of the 
differences relative to controls are similar between the MCI subtypes on a number of 
tasks (Trails B, Stroop CW, and Digit Span Backwards). However, MCI-LB do show 
executive dysfunction versus controls on six measures: phonemic verbal fluency 
(FAS), Stroop CW, Trails B, Trails Difference and Ratio and Digit Span Backwards. 
Executive impairment is not specific to MCI-LB, however, as MCI-AD is impaired 
relative to controls on four outcome measures (Stroop CW, Stroop Ratio Interference, 
Trails B and Trails Ratio). As a differentiating variables between subtypes, MCI-LB 
does perform worse than MCI-AD on verbal fluency, with a medium-large (0.7) effect 
size. This effect size is in line with those reported in executive function in the two 
studies in MCI-LB identified in the structured review (Cagnin, Bussè, Gardini, et al., 
2015; Yoon et al., 2015). Contrary to expectation, both MCI-LB Probable and MCI-
Possible show significantly less Stroop Interference effects when calculating using 
the “Classical” method (Golden, 1978). The effect disappears using the Ratio 
calculation, however, which “corrects” for word reading speed. In conjunction with 
inspection of the descriptive statistics of these variables, this suggest that this is an 
artefact of MCI-LB having a much slower reading speed. 
Both MCI-AD and MCI-LB show impairment on the contrast of the simple and 
alternating conditions of Trails, which captures executive weighting. Simple 
difference scores (Trails Difference) and ratio indices (Trails Ratio) are the most 
common methods of this comparison (Salthouse, 2011), but larger sample sizes 
could allow for a more precise index using residuals derived after computing a 
“predicted” B score based on the A score (Salthouse, 2011). Salthouse (2011) found 
that both ratio and residual contrasts scores better “eliminated the influence of 
speed” than simple differences. In cases of smaller sample sizes, as in the present 
study, they argue that Trails Ratio has greater utility in capturing executive function 
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when residuals cannot be computed. It is thus more telling of executive dysfunction 
that both MCI-LB and MCI-AD are impaired on Trails Ratio, rather than an intact 
Trails Difference score as signalling spared function in MCI-AD. 
 Breitve et al. (2018) notes that only 11.9% (n = 8) of their DLB group were 
able to complete Trails B, versus 27.7% (n = 33) of the AD group. In the present 
study, 3 participants (2 MCI-LB Probable, 1 MCI-LB Possible) could not complete 
Trails B due to inadequate task comprehension. In addition, 6 other MCI-LB 
participants (4 MCI-LB Probable, 2 MCI-LB Possible) completed Trails B in over 300 
seconds, which is the typical cut-off time in administering the task. Participants taking 
over this time may be scored as 300 second completers or removed from the study 
(Salthouse et al., 2000). Therefore, in the present study 100% of MCI-AD participants 
could complete Trails B, while 93.2% of MCI-LB Probable or Possible complete Trails 
B at all. If excluding participants taking over 300 seconds, the MCI-LB Trails B 
completion rate drops to 79.5%. This is markedly higher than in Breitve et al. (2018), 
and it will be clarifying to quantify at follow-ups in the SUPErB study how these 
numbers will change with disease progression to dementia. It is possible that decline 
on Trails B could closely mirror to the decline from MCI to dementia in LB disease. 
As proposed by Miyake et al. (2000), executive functions may be delineated 
as relating to set-shifting, updating and inhibition. Set-shifting refers to switching 
between different task components or response rules, and this is commonly 
measured using Trails B or Trails Difference. In the sample, MCI-AD and MCI-LB 
therefore show comparable evidence of impaired set-shifting. Inhibition, in contrast, 
relates to the ability to suppress automatic (prepotent) responses in order to achieve 
the task demands. For example, in Stroop Colour-Word, the automaticity and ease of 
reading the printed word aloud must be inhibited in order to instead verbalize the 
colour of the font. Using Stroop Interference and Colour-Word Scores, the data 
suggest that both MCI-AD and MCI-LB struggle with inhibition. As discussed, the 
Stroop Classical Interference at first glance suggested superior inhibitory control by 
MCI-LB, but this was due to overall slowed speed of reading. While Classical 
Interference was problematic in this specific population, interference scores are 
generally preferable to the raw Colour-Word scores as they minimize the effects of 
differential colour processing speed, lexical access of colour words, and psychomotor 
speed in colour-word articulation (Taylor, Kornblum, Lauber, Minoshima, & Koeppe, 
1997). The Stroop Ratio Interference score was only impaired relative to controls in 
MCI-AD, thus suggesting that MCI-AD is associated with executive dysfunction, in 
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addition to its more typical amnestic profile. This has previously been demonstrated 
in both “amnestic MCI” (Kramer et al., 2006) and MCI-AD (Zhou & Jia, 2009, using 
Petersen et al. (2005) criteria).  
The last component stressed by Miyake et al. (2000), updating, requires the 
monitoring and coding of new information for task relevancy and the revising or 
removal of now irrelevant information from working memory, in order to instead retain 
the incoming information. It is thus a dynamic management of working memory 
content, rather than passive storage (Miyake et al., 2000). Updating is traditionally 
captured using N-back tests, which were not included in the present study. However, 
the Continuous Performance Test-AX was included in the battery and has been used 
previously to consider the interplay of updating and task-switching (Kessler, 
Baruchin, & Bouhsira-Sabag, 2017). Analysis of the task may be able to more 
precisely delineate poor inhibition versus other failures of executive function and 
attention failures, such as updating and attentional lapses. This will be analysed and 
discussed in Chapter 6. However, Digit Span Backwards both taxes working memory 
and requires active updating and working memory manipulation. On this task, MCI-
LB Probable and Possible performed had significantly worse recall than controls, 
suggesting poor updating. This did not occur in MCI-AD. 
Working memory maintenance is also sometimes considered alongside 
Miyake et al.’s (2000) model as an executive function requiring active maintenance of 
information across a short delay. In contrast to updating, however, this does not 
involve active manipulation. This is often operationalized by Digit Span Forward, 
indicative of the capacity the phonological loop (Bull, Espy, & Wiebe, 2008).  The 
results suggest “normal” capacity or integrity of this component in both MCI subtypes.  
Executive dysfunction has been posited as especially prominent in LBD 
(Ballard et al., 2002), although the results of the present chapter are mixed.  The 
comparisons in Stroop CW and Digit Span Backwards were not significant in contrast 
to Cagnin et al. (2015) and Yoon et al. (2015). MCI-LB are impaired in verbal fluency, 
however, relative to both MCI-AD and controls. Cagnin, Bussè, Gardini, et al. (2015) 
and Jicha et al. (2010) likewise found verbal fluency impairments in that group. 
However, Snyder, Miyake, and Hankin (2015), cautions that FAS is a less specific 
tool, and more precise measurements within the task should be utilized to 
disentangle executive subcomponents. For example, FAS can be scored based on 
switching (transitions between subcategories), clustering, or weighted scores 
encompassing these multiple elements of performance.  
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Taken together, a divergent patterns of impairment is not as immediately clear 
in executive function domain as verbal learning and memory or processing speed. 
However, by breaking down executive scores by components following Miyake et al. 
(2000) and Snyder et al. (2015), we can see that MCI-LB shows dysfunction in 
updating relative to controls, while MCI-AD does not. There remains substantial 
overlap in profile in this domain, however, as both subtypes are impaired in set-
shifting and inhibition. Working memory maintenance/ capacity appears to be intact 
in both aetiologies at this stage in disease. MCI-AD, while hypothesized to be 
characterised by a verbal amnestic cognitive profile, also shows clear executive 
dysfunction.  
 
Processing Speed and Attention 
While MCI-AD showed pronounced deficits relative to both controls and MCI-
LB Probable in the verbal domain, MCI-LB Probable show a consistent profile of 
slowed processing speed. MCI-LB Probable performed worse than controls on CRT, 
DSST, Symbol Copy, Error Check, Coding Time, and Trails A. Relative to MCI-AD, 
their performance was also significantly worse in DSST, Coding Time, Error Check 
and Stroop C (word reading). MCI-LB Probable performance on Trails A was no 
worse than MCI-AD; this stands in contrast to Cagnin, Bussè, Gardini, et al. (2015). 
Brønnick, Breitve, Rongve, and Aarsland (2016) also showed significantly worse 
performance on Trails A at baseline in mild probable DLB versus mild AD. In the 
longitudinal continuation of that same cohort, Breitve et al. (2018) demonstrated that 
Trails A performance declined more rapidly at follow up in mild probable DLB than 
mild AD, after adjusting for age, sex and education. Breitve et al. (2018) correctly 
suggest that Trails A is “relatively cognitively undemanding and motor tempo 
determines the performance to a degree”. 
Processing speed is believed to be a distinct concept yet interrelated with 
working memory and executive function (Luszcz & Bryan, 1999). It is conceptualized 
as the domain-general speed of execution of basic cognitive functions (Nebes et al., 
2000). It therefore limits the completion of higher-order activities, such as memory 
formation (Salthouse, 1992), that depend on basic operations to occur before the 
information held in working memory decays (Craik & Salthouse, 2011). The domain-
general decline of processing speed has long been suggested as the likeliest factor 
in cognitive decline in ageing (Nebes et al., 2000; Salthouse, 1996b).  
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In neuropsychological research, there is a generally-accepted division in 
processing speed tasks that target psychomotor speed versus cognitive speed (Kail 
& Salthouse, 1994; Salthouse & Coon, 1993). Psychomotor speed, sometimes called 
sensorimotor speed or sensory-motor processes, are more motor-dependent and 
based on the time to complete a repetitive, motor-based task. Cognitive speed, in 
contrast, is generally measured using substitution or comparison tasks, like the 
DSST. Following the distinction in processing speed tasks outline above, Trails A can 
be taken as a psychomotor task. The other psychomotor processing speed tasks, like 
SRT and CRT, likewise did not show a significant difference between groups. 
Conversely, the largest effect size between an MCI subtype and controls was in 
DSST, a cognitive speed task, with MCI-LB Probable performing on average two SDs 
below the controls. MCI-AD was also impaired relative to controls on DSST and 
Coding Time (the only two processing speed tasks with a significantly worse score 
versus controls). The latter variable is derived from DSST and Symbol Copy to 
remove the role of graphomotor control in completion of the DSST. In this way, 
Coding Time specifically attempts to further isolate the cognitive processing speed 
from than the psychomotor processing speed. Taken together, this suggests 
cognitive speed and not the psychomotor component of processing speed tasks may 
be the impaired component in MCI-LB.  
The DSST used extensively in clinical and research settings as a sensitive 
measure of processing speed (Salthouse, 1992; Van der Elst, van Boxtel, van 
Breukelen, & Jolles, 2006). There is no doubt that processing speed is involved in the 
task: early work by Salthouse (1992) demonstrated that controlling for performance 
on a simple speed test removed 95% of the age-related variance in DSST. However, 
the DSST clearly necessitates other resources including graphomotor and perceptual 
speed, as well as potential executive function and memory components (Joy, Kaplan, 
& Fein, 2004; Van der Elst et al., 2006). Variations of DSST have been developed to 
delineate the processes involved. Symbol Copy (Kaplan, Fein, Morris, & Delis, 1991), 
performance on which MCI subtypes did not differ significantly, intends to isolate 
DSST’s graphomotor component (Joy et al., 2000). Coding Time, calculated as the 
time per item in DSST minus the time per item in Symbol Copy, is conceptualized as 
a purer measure of processing speed similar to Error Check (Nebes et al., 2000); 
however, both variables includes visual scanning time in addition to mental operation 
time (Joy et al., 2003). Another test variant, Error Check, was first developed by Joy 
et al. (2000) to capture the coding processes involved in DSST without graphomotor 
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demands. In the present study, MCI-LB Probable were found to be significantly slow 
in completing Error Check. That Error Check and not Symbol Copy was differentially 
impaired in MCI-LB versus MCI-AD suggest that it is indeed cognitive speed, and not 
motor speed, that is the differentially impaired resource in MCI-LB.  
The multifactorial nature of DSST and the evidence of its association with 
neurological dysfunction make it a useful exploratory tool in the study of ageing and 
MCI. Executive functions can also be investigated using the DSST, to consider the 
possibility that it is executive weighting and not speed of processing per se that is 
associated with higher-order impairments in MCI. My review of early PD showed that 
patients perform poorly on tasks with executive weighting, regardless of which 
domain they appear to target (working memory, processing speed, visuospatial and 
verbal learning), and despite general intact performance on simpler tasks in those 
domains (Trails A, RAVLT). In the wider literature, declines in executive function have 
been proposed more recently as intrinsic to cognitive healthy ageing and AD 
(Buckner, 2004), while executive dysfunction is considered a hallmark of DLB 
(Collerton et al., 2003; Foltynie et al., 2004; Muslimović et al., 2005) Therefore, it is 
important to consider the interplay of processing speed and executive function in the 
neuropsychological function of MCI-LB. The hypothesis that cognitive, not 
psychomotor speed nor executive deficits, is the critical factor in impairment in MCI-
LB can be further investigated through more subtle analyses of the DSST and its 
variants, and will be pursued in Chapter 5. 
 
Visuospatial 
In the visuospatial domain, MCI-LB Probable performs significantly worse than 
controls on all but one measure while MCI-AD showed less consistently significant 
differences, with smaller effect sizes in only three of the nine outcome measures. 
MCI-LB Probable, relative to controls, demonstrated poor general visuospatial 
estimates (ACE Visuospatial), visuospatial working memory (Corsi Blocks), 
visuoconstruction (MTCF Copy, VPT High and Low), visuospatial memory (MTCF 
recall and as quantified as percent copy score and recall), and visuoperception 
(Pareidolias). MCI-LB Probable performed significantly worse than MCI-AD on only 
pareidolias and VPT High. Therefore, this is a more modest profile of impairment 
than reported by Cagnin et al. (2015), who showed significantly worse scores on 
visuospatial and visuoconstructive tests as well, although with small to medium effect 
sizes.  
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Relative to controls, MCI-LB, and not MCI-AD, showed impaired 
visuoconstructive ability. Poor visuoconstructive skills have previously been shown to 
predict quicker cognitive decline and more severe visual hallucinations in DLB 
(Hamilton et al., 2008). In conjunction with the results showing complex figure 
impairments in the MCI stage in LB, such tasks may serve an important role in 
charting trajectories of decline. Both MCI groups show poorer visuospatial memory 
than controls, even when controlling for copy scores. The effect size in MCI-AD in 
MTCF recall are larger than MCI-AD performance (percent copy score at recall), but 
the scores do not differ significantly between subtypes. The author was unable to 
identify any published studies that used the MTCF in DLB or MCI-LB, and very few 
studies in MCI generally. Paula, Costa, Andrade, Ávila, and Malloy-Diniz (2016) used 
a simplified version if the MTCF test and similarly found multidomain amnestic MCI 
participants were impaired relative to single domain amnestic MCI in figure copying, 
but no difference between MCI groups in recall. The ROCF is used more regularly in 
neuropsychological studies, and copy impairments relative to AD have been 
previously demonstrated by Cagnin, Bussè, Jelcic, et al. (2015) in MCI-LB and 
Ferman, Smith, Boeve, Graff-Radford, Lucas, Knopman, Petersen, Ivnik, Wszolek, 
and Uitti (2006) in established DLB. 
Methodologically, use of the MTCF may have been confounded. Due to the 
large battery of cognitive tests and rigorous schedule of the SUPErB study in 
general, the retention interval before incidental recall was typically filled with other 
cognitive tests or questionnaires. In the validating study, an unchallenging, self-report 
“quality of life” questionnaire was used (Hubley & Tremblay (2002). Moreover, we did 
not include an immediate incidental recall condition in order to keep participants 
unaware of the recall that as to occur at the long delay condition. This procedure was 
chosen as the primary construct of interest was long term visuospatial memory, but 
immediate incidental recall helps to consolidate long term memory. This would 
conceivably make long delay recall easier, although this might not apply to MCI-AD 
due to the characteristic hippocampal atrophy. Thus, long delay recall after an 
immediate recall trial may actually magnify differences between MCI-LB and MCI-AD. 
By omitting immediate recall, the results should be a more conservative estimate of 
effect size of long term visuospatial memory deficits in MCI-AD. The deficits were 
larger, by effect size, than MCI-AD, but not to statistical significance. 
The largest effect size in MCI-LB Probable relative to controls (bias-corrected 
d = -1.18) occurred in Corsi Blocks, on which MCI-AD was not impaired. This task 
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tests spatial-sequential visuospatial working memory in the forward direction only. It 
is used frequently as a core test of sequential spatial working memory with limited 
demand on executive functions and motor ability. This finding runs somewhat 
contrary to results from my structured review of findings in early and MCI-PD, in 
which visuospatial working memory was less frequently reported as impaired versus 
visuospatial memory or visuoconstruction. In more complex tasks like figure copying 
and the VPT, it is difficult to firmly attribute deficits to core components of visuospatial 
working memory as executive functions such as sustained attention, planning and 
organization and verbal coding are more likely to be automatically involved in their 
execution (Shin et al., 2006). Corsi Blocks is less easily reducible to other cognitive 
processes. The findings of the present study therefore provide evidence for 
impairments in more complex visuoconstructive and visuospatial working memory 
and long-term memory tasks, as well as core visuospatial working memory 
components.  
However, evidence from multi-resource models indicate that both spatial and 
visual working memory tasks like MTCF, VPT and Corsi are supported by executive 
function (Thompson et al., 2006). Moreover, research indicates that the visuospatial 
domain is especially dependent on executive processes in spatial information storage 
and processing (Fisk & Sharp, 2003; Miyake, 2001; Vandierendonck, Kemps, 
Fastame, & Szmalec, 2004). This is in contrast to verbal working memory, which has 
been shown to be more automatic and amenable to distinction between executive 
and slave processes (Fisk & Sharp, 2003). The verbal domain of working memory 
should be considered when interpreting visuospatial results as well, nevertheless. In 
addition to failures in executive functions and the episodic buffer, a lack of 
verbalization of visuospatial information may result in poor performance. There is 
considerable debate regarding translation of visuospatial information into verbal 
storage; however, Baddeley (2000) reminds that, “because of the efficiency of the 
phonological store in serial recall, adult subjects typically opt to name and subvocally 
rehearse visually presented items, thereby transferring the information from a visual 
to an auditory code” (p. 419). Research demonstrating that articulatory-suppression 
tasks interfere with performance in purported visuospatial tasks, such as Reverse 
Corsi Block, especially at higher-loads, supports this idea (Baddeley, 2000b; 
Vandierendonck et al., 2004). As discussed with processing speed, multivariate 
statistical techniques can be utilized to disentangle the contribution of these 
components in normal ageing (healthy control group) and pathology (MCI-AD and 
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MCI-LB. Chapter four will consider the potential role of a hierarchy of deficits and 
semantic scaffolding in execution of the visuospatial tasks. 
Given the findings by Brønnick et al. (2016), we would have expected 
visuoperception to be similar in MCI-LB and MCI-AD, despite the poorer 
visuoconstructive abilities of MCI-LB. However, MCI-LB Probable reported 
significantly more pareidolic illusions than both MCI-AD and controls. A third of MCI-
LB Probable participants performed at or below the 5th percentile of controls, while no 
MCI-AD participants did. However, as mentioned previously, this variable was 
extremely skewed. It shows a strong floor effect with 55% of participants receiving a 
score of zero. Transformations were attempted but unsuccessful in correcting for this, 
so it was deemed inappropriate for use in the multivariate analyses of forthcoming 
chapters. However, with further validation, the Pareidolia task could provide useful as 
a classifying variable using a predetermined cut-off, as demonstrated by existing 
work, predominantly out of Japan. Variants of the task have previously been shown 
to be powerful in discriminating between DLB and AD using ROC-determined optimal 
cut-off scores (81% sensitivity, 92% specificity; Mamiya et al., 2016). Yokoi et al. 
(2014) found a sensitivity of 0.71 and specificity of .80 when using a 2.5% cut-off for 
illusory responses in the same face pareidolia task used herein. This test was also 
found to correlate significantly with the total, severity and frequency scores of the NPI 
hallucination scale and an additional domain created for the study to quantify 
fluctuation. Pareidolia is an experimental task and its full analysis is outside of the 
scope of the present PhD, but future work could consider whether it could be 
harnessed for use in the context of MCI-LB, despite its problematic psychometric 
properties. 
 
Percentiles 
The use of percentile rankings, in addition to univariate analyses and forest 
plots by domain, allowed consideration of the individual differences in performance 
across measures. If only comparing scores between groups, interindividual variability 
can increase statistical variation In MCI-LB Probable, for example, three quarters of 
the group perform at least one SD below controls on VPT High, but other visuospatial 
tasks show more modest proportions of the group so impaired. In MCI-AD, about 25–
60% of participants scored at or below least one SD of control means. Particularly 
high proportion of MCI-AD were impaired at the 16th percentile level on RAVLT Short 
Delay (77.8%) and MTCF Percent Retained (75.0%). In the MCI-LB Probable group, 
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particularly high proportions perform at or below the 16th percentile on processing 
speed measures (Trails B, Trails Difference, DSST, Symbol Copy, and Coding Time).  
Moreover, certain tasks, while not differing significantly between subtypes, are 
associated with substantially different proportions of participants performing at or 
below cut off values. For example, MCI-LB Probable and Possible did not differ 
significantly in CRT mean response time with MCI-AD. However, at the 16th 
percentile of controls, only 7.4% of MCI-LB Probable participants score above this 
level, in contrast to 27.8% of MCI-AD participants. MCI subtypes were previously 
typically diagnosed to reflect MCI neuropsychological heterogeneity. Firstly, MCI was 
classified as amnestic and non-amnestic, depending on the degree of memory 
dysfunction (Donaghy & McKeith, 2014). The amnestic subtype has a high rate of 
progression to AD or vascular dementia, while non-amnestic MCI patients with 
deficits in other domains are more likely to convert to DLB, vascular or frontotemporal 
dementias (Ferman et al., 2011). The amnestic and nonamnestic MCI subtypes can 
be further differentiated based on whether other domains are impacted, i.e. single or 
multiple domain (Petersen et al., 2001). In the present study, clinical diagnoses were 
instead used, per emergent criteria from the DLB Consortium (McKeith et al., 2017) 
and in order to avoid circularity when focusing on neuropsychological performance. 
However, it would be illuminating to consider how the patients would be subdivided 
following the older neuropsychological criteria. Similarly, clinical or demographic traits 
may be shared by the participants scoring in the lower percentile cut-offs (Gallagher, 
Gray, Watson, Young, & Ferrier, 2014). These could relate to MCI disease-state 
specifically or perhaps reveal important characteristics impacting performance, such 
as motivation. 
Percentiles were utilised in addition to between-group comparisons to permit a 
more in-depth exploration of the data that highlighted interindividual variation in the 
patient groups. It is also important to acknowledge that HCs are also likely to vary in 
performing at “impaired” levels at various tasks, and that overestimation of “normal” 
score levels can overestimate impairments in patients. Despite clinical assessment 
and global neuropsychological scores indicating normal cognitive status, some 
control participants will perform at “abnormal” levels according to normative data. 
Brooks et al. (2008), for example, found that healthy older adults frequently had at 
least one impaired memory score below the 5th percentile. However, this does not 
necessarily indicate impairment of a neural basis, but rather demonstrates the risk of 
“false positive” MCI (Binder, Iverson, & Brooks, 2009; Brooks et al., 2008). Future 
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work could take control variability into consideration by comparing performance of the 
study’s sample of healthy controls with the extent of impairment that can be 
reasonably expected in a healthy control group, using methods such as Monte Carlo 
simulation as suggested by Crawford, Garthwaite, and Gault (2007). These issues 
also illustrate that there is a risk of overestimating deficits in patients, whether in the 
clinic or in research, when using single tests to represent a domain (Brooks et al., 
2008). Chapter 5 will instead attempt to create data-driven composite scores, which 
also benefits from capturing the breadth of the domains more fully. 
 
Discriminant analyses 
Despite the discussion of the clear differences in performance between MCI 
subtypes in multiple domains, it is important to recognize that there is limited 
discriminant power of the neuropsychological tasks in isolation from clinical data. This 
was evidenced by the results of the stepwise and individually-run discriminant 
analyses. The DSST emerged as the most potent predictor of group allocation in 
both the three-way (including controls) and MCI subtype-only stepwise discriminant 
analyses, in line with my argument that processing speed is a critical determinant of 
cognition in MCI-LB. The eigenvalue for the first function was loaded only by DSST 
and was substantially higher than the second in both cases, suggesting it may be 
sufficient in differentiating the groups. However, the resulting classification results of 
both models remained low (75.9% and 72.9%, respectively). This is in line with 
findings from the LewyPro study that preceded the present work in SUPErB 
(Donaghy, Taylor, et al., 2018). Donaghy, Taylor, et al. (2018) entered the tasks that 
differed between subtypes (ACE-R fluency, ACE-R visuospatial, digit vigilance [mean 
reaction time], and angle discrimination [visuoperceptive]). These tasks that differ 
between MCI groups are congruent with the present study, although the testing 
battery was not identical. The results are similar in retaining visuospatial and 
processing/ attentional measures. However, Donaghy, Taylor, et al. (2018) concludes 
that,  
“the heterogeneity of cognitive impairment observed in MCI-LB and MCI-AD was 
reflected in the poor discriminant ability of four cognitive tests. Thus, though a 
pattern of prominent executive and visuospatial dysfunction is supportive of a 
diagnosis of MCI-LB, it is not sufficient to warrant a diagnosis of MCI-LB in 
isolation. This illustrates the supportive role of neuropsychological assessment in 
the diagnosis of MCI-LB in combination with a thorough clinical assessment for 
other features associated with Lewy body disease” (p. 5).  
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Limitations 
The analyses of the present chapter have several limitations that should be 
noted. Firstly, and applicable to subsequent chapters, the MCI-AD group is limited in 
size (18 participants). Statistical power in MCI subtype comparisons may therefore be 
limited. While differentiating between cognitive performance in MCI-AD and MCI-LB 
is an aim of this thesis, comparisons between MCI-LB and controls will be discussed 
in detail. Similarly, this chapter used univariate approaches to compare mean 
performance between groups. Despite the large number of univariate analyses 
performed, corrections for multiple comparisons was not pursued. This was due to 
the exploratory nature of these patient groups, but this increases the chance of type 
1 errors. Therefore, multivariate approaches will be primarily utilized hereafter. Prior 
to this, PCA will be run to attempt to reduce redundancy in the large dataset.  
Another important limitation concerns diagnostics. The cross-sectional nature 
of this study and the use of emergent criteria means that some diagnoses will likely 
be changed at follow up. The specificity and sensitivity of MCI-LB diagnostic criteria 
remains unclear. Moreover, four control subjects demonstrated possible Lewy 
pathology via biomarker testing. While these imaging results are questionable, their 
clinical examinations had pointed to “healthy” cognitive statuses. Nevertheless, the 
discriminant analyses were re-run having excluded these participants, and no 
substantial differences emerged. If these participants do have latent LB disease, it 
would be only in the early stages and likely present only in the heart or brainstem, as 
captured by the FP-CIT and MIBG images, rather than in the higher cortical areas.  
The longitudinal design of the SUPErB study should provide clarification on 
these issues, however. Such studies are much-needed in DLB to understand which 
neuropsychological declines may signal higher likelihood or speed of progression to 
dementia. Yoon et al. (2015) reported such findings. Their MCI-LB group developed 
DLB with an average follow-up period of 4.9 years. In comparison with a stable MCI 
group (non-converters), converters performed worse at baseline in the domains of 
visuospatial ability and memory (ROCF recognition and copy), executive function 
(Stroop Colour, Verbal Fluency), working memory/ attention (Digit Span Forwards 
and Backwards), and verbal learning and memory (Seoul Verbal Learning Test 
delayed recall). The same or similar tasks were used in the present study, and it will 
be elucidating to track how they relate to participants’ status at follow-up over the 
coming years. 
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Conclusions and next steps  
As discussed in chapter two, advances in neuroimaging and other methods of 
identifying biomarkers in vivo are greatly accelerating diagnostics in the MCI stage; 
nevertheless, neuropsychological measurement remains a critical tool in 
neurodegeneration research and clinical practice (Smith & Bondi, 2013). My results 
show that the cognitive impairment typical of established Lewy body disease and AD 
is evident in the MCI phase in patients diagnosed clinically. In line with the limited 
retrospective work in MCI-LB, this group shows impaired attention, visuospatial and 
executive function (Cagnin, Bussè, Gardini, et al., 2015; Jicha et al., 2010; Yoon et 
al., 2015). MCI-AD is associated with verbal learning and memory deficits, although 
there is likewise evidence of executive dysfunction and slowed cognitive speed. The 
use of traditional significance testing alongside effect sizes, percentile standings and 
discriminant analysis permitted a more in-depth analysis of neuropsychological data 
in the current chapter. 
Overall, the findings of poorer visuospatial and executive ability in MCI-LB 
than MCI-AD is in line with previous work (Alescio-Lautier et al., 2007; Cagnin, 
Bussè, Gardini, et al., 2015; Donaghy, Taylor, et al., 2018). However, processing 
speed emerged as the most potent differentiator of MCI-LB Probable from both 
controls and MCI-AD, suggesting that processing speed may offer additional value in 
understanding and recognizing cognitive impairment in the MCI stages of disease. 
The following chapters will attempt to disentangle the contribution the domain-
general resources of processing speed and executive function to higher-order 
cognitive activities such as visuospatial function, long term visual memory, and verbal 
learning and memory. 
Analyses were run in the present study with MCI-LB Possible as well for 
completeness. However, the interpretation focussed on the MCI-LB Probable 
diagnostic category as it is more robustly representative of LB disease by definition. 
MCI-LB Probable are very unlikely to be the “worried well,” that is, misdiagnosed 
control subjects, because they have confirmed clinical symptoms. MCI-LB Possible 
and MCI-AD, on the other hand, have less demonstrable clinical symptoms of either 
aetiology. The interpretation of MCI-LB Possible relative to MCI-LB Probable remains 
to be clarified, and this will be best achieved during longitudinal follow up, when the 
potential progression of biomarkers and symptoms in these patients will become 
clear. It will be intriguing to consider whether MCI-LB Possible should be considered 
as a milder form of MCI-LB Probable or, alternatively, if it captures a more highly 
88 
 
heterogeneous group than MCI-LB Probable, consisting of a mixture of individuals 
likely to convert to DLB, those that remain “stable” MCI cases, or even those who 
revert to normal cognition (“false positive” MCI). MCI-AD, on the other hand, had the 
highest proportion of misclassification in my stepwise discriminant analysis. There is 
an a priori expectation that some MCI-AD participants will be revealed at follow-up to 
be stable MCI, demonstrate “normal” cognitive status or show LB pathology. For 
these reasons, MCI-LB Probable will continue to be the primary group of interest in 
the present study as they are the most representative of the underlying pathology of 
interest. Instances in which MCI-LB Probable and MCI-AD do differ significantly 
(despite the potential presence of LB pathology in a large proportion of MCI-AD) may 
indicate especially salient neuropsychological effects of LB disease. 
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Chapter Five: The component structure of cognitive performance in 
MCI and healthy older controls 
 
5.1 Introduction 
Overview 
In Chapter Four, univariate analyses of outcome variables from the battery 
provided understanding of the neuropsychological profiles of the patient subgroups 
broadly. In particular, the emergent classification of MCI-LB Probable was clarified 
through visualization using forest plots and discriminant analyses relative to age-
matched healthy controls and MCI-AD. Processing speed emerged as particularly 
impaired in MCI-LB: their worse performance on DSST relative to controls had the 
largest effect size of all the tasks (g = -1.99), and the second largest effect size 
relative to MCI-AD (g = -1.20). Particularly high percentages of MCI-LB Probable 
performed at or below the 16th percentile of control performance in multiple 
processing speed indices. MCI-LB was also observed to have impairments in 
executive and visuospatial abilities.  
 
Data reduction techniques 
The use of a comprehensive neuropsychological battery of established, 
standard measures, as well as a few more experimental tasks (VPT, Pareidolia Test), 
resulted in a large number of outcome variables in the present study. Use of a 
comprehensive battery of neuropsychological tests, while useful to capture the 
breadth of the domains, poses several methodological challenges. Firstly, a large 
number of variables can make more advanced modelling unwieldy and requires 
substantial correction for multiple comparisons, reducing power. The univariate 
analyses of Chapter Three, for example, were not corrected for the high number of 
ANOVAs and independent samples t-tests performed. Multivariate techniques, such 
as hierarchical linear modelling, will also benefit from the use of targeted 
neuropsychological variables in order to retain power. Secondly, a large number of 
tests can be unwieldy to report in entirety in journal articles and may result in 
selection biases in presenting only significant results. Thirdly, the use of large 
batteries can often lead to contradictory findings within domains. However, by 
omitting tasks the breadth of a domain construct may be lost. Executive function, for 
example, involves multiple components including set-shifting, updating, and 
monitoring (Miyake et al., 2000). These may therefore not be reliably and validly 
captured by any single executive function outcome measure. The use of composite 
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domain scores may help to overcome these methodological challenges. Composites 
have been suggested to help bypass task idiosyncrasy, avoid multiple comparisons, 
and increase the power of detection of cognitive change (Crane et al., 2012; Gibbons 
et al., 2012). This approach is advantageous in terms of reducing large datasets into 
manageable variables for multivariate analyses and facilitating comparisons between 
studies.  
A common technique of composite scores is to use of a priori determined 
domains. Composites are derived from variables grouped by theory-driven 
assumptions of the task outcome variables and the domain itself. Composites are 
typically operationalized as average z-scores of a number of variables to retain the 
facets of the domain. Alternatively, a data-driven approach can be a more 
sophisticated method of reducing redundancy, in a bottom-up manner. The data may 
reveal to be organized analogous to the a priori domain assumptions and one can be 
more confident in the appropriateness of these groupings. Moreover, in a data-driven 
approach the process of determining the composites itself can be illuminating: 
performed iteratively and both using the sample as a whole and separately by 
subgroup, the procedure offers insight on underlying factor structure of 
neuropsychological performance. 
The present chapter therefore analysed the neuropsychological data using 
principal components analysis (PCA). PCA is a multivariate data reduction technique 
to extract the crucial data and reduce redundancy from a dataset by using a smaller 
number of linear combinations that captures the more numerous correlations among 
a set of variables (Abdi & Williams, 2010). Mathematically, PCA minimizes the sum of 
the squared perpendicular distances to the axis of the principal component (Truxillo, 
2003). This is achieved by transformation of data to a coordinate system that places 
the largest linear combination of data variance on the first dimension, the second 
largest on the second dimension, and so on. (Rodríguez, de Paz, Rocha, & Riverola, 
2008). Principal components produced by the PCA are composites of original 
variables, weighted to contain both common and unique variance. These methods of 
combination retain maximal variance from the original variables, but each composite 
ultimately includes weighting from all entered items. Instead, the variables identified 
as loading together will be used to manually create unweighted composites (average 
z-scores). The PCA will be employed using an iterative method in which variables are 
selectively removed and added to determine how tests of interest may change 
loadings on the components. When performed by whole sample and separately by 
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subgroup, PCA can therefore demonstrate whether the processes that are 
particularly consequential in neuropsychological performance differ by group. 
 
Rotation methods in PCA 
In factor analysis, one of the primary decisions is the type of rotation used, as 
this will impact how the extracted components are interpreted. Rotation in factor 
analyses like PCA optimizes the factor structure so that the importance of the 
extracted factors is equalized (Field, 2009). There are two primary approaches to 
rotation used in PCA, with ongoing debate as two which is most useful, orthogonal or 
oblique (Field, 2009; Stevens, 2002). While each of the two approaches has multiple 
methods of implementation, the two primarily used are Varimax (orthogonal) and 
direct Oblimin (oblique).  
Varimax rotation (Kaiser, 1958) is the most popular rotation method in PCA 
(Abdi & Williams, 2010). The method iteratively searches for a model in which the 
linear combination of retained variables maximizes the variance of the squared 
loadings (Abdi & Williams, 2010). It prioritizes the creation of factors that are as 
independent as possible from others. The variables that are retained will load very 
highly onto only one component. Each component will be loaded by generally a fewer 
number of these highly-loaded variables, and the remaining variables will load by 
zero or to a very small amount. Component matrices in PCAs run with Varimax 
rotation are hence more readily interpretable: each variable will only be associated 
with one component, and each component includes a smaller number of variables. 
This allows for useful, theoretical distinction between the components; however, this 
is at the expense of minimizing the representation of potential, complex 
interrelationships between the cognitive processes. 
In contrast to Varimax rotation, Oblimin rotation results in a model that permits 
correlation between the extracted factors. The procedure results in two matrices: 
pattern and structure. The pattern matrix shows the loadings of each variable on a 
component after removal of the influence of other variables. In contrast, the structure 
matrix provides the unadjusted factor loading coefficients of each variable. Therefore, 
if the factors are independent, i.e. orthogonal, the pattern and structure matrices will 
match. Divergence between the matrices is also useful in illustrating where variables/ 
factors load across the data rather than stand independently. Indeed, the expectation 
in neuropsychology is substantial interdependence between cognitive processes 
(Field, 2009).  
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These differing techniques provide an opportunity for a process by which both 
the orthogonal and oblique rotation methods are used and compared towards 
development of a final, stable model in which the two methods converge. This 
method has been recommended by several authors (Pedhazur & Pedhazur 
Schmelkin, 1991; Stevens, 2002)  as serving to create “interpretable composite 
scores for use in subsequent regression analyses” while also better understanding 
the “factor structure underlying the tests and processes employed” through the 
iterative process. Using Oblimin rotation, variables with multiple loadings across the 
factors will be iteratively removed, with the strengths of the factor re-assessed at 
each step. Attention will be paid to whether certain processes or variables emerge as 
important in the data structure, perhaps by loading across multiple factors. Through 
process, factors of increasing independence will be produced until the pattern and 
structure matrices of the Oblimin matrix will converge. At this point, by definition, the 
model will be orthogonal, and thus identical to the Varimax rotation solution in terms 
of which variables load onto which factors.   
This approach thus offers two important opportunities for data analyses. 
Firstly, the robust dataset will be reduced to interpretable composite scores informed 
by the data and for use in subsequent regression analyses. Secondly, by comparing 
the two rotation methods, the interrelatedness of the tests and processes targeted by 
the variables will be better understood. However, given that this is a data-driven 
approach, with the above-mentioned advantages in understanding this novel patient 
group, use of the resulting factors involves subjective interpretation by the 
researcher. The components are interpreted in an attempt to accurately capture the 
breadth of clustered variables, but such readings are subjective and likely 
incomplete.  
5.2 Methods 
 
Materials and participants 
The neuropsychological tasks, outcome measures, and administration 
procedures are described in Chapter 4.2. All outcome variables were assessed for 
appropriateness for use in the PCA (described below). PCAs were attempted both as 
the entire group (n = 93; controls, MCI-AD and MCI-LB Probable and Possible) and 
separately by subgroup (controls [n = 31], MCI-AD [n = 18] and MCI-LB Probable [n = 
30]). See Chapter Two for full description of participants.  
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Data cleaning and assessment 
 
Following recommendations of Field (2009) and Stevens (2002), the data 
were firstly cleaned for use in the PCA. Of tests with multiple possible outcome 
measures, only the most representative of specific cognitive processes were 
extracted. The RAVLT in particular produces a large number of outcome variables. 
Because of the anticipated relevancy of this test to MCI-AD in particular, the nine 
most common outcome measures were retained at this early stage. The remaining 
variables were then assessed along a number of criteria for inclusion in analysis. 
Variables with large ceiling effects or a high proportion of missing data were 
removed. All those variables retained had a maximum of n = 13 (14%) missing data 
points, which were replaced using an expectation-maximization approach. Little’s 
Missing Completely at Random Test (MCAR) test was run to test whether data were 
missing completely at random; however, Little’s MCAR test was significant, Chi-
Square (501) = 577.78, p = .010. MCAR was repeated without variables that were 
derived from others, specifically Trails Difference, Trails Ratio, Stroop Ratio, VPT 
Ratio, RALVT Percent Forgetting and Coding Time. In this case, the MCAR test was 
not significant, Chi-Square (350) = 374.09, p = .180. SPSS’s expectation-
maximization approach was used to replace the missing values from 20 variables. 
The derived values (Trails Difference, Trails Ratio, Stroop Ratio, VPT Ratio, Coding 
Time) were then re-computed.  
 
PCA procedure 
Standard exclusion of low-loadings (r < .03) may be too lenient a criterion for 
PCA data cleaning. Instead, correlation matrices of retained variables were inspected 
before entry into the PCA for any extreme values or extremely high, weak or 
nonsignificant correlations. Such variables were evaluated and removal considered in 
favour of others with a greater number of moderate, significant correlations. Matrices 
were sorted into order of correlation strengths can be found in Appendix H.  
 PCAs were performed using both orthogonal and oblique rotations with Kaiser 
normalisation as an exploratory approach, as outlined in more detail below. For each 
PCA, the factorability of the variables was addressed using the Kaiser-Mayer-Olkin 
(KMO) measure of sampling adequacy and Bartlett’s test of sphericity. KMO statistics 
range from 0 to 1, with values close to 1 indicating data are most appropriate for 
factor analysis. If KMO is close to zero, this indicates a large sum of partial 
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correlations versus the sum of correlations, leading to indistinct, unstable factors. 
Kaiser (1974)) recommends cut-off of values greater than 0.5 as “acceptable” (0.5-
0.7 as “mediocre”, 0.7-0.8 “good”, 0.8-0.9 “great”) (Hutcheson & Sofroniou, 1999). A 
significant Bartlett’s test of sphericity indicates that there is a suitable relationship 
between the entered variables (Stevens, 2002). In contrast to orthogonal rotations 
like Varimax, oblique rotations (Oblimin) result in two rotated component matrices: 
pattern and structure. Typically, the pattern matrix is preferred for interpreting factors 
because the coefficients indicate the unique load of a given factor onto variables. The 
coefficients are thus similar to standardized partial regression coefficients in 
quantifying the relative increase in score (in SDs) if a participant’s latent factor score 
increased one SD, if other factors are held constant (Thompson, 2004). However, 
pattern matrices are more unstable and susceptible to small sample sizes (Gorsuch, 
1983). Structure matrixes, on the other hand, provides coefficients indicating the 
zero-order correlation between a factor and a variable; that is, they are without 
reference to relationship with other factors (Thompson, 2004). If two factors are 
highly correlated, the difference in the pattern loading and structure loading of a 
variable will be greater. The loading coefficient will not necessarily rise equally upon 
both factors, as the loading can represent different aspects of the variable’s variance 
(Thompson, 2004). As such, Oblimin rotation provides valuable information on the 
relative independence of each variable or shared component across the resulting 
factors. Through the iterative process of re-assessing the strength of these factors as 
those variables that are multiple-loading are removed, a set of independent factors 
will be produced. As described above, when the pattern and structure matrices are 
equivalent this indicates equivalency with orthogonal rotation. Orthogonal rotation 
produces uncorrelated factors, i.e. factors that are as unique as possible; hence, 
variables can be interpreted based on their loadings by only one factor without 
concern for others that may also effect that item.  
5.3 Results 
5.3.1 PCA #1: Whole group 
PCA #1 - Correlation matrix 
Low numbers of significant correlations were observed with RAVLT Proactive 
interference (all r < .3), RAVLT Percent Max Recalled at Long Delay, RAVLT Percent 
Forgetting, RAVLT Retroactive Interference, and VPT Ratio. These variables were 
removed, which also removed some of the very high loadings observed. The average 
correlation strength of Digit Forward was 0.21 and it was also removed. In order to 
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eliminate prevalence of very high loadings (over .8), the following variables were 
removed: Trails Ratio, Trails B, MTCF Percent Retained, VPT Low, RAVLT Long 
Delay, and DSST Coding Time. In these cases of high correlations between pairs of 
variables, the variable with a higher number of significant correlations within the 
target range (.3< r < .8) was retained. This resulted in 21 remaining variables for 
initial entry in the PCA. Recommended guidelines for dataset with n < 300 
recommend 5-10 cases per included variables (Kass & Tinsley, 1979). Use of 21 
variables with n = 79 equates to only 3.8 cases per variable, outside of the 
recommendation. However, given the novel nature of the dataset and the iterative 
procedure utilized within the PCA, the decision was made to enter this higher number 
of variables. Appendix E contains additional output from the iterative process of 
PCA#1 described below. 
 
Table 15 PCA 1: Communalities (whole group; initial model) 
 Extraction 
ACE Language 0.42 
RAVLT Max T1:T5 0.86 
RAVLT “Learning” 0.69 
RAVLT Short Delay 0.77 
RAVLT Recognition B 0.78 
ACE Visuospatial 0.64 
Corsi 0.69 
MTCF Recall 0.70 
VPT High 0.77 
FAS 0.63 
Stroop C 0.84 
Stroop CW 0.81 
Stroop Ratio Int. 0.83 
Trails Difference 0.73 
Digit Backwards 0.69 
DSST 0.90 
Symbol Copy 0.82 
Error Check 0.83 
Trails A 0.78 
SRT 0.64 
CRT 0.70 
 
PCA #1 - Varimax Rotation 
The PCA was first run using Varimax rotation. The factorability of the variables 
was confirmed in the initial, unrotated model using KMO = .840. Bartlett’s test of 
sphericity was significant (Χ2 = 1344.59, df = 210, p < .001). Inspection of the Anti-
image Matrices output showed the diagonals of the correlation were all greater than 
0.5, with the lowest value being .528 (Stroop Ratio Interference). Communalities 
ranged from .419 to .895 (M = 0.738; see Table 15). In PCA, initial communalities are  
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Table 16 PCA 1: Varimax rotatated component matrix (whole group; initial model) 
 
Component 
1 2 3 4 5 
ACE Language .211 .439 .156 .339 -.208 
RAVLT Max T1:T5 .351 .804 .040 .059 .296 
RAVLT “Learning” .183 .803 -.050 .016 .095 
RAVLT Short Delay .156 .764 .209 .118 .323 
RAVLT Recognition B .068 .287 .085 -.058 .827 
ACE Visuospatial .265 .284 .669 .208 .044 
Corsi .212 .161 .384 .270 .629 
MTCF Recall .075 .484 .636 .218 .071 
VPT High .394 .491 .514 .327 .030 
FAS .752 .032 .003 .219 -.135 
Stroop C .760 .217 .312 -.332 -.098 
Stroop CW .744 .256 .174 .344 .198 
Stroop Ratio Int. -.233 -.034 .097 -.817 -.319 
Trails Difference .668 .267 .328 .257 .205 
Digit Backwards .261 .194 .198 .720 -.158 
DSST .818 .274 .281 .196 .182 
Symbol Copy .798 .172 .293 .128 .214 
Error Check .796 .243 .286 .174 .149 
Trails A .706 .273 .360 .262 .088 
SRT .377 -.153 .666 -.154 .051 
CRT .308 -.063 .731 -.052 .253 
Extraction Method: Principal Component Analysis.  
Rotation Method: Varimax with Kaiser Normalization; converged in 8 iterations. 
 
 
1.00, based on the assumption that all data variance is common. After extraction, the 
communalities indicate the common variance in the data structure. For example, 
Table 15 indicates that only 42% of the variance associated with ACE Language was 
shared variance, versus 90% associated with the DSST. From a factor-perspective, it 
can be said that 90% of DSST’s variance was explained by the retained factors. 
Five factors were extracted in the initial model. The first component explained 
25.93% of the variance, with the subsequent three explaining 15.34%, 14.19%. 
10.07% and 8.30% (cumulative variance = 73.83%). Acceptable threshold of loadings 
are debated, but using a criteria based on sample size is generally advised (Hair, 
Anderson, Tatham, & Black, 1998). Stevens (2002) suggests loadings are practically 
significant depending the sample size and recommends a formula based on the more 
stringent alpha level of .01 to avoid errors due to the multiple comparisons involved. 
Thus, for a two-tailed test with α = .01 with 93 participants, absolute values of 
loadings between n = 100, >2(.256) = .512 and n = 80, >2(.286) = .572 would be 
significant.  
The clustering of the variables on the five components (see Table 16) 
suggested that component 2 relates to verbal learning and memory (RAVLT: Max 
A1:A5, Learning, and Short Delay). Component 1 was loaded by processing speed 
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and executive function measures, such as FAS, Trails A and difference, Stroop, the 
DSST and its variants. Component 3 included both visuospatial (MTCF Recall, ACE-
Visuospatial) and processing speed (SRT and CRT) variables. Components 4 and 5 
were only loaded by two tasks each. In this initial model, no variables load above the 
threshold on more than one component, but two variables do not load above the 
threshold on any component: ACE Language and VPT High. 
 
Table 17 PCA 1: Oblimin Rotation Pattern Matrix (whole group) 
 
Component 
1 2 3 4 5 
RAVLT Max T1:T5 .288 -.715 .038 -.243 .089 
RAVLT “Learning” .125 -.774 .074 -.009 .139 
RAVLT Short Delay .031 -.599 -.003 -.318 .302 
RAVLT Recognition B -.025 -.219 .008 -.880 -.161 
ACE Visuospatial .091 .010 -.017 .000 .777 
Corsi .072 .057 -.226 -.664 .219 
MTCF Recall -.140 -.191 -.026 -.032 .859 
VPT High .253 -.215 -.126 .029 .651 
FAS .863 .036 -.127 .167 -.171 
Stroop C .817 -.102 .487 .116 .081 
Stroop CW .738 -.115 -.242 -.111 .052 
Stroop Ratio Int. -.183 -.027 .845 .218 .034 
Trails Difference .634 -.057 -.119 -.184 .179 
Digit Backwards .196 -.007 -.596 .217 .408 
DSST .822 -.094 -.061 -.139 .081 
Symbol Copy .818 .006 -.008 -.209 .016 
Error Check .795 -.073 -.040 -.090 .109 
Trails A .662 -.077 -.110 -.002 .294 
SRT .346 .426 .295 -.191 .359 
CRT .218 .382 .190 -.400 .438 
Extraction Method: Principal Component Analysis.  
Rotation Method: Oblimin with Kaiser Normalization; converged in 19 iterations. 
 
 
PCA #1: Oblique Oblimin Rotation – Initial Model for whole group 
Direct Oblimin matrices were next computed for comparison with the Varimax 
(orthogonal) rotation, as discussed above, after removal of ACE-Language. In terms 
of variable distribution, the Oblimin oblique rotation appeared quite similar to the 
orthogonal Varimax solution. In the pattern matrix (Table 17, loadings below 
threshold shaded out), the first component loaded eight variables tapping executive 
function (FAS), more basic processing speed measures (Trails A, Symbol Copy, 
Error Check Stroop C), and processing speed with executive weighting (Stroop CW, 
Trails Difference). This therefore included executive function and processing speed 
outcome variables. Component 2 more matched the orthogonal solution as verbal  
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Table 18 PCA 1: Oblimin Rotation Structure Matrix (whole group) 
 
 
Component 
1 2 3 4 5 
RAVLT Max T1:T5 .494 -.804 -.120 -.469 .431 
RAVLT “Learning” .296 -.803 -.070 -.218 .322 
RAVLT Short Delay .355 -.704 -.125 -.531 .523 
RAVLT Recognition B .156 -.335 -.024 -.853 .166 
ACE Visuospatial .492 -.126 -.082 -.294 .824 
Corsi .385 -.131 -.252 -.754 .494 
MTCF Recall .341 -.315 -.097 -.326 .830 
VPT High .627 -.366 -.237 -.303 .813 
FAS .742 -.049 -.222 .000 .218 
Stroop C .777 -.134 .360 -.140 .442 
Stroop CW .842 -.281 -.362 -.349 .505 
Stroop Ratio Int. -.331 .159 .866 .264 -.191 
Trails Difference .799 -.221 -.227 -.428 .587 
Digit Backwards .428 -.153 -.648 .013 .475 
DSST .922 -.253 -.192 -.404 .571 
Symbol Copy .882 -.145 -.120 -.433 .509 
Error Check .890 -.221 -.165 -.354 .563 
Trails A .839 -.232 -.230 -.296 .655 
SRT .484 .335 .287 -.334 .517 
CRT .472 .246 .183 -.546 .617 
Extraction Method: Principal Component Analysis.  
Rotation Method: Oblimin with Kaiser Normalization. 
 
learning and short term memory: RAVLT short delay, “Learning” and Max T1:T5. 
Component 5 was a visuospatial component somewhat similar to component 3 in the 
Varimax solution (ACE Visuospatial, MTCF Recall, VPT High). Only two variables 
loaded onto Components 3 and 4 (Component 3: Stroop Ratio Interference and Digit 
Backwards, Component 4: RAVLT recognition and Corsi). The Structure matrix 
(Table 18) also revealed that more than one variable loaded significantly (and above 
the more conservative threshold) across two measures: Trails A, DSST and VPT 
High. The reaction time measures (SRT and CRT) were not loaded above the 
threshold by a factor, as opposed to the varimax solution in which they were also 
loaded by component 3. These variables were thus iteratively removed one at a time 
from the Oblimin model. After removal of both CRT and SRT, KMO remained 
acceptable (0.845) and the components were loaded by the same variables in the 
Pattern matrix as prior to removal. However, in the Structure Matrix (Table 18) 
multiple variables loaded across more than one component. In particular, VPT High 
(visuospatial), Trails A (processing speed), and Trails Difference (executive function/ 
inhibition) loaded onto both components 1 and 5 beyond the threshold. Hence, with 
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an exploratory aim, three branches of PCA were pursued in which one of these three 
multi-loading variables were removed first.  
Upon removal of VPT High, the KMO remained acceptable, test of sphericity 
remained significant (<.001), and all diagonals of anti-image matrix were above 
0.500. Four components were extracted with cumulative percent explained of 
74.34%. Component 1 remained loaded onto executive function and processing 
speed measures and Component 2 onto verbal learning and short term memory. 
Component 3 positively loaded onto Stroop Ratio Interference and negatively onto 
Digit Backwards. Component 4 remained associated with visuospatial ability, but was 
no longer loaded by ACE Visuospatial above the threshold and it also loaded onto 
RAVLT Recognition. The highest loading by Component 1 was 48.57%. No variables 
loaded across multiple components. Therefore, removing VPT High also resulted in a 
model in which the double loadings of Trails A and Trails Difference no longer 
occurred.  In the subsequent steps, the following variables were removed (as justified 
by): ACE Visuospatial (not loaded by a component above the threshold in the pattern 
matrix), MTCF Recall (not loaded by a component above the threshold in the pattern 
matrix), Stroop Ratio Interference (correlation matrix diagonal < 0.500), and Digit 
Backwards (no longer loaded by a component in either matrix). Finally, this resulted 
in a model in which the pattern and structure matrices matched in terms of factor 
loadings. The model had an acceptable KMO (0.875) and three components that 
cumulatively explained 76.99% of the total variance. Components 1 and 2 remained 
similar in their loading interpretations. Component 1, explaining 54.84%, is 
interpreted as executive function and processing speed loadings (FAS, Trails A, 
Symbol Copy, Error Check Stroop C, Stroop CW, and Trails Difference). Component 
2 (RAVLT Max, “Learning”, Short Delay) is a verbal learning and short term memory 
factor. Component 3, however, is less easily interpreted as it is loaded by RAVLT 
Recognition (verbal memory) and Corsi Blocks (visuospatial working memory).  
In contrast to the matching matrices achieved in Branch 1, Branches 2 and 3 
of PCA #1 (first removing Trails Difference and Trails A, respectively), failed to 
converge. Branch 2 proceeded until a second branching was necessary as both VPT 
High and RAVLT Recognition no longer loaded in the pattern matrix. First removing 
VPT High led to a model in which the Pattern and Structure Matrixes matched with 
three components. However, if RAVLT Recognition is removed, the model resulted in 
multiple loadings of processing measures across two components and failure to 
converge with iterative removal. Similarly, removal of Trails A first (Branch 3) resulted 
100 
 
in the need to remove Stroop Ratio Interference due to an unacceptable correlation 
matrix diagonal value. Following this, a multitude of variables (VPT High, DSST, 
Trails Difference, Digit Span Backwards and Corsi) are loaded by two components. 
Attempts to iterative remove these multiply-loading variables failed to result in a 
stable model. 
 
Table 19 PCA 1: Optimised Model Rotated Component Matrix 
 
Component 
1 2 3 
RAVLT Max T1:T5 .328 .852 .243 
RAVLT “Learning” .152 .860 .006 
RAVLT Short Delay .203 .797 .338 
RAVLT Recognition B .011 .284 .838 
Corsi .334 .084 .810 
FAS .753 -.047 -.026 
Stroop C .776 .163 -.067 
Stroop CW .796 .326 .163 
Trails Difference .765 .211 .351 
DSST .866 .278 .249 
Symbol Copy .828 .214 .231 
Error Check .863 .211 .228 
Trails A .820 .267 .165 
Extraction Method: Principal Component Analysis.  
 Rotation Method: Varimax with Kaiser Normalization, 
converge in 4 iterations/ 
 
PCA #1 - Optimised Model Whole group 
Within the first branch of PCA #1 (whole group), the matched loading of 
individual variables onto components indicates orthogonal factors. This was  
confirmed by performing an orthogonal Varimax rotation with the retained thirteen 
variables. The final model consists of three components (Table 19), which 
cumulatively explained 76.99% of total variance. Component 1 (42.48% variance 
explained) loads onto FAS, Stroop C and CW, Trails A and Difference, DSST, 
Symbol Copy, and Error Check. Thus, it clearly relates to speed of processing speed 
(DSST highest loading of .866), but executive weighting is also clear. It was thus 
interpreted as executive function and processing speed. Component 2 (20.05% 
variance explained) relates to verbal learning and short term memory (RAVLT Max 
T1:T5, “Learning”, and Short Delay). These first two are similar to the results of the 
initial model. Lastly, Component 3 explained only 14.47% of variance and is less 
easily interpretable. It was loaded nearly equally strongly by Corsi and RAVLT 
Recognition. The KMO measure of sampling adequacy was excellent at .875. 
Barlett’s test of sphericity was significant (Χ2 = 832.96, df = 78, p < .001). Inspection 
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of the Anti-image Matrices output showed the diagonals of the correlation were all 
much greater than 0.5, with the lowest value 0.725 (RAVLT “Learning”). 
Communalities ranged from 0.570 (FAS) to 0.892 (M = 0.770).   
 
5.3.2 PCA #2: Control Participants 
PCA #2 - Correlation matrix 
The PCA was then re-run for patients and control subjects separately from the 
point of correlation matrix inspection to investigate differences in the resultant 
models. The same procedure described for the whole group (see section 5.3.1) was 
pursued, although given the smaller number of controls (n = 31), a stricter approach 
of elimination at this point was taken. Entry of 15 variables with n = 31 equated to a 
very low 2.1 cases per variable, but the decision was made (as with the whole 
sample) to enter a higher number of variables for review during the PCA process. An 
acceptable threshold of loading for the control subsample was set as the absolute 
value .722, based on the lowest sample size provided by Stevens (2002) (n = 50). 
Because the control sample is only 31, interpretation must be made cautiously. In the 
correlation matrix, there were no significant low correlations (r < .3), but as in the 
whole group, very high correlations (r > .8) were observed between multiple pairs of 
outcome variables. The mean loadings of significant variables for controls (0.356) 
was higher than in the whole group (0.510), but there seemed to be fewer significant 
correlations between variables. Initial removal resulted in 15 variables entered into 
the PCA. See Appendix F for the correlation matrices and additional SPSS output for 
the PCA#2 summarized below.  
 
PCA #2: Varimax Rotation (controls) initial model 
The initial Varimax rotation showed sampling adequacy (KMO = .620) and a 
significant Bartlett’s Test of Sphericity (Χ2(105) = 361.96, p < .001), but multiple 
variables had low anti-image correlation values. These variables were excluded 
iteratively. In the resulting model, KMO was very high (.813) and Bartlett’s Test again 
significant (Χ2 (55) = 168.66, p < .001). Diagonals of the anti-image correlation matrix 
were high (all .713 or greater). The mean of the PCA communalities was 0.717, 
ranging from .580 (Digit Backwards) to .845 (FAS). Three factors were extracted in 
the initial model. The first component explained 47.35% of the variance, with the 
subsequent two explaining 15.01%, and 9.29%, for a cumulative variance explained 
of 71.65%. 
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However, when unacceptable thresholds (below .722) were removed, Digit 
Backwards, Trails A and Trails B did not load significantly onto a component. 
Component 1 consists of RAVLT Max T1:T5, Stroop CW and Symbol Copy. Its 
interpretation is difficult as it combines Verbal Learning, executive and psychomotor 
variables. Component 2 is clearly a visuospatial component with MTCF Recall, VPT 
High and VPT Low. The only variable loaded onto component 3 above the threshold 
was FAS (executive function). Thus, this initial model suggests an important role for 
executive function as it is prominent across two components. 
 
PCA #2: Oblique Oblimin Rotation – Initial Model 
Direct Oblimin matrices were next computed for comparison with the Varimax 
(orthogonal) rotation, as was pursued with the total sample. Again, three factors were 
extracted, and weak correlations between the extracted factors was observed. In this 
first Oblimin model, the pattern and structure matrices matched except for Trails A, 
which does not load above the predetermined threshold in the Pattern Matrix. As with 
the group overall, the Oblimin oblique and orthogonal Varimax rotation models were 
very similar. However, Varimax and Oblimin differed in the loadings of Trails A and B 
and Digit Backwards. Oblimin Component 1 matched Varimax in terms of RAVLT 
Max T1:T5, Stroop CW and Symbol Copy, plus the addition of DSST and Trails A. 
Thus, Component 1 might be interpreted as a processing speed component with 
strong executive and verbal learning loadings. Components 2 and 3 matched the 
Varimax initial model and are thus visuospatial and executive components, 
respectively. 
Iterative removal of variables to obtain an optimized model led to a final model 
(KMO = .748) with seven retained variables. The matched loadings of the Pattern 
and Structure matrix using Oblimin rotation was reconfirmed with orthogonal Varimax 
rotation. The communalities for the PCA ranged from 0.560 (MTCF Recall) to .818 
(Stroop CW), with a mean of .726. The final model includes only two components, 
explaining 50.44% and 22.13% variance respectively. Component 1 is interpreted as 
a factor of processing speed with some executive weighting (DSST, Symbol Copy, 
Trails A and Stroop CW). Component 2 can be easily assumed to relate to 
visuospatial Memory: MTCF Recall, VPT High and Low. This final two component 
solution retained the overall pattern of the initial Oblimin model that produced 
components representing processing speed and visuospatial function. However, 
through reaching this optimised model, no verbal variables were retained. 
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5.3.3 PCA #3: MCI-LB Patients 
PCA #3 – Correlation Matrix 
MCI-LB Probable had higher mean significant Pearson correlation values than 
controls and the group overall (0.529). The significant loadings were all above 0.300. 
Variables were removed due to problematic correlations as was done in the earlier 
models. This resulted in 17 variables for entry into the PCA. See Appendix I for the 
correlation matrix and supplementary output for PCA#3 summarized below. 
 
PCA #3: Varimax Rotation (MCI-LB Probable) initial model 
PCA was then run in MCI-LB Probable using Varimax rotation. Acceptable 
threshold of loading for the MCI-LB subsample (n = 44) was determined as .722 
(Stevens, 2002). A number of the anti-image correlation matrix diagonals were 
below .500 at first entry and removed. After this, the KMO was acceptable (.787) and 
four factors were extracted, explaining a cumulative 79.32% of variance. However, 
after removal of loadings below .722 (borderline values in yellow), no component 
loaded Trails B and Trails A above the threshold. Component 1 (26.07% variance 
explained) consisted of executive function and processing speed variables (FAS, 
DSST, Symbol Copy and Stroop CW [marginal loading threshold]). Component 2 
consisted of visuospatial variables (ACE Visuospatial, Corsi and MTCF Recall). 
Component 3 can be read as a verbal learning and memory factor (RAVLT Max 
T1:T1, Short Delay and Long Delay). Component 4 was similar to component 1 in 
capturing processing speed (Stroop C), with an emphasis on a cognitive/ working 
memory component (CRT). 
 
PCA #3: Oblique Oblimin Rotation – Initial Model (MCI-LB Probable) 
The seventeen variables were re-entered into a PCA with Oblimin (oblique) 
rotation. Again, four factors were extracted, and weak correlations between the 
extracted factors was observed. Unlike in the Varimax model, the Oblimin rotation 
yielded fewer variables loading across components. In the pattern matrix, the first 
component was loaded only by FAS above the threshold, showing the importance of 
executive function. The three lower components were similar to the Varimax solution. 
Component 2 represents verbal learning and memory, loaded by RAVLT Max 
Learning T1:T5, Short and Long Delay free recall. Component 3 can be clearly 
interpreted as visuospatial (ACE Visuospatial, Corsi and MTCF recall). Component 4 
again represents a second processing speed measure (Stroop C, CRT).  In the 
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structure matrix of this oblique rotation model, the DSST loaded on component 1, but 
loaded nearly to the pre-set threshold on component 4 as well. Similarly, Trails A 
loaded near threshold level on three components, suggesting strong correlations of 
the components with processing speed.  
An optimised model was sought using iterative removal of variables with poor 
or absent loading or high collinearity. In the subsequent steps, processing speed 
measures (Trails A, Trails B and Stroop CW) were removed based on near-
acceptable threshold loading in the Pattern Matrix across two components: 
component 1 (executive and processing speed) and 2 (visuospatial). Trails A, Trails 
B and Stroop CW were firstly removed one at a time. This resulted in a model with 
which the DSST loaded near but below the conservative threshold on two 
components that loaded other processing speed and executive function measures. At 
this stage, VPT High also emerged in the structure matrix as loading quite strongly 
onto visuospatial component 3, but was also moderately correlated (0.580) with the 
component loading onto verbal learning and memory variables (RAVLT Max T1:T5, 
Short and Long Delay). It was not loaded above a threshold in the pattern matrix (-
0.624). At this stage, either DSST or VPT High could be removed. In both scenarios, 
processing speed measures (Symbol Copy, Stroop C, DSST) loaded strongly or 
moderately across two components.  
Variables were removed in instances of falling below where the anti-image 
correlation diagonals fell below the threshold. If DSST was removed, the pattern and 
structure matrices eventually matched; however, two variables did not load above the 
pre-set threshold in the pattern matrix in this case (ACE Visuospatial, 0.675; MTCF 
Recall, 0.697). Component 1 (43.28% variance explained) can be interpreted again 
as visuospatial (ACE Visuospatial, Corsi, MTCF Recall), component 2 (21.01% total 
variance explained) as verbal learning and memory (RAVLT Max A1:A5, Short and 
Long Delay), and component 3 as a processing speed factor (Stroop C and CRT). 
The cumulative variance explained by the model was 77.77%. However, when VPT 
High was removed first instead of DSST, the extracted factors were less easily 
interpretable. Component 1 loaded onto both visuospatial and processing speed 
variables (ACE Visuospatial, MTCF Recall Stroop C and CRT). Component 2 
remained a verbal learning and memory component (RAVLT Max A1:A5, short and 
long delay). Component 3 was similarly difficult to interpret, with only two variables: 
FAS and Symbol Copy, relating to executive and psychomotor speed. 
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These divergent results suggested instability in the factor structure in the MCI-
LB Probable data subset. To further investigate this, the Oblimin model was re-run 
with either DSST or VPT High omitted at first entry (n = 16 variables). A number of 
steps to remove variables with insufficient loading eventually failed to converge after 
100 iterations. Therefore, without inclusion of these two variables at first entry, the 
models ultimately collapsed upon themselves. 
 
5.3.4 PCA #4: MCI-AD Patients 
Inspection of the MCI-AD correlation matrix revealed fewer, but broadly 
stronger significant correlations than in controls or MCI-LB (see Appendix J). The 
process of inspection of intercorrelations before entry into PCA was attempted as 
with the whole group and MCI-LB Probable samples; however, using the same 
criteria resulted in only three suitable variables for entry into the PCA. Instead, the 
decision was made to enter fourteen variables, given that the significant 
intercorrelations were of moderate size and the PCA was exploratory. However, upon 
entry of these fourteen variables, the PCA produced a model with an inadequate 
KMO score (.366). This is likely due to the small sample size (n = 18). For this 
reason, a PCA within the MCI-AD patient group was abandoned. 
 
5.3.5 Composite calculation 
When using the entire sample in the PCA (whole group), three stable 
components emerged, but the third component only consists of two variables, RAVLT 
Recognition and Corsi Blocks, which are difficult to interpret as representing a 
singular cognitive construct. Moreover, the exploratory PCA process utilised above 
revealed instability in the factor structure of MCI-LB Probable and that the MCI-AD 
was unsuitable for PCA, largely due to the small sample size (n = 18). As such, the 
decision was made to utilize the two control-informed composites of processing 
speed (DSST, Symbol Copy, Trails A and Stroop CW) and visuospatial memory 
(MTCF Recall, VPT High and Low) and the individual tests that emerged as important 
across the data when conducting the PCA. Specifically, the DSST and VPT High 
loaded across multiple components at multiple steps. Therefore, composites and the 
singular variables of interest were converted to control-centred z-scores for use in 
multivariate analyses in subsequent chapters.  
 
106 
 
5.4 Discussion 
The present chapter aimed to reduce redundancy in the large dataset by 
determining appropriate composite scores using an exploratory PCA approach. The 
comprehensive neuropsychological battery resulted in a very large number of 
outcome measures, particularly in verbal learning and memory, all of which could be 
argued to validly capture aspects of a domain. Often domain-level composites are 
computed based on a priori theoretical assumptions about a domain; however, PCA 
can be used to provide confidence that tasks have been grouped to domains 
correctly. Moreover, the series of PCAs conducted also served to further clarify the 
profile of test performance and neuropsychological processes, both in the sample 
overall and individually for MCI-LB Probable patients and controls. The exploratory 
use of both Varimax (orthogonal) and Oblimin (oblique) rotation methods in the PCA 
allows consideration of which variables may be particularly important across domains 
within the data. Firstly, orthogonal rotation was used to produce factors that are 
maximally independent from each other. From this variable loading pattern, 
composite scores can be derived. Orthogonal rotation suffers, however, from ignoring 
the likely interrelatedness of neuropsychological processes. Therefore oblique 
rotation was used secondly. In an iterative process, variables were considered 
individually based on appropriate loadings (sufficient in magnitude [above the 
predetermined threshold] and unique to a single component). If the underlying 
structure of the data permits, this process leads to a stable model in which the 
oblique pattern and structure matrices are equivalent, which is then reconfirmed via a 
final orthogonal rotation. By using such a method in both the whole-group dataset 
and the group subsets separately (control, MCI-LB Probable, and MCI-AD), 
comparisons can be made regarding the underlying neurocognitive structure of 
performance. Unfortunately, MCI-AD consisted of too few participants to complete a 
PCA with enough power. However, inspection of the correlation matrix suggests that 
MCI-AD scores are less frequently correlated than in MCI-LB or controls, although 
those correlations that were significant tended to be quite strong. Additionally, the low 
number of significant associations between variables is likely in part due to the small 
sample size.  
In MCI-LB Probable, the PCA process suggested that this data in isolation 
does not result in stable, discernible factors. Two divergent models with three 
extracted components were produced through iterative removal of variables in MCI-
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LB Probable. In the first branch, components were interpreted as visuospatial, verbal 
learning and memory, and processing speed. In the second, the three components 
were visuospatial and processing speed combined, verbal learning and memory, and 
executive and psychomotor speed. In the second branch, it is difficult to interpret the 
first and third component as clean factors that relate to current theoretical 
understanding of cognitive domains. The first, for example, loads onto two 
visuospatial variables: one that measures visuospatial working memory (ACE 
Visuospatial) and one that taps visuospatial long-term memory (MTCF Recall). This 
shows domain-specific tasks in visuospatial ability loading alongside domain-general 
speed of processing measures. The factor may therefore be related to the processing 
speed component embedded within these visuospatial tasks, suggesting it is an 
important element of those tasks’ completion. However, it is important to note that 
both of these visuospatial variables were loaded slightly below the pre-set threshold 
for acceptability following the formula by Stevens (2002). This could be further 
evidence of instability in the underlying data structure and/ or that only part of the 
visuospatial measures’ variance is loaded by that factor, i.e. that that is related to 
processing speed.  
The third component of the first branch in MCI-LB Probable also had loadings 
from both a processing speed measure (Stroop C), which has no motor component, 
and a motor-dependent measure of processing speed (CRT). CRT is the mean 
correct reaction time in a computerised left-right decision task. Both CRT and Stroop 
C measure processing speed and require sustained attention; however, the CRT 
requires attention be divided amongst two stimuli. It also has greater executive 
weighting by requiring decision making and response inhibition of the incorrect button 
(Magill & Anderson, 2007). Component 3 in the second model similarly combines 
executive (FAS) and psychomotor (Symbol Copy) measures. Thus, while these two 
components have substantial overlap and are not easily interpreted as representative 
of a unitary domain, they stress the importance of executive function and processing 
(including psychomotor) speed to the neurocognitive data of MCI-LB Probable. 
Taken together, it is possible that orthogonal rotation is unsuited to the cohort of MCI-
LB Probable patients due to a less independent neurocognitive structure. Work in 
chapter 5 will attempt to fractionate the processes and resources that have emerged 
as salient across components in these analyses, namely processing speed and 
executive function. 
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In contrast to MCI-LB Probable and MCI-AD, the whole-group and control-only 
analyses did lead converge on acceptable models. With the whole-sample data, 
however, one of the three extracted components is difficult to interpret. Component 3 
loads onto RAVLT Recognition, a cued long-term verbal recognition memory task, 
and Corsi, a visuospatial working memory task, targeting the inner scribe specifically 
(Logie & Pearson, 1997). It is unclear what shared factor could be loading onto these 
two outcome variables. Moreover, it is often recommended that factors load onto 
more than two variables to be assumed as suitably stable (Raubenheimer, 2004). 
Control data revealed a two-factor structure with only processing speed (including 
some executive weighting) and visuospatial memory components. In this way, the 
overall pattern of the initial Oblimin output that produced components representing 
processing speed and visuospatial function is retained, suggesting it is a more 
parsimonious representation of the trends in the control data overall. However, in this 
optimised model no verbal variables were retained. In contrast, in both the whole-
group and MCI-LB subsets, the second-ranked components related to verbal learning 
and memory. MCI-LB Probable (both resultant models) produced a component 
loading onto RAVLT Max T1:T5, Short and Long Delay free recall. The data as a 
whole was modelled with a component with RAVLT Max T1:T5, Short Delay free 
recall, and the “Learning” score. Therefore, while composites of visuospatial and 
processing speed are supported by this control-informed PCA, verbal memory and 
learning will have to be investigated in the multivariate analyses separately using 
individual outcome measures. 
It was hoped that PCA results could be compared between controls and 
disease-specific (MCI-LB Probable) datasets, especially given the equivocal results 
of the PCA of the data as a whole. However, this was not possible due to the failure 
of the MCI-LB Probable PCA to suitably converge and the unclear factors that 
emerged from the entire group. The decision was made to utilize the control-informed 
composites of processing speed (DSST, Symbol Copy, Trails A and Stroop CW) and 
visuospatial memory (MTCF Recall, VPT High and Low). This approach has several 
advantages. Firstly, the control group was specifically recruited for the study in order 
to provide more reliable and valid normative data, particularly for tracking longitudinal 
changes in the future. Controls were recruited to match on age and gender (to entire 
MCI sample). By using a local control group as the normative data, there is also an 
increased likelihood of equivalence between groups in unquantified socioeconomic 
and geographical variable. Secondly, this design helps to avoid idiosyncrasies in test 
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administration that might occur. The control volunteers underwent the same battery 
of neuropsychological tests, largely in the same order, and in the same testing 
contexts as patient volunteers. Thus, the control data and PCA results have utility in 
determining optimum composites. We can be further confident of the relevancy to the 
dataset as a whole as two components extracted from the control data are very 
similar to two of the three whole-group components. Lastly, the control visuospatial 
composite offers a cleaner, more distinct and theoretically-supported factor of 
visuospatial memory. The MCI-LB Probable visuospatial component, in contrast, 
clustered Corsi together with MTCF Recall. The latter variable is theoretically 
designed to target visuospatial long-term memory, while Corsi is taken as a “core” 
test of the inner scribe of the visuospatial component of multicomponent models of 
working memory (Logie & Pearson, 1997). 
The individual tests that emerged as pertinent when conducting the PCA will 
also be utilized in the multivariate and MRI analyses in the subsequent chapters. Of 
particular interest instances are variables that consistently load significantly across 
two or more components. This may signal the contribution of the processes 
embedded in such measures to different components. Specifically in MCI-LB 
Probable, the DSST and VPT High loaded across multiple components at multiple 
steps. If these variables are removed, other processing or executive-weighted 
processing tasks begin to load across multiple components as well. VPT High and 
DSST were also excluded from the first step of the PCA, both together and 
separately, to determine the impact on the data structure. This led to a sequence of 
suboptimal models that did not match structure and pattern matrices, failure to 
converge within 25 iterations, and, ultimately, collapse into single-variable factors 
when 100 iterations were permitted. Taken together, this process of PCA in MCI-LB 
Probable revealed that order of entry of VPT High and DSST dictated whether the 
dataset produced a stable factor component structure. It is possible that features of 
VPT High and DSST are critically related to other processes and task performance. 
Therefore, their inclusion and loading across factors allowed production of models 
that retained other, related variables. By removing them, the structure of the data 
collapsed. While speculative, this suggests that VPT High and DSST may be 
especially important measures in understanding cognition in MCI-LB Probable. 
The importance of processing speed was further emphasised within MCI-LB 
Probable when comparing results with controls. At initial Varimax rotation, the MCI-
LB Probable data produced a model with two components relating to processing 
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speed with some executive weighting. At the first Oblimin rotation, the DSST is 
loaded by component 1 and (near-threshold) component 4. Similarly, Trails A loaded 
near to the conservative threshold level on three of the four components. This 
suggests strong correlations of the extracted components with processing speed in 
the pattern of MCI-LB Probable neuropsychological performance. In contrast, at first 
entry, control data did not produce a clear processing speed component, although 
component 1 did include a psychomotor (Symbol Copy) variable. 
Very few studies report a PCA or factor analytic approach to psychological 
data in MCI or DLB. In MCI-AD, Chapman et al. (2011) reduced a dataset at baseline 
to PCA components for use in discriminant analyses to predict conversion to AD at 
follow up. The composites they produced, however, were weighted, both in terms of 
variable loadings across factors and differential weighting of components based on 
discriminant coefficients. Thus while quite statistically successful in predicting 
conversion (86% sensitivity, 83% specificity), the model was not used to consider 
domain-level performance separately. Within established AD, Fabrigoule et al. (1998) 
used PCA to argue for the importance of a “general factor” relating to cognitive 
control, i.e. executive function, in their sample. Interestingly, they also concluded that 
this factor was best characterised by the DSST and the Isaacs Set Test, a semantic 
verbal fluency test (Fabrigoule et al., 1998). DSST and Isaac Set Test scores had 
loadings on component 1 more than twice as large as on any other component, 
indicating their centrality to that underlying factor (Fabrigoule et al., 1998; Horn & 
Cattell, 1967). While the MCI-AD cohort was too small for analysis using PCA, the 
subsequent chapters will attempt to further consider the importance of speed of 
processing to disease-associated cognitive deficits in MCI, which has emerged as 
potentially critical in this chapter. 
 
Conclusions and limitations 
PCA analyses served as a data reduction technique to preserve the richness 
within the dataset in preparation for multivariate analyses. Control-informed 
composites help to reconfirm theoretical assumptions about grouping of processing 
speed and visuospatial measures. While the PCA was a useful approach given the 
dual aims of this chapter, it has certain limitations as well as important distinctions in 
interpretation from exploratory factor analysis (EFA), a different statistical method.  
From my PCA results, I have computed composite scores as averaged 
control-adjusted z-scores of the individual variables loading most strongly onto 
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individual factors. However, PCA statistically allows for both common and unique 
variance, determining the linear combination of entered variables that will retain the 
maximum amount of information from the original data (Stevens, 2002). It is 
commonly misconstrued that PCA serves to provide definitive information on the 
underlying latent factors in the dataset. Such factors, argued to be demonstrated in 
EFA, are the unobservable variables that exert influence across variables and 
mediate any covariance (Brown, 2014; Santos et al., 2015; Thurston, 1947). However, 
factor analysis, not PCA, is the appropriate method for determining common factors 
(Stevens, 2002). 
However, PCA has been demonstrated to provide very similar results to EFA 
(Fabrigar, Wegener, MacCallum, & Strahan, 1999), particularly when communalities 
are high, as in the present sample (Field, 2013). It is a popular approach that may be 
advantageous over EFA due to its computational simplicity and avoidance over-
inflation of variance estimation that can occur in EFA (Guadagnoli & Velicer, 1988; 
Velicer & Jackson, 1990). In addition to PCA functioning to capture as much variance 
in the test battery as possible, the decision to use PCA instead of EFA is particularly 
appropriate in this novel diagnostic group. Results also indicate the magnitude of the 
association between an individual variable and each linear component, which can 
offer understanding of the neuropsychological profile of each group.  In this way, 
PCA explored the loading of standard neuropsychological tests and processes onto 
shared components to better understand how cognitive structure may differ in MCI-
LB. PCA, unlike EFA, also served to help compute composite scores corresponding 
to extracted principal components, one of the primary aims of the present chapter 
(Fabrigar et al., 1999). 
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Chapter Six: Hierarchical structure of neuropsychological 
performance in MCI-LB and MCI-AD 
 
6.1 Introduction 
A primary aim of this PhD was to consider how the hierarchical organisation of 
cognition may inform the conceptualisation of neuropsychological impairments in 
these conditions . Many studies in clinical populations suffer from use of complex 
tasks without a clear theoretical framework. To interpret results of complex tasks as 
indicative of a deficit in one cognitive component may ignore the participation and 
coordination of multiple cognitive resources. This can conflate deficits across 
constructs and explain some of the contradictory findings in the literature to date 
(Smith & Bondi, 2013). If they are not independent of each other, observed deficits 
should be conceptualised in a fundamentally different way (Gallagher et al., 2014). 
As such, models of cognition will first be introduced briefly below.  
 
Models of Working Memory 
In cognitive psychology, working memory refers to systems that are involved in 
performing complex cognitive tasks through the storage and manipulation of 
temporarily-held information (Baddeley, 2000b). In multicomponential models, 
working memory is fractionated into domain-specific components, with separate 
functions and capacities, that work to meet a task’s demands (Logie, 2011). One of 
the most prominent multicomponential models was proposed by Baddeley and Hitch 
(1974) and has been supported by empirical evidence from psychological, 
neuropsychological, developmental and neuroimaging studies. In this model, the 
phonological and visuospatial divisions are “slave systems” to the central executive, 
which is an attentional control system. Within the phonological (verbal) loop, a 
subvocal articulatory system is proposed that allows rehearsal of information held in 
the passive, temporary verbal store. Logie (1995) expounded upon this model to 
further subdivide visuospatial working memory into similar components (Figure 10). 
In this model, the visual cache supports visuospatial working memory by holding 
temporary visual representations of recently-presented stimuli, with limits to the 
amount of complexity that can be retained (Luck & Vogel, 1997). The inner scribe 
alternatively retains spatial-sequential information, such as a short sequence of 
movements (Logie, 1995).  
However, it is critical to remember that these components, regardless of 
reference to which specific model, will work in concert in the process of completing a  
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Figure 9 Working Memory Model adapted from Baddeley (2000) 
 
task. Processing across modalities will support, or scaffold, memory performance 
(Brown & Wesley, 2013). For example, the visual cache has also been demonstrated 
to store verbally-described visual stimuli or haptic stimuli. Moreover, both episodic 
and semantic long term memory can be activated by visual mental imagery (Logie, 
1995; Logie, 2003). 
In the model proposed by Logie (1995), specifically, perceptual information 
first enters episodic memory. Many tasks purporting to target the subsystems require 
maintenance and frequent recall of information across trials, and thus benefit from 
this semantic, long-term memory scaffolding. Baddeley’s (2000) model (Figure 9) 
includes the episodic buffer, which synthesizes long-term memory with information 
from the slave subsystems, and the Central Executive, which maintains attentional 
control of working memory (Baddeley, 1996b; Monaco, Costa, Caltagirone, & 
Carlesimo, 2013). Vandierendonck et al. (2004) found that central executive 
resources are employed when visuospatial sequences are longer than three or four 
items in order to assist with the maintenance of visuospatial representation. Thus, 
increasing span length, or task “memory load” will increase the engagement of the 
executive. Therefore, poor immediate recall of visuospatial information, for example, 
could be due to central executive dysfunction by not sufficiently utilizing the episodic 
buffer or long term memory scaffolding in retaining and applying task information.  
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Figure 10 Working Memory Model adapted from Logie (1995, 2011) 
 
Task errors may not relate to a deficit in “spatial working memory” per se, but rather 
indicate dysfunction or diminished capacity of the coordinating executive functions, 
episodic buffer, or, even, long term memory. Research indicates that the visuospatial 
domain (both storage and processing) is especially dependent on executive 
processes (Fisk & Sharp, 2003; Miyake, 2001; Thompson et al., 2006; 
Vandierendonck et al., 2004). This is in contrast to verbal working memory, which 
has been shown to be more automatic and amenable to distinction between 
executive and slave processes (Fisk & Sharp, 2003). 
 
Visuospatial function in working memory 
In addition to scaffolding by long-term memory and support of the central 
executive, visuospatial performance can depend on success of verbal coding. The 
engagement of the phonological loop and sub vocal rehearsal of verbal labels of 
visuospatial material can be important factors in many ostensibly “visuospatial” tasks 
(Logie & Pearson, 1997).  
Early experimental work by Carmichael, Hogan, and Walter (1932) established 
that through the provision of different verbal labels, the recall of abstract line 
drawings could be manipulated. For example, if a rather amorphous drawing was 
accompanied by the words “eye glasses,” participants would produce figures 
resembling glasses at free recall. The VPT (Della Sala et al., 1997) used in the 
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present study is a specific example of a matrix visuospatial task, frequently used in 
basic and applied psychological research studies to measure spatial working 
memory. These tasks, described in more detail in Chapter 3, involve black and white 
matrices in which the black squares must be retained and recalled over a short 
retention interval and recalled onto a blank white matrix. These matrices were 
designed to specifically tap the visual cache, and thus be difficult to verbally code 
(Della Sala et al., 1997; Della Sala, Gray, Baddeley, Allamano, & Wilson, 1999). 
However, from the large set of initial stimuli, Brown et al. (2006) created and 
validated two subsets that were either especially easy to verbally recode (“VPT 
High”) or least amenable to semantic labels (“VPT Low”). The High stimuli may 
resemble letters, numbers, symbols and shapes, or be more easily quickly verbally 
quantified. Such verbalisation, in a multi-componential model, allows an easing of 
pressure off the visuospatial sketchpad and an increase in its capacity. Brown et al. 
(2006) showed that visual working memory capacity was reliably higher in the “High” 
version of the VPT. Therefore, spatial working memory is not the only component 
affecting performance. This also emphasizes that the two discrete subsystems of 
working memory are able to cooperate when the demands of task require it. 
Vandierendonck et al. (2004), for example, begrudgingly acknowledges that flooding 
of visuospatial storage system may induce executive function and, as a last resort, 
verbalization of spatial information during task completion. 
Based on similar evidence of executive function involvement within the 
visuospatial domain, Thompson et al. (2006) goes so far as to suggest tweaking of 
the multi-resource cognitive models to reflect the closer relationship between 
visuospatial and executive function than between the verbal system and executive 
function (indicating a lack of symmetry in the overall model). The demonstrated 
dependence of the visuospatial domain on executive function means that 
performance is dependent on both processes, and can thus be impacted by deficits 
in either.  
In Chapter 3, MCI-AD showed less visuospatial impairment relative to controls 
than MCI-LB Probable. Significantly poorer scores were isolated to visuospatial 
memory (MTCF Recall and percent retained) and visuospatial working memory, but 
in the latter case only in the high verbalization subset (VPT High). This firstly 
suggests impaired passive storage impairments in the visuospatial domain, rather 
than poor visuoperceptive and visuoconstructive skills, due to MTCF Copy scores on 
par with controls. Poor performance on the VPT High but not VPT Low subsets could 
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be related to poor verbal coding or semantic scaffolding (automatic activation of long 
term memory or semantic) or executive functions, as discussed using above. MCI-
LB, on the other hand, was impaired in all but visuospatial outcome measures, as 
well as many executive tasks, processing speed measures, and some verbal tasks. 
Statistical methods to model the contribution of such resources to task completion 
can help disentangle this issue, pinpoint where in the models the dysfunction lies, 
and how this may differ between MCI subtypes. 
 
Processing Speed 
Broad cognitive impairments that are observed across domains and tasks 
have also been posited as the secondary results of core, domain-general, primary 
impairments in cognitive resources. This is an ongoing debate in both the study of 
normal cognitive ageing and applied clinical work. Both executive function and 
processing speed have been posited as the potential candidates to explain both age- 
and disease-associated broader declines.  
The term processing speed has been used to refer to a variety of measures 
that aim to quantify the speed of perceptual and cognitive processes. Processing 
speed is believed to be a distinct concept yet interrelated with working memory and 
executive function (Luszcz & Bryan, 1999). Processing speed is conceptualized as 
the domain-general speed of execution of basic cognitive functions (Nebes et al., 
2000). It therefore limits the completion of higher-order activities, such as memory 
formation (Salthouse, 1992), that depend on basic operations to occur before the 
information held in working memory decays (Craik & Salthouse, 2011). 
Salthouse (1996) suggests a theory in which slowed speed of processing 
explains age-related changes in cognitive performance in different domains. This 
argument hinges on the idea that slowed speed of processing that occurs in age will 
constrain an individual’s performance on a task. In line with this, slowed processing 
speed has been strongly linked to cognitive aging, with cross-sectional studies 
suggesting it to explain up to 79% of age-related variance in many cognitive 
functions. In earlier cross-sectional work, Salthouse (1992) used DSST and 
concluded that the decline in processing speed with age was gradual and occurred 
across the score distribution. This is in contrast to the common pattern of decline in 
neuropsychological tasks in which a subset of individuals decline sharply while most 
remain at levels similar to younger cohorts. Instead, a decline across the score 
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distribution suggests a closer association between age and the construct (Albert & 
Moss, 1988; Lachman, 1986).  
As such, the domain-general decline of processing speed has become 
considered the likeliest factor in cognitive decline in ageing (Nebes et al., 2000; 
Salthouse, 1996). Two mechanisms have been supported with empirical support. 
Firstly, cognitive processing may be too slow to “support behavioural performance in 
the specified time, leading to slowed and less accurate responding.” Alternatively, 
slowed processing speed may prevent the simultaneous processing of task-related 
information before it degrades in working memory, which would result in increased 
errors.  
This work has also been extended clinically, with studies investigating the 
hierarchical nature of cognition in neuropathological disorders. Within DLB, a small 
study by Kao et al. (2009) compared neuropsychological function in the 
synucleinopathies (PD, DLB and multiple system atrophy) and found that DLB 
displayed significant slower processing speed than the other two groups. 
Functionally, generalized slowing in everyday tasks, like activities of daily living, may 
be an early marker of change in MCI (Wadley, Okonkwo, Crowe, & Ross-Meadows, 
2008). Ballard, O'Brien, et al. (2001) also found processing speed, as measured by 
reaction time, to be the only attentional measure in deficit in DLB versus controls. 
Their AD participants, on the other hand, were not impaired relative to controls, 
leading them to suggest that DLB may be characterised by slowed central processing 
speed. However, it is unclear whether normal age-associated slowing accounts for 
much the slowing observed in pathologies. De Jager and Budge (2005), for example, 
report declines in processing speed over the course of a two-year population study in 
both controls and MCI. Processing speed measures did become predictive for MCI at 
follow-up, leaving open the possibility for MCI-specific slowing independent of 
decreases anticipated with healthy aging (De Jager & Budge, 2005). 
Processing speed emerged as the impact domain in MCI-LB in Chapter 3, 
including the largest effect size relative to controls using the DSST, Due to its 
consistent and strong relationship with age, processing speed is sometimes ‘factored 
out’ to allow focus on specific, higher-level abilities such as executive function 
(Cepeda, Blackwell, & Munakata, 2013; Foster, Black, Buck, & Bronskill, 1997). This 
strategy typically involves the application of ANCOVA or hierarchical regression 
analysis. The premise here is that if a particular impairment (e.g., executive 
functioning) is mediated by another (e.g., processing speed) after establishing that 
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between-subjects differences exist, then entry of ‘group’ would not explain significant 
additional variance in the model.  
 
Executive function 
Executive functions are domain general higher-order processes involving the 
planning and regulation of goal-directed behaviours (Alvarez & Emory, 2006; 
Denckla, 1996). Executive functions have considerable overlap with the coordination 
aspect of working memory, but can be considered a broad, superordinate cognitive 
resource (Luszcz & Bryan, 1999). Executive function is related to processing speed, 
as the latter influences the efficiency and speed of the execution of its duties (Hasher 
& Zacks, 1979; Nebes et al., 2000). 
In healthy ageing, mild executive function decline is common (Keys & White, 
2000). In fact, Santos et al. (2015) argues that “evidence on age-associated memory 
and executive cognitive changes are so well-established that they might be 
considered the baseline against which other variables are analysed” (p. 2). In 
addition to processing speed, executive function has been proposed more recently 
as explaining cognitive dysfunction in pathologies such as late-life major depressive 
disorder (Baudic et al., 2004; Reppermund et al., 2014). Deficits in executive function 
have the potential to impair cognition at various stages, for example at both encoding 
and retrieval points in the case of memory function, thereby compounding their 
impact (Luszcz & Bryan, 1999). Interpretation of results can be complicated by 
studies that subsume processing speed as an executive function (Lockwood, 
Alexopoulos, & van Gorp, 2002). Conflation of these distinct yet interacting 
constructs will mask the mediating role of one resource, if it does in fact fully explain 
the decline. 
As discussed in previous chapters, executive dysfunction is considered a 
hallmark of advanced DLB (McKeith et al., 2017) and to be related to frontal-
subcortical degradation. However, the extent to which these advanced deficits are 
evident in MCI-LB is unclear. Kao et al. (2009) comparative study in 
synucleinopathies found mixed results in executive function tasks: DLB were no 
further impaired in those tending to involve language (digit span backwards, letter 
verbal fluency), but had more errors on other tasks than multiple system atrophy and 
PD groups. The structured review in MCI-LB concluded that early PD patients 
perform poorly on tasks with executive weighting, regardless of which domain they 
appear to target (working memory, processing speed, visuospatial and verbal 
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learning), and despite general intact performance on simpler tasks in those domains. 
The findings (Chapter 3) in executive performance were mixed, with only verbal 
fluency scores significantly poorer in MCI-LB Probable than MCI-AD. However, 
greater executive demands within a task may explain why MCI-LB Probable 
performed worse on certain visuospatial or verbal tasks and not others. Executive 
function may also explain variance in processing speed measures: a variety of tasks 
were used in the presence study and most likely necessitate varying amount of 
executive control. Even very simple tasks will require some maintenance of task 
goals and inhibition of background information, which may be more evident in aging 
populations (Cepeda et al., 2013). 
 
Aims 
The present chapter aimed to utilize a cognitive psychology framework to 
investigate whether some abilities, such as visuospatial or verbal function, are 
scaffolded by others, namely processing speed or executive function. Hierarchical 
linear regression will be used on the control-informed composite scores derived in 
Chapter 4 as well as individual outcome variables that emerged as pertinent from the 
univariate analyses of Chapter 3. 
 
6.2 Methods 
 
Materials and Participants 
Composite processing speed and visuospatial scores were computed as 
average z-scores based on the mean and SD of controls. The variables included 
were determined by control-informed PCA results (see section 5.3.5). Single outcome 
measures were brought forward from Chapter 3 as z-scores adjusted to control-
means to capture the other processes of interest (VPT High, VPT Low, Corsi, FAS, 
RAVLT Short Delay, Long Delay and Max T1:T5). Age and NART IQ were entered in 
the first step of every hierarchical linear regression (HLR) to account for pre-morbid 
intelligence and age-associated variance. See Chapter 3 for full description of tasks 
and Chapter 2 for participant details. 
 
Data cleaning and assessment 
The data presented in this study is post-initial data cleaning (for example, with 
outliers removed) as described in Chapter 3. To check for linearity and select which 
120 
 
HLRs models to execute, Pearson’s (r) correlation coefficients were examined before 
regressions were conducted, and all analyses were two-tailed. Scatterplots of 
variables were inspected to confirm linearity between independent and dependent 
variables. HLR assumptions for independence of data, variable/predictor type 
(continuous) and no multicollinearity (variance inflation factor < 10; Myers, 1990) 
were met. Values of the residuals were confirmed to be independent using the 
Durbin-Watson statistic, which should be close to a value of 2: MCI-LB Probable 
(1.97), MCI-AD (2.22) and control (2.25) Durbin-Watson statistics were appropriate. 
Cook’s Distance values were well under 1, suggesting individual cases are not 
unduly influencing the regression. The assumptions of homoscedasticity and normal 
distribution of residuals were met using regression plots and P-P plots, respectively. 
However, the residual plot was quite undulating in MCI-AD, suggesting the 
assumption of normality of residuals may be violated in this group. This is likely due 
to the small size of this group. As such, results in MCI-AD should be interpreted 
cautiously.  
 
Between-group comparisons  
Composite scores and control-weighted z-scores of individual outcomes 
measures were compared for differences between group subtype (MCI-LB Probable, 
MCI-AD, controls) using one-way ANOVA. Bivariate Pearson correlation coefficients 
were calculated between visuospatial outcome measures (visuospatial composite, 
VPT High and Low) and predictors (domain-general resources [processing speed 
composite, FAS], Corsi, and RAVLT Short Delay). RAVLT Short Delay was chosen in 
these analyses as it emerged in the univariate and discriminant analyses of Chapter 
3 as the most critical and predictive verbal memory measure. Correlations were also 
calculated between domain general resources (executive function and processing 
speed) and measures of verbal learning and memory (RAVLT Max Recall T1:T5, 
Short and Long Delay).  
To understand the relationship between neuropsychological processes such 
as executive functioning, processing speed, and verbal memory in controls versus 
MCI subtypes, a series of hierarchical multiple regressions (using the Enter method) 
were performed. The dependent variables consisted of the visuospatial composites, 
VPT High and VPT Low. The relationship between executive function and processing 
speed was also investigated by alternating order of entry. Following a similar 
statistical procedure as (Nebes et al., 2000) the proportion of diagnosis-related 
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variance was examined by entering “group” (control, MCI-AD or MCI-LB Probable) as 
the predictor variable after age and NART IQ. Secondly, separate regressions are 
run, entering variables of interest (namely processing speed) in the second step and 
Group in the third. This procedure controls for the variance due to those constructs 
before regressing MCI status (Nebes et al., 2000). The degree to which accounting 
for the first predictor decreases the variability explained by “group” therefore 
quantifies how much that processing resource mediates the MCI-related deficit 
(Nebes et al., 2000).  
 
Table 20 Means (standard deviations) by subtype and p-value of the one-way ANOVA 
between MCI subtypes, MCI-LB Probable versus controls, and MCI-AD versus controls. 
 MCI-LB  MCI-AD Subtype 
comparison 
p-value 
MCI-LB vs. 
Controls 
MCI-AD vs. 
Controls 
Processing 
Speed 
-1.76 (1.07) -1.17 (0.77) .094 <.001 <.001 
Visuospatial -1.48 (1.22) -0.98 (0.94) .224 <.001 .005 
VPT High -1.84 (1.30) -1.04 (1.04) .052 <.001 .008 
VPT Low -1.69 (1.68) -0.90 (1.07) .119 <.001 .059 
Corsi -1.32 (1.20) -0.87 (1.21) .373 <.001 .029 
FAS -1.39 (1.57) -0.40 (1.24) .032 <.001 .562 
RAVLT Max 
T1:T5 
-1.24 (1.16) -1.44 (1.37) .815 <.001 <.001 
RAVLT Short 
Delay 
-1.12 (1.21) -1.88 (1.31) .077 .001 <.001 
RAVLT Long 
Delay 
-0.83 (1.04) -1.31 (1.33) .309 .012 <.001 
 
6.3 Results 
6.3.1 Group differences 
Levene's test showed that the variances for the processing speed composite, 
F(2,76) = 3.30, p = 0.042, VPT Low, F(2,76) = 3.69, p = 0.030, and FAS, F(2,76) = 
4.02, p = 0.042, were not equal. The between-subjects effect for group was 
significant as expected for each one-way ANOVA (DSST, VPT High, VPT Low, Corsi, 
FAS, RAVLT Short Delay, Long Delay and Max T1:T5), all ps < .001. One-way 
ANOVAs reconfirmed findings from Chapter 3 that MCI-LB Probable has significantly 
lower scores in VPT High (on trend) and FAS versus MCI-AD (see Table 20). In 
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comparison with controls, MCI-LB Probable performed significantly worse on all 
measures). MCI-AD was significantly impaired relative to controls on Processing 
Speed, Corsi, RAVLT Max T1:T5 , RAVLT Short Delay and RAVLT Long Delay. 
 
Table 21 Pearson correlations between cognitive measures predictors and dependent 
visuospatial variables prior to hierarchical linear regression in MCI-LB Probable (n = 30), 
MCI-AD (n = 18) and controls (HC; n = 31). 
 Visuospatial Composite VPT High VPT Low 
 MCI-
LB 
MCI-
AD 
HC MCI-
LB 
MCI-
AD 
HC MCI-
LB 
MCI-
AD 
HC 
Processing 
Speed 
.659** 0.415 0.355 .678** 0.441 0.302 .674** 0.424 0.348 
Corsi .452* 0.372 0.156 .429* 0.384 0.017 .388* 0.320 0.056 
FAS 0.135 0.298 0.157 0.274 0.404 0.089 0.128 0.383 0.069 
RAVLT 
Short Delay 
.501** .572* 0.296 .523** 0.575* 0.177 .439* 0.432 0.289 
*Significance at p = .01 level; ** Significance at p = .05 level. 
 
By group, there was a significant correlation between Corsi and the 
visuospatial measures in MCI-LB Probable, where the variance explained was 20.4% 
of the visuospatial composite, 18.4% of VPT High, and 15.1% of VPT Low (Table 
21). The other significant correlations are investigated further using multiple linear 
regression below. Moreover, FAS and the processing speed composite were 
significantly positively correlated with each other in all groups: MCI-LB Probable 
r(28)=0.478, p = .008 , MCI-AD, r(16)= 0.633, p = .003, and controls, r(29)=0.475, p 
= .007. FAS was not significantly correlated with any of the visuospatial outcome 
measures. Processing speed was strongly positively correlated with all three 
visuospatial scores in MCI-LB (all ps < .001), but not in MCI-AD or healthy controls.  
Short delay free recall of the RAVLT was significantly associated with the 
visuospatial composites scores and with VPT High in both MCI subtypes. In MCI-LB 
Probable, there was a moderate positive correlation between RAVLT Short Delay 
and VPT Low, r(28)=0.439, p = .015, as well. 
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6.3.2 Predicting visuospatial composite 
 
Table 22 Predicting visuospatial composites scores with group and processing speed 
composite in all groups (MCI-AD, MCI-LB Probable and controls). 
 R2 Adjusted 
R2 
ΔR2 F Change Sig. F 
Change 
Std. Beta 
Coefficients 
Std. Beta 
Sig 
Age       -0.38 < .001 
NART 0.22 0.20 0.22 10.72 < .001 0.35 .001 
        
Age      -0.34 .001 
NART 0.22 0.20 0.22 10.72 < .001 0.33 .002 
Group 0.27 0.24 0.05 4.68 .034 0.22  .034 
        
Age      -0.10 .287 
NART 0.22 0.20 0.22 10.72 < .001 0.03 .741 
Proces. Speed 0.49 0.46 0.26 37.69 < .001 0.64 < .001 
        
Age      -0.13 .287 
NART 0.22 0.20 0.22 10.72 < .001 0.04 .695 
Proces. Speed 0.49 0.46 0.26 37.69 < .001 0.62 .000 
Group 0.49 0.46 0.89 0.41 .524 0.06 .524 
        
Age &      -0.35 .001 
NART 0.22 0.20 0.22 10.72 < .001 0.24 .040 
Exec. Func. 0.27 0,24 0.05 4.75 0.032 0.24 .032 
        
Age      -0.32 .002 
NART 0.22 0.20 0.22 10.72 < .001 0.23 .046 
Exec. Func, 0.27 0,24 0.05 4.75 0.032 0.23 .039 
Group 0.31 0.27 0.04 4.36 .040 0.21 .040 
        
Age      -0.09 .364 
NART 0.22 0.20 0.22 10.72 < .001 0.05 .634 
Exec. Func, 0.27 0,24 0.05 4.75 0.032 -0.09 .409 
Proces. Speed 0.49 0.46 0.22 31.51 <.001 0.70 .000 
        
Age      -0.09 .364 
NART 0.22 0.20 0.22 10.72 < .001 0.05 .634 
Proces. Speed 0.49 0.46 0.26 37.69 <.001 0.670 .000 
Exec. Func, 0.49 0.46 0.01 0.69 .409 -0.09 .409 
 
After entering age and NART IQ, group was entered in the second step and 
explains 5.0% of visuospatial composite scores, (see Table 22). If processing speed 
composite is entered at step 2, it accounts for 26.0% of visuospatial scores and is the 
only significant variable in the standardized regression model. Finally, processing 
speed was entered at step 2 before group at step 3. In this model, the effect of group 
disappears. Processing speed therefore explains the small but significant diagnosis-
associated variance in visuospatial scores. Executive function accounts for a much 
smaller proportion of variance in visuospatial composite scores (5.0%, p = .032). If 
entered before Group, Group’s explained variance drops to 4.0%, indicating 25.0% of 
the small amount of group-related variance in visuospatial scores is accounted for by 
executive function. Through manipulating order of entry, it is shown that executive  
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Table 23 Predicting VPT High with group and processing speed composite and executive 
function (FAS) in all groups (MCI-AD, MCI-LB Probable and controls). 
 R2 Adjusted 
R2 
ΔR2 F Change Sig. F 
Change 
Std. Beta 
Coefficients 
Std. Beta 
Sig 
Age &      -0.35 .001 
NART 0.21 0.19 0.21 10.21 <.001 0.37 .001 
        
Age &        
NART 0.21 0.19 0.21 10.21 <.001   
Group 0.25 0.22 0.04 3.61 0.61   
        
Age &      -0.07 .485 
NART 0.21 0.19 0.21 10.21 <.001 0.04 .676 
Proces. Speed 0.49 0.47 0.28 39.95 <.001 0.66 .000 
        
Age &      -0.31 .002 
NART 0.21 0.19 0.21 10.21 <.001 0.21 .058 
Exec. Func. 0.30 -.27 0.06 9.01 .004 0.33 .004 
        
Age        
NART 0.21 0.19 0.21 10.21 <.001   
Proces. Speed 0.49 0.47 0.28 39.95 <.001   
Exec. Func, 0.49 0.46 0.00 0.02 .885   
        
Age      -0.07 .479 
NART 0.21 0.19 0.21 10.21 <.001 0.04 .703 
Exec. Func. 0.30 -.27 0.06 9.01 .004 0.02 .885 
Proces. Speed 0.49 0.46 0.19 27.23 <.001 0.65 .000 
 
function does not add unique variance above and beyond processing speed (p 
= .409). 
To further fractionate visuospatial function, performance was analysed on the 
two subsets of VPT: VPT High and Low. Run as a single group, both processing 
speed and executive function (FAS) significantly predicted variance in VPT High, 
28.0% and 6.0% respectively (Table 23). Order of entry of FAS and processing 
speed were iteratively alternated, revealing that FAS does not predict additional 
variance in VPT High beyond processing speed (p = .885). On the other hand, if 
processing speed is entered after FAS-associated variance is controlled for (step 2), 
it adds an additional 19.0% of variance to the model. 
However, the model of group predicting VPT High after entering age and 
NART IQ was not significant (p = .61). Because of this, order of entry to predict 
group-associated variance was not pursued. Instead, the HLRs were re-run 
separately by group to determine if processing speed and executive function are 
interrelated in predicting VPT High (Table 24).  
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Table 24 Predicting VPT High from processing speed (composite) and FAS (executive 
function), separately by group. 
 R2 Adjusted R2 ΔR2 F 
Change 
Sig. F 
Change 
MCI-LB Probable 
Age, NART 0.24 0.187 0.24 4.33 0.023 
Proces. Speed 0.50 0.439 0.25 13.14 0.001 
MCI-AD 
Age, NART 0.14 0.02 0.14 1.17 0.338 
Proces. Speed 0.27 0.12 0.14 2.64 0.127 
Control 
Age, NART 0.10 0.03 0.10 1.46 0.251 
Proces. Speed 0.11 0.01 0.02 0.50 0.487 
MCI-LB Probable 
Age, NART 0.24 0.19 0.24 4.33 .023 
Exec. Func. 0.25 0.16 0.01 0.27 .606 
MCI-AD 
Age, NART 0.14 0.02 0.14 1.17 .338 
Exec. Func. 0.30 0.16 0.17 3.41 .086 
Control 
Age, NART 0.10 0.03 0.10 1.46 .251 
Exec. Func. 0.10 0.00 0.01 0.13 .721 
 
Processing speed does not predict VPT High performance in controls or MCI-
AD. The only significant two-step model produced was in MCI-LB Probable, whereby 
processing speed explains additional 25.4% of variance explained in MCI-LB 
Probable VPT High scores after accounting for age and NART IQ associated 
variance.  
RAVLT Short Delay was next utilised as an indicator of verbal ability in 
determining how that ability may impact VPT performance (Table 25). RAVLT Short 
Delay predicts VPT High scores in both MCI-AD (25.0%) and MCI-LB Probable 
(15.0%). Control VPT High scores were not successfully predicted by their RAVLT 
Short Delay scores. When order of entry is considered, processing speed contributes 
7% less variance to VPT Low scores in MCI-LB Probable if RAVLT Short Delay is 
entered first, indicating shared variance between the two predictors. RAVLT Short 
Delay also predicts unique variance (8.0%) after processing speed is controlled, 
again emphasizing unique contribution of the memory measure to the model. 
Regardless of order of entry, however, processing speed adds additional unique 
variance in predicting VPT High scores in MCI-LB, beyond the overlap in variance 
with RAVLT Short Delay. In MCI-AD, the significance of RAVLT Short Delay 
predicting VPT High is lost (p = 0.60) when processing speed is entered first; 
however, this is likely due to loss of power as processing speed is not a significant 
predictor at second step in MCI-AD. 
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Table 25 Investigating order of entry in predicting VPT High from processing speed 
(composite) and RAVLT Short Delay, separately by group. 
 R2 Adjusted R2 ΔR2 F 
Change 
Sig. F 
Change 
MCI-LB Probable 
Age, NART 0.09 0.58 0.09 2.79 0.106 
RAVLT S. Delay 0.40 0.33 0.15 6.55 0.017 
MCI-AD 
Age, NART 0.14 0.02 0.14 1.17 0.338 
RAVLT S. Delay 0.38 0.25 0.25 5.65 .032 
Control 
Age, NART 0.10 0.03 0.10 1.46 0.251 
RAVLT S. Delay 0.10 -0.01 0.00 0.05 0.824 
MCI-LB Probable 
Age, NART 0.24 0.187 0.24 4.33 0.023 
RAVLT S. Delay 0.40 0.33 0.15 6.55 0.017 
Proces. Speed 0.58 0.51 0.18 10.70 0.003 
MCI-AD 
Age, NART 0.14 0.02 0.14 1.17 0.338 
RAVLT S. Delay 0.38 0.25 0.25 5.65 0.032 
Proces. Speed 0.45 0.28 0.07 1.61 0.227 
MCI-LB Probable 
Age, NART 0.24 0.187 0.24 4.33 0.023 
Proces. Speed 0.50 0.44 0.25 13.14 0.001 
RAVLT S. Delay 0.58 0.51 0.08 4.70 0.040 
MCI-AD 
Age, NART 0.14 0.02 0.14 1.17 0.338 
Proces. Speed 0.27 0.12 0.14 2.64 0.127 
RAVLT S. Delay 0.45 0.28 0.18 4.26 0.60 
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Table 26 Predicting VPT Low with group and processing speed composite and executive 
function (FAS) in all groups (MCI-AD, MCI-LB Probable and controls). 
 R2 Adjusted 
R2 
ΔR2 F Change Sig. F 
Change 
Std. Beta 
Coefficients 
Std. Beta 
Sig 
Age &      -0.34 .002 
NART 019 0,17 0.19 8.90 <.001 0.33 .002 
        
Age &      -0.32 .003 
NART 0.19 0.17 0.19 8.90 <.001 0.32 .003 
Group 0.21 0.18 0.02 1.73 .193 0.14 .193 
        
Age &      -0.06 .520 
NART 0.19 0.17 0.19 8.90 <.001 0.01 .896 
Proces. Speed 0.46 0.44 0.27 37.01 <.001 0.65 .000 
        
Age &      -0.32 .003 
NART 0.19 0.17 0.19 8.90 <.001 0.23 .054 
Exec. Func. 0.23 0.20 0.04 4.08 .047 0.23 .047 
        
Age      -0.47 .643 
NART 0.19 0.17 0.19 8.90 <.001 0.32 .753 
Proces. Speed 0.46 0.44 0.27 37.01 <.001 5.68 <.000 
Exec. Func, 0.47 0.44 0.01 1.04 .312 -1.02 .312 
        
Age      -0.05 .643 
NART 0.19 0.17 0.19 8.90 <.001 0.03 .753 
Exec. Func. 0.23 0.20 0.04 4.08 .047 -0.12 .312 
Proces. Speed 0.47 0.44 0.24 32.27 <.001 0.72 .000 
 
As executive function (FAS) and the processing speed composite were also 
both significantly correlated with VPT Low scores, the HLRs were re-run in predicting 
VPT Low (Table 26). In MCI-LB Probable, both processing speed and executive 
function (FAS) significantly predicted variance in VPT Low, 27.0% and 4.0% 
respectively. Analogous with the results in VPT High, FAS did not predict further 
variance in VPT Low after processing speed (p = .312), but processing speed adds 
an additional 24.0% (p < .001). As in VPT High, the model of group predicting VPT 
Low after entering age and NART IQ was not significant (p = .193), and the analyses 
we re-run separately by group. 
In MCI-LB Probable we firstly see age and NART IQ explaining 21.0% of the 
variance (Table 27). Processing speed, in step two, explains an additional 27.0% of 
variance, p = .001. RAVLT Short Delay is on trend to explain 10.0% of the variance in 
VPT Low in MCI-LB. Regardless of order of entry, processing speed predicts 
significant amount of variance in VPT Low in MCI-LB: if RAVLT Short Delay is 
entered at stage 2, it adds an additional 21.0% unique variance.  
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Table 27 Predicting VPT Low from processing speed (composite) and RAVLT Short Delay). 
 R2 Adjusted R2 ΔR2 F 
Change 
Sig. F 
Change 
MCI-LB Probable 
Age, NART 0.21 0.15 0.21 3.59 0.042 
Proces. Speed 0.48 0.42 0.27 13.24 0.001 
MCI-AD 
Age, NART 0.04 -0.09 0.04 0.33 0.727 
Proces. Speed 0.21 0.04 0.16 2.88 0.112 
Control 
Age, NART 0.13 0.07 0.13 2.10 0.143 
Proces. Speed 0.16 0.07 0.03 0.92 0.347 
MCI-LB Probable 
Age, NART 0.21 0.15 0.21 3.59 0.042 
RAVLT S. Delay 0.31 0.23 0.10 3.70 0.066 
MCI-AD 
Age, NART 0.04 -0.09 0.04 0.33 0.727 
RAVLT S. Delay 0.20 0.02 0.15 2.69 0.123 
Control 
Age, NART 0.13 0.07 0.13 2.10 0.143 
RAVLT S. Delay 0.16 0.06 0.03 0.79 0.383 
MCI-LB Probable 
Age, NART 0.21 0.15 0.21 3.59 0.042 
RAVLT S. Delay 0.31 0.23 0.10 3.70 0.066 
Proces. Speed 0.52 0.44 0.21 10.78 0.003 
MCI-LB Probable 
Age, NART 0.21 0.15 0.21 3.59 0.042 
Proces. Speed 0.48 0.42 0.27 13.24 0.001 
RAVLT S. Delay 0.52 0.44 0.04 2.05 0.165 
 
6.3.4 Predicting verbal learning and memory scores 
 
The relationship between processing speed and scores on verbal learning and 
memory were explored between MCI-LB Probable and controls as both groups had 
significant correlations between these variables. There was an overall (whole group) 
significant association between processing speed, executive function and RAVLT 
Max T1:T5, but this association was not evident within the MCI-AD in isolation (see 
Table 28). These participants were therefore omitted in order to focus on the effects 
in MCI-LB.  
 
Table 28 Pearson correlations between cognitive measures predictors and dependent verbal 
learning and memory variables prior to hierarchical linear regression in MCI-LB Probable (n = 
30), MCI-AD (n = 18) and controls (n = 31). 
 RAVLT Max T1:T5 RAVLT Short Delay RAVLT Long Delay 
 MCI-
LB 
MCI-
AD 
HC MCI-
LB 
MCI-
AD 
HC MCI-
LB 
MCI-
AD 
HC 
Processing 
Speed 
.430* .396 .504* .341 .269 .402* .207 .278 .351 
FAS .219 .112 .080 -.034 .035 .088 -0.12 -.002 -.026 
*Significance at p = .01 level.  
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Table 29 Predicting RAVLT maximum number of words recalled during learning trials with 
processing speed (composite) in MCI-LB Probable and controls. 
 R2 Adjusted 
R2 
ΔR2 F Change Sig. F 
Change 
Std. Beta 
Coefficients 
Std. Beta 
Sig 
Age  0.29 0.27 0.29 11.72 < .001 -0.44 < .001 
NART      0.37 .002 
        
Age      -0.40 <.001 
NART 0.29 0.27 0.29 11.72 <.001 0.20 .077 
Group 0.42 0.39 0.13 12.55 .001 0.40  .001 
        
Age      -0.23 .046 
NART 0.29 0.27 0.29 11.72 < .001 0.10 .419 
Proces. Speed 0.44 0.41 0.15 15.24 < .001 0.50 < .001 
        
Age      -0.28 .021 
NART 0.29 0.27 0.29 11.72 < .001 0.10 .433 
Proces. Speed 0.40 0.39 0.40 39.58 < .001 0.35 .039 
Group 0.47 0.43 0.02 2.23 0.141 0.21 .141 
        
Age        
NART 0.29 0.27 0.29 11.72 < .001   
Exec. Func. 0.33 0.29 0.03 2.84 .097   
 
Firstly, HLRs were run to predict maximum recall during RAVLT learning trials 
(T1:T5; see Table 29). Age and NART were entered together in the first step, 
explaining 29.0% of variance. When entered in the second step, Group (MCI LB 
Probable or controls) explains 13.0% additional variance in RAVLT Max T1:T5. 
Processing speed, entered alternatively in the second step, explains a slightly higher 
15.0% of score variance. However, by entering processing speed at step 2, Group no 
longer predicted a significant proportion of variance, p = .141.  This indicates that 
processing speed explains all of the MCI-LB Probable-associated variance in RAVLT 
T1:T5 maximum free recall. FAS, in contrast, did not predict RAVLT Max T1:T5 
scores in the analysis (p = .097). 
Secondly, HLRs were re-run to predict scores on RAVLT Short Delay (Table 
30). As executive function did not correlate significantly with Short Delay scores in 
the group overall, it was not included. Similar to RAVLT T1:T5, age and NART 
together explained 24.0% of RAVLT Short Delay score variance. If entered second, 
Group and processing speed both explain 9.0% of remaining variance. When 
processing speed is entered prior to Group, the effect of group disappears. As with 
RAVLT Max Recall T1:T5, the MCI-LB Probable-associated variance in RAVLT Short 
Delay recall is fully explained by processing speed. 
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Table 30 Predicting RAVLT Short Delay free recall during learning trials with processing 
speed (composite) in MCI-LB Probable and controls. 
 R2 Adjusted 
R2 
ΔR2 F Change Sig. F 
Change 
Std. Beta 
Coefficients 
Std. Beta 
Sig 
Age       -0.31 .010 
NART 0.24 0.21 0.24 9.03 < .001 0.42 <.001 
        
Age      -0.28 .015 
NART 0.24 0.21 0.24 9.03 < .001 0.28 .023 
Group 0.33 0.30 0.09 7.53 .008 0.33  .008 
        
Age      -0.14 .251 
NART 0.24 0.21 0.24 9.03 < .001 0.21 .123 
Proces. Speed 0.33 0.30 0.09 7.89 .007 0.40 <.007 
        
Age      -0.19 .152 
NART 0.24 0.21 0.24 9.03 < .001 0.20 .127 
Proces. Speed 0.33 0.30 0.09 7.89 .007 0.25 .171 
Group 0.357 0.31 0.02 1.61 .210 0.205 .210 
 
6.3.5 Comparison of processing speed and executive function by group 
 
Table 31 Predicting processing speed composite by group in all participants, with and without 
entry of FAS (executive function). 
 R2 Adjusted 
R2 
ΔR2 F Change Sig. F 
Change 
Std. Beta 
Coefficients 
Std. Beta 
Sig 
Age       -0.43 < .001 
NART 0.36 0.34 0.36 21.10 < .001 0.49 < .001 
        
Age      -0.39 <.001 
NART 0.29 0.27 0.29 11.72 <.001 0.47 <.001 
Group 0.43 0.40 0.07 8.48 .005 0.26  .005 
        
Age      -0.38 < .001 
NART 0.36 0.34 0.36 21.10 < .001 0.27 .003 
Exec. Func. 0.55 0.53 0.19 30.00 < .001 0.48 < .001 
        
Age      -0.34 <.001 
NART 0.36 0.34 0.36 21.10 < .001 0.26 .003 
Exec. Func. 0.55 0.53 0.19 30.00 < .001 0.47 <.001 
Group 0.60 0.58 0.05 9.81 .002 0.24 .002 
 
The interrelatedness of executive function and processing speed was next 
considered. In the group overall, FAS and processing speed composite were strongly 
positively correlated, r(75) = .613. After accounting for the variance associated with 
age and NART IQ, group predicts 7.0% of variance in processing speed composite 
scores (Table 31). Executive function as measured by FAS on the other hand, 
predicts 19.0% of processing speed score variance. If group is entered after FAS, it 
still explains 5.0% of score variance. Thus, FAS accounts for 40.0% of the group-
associated variance in processing speed composite scores. Alternatively, FAS is not 
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significantly predicted by group allocation when entered after NART IQ and age, adj. 
R2 = .21, F(3,74) = 0.24, p = .623.  
 
6.4 Discussion 
The present chapter aimed to investigate the hierarchical organisation of 
deficits in cognitive performance observed in Chapter 3. The results of Chapter 3 
showed that processing speed was the most impaired domain in MCI-LB relative to 
both controls and MCI-AD. As both speed of processing and executive function are 
suggested as explanatory factors in disease- and age-associated impairments in 
cognitive ability, hierarchical linear regressions were utilized to determine whether 
they predict score variance in domain-specific abilities such as verbal or visuospatial 
learning and memory. Chapter 4 similarly emphasized the role of processing speed 
across the structure of neuropsychological performance in MCI-LB. PCA analyses of 
control data resulted in a processing speed factor, again suggesting that this may be 
a predictive component in healthy ageing as well. However, the results of the present 
chapter’s multivariate analyses indicate that processing speed is predictive of MCI-
LB-associated declines in visuospatial and verbal ability. 
Firstly, correlational analyses indicated strong relationship between faster 
processing speed and higher scores on visuospatial tasks ([MTCF recall, VPT High 
and Low). In contrast, processing speed did not correlate with visuospatial ability in 
controls or MCI-AD. Processing speed was also significantly related to verbal 
learning ability in MCI-LB Probable, and not the other two groups. Secondly, a series 
of HLRs run to predict both visuospatial memory and verbal learning indicates that 
processing speed fully accounts for the small but significant diagnosis-associated 
variance in visuospatial composite scores. Run separately by group, processing 
speed predicts 25.7% of visuospatial composite scores in MCI-LB Probable. Similar 
results were found with the VPT task. Neither MCI-AD nor controls demonstrated an 
association between their visuospatial scores and speed of processing. In addition to 
visuospatial scores, processing speed was associated with verbal learning ability in 
MCI-LB Probable, but not MCI-AD. HLRs were run between MCI-LB and controls 
because both groups had significant correlations between processing speed and 
verbal learning/ memory measures. These analyses indicate that the group-
associated variance in verbal learning (13.0%) and in verbal memory (short delay; 
9.0%) is completely explained by processing speed differences. As such, processing 
speed was predictive of MCI-LB Probable scores across visuospatial working 
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memory, long-term memory, visuosconstruction (MTCF) and even verbal learning 
(RAVLT). While speculative, it is possible that this can be attributed to cognitive de-
differentiation in the subtype (Baltes, Cornelius, Spiro, Nesselroade, & Willis, 1980; 
Lindenberger & von Oertzen, 2006; see Chapter 10). In contrast, the results provide 
no evidence for a predictive role of executive function in domain-specific abilities. 
FAS did predict a small amount (4-6%) of diagnosis-related variance in visuospatial 
scores. However, through the use of sequential entry in the multiple regression, we 
have demonstrated that this relationship is fully explained by processing speed. As 
such, the sample provides evidence for a processing speed mediated decline in LB 
disease in the MCI stage.  
 
Executive function in MCI 
The limited evidence of executive function’s predictive ability of visuospatial 
tasks is out of line with existing literature that suggests the visuospatial domain is 
particularly dependent on such skills (Thompson et al., 2006). VPT scores, however, 
seems to be unrelated to executive abilities, suggesting this cognitive resource is 
less critical to its performance than processing speed and verbal memory. In healthy 
controls, there was no significant relationship between executive function and the 
VPT, while patients show a strong association between their speed of processing 
and higher scores on the VPT. However, it is possible that the measure of executive 
function (FAS) may be limited in its ability to capture executive function fully. As 
introduced in chapter 3, executive functions have previously been empirically 
delineated to relate to a number of processes including set-shifting, updating and 
inhibition (Miyake et al., 2000). Phonemic verbal fluency tasks like FAS are 
commonly used as measures of executive function (Snyder et al., 2015). However, 
despite its seeming simplicity, FAS engages other non-executive processes like 
semantic knowledge (Rende, Ramsberger, & Miyake, 2002). Conversely, using FAS 
alone to capture executive ability may draw conclusions about only a narrow aspect 
of executive function. Executive function has been argued since Teuber (1972) to 
have the quality of both “unity” and “diversity.” Subcomponents of executive functions 
can be separated from each other, but relate to a common underlying factor (Teuber, 
1972). A plethora of models differ in conceptualization of the interrelatedness of 
executive function, from two-factor levels with supervisory top-down functions 
managing lower-level processes (Shallice, 2002) to the central executive that 
integrates functions in a less hierarchical manner (Baddeley, 1996a). Regardless,  
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behavioural measurement of executive functions may require more extensive testing 
in order to capture the breadth of the construct (Snyder et al., 2015). Future work in 
MCI should consider utilizing more tasks that can be analysed in conjunction in order 
to both localize where dysfunction may operate in executive tasks and to offer clarify 
on the multitude of models of executive function proposed. Furthermore, as a 
simultaneous-presentation task, the VPT inherently requires fewer executive 
resources than serial-sequential visuospatial tasks, which requires retention of both 
item and order information (Rudkin, Pearson, & Logie, 2007). Other visuospatial 
tasks in this population might reveal executive dysfunction differently. Therefore, 
while the present study does not provide evidence of executive-mediated declines in 
verbal or visuospatial function in MCI, we cannot fully rule out the importance of 
executive functions without further testing.  
 
Visuospatial Function in MCI-LB 
The analyses in the present chapter re-emphasize the poor visuospatial 
function in MCI-LB Probable demonstrated in Chapter 3. Such deficits are expected 
in synucleinopathies (Kao et al., 2009) and in DLB in particular (McKeith et al., 2017), 
and were thus anticipated in MCI-LB specifically. VPT offered the opportunity to 
consider how the structure and interrelatedness of components in working memory 
may function differently in MCI subtypes, which differ in terms of location of neural 
damage (Brown et al., 2006). Findings suggest that verbal memory ability is 
important to MCI-LB performance on these tasks. The high verbal-coding subset was 
developed and validated by Brown et al. (2006) as being prone to verbal labels; thus, 
the association between verbal learning ability and VPT High scores are not 
unexpected. However, this only occurred in MCI-LB Probable. While not significant, 
10% of variance in the low-verbal coding subset would be predicted by verbal 
memory ability in MCI-LB Probable as well. Again, this did not reach statistical 
significance and could be investigated using a larger cohort. However, if confirmed, it 
could indicate that MCI-LB is recruiting verbal coding as an intact neuropsychological 
process, in order to compensate for the significant deficits in the visuospatial store. 
Such compensatory scaffolding has been demonstrated to occur in normal ageing 
(Park & Reuter-Lorenz, 2009); however, as the relationship between verbal memory 
and VPT does not exist in controls in this data, this may be a mechanism specific to 
LB pathology. 
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One of the potential mechanisms that may explain the higher recall in VPT 
High and its relationship to verbal memory is concreteness. This is a concept that is 
usually studied in the context of verbal memory, but has applicability to the 
visuospatial domain as well. The concreteness effect is based on improved memory 
for “concrete” words (e.g. bed) versus abstract words (e.g. freedom) 
(Schwanenflugel, Harnishfeger, & Stowe, 1988). Retention and recall of concrete 
words benefit from processing across modalities, i.e. visual elaboration to support the 
verbal coding (Paivio, 1991). However, others have argued that increased 
“concreteness” impedes high-fidelity recollection of visuospatial information, 
particularly if it is abstract in nature (Brandimonte, Hitch, & Bishop, 1992; Schooler & 
Engstler-Schooler, 1990). 
In Brown and Wesley (2013), a series of experiments aimed to determine the 
source of the benefit of the higher verbalization VPT stimuli. They argued that there 
were three theoretically-derived possibilities. Firstly, subvocal rehearsal of verbal 
codes in working memory’s phonological loop may retain visual patterns over the 
short retention period (Baddeley, 2007; Logie, 2011). Secondly, long-term memory 
and semantics that are automatically activated by visual stimuli would scaffold 
performance (Logie, 2011). Thirdly, the episodic buffer’s multimodal integration of 
semantic information, visual stimuli and executive resources facilitate VPT High 
performance (Baddeley, 2000a). Through the use of a dual-task articulatory 
suppression paradigm, Brown and Wesley (2013) conclude that is does not derive 
from the phonological loop. Moreover, while central executive functions were 
implicated in the increased capacity of the visual cache, the authors argue that 
automatic semantic activation is the most likely source of the high-verbalization 
benefit (Brown & Wesley, 2013; Mate, Allen, & Baqués, 2012). In the low VPT, older 
cognitively-intact adults who reported “mostly” or “always” using verbal strategies to 
help complete the visuospatial task had higher scores than those who “rarely” or 
“never” used a dual strategy (Brown & Wesley, 2013). However, this predictive effect 
of self-reported strategy lose was not present in the High VPT version. This suggest 
“a second source of increased task performance, specifically related to higher 
verbalisation, which may be the automatic use of semantic knowledge” (Brown & 
Wesley, 2013, p. 333). In my results, both MCI-LB and MCI-AD VPT High scores 
were predicted by their verbal memory ability. If VPT High performance is dependent 
on automatic semantic elaboration, rather than articulatory rehearsal per se, one 
might expect to see this effect more clearly in MCI-AD, due to its characteristic 
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amnestic profile and hippocampal pathology. However, the difference between 
groups on mean VPT High score was only on trend. Brown and Wesley (2013) also 
suggest an active aspect of long-term activation in remembering abstract visuospatial 
stimuli, which would increase the executive demands of the task; however, the data 
do not support this hypothesis in the context of MCI, as there was no relationship 
between executive ability and VPT performance when considered by subtype. 
Chapter 10 considers the potential clinical relevancy of this evidence of verbal 
coding in more detail. Overall, visuospatial working memory remains less understood 
than the verbal domain (Vandierendonck & Szmalec, 2011). Accordingly, it may be 
necessary to take “steps-back” from such complex tasks and to investigate the 
usefulness of the models and validity of the tasks. Tasks that validly and reliably 
manipulate one component of cognition are extremely valuable (Luciana, Conklin, 
Hooper, & Yarger, 2005). However, some would argue that the ability to isolate and 
study individual cognitive components is unlikely or lacks ecological validity 
(Thompson et al., 2006).  
 
Limitations and future work 
As in previous chapters, analyses of the MCI-AD data subset are limited by 
the small sample size. Failure to see significant correlations between 
neuropsychological variables as well as demographics (such as age and premorbid 
IQ) could be consequent to a lack of power. Specifically, when predicting VPT High 
with verbal memory ability, the relationship drops to on trend when processing speed 
is entered first. However, in univariate analysis processing speed is not associated 
with VPT High. Therefore, it is important that conclusions regarding findings in the 
MCI-AD group are interpreted cautiously. The study had aimed overall to compare 
performance in the two MCI subtypes, but lower numbers of MCI-AD participants 
than expected challenge execution of this aim. Analyses in the subsequent chapters 
will continue to consider MCI-AD in an exploratory manner, but by necessity the 
focus will be on MCI-LB Probable relative to controls. 
Methodologically, the VPT’s association with measures of information 
processing speed may have been influenced by the short presentation time during 
the task. The VPT is typically administered with a presentation time of 3000ms (Della 
Sala et al., 1997), which is shorter than the 2000ms presentation procedure used in 
the present study. Tasks in which stimuli have shorter presentation times may show 
greater interrelatedness in the constructs of processing speed and the particular 
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subcomponent of working memory that is targeted, such as the visual cache. This will 
remain an ongoing methodological challenge in the study of processing speed and 
working memory. Another limitation and challenge for future research is the potential 
construct overlap and validity issues in measuring processing speed alongside other 
neuropsychological components, particularly executive function. In the present data, 
executive function and processing speed were strongly positive correlated. Executive 
function explained 40% of the group-related variance in processing speed. Thus 
while executive function (FAS) did not show a strong relationship with measures of 
broader cognitive function, it is clearly interrelated with processing speed itself. 
Conceptually, executive functions work over a longer time frame than working 
memory (Duke & Kaszniak, 2000). In this way, they may be especially influenced by 
differential speeds of processing. Indeed, in normal ageing psychomotor speed 
largely explained age-related decline in executive function (Keys & White, 2000). 
However, whether psychomotor speed or a more ‘cognitive’ component is the critical 
factor in MCI remains unclear.  
In the present chapter, a processing speed composite was used based on the 
results of the PCA, in an attempt to capture the breadth of the construct and avoid 
various methodological challenges (see chapter 4). However, two possibilities will be 
investigated in the coming chapters. Firstly, can one task validly capture “processing 
speed”? The HLR was re-run using only the DSST (one of the variables included in 
the processing speed composite) and similarly predicted visuospatial function. If the 
DSST can be used in place of a larger battery to capture processing speed, this may 
have clinical utility in identifying MCI-LB. However, the DSST certainly involves other 
cognitive components. Of the Weschler Intelligence Scales (Wechsler, 1944), it is the 
most sensitive to neurological dysfunction of the subtests (Lezak, 1995; Van der Elst 
et al., 2006). However, this sensitivity is nonspecific as impairment in either 
processing or graphomotor speed could induce similar deficits (Joy, Fein, & Kaplan, 
2003). Therefore, Chapter 7 will attempt to fractionate the DSST into its cognitive and 
graphomotor components. Secondly, the relationship between processing speed, 
attention and reaction time will be considered. The computerised reaction time tests 
did not reveal a difference between MCI subtypes, and MCI-LB performed in line with 
controls on SRT. Traditional processing speed measures may fail to capture 
intermittent long response latencies, which might be a hallmark of MCI-LB given the 
phenotype of generalized slowing. Alternatives to a Gaussian conceptualisation of 
reaction times will be investigated in Chapter 8. 
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Chapter Seven: Analysing components of processing speed using 
the Digit Symbol Substitution Test (DSST) 
 
7.1 Introduction 
Chapters four, five and six suggest that processing speed as measured by 
DSST may be a core deficit in MCI-LB: it not only resulted in the largest observed 
effect size (Chapter 4), but can statistically account for deficits in other domains 
(visuospatial and verbal memory; Chapter 6). DSST is often implied to be a “pure” 
measure of processing speed; however, it is in fact a complex task that likely 
engages a multitude of cognitive processes in its completion (Cepeda et al., 2013). 
The current chapter aims to differentiate the DSST as a measure of processing 
speed, to understand how the contributing processes are impaired in MCI-LB 
Probable. 
As mentioned previously, the DSST (Wechsler, 1944) is a processing speed 
measure used frequently and in a variety of populations. Its ubiquity seems highly 
justified. It’s sensitive to neurological dysfunction (Lezak, 1995; Van der Elst et al., 
2006) and is highly (negatively) correlated with age, with typical (r) coefficients 
between -.46 and -.77 (Joy et al., 2000). It has been used to study factors relating to 
intelligence (see DeLuca & Kalmar, 2013 for a review) as well as to attempt to 
delineate the factors of cognitive decline in ageing. A meta-analysis by Hoyer, 
Stawski, Wasylyshyn, and Verhaeghen (2004) reaffirmed that older adults complete 
DSST significantly slower than younger adults, to a very large effect size (d = -2.07 
based on 141 studies). The DSST and other substitution tasks are also commonly 
used in clinical populations; for example, substitution tasks are included as 
suggested criteria for the MDS’s neuropsychological definition of PD-MCI (Litvan et 
al., 2012).  
The complexity of the task has been acknowledged by the development of 
variations by WAIS and independent laboratories in order to help delineate the 
processes involved. An adaptation of DSST, Symbol Copy, was first included on 
WAIS-R (Kaplan et al., 1991) to isolate DSST’s graphomotor component (Joy et al., 
2000). Participants must simply copy each symbol in the grid into an empty box 
directly below it as fast as possible. A small meta-analysis by Joy and Fein (2001) 
reported that Symbol Copy, like DSST, has a strong negative relationship with age 
that becomes significantly stronger beginning at age 50. Moreover, Symbol Copy and 
DSST have been reported to share 36% to 50% of their variance: a substantial 
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proportion but nevertheless indicative of other predictive processes within DSST (Joy 
& Fein, 2001; Joy, Fein, & Kaplan, 2003). 
Another test variant, Error Check, was first developed by Joy et al. (2000) to 
capture the coding processes involved in DSST without graphomotor demands. Error 
Check involves scanning a completed DSST for errors in relation to the key above 
and marking any with a pencil slash. Visual scanning speed has been reported to 
explain 23% of the variance in DSST, a smaller contribution than Symbol Copy (Joy 
et al., 2003).  A third variable that is often investigated in such studies is Coding 
Time. Based on the principles of mental chronometry (Jensen, 2006), the difference 
when subtracting the time per item to complete Symbol Copy from that of DSST 
represents the mental processing time. Coding Time also increases with age, with 
significantly more time spent on coding than on copying in later decades (Joy et al., 
2000). This variable is conceptualized as a purer measure of processing speed 
resources than Error Check (Nebes et al., 2000); however, both variables include 
visual scanning time in addition to mental operation time (Joy et al., 2003). The 
multifactorial nature of the DSST and its variants, as well as the evidence of its 
association with neurological dysfunction, make it a useful exploratory tool in the 
study of subtypes of MCI. In particular, the DSST tests will be analysed together to 
consider the contribution of cognitive processing speed and graphomotor speed to 
the psychomotor task. To the author’s knowledge, such a method of deconstructing 
the DSST has not been pursued in AD, DLB or MCI previously.  
There is also a methodological need to question whether motor impairments 
associated with LB disease may confound interpretation of performance on these 
processing speed tasks. As stated above, previous chapters have pointed to a salient 
difference between MCI subtypes in processing speed. Moreover, HLRs run in 
Chapter 5 indicate a potential mediating role of processing speed (as measured by 
both DSST alone and a composite including DSST) to higher-order cognitive abilities, 
including visuospatial working memory and long-term memory, visuoconstructive 
ability, and verbal learning. Using Symbol Copy, fine motor impairment did not differ 
between groups; however, the impairments on the DSST could nevertheless be 
explained by the motor symptoms that are typical in MCI-LB. As such, the UPDRS 
will be used in conjunction with the DSST sub-analyses to determine the role of gross 
motor dysfunction in completion of these commonly used processing speed 
measures. 
139 
 
The present chapter will utilize a hierarchical linear regression approach to 
examine how processing resources, constructed through the DSST test variants, and 
motor impairment (UPDRS) explain MCI-LB-related variance in DSST. It is predicted 
that graphomotor speed will emerge as the primary predictor of DSST, as in previous 
research, but that processing speed (Error Check and Coding Time) will explain 
additional MCI-related variance. Whether the impact of processing and graphomotor 
speed differs between groups will be determined.  
 
7.2 Methods 
 
Participants 
Participant recruitment, demographic and broad cognitive scores for the group 
(control [n = 31], MCI-AD [n = 18] and MCI-LB Probable [n = 30]) can be found in 
previous chapters. 
 
Materials 
The DSST, Symbol Copy and Error Check were administered as part of the 
large battery of neuropsychological tasks (see Chapter 4 and Appendix K for copies 
of the tasks). Coding Time was calculated as the DSST time per item minus the 
Symbol Copy time per item. Neuropsychological data was first analysed for outliers 
and normality. Missing data points were replaced using MCAR and Coding Time was 
computed from the DSST and Symbol Copy. Scores were converted to standardized 
z-scores adjusted to control means. As described in more detail in Chapter 2, the 
Unified Parkinson's Disease Rating Scale (UPDRS) was scored by an experienced 
clinician during baseline assessment. 
 
Background variables 
As discussed above, performance on the DSST is well-established to have 
inverse relationship with increasing age. By firstly regressing age-associated 
variance in DSST, the analyses will better reveal differences due to cognitive status. 
Subgroups differed significantly in terms of estimates of premorbid IQ (NART), with 
significantly lower mean scores in the MCI-LB Probable group. As such, all HLRs 
were run with NART IQ and age entered in the first step.  
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Treatment of data 
Variables were assessed for normality. One outlier in Coding Time (z-score = -
5.34) from the MCI-LB Probable group was removed. Coding Time was substantially 
positively skewed and was therefore log transformed. Inspection of histograms and 
skew and kurtosis statistics confirmed the transformation was successful.  
 
7.3 Results 
 
Table 32 Mean (standard deviation) of adjusted z-scores of DSST and variants, with 
independent samples t-test results of comparison between MCI subtypes. 
 MCI-LB Probable* MCI-AD*  
n 30 18 t-stat p value Effect size (g) 
DSST  -1.94 (0.87) -1.25 (0.69) 2.82 .007 0.85 
Symbol Copy -2.00 (1.20) -1.34 (1.05) 1.92 .062 0.57 
Error Check -1.87 (1.14) -0.73 (0.71) 4.29 <.001 1.14 
Coding Time** -6.99 (2.31) -5.51 (0.99) 3.04 .004 0.77 
UPDRS 24.37 (15.15) 16.94 (10.76) 1.98 .076 0.53 
* MCI subtype scores significantly lower than controls (n = 31) at p < .01  
** MCI-LB Probable Coding Time n = 29  
 
As was shown in the univariate analyses of Chapter Four and replicated 
above (Table 32), MCI-LB Probable has significantly worse performance than MCI-
AD on the DSST, Error Check and Coding Time indices. The differences in Symbol 
Copy (graphomotor speed) and UPDRS were not significant. Both MCI groups had 
significantly lower scores than controls on all measures (all ps < .01), including 
UPDRS (control M = 5.42, SD = 4.42). In the total sample, a strong positive 
relationship was observed between DSST and the variants Error Check, r(79) = .899, 
p < .001, and Symbol Copy, r(79) = .830, p < .001. Symbol Copy and Error Check 
were positively correlated with each other, r(79) = .739, p < .001, as were Error 
Check and Coding Time, r(74) = .832, p < .001. 
HLRs were run to investigate how the variants predict DSST performance in 
the group overall (Appendix L). Firstly, NART IQ and age were entered in the first 
step of every HLR, predicting 28.1% of variance (p < .001). Secondly, the amount of 
diagnosis-related variance on DSST was examined by entering “group” (control, MCI-  
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Table 33 Predicting DSST and Group status after UPDRS scores. 
 R2 Adjusted 
R2 
ΔR2 F Change Sig. F 
Change 
Std. Β 
Coefficients 
Std. Β 
Sig 
Age &      -0.36 <.001 
NART IQ .281 .262 .281 14.64 <.001 0.45 <.001 
Age &      -0.30 .001 
NART IQ .281 .262 .281 14.64 <.001 0.39 < .001 
Group .421 .398 .141 17.97 < .001 -0.38 < .001 
Age &      -0.20 .027 
NART IQ .281 .262 .281 14.64 <.001 0.29 .002 
UPDRS .446 .424 .166 22.14 <.001 -0.35 .001 
Group .508 .481 .062 9.17 .003 -0.27 .003 
Age &      -0.09 .186 
NART IQ .281 .262 .281 14.64 <.001 0.09 .231 
UPDRS .446 .424 .166 22.14 <.001 -0.05 .529 
Symbol Copy .702 .686 .256 62.57 <.001 0.67 < .001 
Group .716 .696 .014 3.48 .066 -0.13 .066 
Age &      -0.09 .186 
NART IQ .281 .262 .281 14.64 <.001 0.09 .231 
Symbol Copy .698 .686 .418 102.41 <.001 0.67 .000 
UPDRS .702 .686 .004 0.88 .351 -0.05 .529 
Group .716 .696 .014 4.48 .066 -0.13 .066 
Age &      -0.02 .730 
NART IQ .281 .262 .281 14.64 <.001 0.03 .555 
UPDRS .446 .424 .166 22.14 <.001 -0.08 .134 
Error Check .837 .828 .390 174.54 <.001 0.79 < .001 
Group .864 .855 .028 14.60 <.001 -0.18 < .001 
Age &      -0.09 .105 
NART IQ .281 .262 .281 14.64 <.001 0.18 .003 
UPDRS .441 .418 .148 19.40 <.001 -0.13 .045 
Coding Time .770 .757 .329 103.15 <.001 0.64 < .001 
Group .812 .799 .042 15.86 <.001 -0.23 < .001 
 
LB or MCI-AD) as the second-step predictor. Group explained 14.1% of the variance 
in DSST (p < .001).  Next, separate regression analyses were performed with the 
DSST variants entered in the second steps and Group in the third (see Table 33). 
This procedure accounts for the variance due to those constructs before regressing 
cognitive status (Nebes et al., 2000). The degree to which controlling for the first 
predictor decreases the variability explained by group therefore quantifies the 
processing resource’s mediation of the cognitive status-related deficit (Nebes et al., 
2000). Accounting for Error Check, Symbol Copy or Coding Time results in Group 
continuing to contribute a significant but small 1.6%  (p = .049), 3.7% (p < .001) or 
6.2%  (p < .001) of remaining DSST variance. Therefore, Symbol Copy explains the 
highest proportion of cognitive status-related variance on the DSST ([(14.1-
1.6)/14.1]*100 = 88.7%). However, none of the variants or the Coding Time index 
alone fully explain group relationship with DSST. As both Error Check and Coding 
Time are intended to capture the cognitive aspects of the DSST with minimal 
graphomotor involvement, their order of entry with Symbol Copy was next 
considered. Regardless of order of entry, the scores explain additional variance in 
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DSST. Moreover, group still explains 1.6% or 1.8% of DSST variance after both 
Symbol Copy and Error Check or Coding Time are included  (ps = .002), indicating 
some diagnosis-associated variance in scores remains unexplained by the variants. 
The proportion of variance explained is similar to the contribution by group after 
entering only Symbol Copy, suggesting that adding Error Check/ Coding Time to the 
model add little predictive value in group-related DSST score variance. 
Despite entering UPDRS at step 2, Symbol Copy still explains an additional 
25.6% of DSST score variance. UPDRS does not add significant variance if entered 
after Symbol Copy. Moreover, regardless of whether UPDRS or Symbol Copy is 
entered before the other, the only significant standardized β coefficient in the 
resultant four-step model is Symbol Copy. Together this indicates that Symbol Copy 
and DSST are related to each other beyond the motor impairment quantified by 
UPDRS. UPDRS does decrease the ΔR2 upon entry of Error Check (from .543 
to .390) or Coding Time (from .446 to .329), perhaps indicating that motor ability 
persists in these variants designed to minimize its role. However, ΔR2 associated with 
Group in the final step does not decrease substantially (after Error Check: from .037 
to .028; after Coding Time: from .062 to .042), suggesting this finding is not 
particularly relevant to group allocation. To further analyse the relationship of the 
variants with DSST, HLRs were run separately by group (Table 34). 
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Table 34 Predicting DSST with Error Check and Symbol Copy separately by group. 
Model R2 Adjusted 
R2 
ΔR2 F Change Sig. F 
Δ 
Std. Β 
Coefficients 
Std. Β Sig 
Control 
Step 1  
Age &      -0.41 .015 
NART IQ .349 .301 .349 7.24 .003 0.50 .004 
Step 2 
Age &      0.00 .974 
NART IQ .349 .301 .349 7.24 .003 0.11 .338 
Symbol Copy .464 .402 .115 5.58 .026 0.25 .077 
Error Check .789 .755 .325 38.39 <.001 0.68 < .001 
Age &      0.00 .974 
NART IQ .349 .301 .349 7.24 .003 0.11 .338 
Error Check .760 .732 .411 44.47 <.001 0.68 <.001 
Symbol Copy .789 .755 .029 3.41 .077 0.25 .077 
Age &      -0.13 .081 
NART IQ .349 .301 .349 7.24 .003 0.08 .245 
Symbol Copy .464 .402 .115 5.58 .026 0.36 < .001 
Coding Time  .929 .918 .465 163.94 <.001 0.73 < .001 
Age &      -0.13 .081 
NART IQ .349 .301 .349 7.24 .003 0.08 .245 
Coding Time .864 .848 .515 98.42 <.001 0.73 <.001 
Symbol Copy  .929 .918 .065 22.96 <.001 0.36 <.001 
Age &      -0.28 .003 
NART IQ .349 .301 .349 7.24 .003 0.21 .012 
Coding Time .864 .848 .515 98.42 <.001 0.60 <.001 
Error Check  .877 .858 .013 2.68 .114 0.22 .114 
Age &      -.276 .003 
NART IQ .349 .301 .349 7.24 .003 .212 .012 
Error Check .760 .732 .411 44.47 <.001 .219 .114 
Coding Time .877 .858 .117 23.88 <.001 .601 .000 
MCI-LB Probable 
Step 1  
Age &      -0.44 .017 
NART IQ .225 .168 .225 3.93 .032 0.25 .159 
Step 2 
Age &      -0.03 .731 
NART IQ .225 .168 .225 3.93 .032 -0.01 .874 
Symbol Copy .671 .634 .446 35.31 < .001 0.28 .024 
Error Check .854 .830 .182 31.07 < .001 0.70 < .001 
Age &      -0.03 .731 
NART IQ .225 .168 .225 3.93 .032 -0.01 .874 
Error Check .819 .799 .594 85.57 <.001 0.70 <.001 
Symbol Copy .854 .830 .034 5.81 .024 0.28 .024 
Age &      -0.07 .413 
NART IQ .240 .182 .240 4.12 .028 0.08 .318 
Symbol Copy .668 .628 .427 32.18 <.001 0.39 .001 
Coding Time  .863 .840 .195 34.22 <.001 0.60 <.001 
Age &      -0.07 .413 
NART IQ .225 .168 .225 3.93 .032 0.08 .318 
Coding Time .773 .745 .532 58.46 <.001 0.60 <.001 
Symbol Copy  .863 .840 .091 15.88 .001 0.39 .001 
Age &      0.05 .579 
NART IQ .240 .182 .240 4.12 .028 0.09 .278 
Coding Time .773 .745 .532 58.46 <.001 0.43 .004 
Error Check  .858 .834 .085 14.41 .001 0.54 .001 
Age &      0.05 .579 
NART IQ .240 .182 .240 4.12 .028 0.09 .278 
Error Check .799 .775 .559 69.48 <.001 0.54 .001 
Coding Time .858 .834 .059 9.94 .004 0.43 .004 
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MCI-AD 
Step 1  
Age &      -0.34 .199 
NART IQ .130 .014 .130 1.12 .353 -0.06 .809 
Step 2 
Age &      0.00 .990 
NART IQ .130 .014 .130 1.12 .353 -0.31 .029 
Symbol Copy .595 .508 .465 16.08 .001 0.46 .004 
Error Check .829 .776 .234 17.79 .001 0.59 .001 
Age &      0.00 .990 
NART IQ .130 .014 .130 1.12 .353 -0.31 .029 
Error Check .666 .594 .536 22.47 <.001 0.59 .001 
Symbol Copy .829 .776 .163 12.40 .004 0.46 .004 
Age &      -0.04 .472 
NART IQ .130 .014 .130 1.12 .353 -0.09 .078 
Symbol Copy .595 .508 .465 16.08 .001 0.58 <.001 
Coding Time  .973 .964 .378 180.19 <.001 0.65 <.001 
Age &      -0.04 .472 
NART IQ .130 .014 .130 1.12 .353 -0.09 .078 
Coding Time .668 .597 .538 22.70 <.001 0.65 <.001 
Symbol Copy  .973 .964 .305 145.34 <.001 0.58 <.001 
Age &      -0.06 .711 
NART IQ .130 .014 .130 1.12 .353 -0.17 .303 
Coding Time .668 .597 .538 22.70 <.001 0.45 .042 
Error Check  .760 .686 .092 4.99 .044 0.47 .044 
Age &      -.058 .711 
NART IQ .130 .014 .130 1.12 .353 -.172 .303 
Error Check .666 .594 .536 22.47 <.001 .469 .044 
Coding Time .760 .686 .094 5.10 .042 .448 .042 
 
Symbol Copy entered after NART IQ and age explains 11.5% of the variance 
in controls. However, when Error Check (visual scanning) is first accounted for, 
Symbol Copy no longer explains significant variance in controls. In MCI-LB Probable, 
however, Symbol Copy explains a much greater proportion of DSST score variance 
at step 2 (44.6%). Moreover, if entered after Error Check, Symbol Copy still explains 
a small but significant additional residual variance (3.4%). Within the MCI-AD sample, 
Symbol Copy entered first explains a similar amount of variance as in MCI-LB 
Probable (46.5%). After entering Error Check or Coding Time first, Symbol Copy still 
explains 16.3% and 30.5% unique variance respectively.   
Across the three groups, Coding Time explains similar amounts of DSST 
score variance: 51.5% in controls, 53.2% in MCI-LB Probable, and 53.8% in MCI-AD 
(all ps < .001). It explains the highest amount of variance at Step 2 in controls of the 
three variants (Coding Time, Error Check or Symbol Copy). Order of entry using 
Error Check and Coding Time was considered, as both are intended to isolate 
cognitive processing speed with limited graphomotor demands. In controls, Error 
Check does not add significant variance if entered after Coding Time (p = .114). If 
Error Check is added first, Coding Time contributes an additional 11.7% of DSST 
score variance (p < .001). In contrast, in both MCI-LB Probable and MCI-AD both 
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processing speed measures (Error Check and Coding Time) contribute unique 
variance regardless of order of entry (all ps < .05). In the MCI-LB Probable group, 
specifically, entering Coding Time before Error Check decreases the latter’s variance 
explained by 84.8% ([(.559-.08)/.559]*100). In the opposite scenario, Error Check 
accounts for 88.9% of Coding Time’s prediction of DSST scores, indicating shared 
variance between the tasks. 
 
Table 35 Predicting DSST scores using participant age, NART IQ and UPDRS scores in the 
first step, followed by DSST variants if applicable. 
Model R2 Adjusted 
R2 
ΔR2 F Change Sig. F 
Change 
Std. Β 
Coefficients 
Std. Β Sig 
Control 
Step 1  
Age,      -0.41 .051 
NART IQ &      0.50 .005 
UPDRS .349 .274 .349 4.65 .010 -0.01 .957 
MCI-LB Probable 
Step 1  
Age,      -0.40 .043 
NART IQ &      0.23 .210 
UPDRS .232 .144 .232 2.62 .072 -0.09 .630 
MCI-AD 
Step 1  
Age,      -0.21 .330 
NART IQ &      -0.06 .766 
UPDRS .465 .351 .465 4.06 .029 -0.59 .010 
Step 2 
Age,      0.00 .996 
NART IQ &      -0.30 .043 
UPDRS .465 .351 .465 4.06 .029 -0.03 .870 
Symbol Copy .624 .508 .159 5.48 .036 0.45 .020 
Error Check .829 .758 .206 14.46 .003 0.58 .003 
Age,      0.00 .996 
NART IQ &      -0.30 .043 
UPDRS .465 .351 .465 4.06 .029 -0.03 .870 
Error Check .727 .643 .262 12.45 .004 0.58 .003 
Symbol Copy  .829 .758 .102 7.21 .020 0.45 .020 
Age,      -.035 .474 
NART IQ &      -.085 .091 
UPDRS .465 .351 .465 4.06 .029 -.091 .161 
Symbol Copy .624 .508 .159 5.48 .036 .523 <.001 
Coding Time .977 .967 .353 184.41 <.001 .637 <.001 
Age,      -0.04 .474 
NART IQ &      -0.09 .091 
UPDRS .465 .351 .465 4.06 .029 -0.09 .161 
Coding Time .834 .782 .368 28.76 <.001 0.64 <.001 
Symbol Copy  .977 .967 .143 74.91 <.001 0.52 <.001 
 
In order to ensure that gross motor impairment was not responsible for group 
differences in Symbol Copy, DSST, Error Check or Coding Time performance, HLRs 
predicting DSST were run separately by group entering UPDRS in the first step 
(Table 35). UPDRS was not retained in the first, one-step model in controls (β = -
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0.01, p = .957) or MCI-LB Probable (β = -0.09, p = .630), indicating that it is not 
predictive of DSST scores. Subsequent models with UPDRS were thus not run in 
those subgroups. 
 
7.4 Discussion 
Main findings and implications for MCI-LB 
The present chapter aimed to utilize hierarchical linear regression to examine 
how cognitive and psychomotor resources, assessed through the DSST test variants, 
explain group differences in overall DSST performance. In the group overall, DSST 
and Symbol Copy were found to share 41.8% of their variance, in line with previous 
work (Joy & Fein, 2001; Joy et al., 2003). This reconfirms the role of graphomotor 
speed in predicting DSST performance. Contrary to expectations, Error Check was 
the strongest predictor of DSST performance in the group overall (after first 
accounting for age and premorbid IQ) and explained considerably more variance in 
DSST(54.3%) than previously reported (Joy et al., 2003). Alternatively, Joy et al. 
(2003) found graphomotor speed to be the best predictor of DSST in a study with 
healthy undergraduates, with Error Check explaining only 23% (Joy et al., 2003). As 
argued by Laux and Lane (1985), different underlying resources may indeed be 
important to DSST performance in different populations.  
In MCI, graphomotor speed explains almost half of the variance in DSST 
scores. Conversely, it predicts only 11.5% of DSST score variance in controls. This 
figure is much lower than expected in healthy older controls, especially as substantial 
motor slowing in ageing is anticipated even in SRT tasks (Sobin & Sackheim, 1997). 
If valid, this suggests that processing speed task differences between healthy older 
adults and MCI patients may be particularly driven by differences in graphomotor 
speed. However, it is possible that the closer association of graphomotor speed and 
DSST in patients is due to their broader motor impairments or parkinsonism severity, 
present in many MCI-LB patients. In order to address this potential confound, whole-
group analyses were re-run with the inclusion of UPDRS scores. This revealed that 
graphomotor speed explains an additional quarter of DSST score variance even after 
controlling for UPDRS scores. In contrast, clinical motor ratings (UPDRS) did not add 
additional unique variance above and beyond Symbol Copy. Regardless of order of 
entry, graphomotor speed, and not UPDRS, is retained as a significant predictor of 
the DSST, indicating that it is capturing fine motor speed independent of 
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parkinsonism. Moreover, group-associated variance did not drop substantially when 
UPDRS was included in the model. Taken together, these findings suggest that gross 
motor function, while related to both graphomotor speed and processing speed, does 
not confound interpretation of performance on these tasks, including Symbol Copy. 
Therefore, use of the DSST and its variants appears to be reliable even in MCI 
conditions typified by clinical motor impairments. 
While fine motor speed is important to DSST completion, the results also 
provide support that the DSST is a measure of information (cognitive) processing 
speed beyond its graphomotor component. Within MCI-LB Probable, for example, 
Error Check predicted the largest proportion of variance in DSST of the three 
measures. Graphomotor speed only added a small amount of unique variance when 
cognitive speed (Coding Time) or visual scanning (Error Check) were controlled. This 
indicates that while graphomotor speed remains an important process in DSST 
performance, the DSST can be assumed to successfully capture cognitive speed, as 
intended. Thus the importance of the DSST and processing speed more broadly to 
the neurocognitive structure of MCI-LB, discussed in the earlier chapters of this 
thesis, is further supported. Chapter four, for example, showed that the DSST 
produces the largest deficit in performance in MCI-LB Probable relative to controls. 
Moreover, it was found to be the statistically strongest predictor of group allocation in 
the discriminant analyses, whether discriminating only between MCI subtypes or 
across all participants (including controls). Taken together, this suggests that the 
DSST may have utility in differentiating MCI subtypes from each other, and from 
controls, despite the presence of motor symptoms in MCI-LB. However, this requires 
confirmation in larger samples. 
It should be noted that UPDRS scores accounted for much of the variance 
associated with graphomotor speed in the MCI-AD group. This did not occur in MCI-
LB or controls. However, the standardized beta coefficient of UPDRS in the final 
model was not significant in MCI-AD. It is thus unwise to make strong inferences 
about this finding. Future work specific to MCI-AD could consider whether motor and 
graphomotor impairments in completion of the DSST threaten its validity as a 
processing speed measure. 
Other distinct processes have been suggested as involved in completion of 
the DSST that were not taken into consideration in the present chapter. For example, 
incidental memory (non-instructed and non-intentional learning that facilitates 
completion during the task) has been investigated in DSST in the past using paired-
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associates tests (Burik, 1950; Erber, Botwinick, & Storandt, 1981; Murstein & Leipold, 
1961). Following completion of the DSST and without prior warning, participants are 
asked to reproduce the symbols for each digit without use of the key. Such research 
has generally concluded that incidental learning only very minimally aids 
performance and, if it occurs, is secondary to processing or graphomotor speed in 
determining DSST scores (Joy et al., 2003; Joy et al., 2004; Kreiner & Ryan, 2001; 
Stephens, 2006). However, incidental memory may play an increasingly determinant 
role in task completion after age 50 (Joy et al., 2004), possibly due to cognitive de-
differentiation. As such, it may be relevant to these samples. It seems unlikely, that 
incidental memory could be involved in Symbol Copy completion due to the narrow 
demands of the task. Error Check performance would be more likely scaffolded by 
executive or visuospatial abilities (Sweet et al., 2005). While executive function has 
not emerged in previous chapters as particularly impaired in MCI-LB, its role in 
processing speed tasks should still be considered. Such tasks likely involve varying 
amount of executive control, and even the simplest tasks will require some 
maintenance of a task goal and the filtering of background information. Moreover, the 
only processing speed outcome variable in which MCI-LB Probable did not perform 
significantly worse than controls is SRT. This suggests that basic psychomotor speed 
is not impaired per se, but that higher task demands or executive weighting are 
needed to reveal impairments in MCI-LB. The structured review (Chapter 2) suggests 
a similar dynamic in PD. Early PD patients perform poorly on tasks with executive 
weighting, regardless of which domain they appear to target (working memory, 
processing speed, visuospatial and verbal learning), and despite general intact 
performance on simpler tasks in those domains (Trails A, RAVLT). Chapter 8 will 
therefore consider how performance on more challenging speed of processing tasks 
reveal differences in MCI-LB. In particular, the Continuous Performance Test will be 
used as it requires sustained attention (higher task demands). Errors on the test can 
also be inspected to consider how they may reflect executive dysfunction, such as 
impaired inhibition or updating. 
 In addition to the issue of executive weighting and sustained attention, which 
will be addressed in Chapter 8, performance on DSST tests may also depend on 
oculomotor control. Such control would fall under the umbrella term of perceptual 
speed, rather than cognitive or graphomotor speed. For example, within Error Check 
saccadic eye movements are required to move from scanning the completed DSST 
to scanning the key above it. Saccadic eye movement may be less obviously 
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involved in Symbol Copy, but the ability to maintain visual attention on the lines of 
symbols would certainly be necessary for a quick completion. Therefore, Coding 
Time, being derived from the DSST and Symbol Copy, should remove some of the 
variance associated with visuoperceptive control. Oculomotor control is also relevant 
in the context of ageing, as saccadic latency has been shown to increase after 30 
years of age (Hikosaka, Takikawa, & Kawagoe, 2000). To the author’s knowledge, no 
study has examined eye movement in DSST in DLB or MCI, nor during Symbol Copy 
or Error Check in any population. However, Stephens (2006), using DSST, found no 
evidence of different eye movements in older versus younger healthy participants; 
however, this study must be interpreted cautiously as only 18 individuals were tested. 
Moreover, time spent searching the key was not considered, which was specifically 
noted as a potential separate resource by Salthouse (1978) and is clearly a major 
component of Error Check. If oculomotor dysfunction is found to be important in the 
performance of such tasks, this would lend credence to an opposing theory of 
cognitive dysfunction in aging, the Common Cause Hypothesis, first proposed by 
Baltes and Lindenberger (1997). This perspective argues that sensory abilities are 
intrinsically linked to brain integrity and are in fact the critical factor in cognitive 
decline (Baltes & Lindenberger, 1997). Baltes and Lindenberger (1997) presented 
evidence that measurements of sensory function provided a better model of the 
declines observed ageing than processing speed. However, it is possible that 
sensorimotor resources and processing speed are similarly strong contributors to 
cognition in older adults (Salthouse, 1994). Analyses to consider the role of these 
resources are beyond the scope of the present chapter and hence cannot be ruled 
out as explanatory. 
 
Conclusion 
In conclusion, while the DSST and related coding tests aim to quantify speed 
of processing, they are complex tasks that required a number of cognitive resources 
(Lezak, Howieson, Loring, & Fischer, 2004). The present chapter aimed to fractionate 
DSST performance following a processing resource account by considering the role 
of visual scanning and graphomotor speed to its performance. Secondly, processing 
speed measures were evaluated with reference to broader motor symptoms to 
consider the former’s validity in MCI-LB. These results provide greater confidence in 
utilization of the DSST as a valid measure of cognitive processing speed in healthy 
controls and MCI-LB Probable specifically. 
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Chapter Eight: Intraindividual variability in attention 
 
8.1 Introduction  
Analyses in the previous chapters have emphasized the importance of speed 
of processing to the neuropsychology of MCI-LB. Separate analyses of the DSST 
using graphomotor variants also suggest that slowed processing speed is due to 
cognitive slowing and not simply slowed motor responses. In general as well as 
within the present project, processing speed is typically indexed by tasks involving 
attentional cognitive resources, such as the DSST, Stroop and Trails. Attentional 
difficulties are common in advanced DLB (as well as PD and PDD) and have been 
shown to be more pronounced than in AD (Baddeley et al., 2001; Ballard et al., 
2002). Ballard, O'Brien, et al. (2001), for example, argues that slowed central 
processing speed is specific to DLB and not demonstrable in AD patients with MMSE 
scores of more than 10. The present study has demonstrated that attentional deficits 
are evident in the MCI-LB phase as well. However, the computerised SRT and CRT 
tests were not different between MCI subtypes, and MCI-LB did not differ significantly 
from controls on SRT. Moreover, a review concluded preclinical AD to be 
characterized by subtle attentional dysfunction, with slowed speed of processing also 
reported in 43% of the included studies (Twamley, Ropacki, & Bondi, 2006). Hence, it 
is unclear whether processing speed and poor attention can serve to distinguish 
between MCI subtypes or if it is common to MCI aetiologies. 
Reaction time testing can be problematic due to the tendency to focus on 
mean (average) performance over a given temporal period, i.e. measures of central 
tendency. Such an emphasis in line with the current dominating perspective of 
general stability in developmental research (Hultsch, Strauss, Hunter, & MacDonald, 
2008; Jackson, Balota, Duchek, & Head, 2012). It is a framework that presumes a 
similar trajectory of change for all individuals over time, and thus conceptualizes 
average, age-related effects (Hultsch et al., 2008). In contrast, within-person 
variability, or inconsistency, has received much less attention in the fields of 
developmental and cognitive psychology. Inconsistency concerns fluctuations in 
reaction time that occur on a trial-by-trial basis, rather than a generalized slowing that 
would be reflected in mean performance (Jackson, Balota, Duchek, & Head, 2012). 
Such intraindividual variability (IIV) has typically been viewed as ‘noise’ in standard 
reaction time paradigms. However, it has since been proposed as a “coherent, 
interpretable steady-state ‘hum’ that describes the base condition of the individual” 
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(Nesselroade, 1991, p. 94) and should not be dismissed as invariance/error. Indeed, 
analyses have shown that IIV is strongly internally consistent, correlates reliably with 
independent measures of cognitive fluctuations, and offers additional information on 
an individual’s attentional profile beyond mean speed of response (Walker, Ayre, 
Cummings, Wesnes, McKeith, O’Brien, et al., 2000). As such, an alternative to 
Gaussian (normal) distribution modelling may be required to capture long latencies. It 
may be advantageous to include intermittent long responses, as they may be a 
hallmark of MCI-LB due to its clinical feature of cognitive fluctuations. Background on 
IIV in aging and pathology as well as ex-Gaussian modelling approaches are 
discussed in the following sections.   
 
Sustained attention 
Tasks that quantify reaction times are typically measures of attention. Some of 
the most prominent and distinguishing neuropsychological impairments of DLB have 
been demonstrated by tasks requiring attention (Calderon et al., 2001; Ferman, 
Smith, Boeve, Graff-Radford, Lucas, Knopman, Petersen, Ivnik, Wszolek, Uitti, et al., 
2006; Walker, Allen, Shergill, & Katona, 1997). The concept of attention includes 
abilities, states of consciousness and processes that focus cognition, although a 
singular definition is elusive and often differs by context (Zomeren & Brouwer, 1994). 
It has been suggested to include multiple sub-processes such as selective, focused 
and sustained attention (Tröster, 2008). The latter is believed to be particularly 
impaired in DLB. Sustained attention concerns attention occurring over a length of 
time, thus requiring vigilance, continual effort, as well as elements of selective and 
focused attention (Cohen, Sparling-Cohen, & O'Donnell, 1993; Mirsky, Anthony, 
Duncan, Ahearn, & Kellam, 1991). Sustained attention is less passive than 
anticipation and is typified by tasks that require intense, active processing.  
Scientific investigation of sustained attention has its roots in 1950s military 
research on signal detection, using tasks in which a signal must be detected during 
long periods of inactivity (Jerison, 1970). Signal detection, however, is just one 
example of a task that necessitate intact sustained attention. Indeed, most 
neuropsychological tests, while perhaps targeting other cognitive components, will be 
influenced by deficits in sustained attention due to the conceptual dependence of 
attention on time (Ibarretxe-Bilbao et al., 2009). Time is a predictor of attention and 
measuring attention depends on whether or how it changes over time. Selective 
attention, for example, could be targeted separately from sustained attention at a 
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given moment; however, because information is processed sequentially over a period 
of time, in both most real-life situations and laboratory cognitive tasks sustained 
attention is engaged.  
 
Attentional dysfunction in DLB and AD 
Brief consideration of the differences in attentional dysfunction between DLB 
and AD is warranted, particularly as clinicopathological studies suggest that DLB is 
often misdiagnosed as AD during a patient’s lifetime (Hansen, Salmon, 1990; 
McKeith, Fairbairn, 1994). In general, attentional impairment is statistically greater in 
DLB than in AD and may serve as a reliable differentiating factor (Ballard, O'Brien, et 
al., 2001; Calderon et al., 2001; Collerton et al., 2003); but, such findings have not 
always been replicated (Galasko, Katzman, Salmon, & Hansen, 1996; Gnanalingham 
et al., 1997; Salmon et al., 1996). Walker, Ayre, Cummings, Wesnes, McKeith, 
O’Brien, et al. (2000) found fluctuations to be both more prevalent and more severe 
in DLB (81%) in contrast to both AD (8% AD) and vascular dementia (18%), thus 
representing the largest difference in symptom frequency between the causes of 
dementia. In a study using a matched control group, AD had intact performance in 
sustained attention (Calderon et al., 2001). Conversely, DLB performed below AD 
participants in attentional tasks requiring sustained, selective or divided attention, in 
addition to most visuospatial tasks (Calderon et al., 2001). The findings confirm 
relevancy of attentional dysfunction in clinical practice, where assessing severity may 
help differentiate between DLB and AD (Walker, Ayre, Cummings, Wesnes, McKeith, 
O’Brien, et al., 2000). However, attention deficits will be more pronounced and less 
qualitatively distinguishable as both conditions advance, obscuring difference 
between the groups (Ballard et al., 1995). Dementia patients are often unable to 
tolerate sustained attention tasks and, in the case of DLB, motor symptoms often 
worsen with disease progression, complicating standardized, computerised testing. 
As such, the MCI stage may offer an important window for researching attentional 
dysfunction. 
 
IIV and Normal Ageing 
There is a well-established increase in inconsistency in neurocognitive speed 
with age believed to reflect decreasing functional status of the central nervous 
system (de Frias, Dixon, Fisher, & Camicioli, 2007; Hultsch & MacDonald, 2004a; 
Hultsch et al., 2008; Li & Lindenberger, 1999) and cognitive ability (Bunce, 
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MacDonald, & Hultsch, 2004; Fozard, Vercruyssen, Reynolds, Hancock, & Quilter, 
1994; West, Murphy, Armilio, Craik, & Stuss, 2002). IIV has a U-shaped 
developmental trajectory across the lifespan, being highest in childhood and older 
age, particularly after the mid-70s (Hultsch et al., 2008). These age-related trends 
are independent of motor decline, practice, fatigue and age-related difference in 
mean performance level (Williams, Hultsch 2005; Bruce, Macdonald, Hultsch 2004).  
Cognitively, IIV may underlie decreased age-related performance in a number 
of domains. For example, Hultsch, MacDonald, and Dixon (2002) found that 
inconsistency in reaction time tests predicted poorer perceptual speed, working 
memory and episodic memory performance. The relationship between variables was 
also stronger as age increased (Hultsch et al., 2002). In a six-year longitudinal study 
by MacDonald, Hultsch, and Dixon (2003), variability explained 96% of the variance 
in performance in subsequent testing periods. Declines in all cognitive measures 
were significantly predicted by inconsistency in SRT and CRT tasks taken at the first 
testing session (MacDonald, Hultsch, et al., 2003). IIV seems to be a critical predictor 
of cognitive ageing (Hultsch & MacDonald, 2004b) and is also associated with poorer 
prognoses in aging. In a five-year longitudinal study of healthy older adults, 
inconsistency in reaction time was a significantly greater risk factor for pathological 
status, like MCI, than slower mean reaction time (Bielak, Hultsch, Strauss, 
MacDonald, & Hunter, 2010). 
Sustained attention tasks are especially relevant to study of age-associated 
cognitive decline as they require intense, endogenous focus (Braver, Satpute, Rush, 
Racine, & Barch, 2005). Indeed, situations requiring a high degree of cognitive 
control are some of the most effective in revealing age-related cognitive changes 
(Braver et al., 2005). This may be especially true when response inhibition (May, 
Zacks, Hasher, & Multhaup, 1999; Spieler, Balota, & Faust, 1996) or active 
maintenance of working memory (Craik, Morris, & Gick, 1990; Daigneault & Braun, 
1993) are required, as is the case with the Continuous Performance Test-AX (CPT-
AX) described in detail below. In addition to healthy ageing, increased IIV has been 
demonstrated in various neurological conditions such as traumatic brain injury 
(Stuss, Pogue, Buckle, & Bondar, 1994), PD (Burton, Strauss, Hultsch, Moll, & 
Hunter, 2006) and dementia (Gordon & Carson, 1990). 
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IIV in MCI and AD 
Increased IIV in reaction time may precede the development of cognitive 
decline (Bielak et al., 2010; Cherbuin, Sachdev, & Anstey, 2010; Lövdén, Li, Shing, & 
Lindenberger, 2007; MacDonald, Hultsch, et al., 2003). IIV, for example, is higher in 
both MCI and AD versus healthy ageing (de Frias et al., 2007; Gorus, De Raedt, 
Lambert, Lemper, & Mets, 2008). Dementia research has primarily focussed on AD, 
with consistent reports of elevated IIV (Hultsch, MacDonald, Hunter, Levy-
Bencheton, & Strauss, 2000; Murtha, Cismaru, Waechter, & Chertkow, 2002). 
Duchek et al. (2009), for example, found that increased variability was associated 
with both age and early stage AD diagnosis when using coefficient of variation (CoV) 
to quantify IIV. Furthermore, CoV in Stroop task performance discriminated 
apolipoprotein E4 carriers from non-carriers in healthy older controls. Hultsch et al. 
(2000) investigated the contribution of neurological and somatic health status to 
variability and found IIV to be related to overall cognitive performance and predictive 
of AD independent of performance level. Their findings suggest IIV to be a stable 
cognitive trait relating to central nervous system integrity, rather than to potentially 
transient somatic health status. Other studies have similarly controlled for potential 
confounding variables, such as severity of dementia and parkinsonism, motor status 
and reaction time latency, to demonstrate that increased IIV in DLB nevertheless 
remains (Ballard, O'Brien, et al., 2001; Ballard et al., 2002; Walker, Ayre, Cummings, 
Wesnes, McKeith, O’Brien, et al., 2000). 
IIV has also been shown in MCI to be predictive of conversion to dementia 
(reviewed in Jackson et al., 2012; Phillips, Rogers, Haworth, Bayer, & Tales, 2013). 
Indeed, IIV may represent an early indicator of an underlying pathological and 
progressive decline in brain integrity before decreases in mean level performance 
become evident. For example, IIV in a target detection task was found to be 
predictive of which amnestic MCI patients converted to dementia by 2.5 years follow-
up (Tales et al., 2012). Non-converters displayed equivalent variability at baseline as 
healthy controls (Tales et al., 2012). As a possible confound to this finding, MMSE 
scores were lower at baseline in converters versus non-converters (Tales et al., 
2012). However, as MMSE did not correlate with or predict IIV within each of the 
groups, the authors concluded it was unlikely that the poorer general cognitive status 
of the converter group accounts for the difference in IIV observed (Tales et al., 2012). 
Gorus et al. (2008) found variability and response latency were greater in cognitively 
impaired persons, with speed of processing decreasing with degree of impairment 
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(moderate AD versus mild AD versus amnestic MCI). The study also utilized a 
paradigm of increasingly complex reaction times tasks to delineate motor and 
cognitive components of performance. Gorus et al. (2008) found that longer reaction 
time latencies were associated with both the cognitive and motor aspects of the task, 
while IIV mainly related to the cognitive component of reaction times. As such, IIV is 
a more purely cognitive task index and is less dependent on motor speed variability. 
The IIV measure was also the best predictor of amnestic MCI status, over mean 
processing speed, highlighting the additional value of variability above and beyond 
response latency (Gorus et al., 2008).  
Other work in MCI contradicts this picture of IIV. Christensen et al. (2005), also 
using HLRs, found greater IIV in MCI, but IIV did not predict diagnostic status beyond 
mean levels of reaction time performance. This study had a narrow patient age range 
(60-64 years) and used basic reaction time tasks (SRT/ CRT), which may have failed 
to capture the phenomenon. Conversely, both Dixon et al. (2007) and Strauss, 
Bielak, Bunce, Hunter, and Hultsch (2007) found variability to be superior to 
response latency in differentiating patient groups. These studies shared some 
participants and used a wider age range (64-90+) and a stricter definition of MCI than 
Christensen et al. (2005), which may explain the differing results. Moreover, the tasks 
of Dixon et al. (2007) and Strauss et al. (2007) included those of higher complexity 
such as the n-back choice reaction time task. MCI may therefore be associated with 
greater IIV relative to healthy controls but only on tasks requiring additional executive 
functions, such as manipulating held information, cognitive set switching, or inhibition 
(Strauss et al., 2007). This is line with similar concerns in identifying age-related 
deficits discussed above.  
 
IIV and DLB 
Of the existing IIV research in DLB, studies typically include both DLB and AD 
or other dementia patient groups. Overall, results of such studies suggest that 
variability is greater in DLB than in AD (Walker, Ayre, Cummings, Wesnes, McKeith, 
O’Brien, et al., 2000; Walker, Ayre, Perry, et al., 2000), including on tasks specifically 
targeting vigilance or sustained attention (Ballard et al., 1995). Bradshaw, Saling, 
Anderson, Hopwood, and Brodtmann (2006) for example, found greater IIV in DLB in 
all aspects of attention measured, including simple reaction times, focused selective 
attention, divided attention and supervisory attentional control, even when matched 
on dementia stage and severity. Walker, Ayre, Cummings, Wesnes, McKeith, 
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O’Brien, et al. (2000) used a 90 second CRT and demonstrated second-to-second 
fluctuations in cognition and EEG. In line with Ballard et al. (2002) and Bradshaw et 
al. (2006), Walker, Ayre, Cummings, Wesnes, McKeith, O’Brien, et al. (2000) found 
that greater IIV in DLB persisted despite controlling for dementia and parkinsonism 
severity or mean response time latency. Interestingly, the forced-choice, two-
response paradigm used in that study is less cognitively demanding than the more 
challenging n-back task. As discussed above, more challenging tasks have been 
shown to be necessary to reliably reveal increased IIV in the case of AD patients 
(Strauss et al., 2007). This further supports the hypothesis that IIV will be more 
pronounced in DLB than in AD.  
 
CPT-AX and other paradigms for measuring attention and IIV 
Historically, neuropsychological assessment of inconsistency of attention has 
relied on behavioural observation and pen-and-paper or oral tasks, such as digit 
span. These can be useful measures of attention span, but they do not target 
aspects such as selective or sustained attention (Cohen et al., 1993) nor require 
substantial cognitive effort (Zomeren & Brouwer, 1994). Simple attentional tasks do 
not always reveal deficits in dementia (Gnanalingham et al., 1997; Salmon et al., 
1996; Walker et al., 1997), although this has been successfully reported in a few 
studies (Hansen et al., 1990). Moreover, the aforementioned dependency of attention 
on time is difficult to manipulate using most pen-and-paper tasks (Cohen et al., 
1993). For these reasons, their appropriateness in differentiating between dementia 
syndromes is questionable (Bradshaw et al., 2006). Instead, more complex, 
standardised attentional tasks that target specific subcomponents (sustained, 
selective, divided, etc.) are needed to elicit and reliably capture differential 
performance in dementia subtypes (Tröster, 2008).  
The advent of technologies such as the tachistoscope and, subsequently, 
computers, allowed increased standardization, reliability and nuance in studying 
attention through reaction time (Cohen et al., 1993). The CPT was one of the earliest 
computerised neuropsychological paradigms to be widely adapted and has been 
used to illustrate deficits in a variety of conditions including schizophrenia 
(Nuechterlein, 1983) and Attention Deficit Disorder (Epstein et al., 2003). Presently, a 
number of versions of CPTs are available for commercial and research use and have 
collectively come to be the most regularly used to assess sustained attention. While 
varying in particularities, a CPT presents stimuli (typically numbers or letters) 
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sequentially and requires participants to attend to and respond to a target stimulus 
while ignoring non-target distractor stimuli over an extended testing period. 
Performance on CPTs correlates well with other information processing-based 
measures and speeded tests of attention and executive function (such as Stroop and 
Trails) and benefits from good test-retest reliability in healthy older adults (Braver et 
al., 2005).  
CPT-AX is a conditional variant of CPT in which responses to the target (“X”) 
should only be made when it occurs immediately after an “A”. Some versions require 
a different response (typically a second button is pressed) to any non-target stimuli 
(Braver et al., 2005). Regardless of the response requirement, AX paradigms 
importantly have executive demands, primarily context maintenance, inhibition and 
set shifting, in addition to requiring sustained attention. This increases the difficulty 
relative to simpler reaction time tasks. CPT-AX also has the value of multiple 
outcomes measures, including correct responses, errors of omission and 
commission, and reaction time, as well as secondary/ derived signal detection 
measures. Signal detection analyses are useful in investigating error type between 
groups, but does not address IIV nor directly quantify performance variability over 
time. 
CPT-AX is also useful in measuring IIV due to its complexity. Age-related 
increases in IIV are greater when using more complex tasks. West et al. (2002), for 
example, found IIV to be greater in older versus younger participants in higher 
executive control conditions of the sustained attention task, but comparable in the 
low executive control conditions. Bradshaw et al. (2006) used a task modelled on the 
Visual Focussed Attention Test (Eriksen & Eriksen, 1974) to manipulate task 
complexity and investigate how executive function demands impact sustained 
attention. As expected, DLB were significantly more variable in task conditions with 
added executive control and spatial processing demands (Bradshaw et al., 2006). 
The executive weighting of CPT-AX should may be particularly useful for 
discriminating MCI-LB given that executive impairment is an earlier and more 
pronounced feature of DLB than of AD (Calderon et al., 2001; Collerton et al., 2003; 
Mori et al., 2000; Mosimann et al., 2004). However, while early executive impairment 
was demonstrated in LewyPro (the precursor the SUPErB) (Donaghy, O'Brien, 
Colloby, et al., 2015), it was less clear in my univariate analyses (see section 4.4). 
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The ex-Gaussian model and modelling of CPT-AX in MCI 
Previously discussed studies in DLB to date have generally used rather crude 
measures of IIV, typically either the individual SD, CoV (individual SD divided by the 
individual’s mean) or interquartile range. However, reaction time distributions are 
typically positively skewed, leading to overestimation of population medians if using 
only sample medians to define the curve (Miller, 1988). Such descriptive statistics 
often fail to sufficiently characterize the shape of a distribution of response time data 
by viewing longer latencies as noise and obscuring critical features of the curve. For 
example, two distributions of reaction times could be viewed as equivalent based on 
their means, but nevertheless have highly different modal portions of the distribution 
(mu) or tail length (tau) (Heathcote, Popiel, & Mewhort, 1991). Tail features may be 
especially important to DLB, as discussed below.  
Recent work has applied alternative mathematical techniques to better model 
empirical reaction time measures and therefore understand IIV, in particular using an 
exponentially-modified Gaussian (or ex-Gaussian) distribution. The ex-Gaussian 
distribution modifies the Gaussian curve (normal distribution) by combining it with an 
exponential distribution (Ratcliff, 1979; see figure 1). The symmetrical Gaussian/ 
normal curve is extremely common to a variety of human processes, such as 
perceptual and motor tasks (Lacouture & Cousineau, 2008), but will omit the positive 
skew that typifies reaction time data in the tail of the distribution. The exponential 
distribution, in contrast, is characteristic of decision processes (Luce, 1986; chapter 
6). The resulting summation of these two models provides a probabilistic function that 
is more representative of reaction time data, such as of the CPT-AX. In particular, the 
right-sided skew of reaction times are included, preserving the variability data rather 
than only focusing on central tendency. The ex-Gaussian curve has three parameters 
of interest: mu (mean), sigma (SD) and tau (the exponentially distributed tail of the 
distribution). Because the sum of mu and tau is equal to the arithmetic mean of the 
reaction time distribution, ex-Gaussian and Gaussian distributions can be directly 
compared.  
Lacouture and Cousineau (2008) explain that ex-Gaussian’s growing 
popularity is due to its theoretical justification, provision of easily interpreted 
parameters and facilitation of hypothesis testing on underlying cognitive processes of 
reaction time tasks. Sigma has generally become conceptualized as indicative of 
response preparation or execution problems, primarily from work in ADHD 
(Fassbender et al., 2009; Schall & Hanes, 1998; Vaurio, Simmonds, & Mostofsky, 
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2009). Tau, alternatively captures the strength of the slow-tail of the ex-Gaussian 
distribution and is believed to reflect trials in which “lapses in attention,” i.e. cognitive 
microfluctuations, have occurred (Lee et al., 2015; Leth-Steensen, Elbaz, & Douglas, 
2000; Tamm et al., 2012). Tau may therefore be particularly relevant to DLB and 
neurological integrity. Distributional parameters are likely differentially impacted in 
normal ageing and pathologies including DLB. Tse (2010), for example, 
demonstrated that age was associated with both a greater positive skew (larger tau 
values) and changes in mu on attentional control reaction time tasks, but only tau 
was impacted by early AD status. Balota (2010), in a twelve-year longitudinal study, 
found that tau (as well as Stroop error rates) significantly discriminated between 
converts to AD and nonconverters, beyond most other psychometric measures. 
Balota (2010) concludes that tau may be an early marker of likelihood to develop AD.  
 
 
 
Figure 11 Three distributions of response times with same sample mean. Panel (A) 
exponential function distribution. Panel (B) normal distribution. Panel (C) ex‐Gaussian 
function distribution.  Image taken from Lacouture and Cousineau (2008). 
 
Hypotheses and Aims 
Reaction times, signal detection indices, IIV, and types of errors made within 
CPT-AX, a sustained attention task will be analysed to allow greater understanding of 
MCI-LB Probable cognitive performance in situations requiring sustained attention, 
context maintenance and response inhibition relative to healthy controls and MCI-AD. 
It is hypothesized that increased IIV in reaction time performance will be observed in 
both MCI groups. Ex-Gaussian modelling techniques will be used to delineate and 
investigate the components of IIV within the SRT and CRT paradigms in addition to 
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CPT-AX. Evidence that increased IIV in MCI is associated with greater likelihood of 
conversion to AD in MCI subjects makes it difficult to confidently predict how MCI-AD 
and MCI-DLB will differ in their IIV subcomponents (reviewed in Phillips et al., 2013). 
However, the prominent executive dysfunction associated with advanced DLB makes 
it likely that IIV will be elevated in MCI-LB Probable in CPT-AX performance. Lastly, 
IIV will be investigated as underpinning function in higher cognitive activities 
(visuospatial function and global cognitive scores) and compared to the DSST. The 
final comparison is in order to consider whether IIV offers utility above and beyond 
processing speed as measured by the DSST, which emerged as the strongest 
predictor of group allocation and the task showing the largest effect size between 
MCI-LB Probable and controls (see Chapter 4). Processing speed, as measured by 
DSST, was also a significant predictor of visuospatial scores, global cognitive 
function, and verbal learning (Chapter 6). 
 
8.2 Methods 
Participants 
See Chapter two for participant recruitment, initial screening, diagnostic group 
allocation process, and full study testing procedures. The computerised reaction time 
tests were completed by different numbers of participants due to technical issues and 
testing time restrictions. Demographic details (by group) are presented in the results 
sections below. 
 
Procedure 
The computerised reaction time tests were completed as part of the larger 
battery of SUPErB. Participants were generally tested in a dedicated study room at 
the Clinical Ageing Research Unit, Institute for Ageing and Health, Newcastle 
University on the fifth and final visit of the SUPErB study (see Chapter 2). Testing 
was completed at participants’ homes as needed due to time constraints. Regardless 
of location, the testing took place in a darkened room at a desk using a 12.5 inch 
screen laptop. The reaction time tests were administered as part of the larger 
computerised battery (see section 4.2).  
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Materials 
Computer and external buttons 
All participants were trained on how to hold the external buttons in their hands. 
Thumbs or pointer fingers could be used to depress the button. The author ensured 
the participant could comfortably and accurately use the buttons in cases of any 
motor issues such as arthritis or tremor. One participant (MCI-LB Probable) was 
unable to show adequate comprehensive of the task demands and their data were 
omitted from the following analyses. 
 
Simple (SRT) and choice (CRT) reaction time 
SRT and CRT are 40-trials tasks measuring reaction time to a visual stimulus. 
Participants must respond “as quickly as possible” using external buttons to an 
intermittently appearing stimulus, either a white “X” (SRT) or white arrow (CRT) that 
appears in the centre of a black screen. In CRT, participants must press the left or 
right button if the arrow is pointing to the left or right, respectively. Stimuli displays for 
up to 3000ms without a keypress, with a minimum display time of 500ms. 
Interstimulus interval (ISI) is randomly determined, with a minimum wait of 1500ms. 
Responses are recorded as the first key press response time in SRT, unless there is 
“no response” or “anticipated” response (less than 100ms. For CRT, reaction times 
are either “correct,” “multiple key press” (both pressed simultaneously), or “incorrect” 
(wrong key pressed). Both SRT and CRT have 40 stimuli, corresponding to 40 
reaction time measures per participant, unless in cases of nonresponse. Distribution 
of the results were assessed using z-scores as discussed further in the results 
section. 
 
CPT-AX 
A modified version of the CPT-AX was administered. As introduced above, the 
CPT-AX is a test of sustained attention measured using reaction times and hit/ error 
rates. In the centre of a grey screen, white, 40 point letters appear consecutively 
(presentation time = 85ms, ISI = 900ms) Participants are required to respond with a 
keypress “as quickly as possible” to “X” when it has come immediately following an 
“A” (“AX” trial). Participants are instructed to not respond to any other letters. There 
was no specific training period, but paper examples of the stimuli were used and 
comprehension of the instructions was assessed by the researcher prior to 
administering the task. Of the 240 pairs of letters, AX trials requiring a response  
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Table 36 Description of the different response types in the CPT-AX task. 
Presentation Pair and 
Response Type 
Description Frequency of 
occurrence 
AX Hit Correct target with keypress occurring on the “X” 70% 
AY False Alarm Non-target that comes after an “A”: “A, B, C, F, G, J, N, O, 
Q, S, U, V, W, Y, Z”. High frequency of AX targets in task 
primes participants to respond after A’s as a response 
would be correct in the majority of cases. Avoidance of 
AY errors requires inhibition of response. 
5% 
BX False Alarm X that occurs after a non-A; Avoidance of BX errors 
requires intact context maintenance, i.e. participants must 
keep an up-to-date representation of the previous 
stimulus in order to correctly withhold a response 
10% 
BY False Alarm Non-X after non-A; indicative of general sustained 
attention dysfunction. 
10% 
Other A False Alarm “A” always, before something other than X, i.e. the A in 
“AY” false alarms; indicative of general sustained 
attention dysfunction. 
5% 
 
appear frequently (70% of pairs). “AY” and “BX” false alarm pairs each make up of 
10.0% of the total stimuli pair presentations. Target presentation was pseudo-
randomized. The primary outcome measures are % hits (high = better attention 
performance), % miss (AX errors; high = inadequate focus on stimuli, slow 
processing speed, or inability to respond rapidly), and false alarms errors of 
commission of four types (AY errors, BX errors, BY errors, and other A errors; 
response to non-targets or failure to inhibit responding), and the reaction time ex-
Gaussian parameters of mu, sigma and tau. Hit rates were calculated as the 
proportion of correct responses to the “AX” trials. In cases of hit rates of 1 or false 
alarm rates of 0, small constant adjustments were used to allow for signal detection 
calculations: correct hit rate = 1 – 1/(2n) where n = 140 (maximum possible number 
of hits); false alarm rates = 0 + 1/(2n) where n = 60, max possible number of false 
alarms. This correction was adapted from Macmillan and Kaplan (1985). Error rate 
descriptions are presented in Table 36.  
Three signal detection measures were computed from the primary measures: 
response criterion, discrimination index (d’ calculated based on total number of errors 
of commission and of omission) and context d’ following the methods in Robinson et 
al. (2013).  Response criterion represents target detection at the expense of greater 
false alarms and is calculated as -0.5*(z(proportion hits)+z(proportion false alarms). 
Higher response criterion values relate to a stricter response criterion in which a 
response requires higher confidence the correct target (AX) is present. Increasing 
response criterion values relate to increasing misses, but fewer false alarms. d’ is 
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calculated as z(proportion hits)-z(proportion total false alarms), i.e. the total number 
of hit minus the total number of errors of omission. Context d’ is calculated as 
z(proportion hits) – z(proportion BX false alarms). Both d’ and context d’ provide 
measures of accuracy based on the standardized scores. However, context d’ bases 
accuracy only on trials with intact context processing. 
 
Treatment of data 
Data were analysed using the SPSS version 24, Microsoft Excel 2016 and 
MATLAB R2017a. Raw data was trimmed based on established absolute cut-offs for 
reaction times with any responses below 100 ms removed (Luce, 1986). Keypresses 
were considered valid if occurring within the ISI but after the 100 ms cut-off. Errors in 
the CRT (incorrect keypress, nonresponse, or anticipated) and the CPT-AX were 
coded appropriately. Only RTs from correct responses (“hits” in the case of CPT-AX) 
were entered into the ex-Gaussian analyses. This resulted in total numbers of 
reaction times for ex-Gaussian modelling of 2,890 from the SRT, 2,643 from the 
CRT, and 10,441 from the CPT-AX. The ex-Gaussian probability density function was 
fit to the correct response times of the three tasks separately using the DISTRIB 
toolbox (Lacouture & Cousineau, 2008) in MATLAB. Three parameters of the ex-
Gaussian distribution are estimated per individual using this function; mu, sigma, and 
tau. For between-group and mixed-ANOVA comparisons, all data were checked for 
assumptions including normal distribution using the Shapiro-Wilk test and inspection 
of histograms. Age, UPDRS and NART IQ were firstly entered as covariates but 
removed if they were not significant in the model. Reaction time data was also 
analysed through the creation of eight equal Vincentile bins that rank order means 
from the fastest 12.5% to the slowest response latencies of each task separately. 
This allows visualization of the data without prior assumptions regarding shape 
(Balota, Yap, Cortese, & Watson, 2008). 
 
8.3 Results  
8.4.1 CPT-AX errors and signal detection measures 
 
Overall, seventy-two participants completed the CPT. However, one 
participant was removed due to hardware malfunction. Three participants had 
accuracy scores of less than 50.0% and were removed. This left a total sample size 
of 69 (see Table 37). Hit Rate was transformed exponentially. AY and A error rates 
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Table 37 CPT-AX Hit, Error/ False Alarm Percentages and signal detection indices presented 
by Group. 
Measure Control MCI-LB Probable MCI-AD 
 n = 29 n = 24 n = 16 
 M SD M SD M SD 
Hit Rate 96.59% 4.04% 82.61% 12.87% 90.89% 7.39% 
Miss Rate 3.41% 4.04% 17.39% 12.87% 9.12% 7.39% 
AY False Alarm 18.82% 16.76% 26.22% 21.33% 25.00% 21.73% 
BX False Alarm 8.91% 8.68% 15.80% 11.66% 12.24% 11.02% 
BY Error Rate 0.14% 0.77% 2.08% 2.75% 0.78% 1.68% 
Other A Error Rate 3.48% 4.11% 13.95% 10.80% 9.86% 8.48% 
d' 0.94 1.08 -1.10 1.46 -0.05 1.19 
d'-context 0.88 0.99 -1.08 1.81 0.03 1.61 
Response criterion -0.11 0.42 0.18 0.88 -0.07 0.56 
 
were moderately positive skewed and transformed using square root. However, there 
was large positive skew in BY Rate (2.04) that could not be successfully corrected 
with transformation. 
Age, NART IQ and UPDRS were evaluated as potential covariates 
(ANCOVA), however, none were significant and were not used in subsequent 
analyses. One-way ANOVAs show that groups differed significantly in Hit Rate, 
misses (%), BY-errors and “other-A” errors (all ps < .01). There was a statistically 
significant difference between group in Hit Rate, F(2,66) = 16.68, p < .001). Tukey 
post-hoc testing showed MCI-LB Probable had a lower hit rate than both controls (p 
< .001, d = 1.47) and MCI-AD (p = .013, d = 0.79), with large effect sizes. The 
difference between MCI-AD and controls was not statistically significant (p = .100).  
Both MCI-LB Probable (p < .001, d = 1.28) and MCI-AD (p = .034, d = 0.96) 
committed more “other A” errors than controls, but the MCI subtypes did not differ (p 
= .261). MCI-LB Probable also made more BY (p = .001, d = 0.96) errors than 
controls, but not MCI-AD (p = .523). The ANOVA for BX was on trend, F(2,66) = 2.92, 
p = .061, with post-hoc Tukey comparisons showing significantly higher rates of BX 
errors in MCI-LB Probable than controls (p = .048, d = 0.67). Groups did not differ on 
AY False Alarm rates (p = .355).  
One Hit Rate and one False Alarm Rate required correction as described in 
the Methods. Overall, groups did not differ in their response criterion (“C”), F(2,66) = 
1.50, p = .230, but the one-way ANOVA was significant for d’ (F(2,66)=17.63, p 
< .001) and d’-context (F(2,66) = 11.83, p < .001). MCI-LB Probable showed poorer 
target discriminability relative to controls (p < .001) and MCI-AD (p = .035), as 
measured by d’. Using d’-context, MCI-LB Probable again performed worse than 
controls (p < .001), with the comparison with MCI-AD on trend (p = .055). d’ was re-
assessed by ANCOVA, evaluating age, NART IQ and UPDRS scores as covariates. 
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However, none of the covariates were significant and the other signal detection 
measures were no re-run using ANCOVA. 
 
8.4.2 Ex-Gaussian analyses of SRT, CRT and CPT-AX 
 
 
Figure 12 Histograms of response time (ms) distributions of the three reaction time tests 
(Simple Reaction Time [SRT], Choice Reaction Time [CRT] and Continuous Performance 
Test-AX [CPT-AX]) for all participants. 
 
Histograms of response reaction times indicated non-normal distributions of 
the data, with positive skews in line with an ex-Gaussian distribution (Figure 12). SRT 
was completed by 74 participants. Responses were considered “anticipated” if they 
occurred before or less than 100msec after stimulus presentation. After cleaning data 
of anticipated and non-responses, all remaining reaction times were above 100 
msec. After removal of the incorrect responses and outliers, the total sample had a 
mean reaction time of M = 372 msec, SD = 156.7 (see Table 38). The ex-Gaussian 
distribution failed to fit three cases. CRT was completed by 70 participants. 95% of 
keypresses were correct in the group overall (96% in controls, 94% in MCI-LB  
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Table 38 Ex-Gaussian indices of reaction time performances on three tasks (Simple Reaction 
Time [SRT], Choice Reaction Time [CRT], and Continuous Performance Test AX [CPT-AX]) 
by participant subgroup. 
 Controls MCI-LB MCI-AD 
 Mu Sigma Tau Mu Sigma Tau Mu Sigma Tau 
n 27 26 18 
SRT 275.32 
(42.34) 
20.02 
(15.31) 
50.12 
(24.88) 
316.01 
(89.59) 
34.16 
(30.45) 
73.12 
(32.64) 
287.86 
(79.14) 
23.99 
(26.03) 
99.45 
(70.94) 
n 16 23 14 
CRT 462.51 
(82.39) 
48.58 
(17.01) 
60.82 
(21.30) 
543.64 
(141.31) 
82.18 
(47.12) 
95.59 
(38.20) 
490.33 
(73.52) 
72.23 
(31.81) 
97.81 
(44.98) 
n 28 26 17 
CPT-
AX 
298.06 
(62.05) 
39.27 
(22.92) 
75.31 
(39.39) 
292.38 
(94.19) 
46.95 
(33.12) 
114.46 
(57.38) 
286.84 
(42.88) 
48.54 
(32.18) 
110.37 
(29.97) 
 
Probable and 95% in MCI-AD). Overall, 64% of participants made at least one 
“wrong” keypress. Groups did not differ significantly in total errors of all types 
committed, p = .228. All but correct keypresses were removed and all remaining 
reaction times were above 100 msec. From the remaining 2,634 reaction times, the 
total sample had a mean reaction time of M = 585.83 msec, SD = 177.77.  The ex-
Gaussian model failed to fit 17 cases. Data were re-run using a less conservative 
trimming method (±3.0 SDs) but it was equally as unsuccessful. Therefore, the 
original output was retained. In the CPT-AX, 254 reaction times of less than .100 
seconds were removed. The short interstimulus interval of this task makes data 
trimming unnecessary. The mean reaction time for correct hits was 379.56 msec, SD 
= 141.58. The ex-Gaussian model failed to fit CPT-AX data from two participants. 
See Appendix M for more details on data cleaning, such as removal of anticipated 
and non-responses, for the three tasks. 
 One-way ANCOVAs were run on the ex-Gaussian measures entering age as a 
covariate. UPDRS was initially included as well but it was not significant and removed 
from all subsequent analyses (all ps > .05). The between-subjects effects of the 
models were not significant in SRT mu (p = .141), SRT sigma (p = .121); CRT mu (p 
= .096), CPT-AX mu (p = .141), or CPT-AX sigma (p = .458). One-way ANCOVA 
showed groups differ significantly in CRT sigma (F(2,49) = 4.06, p = .023 partial Ƞ2 
= .142. Age was not significant in the model (p = .711). Post-hoc tests show MCI-LB 
Probable CRT sigma values are significantly greater than in controls (p = .020, d = 
0.95). 
For the CRT, tau differed significantly by group, F(2,49) = 4.02, p = .024, 
partial Ƞ2 = .141. Post-hoc analyses show MCI-LB Probable have significantly larger 
tau values than controls (p = .031, d = 1.12). MCI-AD was not significantly different 
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relative to controls (p = .089) and MCI-LB (p = 1.00); however, the marginal means 
and SDs of tau are very similar for both MCI subtypes. The CRT comparisons are 
likely very underpowered due to the poor fit in the ex-Gaussian model. However, 
groups also differ significantly in CPT-AX tau using one-way ANCOVA with age as a 
covariate, F(2,68) = 5.42, p = .007, partial Ƞ2 =.137. Age was on trend for 
significance in the model (p = .051). Post-hoc pairwise comparison shows that tau 
measures are greater in MCI-LB Probable (p = .007, d = 0.80) than in controls. MCI-
AD did not differ significantly from controls (p = .090) or MCI-LB Probable (p = 1.00). 
One-way ANCOVA for difference in SRT tau was significant, F(2,67) = 6.36, p = .003, 
partial Ƞ2 = .160. Age was not significant in the model (p = .651). MCI-AD had 
significantly higher SRT tau values than controls (p = .002, d = 0.93).  
 
8.4.3 Vincentile plots and mean reaction times 
Vincentile plots were created to illustrate reaction time data by rank order of 
means. Vincentiles were analysed with a 3 (Group) × 3 (Task) × 8 (Vincentile Bin) 
mixed-factor ANOVA. There was a significant main effect of group F(2,64) = 5.04, p 
= .009, indicating differences in reaction times regardless of task or bins. There was 
also a significant main effect of task, F(1.71, 128) = 150.46, p < .001, with mean 
reaction times in CRT significantly slower than in both SRT and CPT-AX (both ps 
< .001). There was also a significant interaction between task and group, 
F(3.41,109.15) = 7.76, p = .013. Figure 13 and Figure 14 show both MCI-LB 
Probable and MCI-AD with longer response latencies than controls on SRT and CRT, 
but no difference between MCI subtypes. There was a significant main effect of bin, 
F(1.31,83.67) = 562.99, p < .001, and a significant interaction between group 
allocation and bin, F(2.62,83.67) = 11.91, p < .001, indicating that reaction times 
differ in controls and MCI depending on Vincentile bin. The task x Vincentile bin 
interaction was also significant, F(3.07,196.34) = 15.86, p < .001, indicating that the 
reaction times of bins were longer for one of the tasks than the other. However, the 
three-way interaction between group, task and Vincentile bin was not significant, 
F(6.14,196.34) = 1.18, p = .317. Therefore, the data does not indicate that the task x 
Vincentile bin interaction effect is different for the three different groups.  
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Figure 13 Simple Reaction Time task mean reaction times by Vincentile bin, separated by 
group (control, MCI-LB Probable and MCI-AD). 
 
 
Figure 14 Choice Reaction Time task mean reaction times by Vincentile bin, separated by 
group (control, MCI-LB Probable and MCI-AD). 
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Figure 15 Continuous Performance Test-AX task mean reaction times by Vincentile bin, 
separated by group (control, MCI-LB Probable and MCI-AD). 
 
Post-hoc one way ANOVAs indicated that MCI-LB Probable had significantly 
longer response latencies than controls in Vincentiles bins 4-8 in SRT, 2-8 in CRT, 
and 7-8 in CPT-AX (see Figure 15; all ps < .05). MCI-AD had significantly longer 
reaction times than controls in the last bin of each task. 
 
8.4.4 Relationship with visuospatial and global cognitive function 
 
It was next considered whether IIV (tau) is an equivalent, or possibly superior, 
predictor of group variance in higher-order cognitive ability above speed of 
processing. When considering only MCI-LB Probable and control subjects, 19.0% of 
Visuospatial Composite scores are explained by group (p < .001). DSST scores fully 
account for this group-associated variance when entered at the second step after 
age and NART IQ (ΔR2 = 0.21, p < .001). HLRs were run to predict visuospatial 
composite and ACE-R (global cognitive measure) scores using SRT and CPT-AX tau 
(see Table 39). SRT, but not CPT-AX (p = .214), tau explained significant a 
significant amount of variance visuospatial composite scores (5%), thus accounting 
for 42% of group-associated variance in the visuospatial composite. Manipulation of 
order of entry in the multiple regressions showed that SRT tau-associated variance in  
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Table 39 Predicting MCI-LB Probable and control visuospatial composites scores with group, 
DSST and tau (Simple Reaction Time and Continuous Performance Test-AX). 
 R2 Adjusted 
R2 
ΔR2 F Change Sig. F 
Change 
Std. Beta 
Coefficients 
Std. Beta 
Sig 
Age       -0.36 .002 
NART 0.28 0.26 0.28 11.12 < .001 0.43 <.001 
        
Age      -0.32 .002 
NART 0.28 0.26 0.28 11.12 < .001 0.23 .036 
Group 0.47 0.44 0.19 20.14 <.001 0.48  <.001 
        
Age      -0.17 .110 
NART 0.28 0.26 0.28 11.12 < .001 0.13 .248 
DSST 0.49 0.46 0.21 22.72 < .001 0.57 < .001 
        
Age      -0.21 .047 
NART 0.28 0.26 0.28 11.12 < .001 0.13 .252 
DSST 0.49 0.46 0.21 22.72 < .001 0.37 .023 
Group 0.52 0.48 0.03 3.48 .068 0.26 .068 
        
Age &      -0.35 .008 
NART 0.31 0.28 0.31 11.03 < .001 0.32 .008 
SRT tau 0.36 0.32 0.05 4.01 .051 -0.26 .051 
        
Age      -0.34 .006 
NART 0.31 0.28 0.31 11.03 < .001 0.20 .096 
SRT tau 0.36 0.32 0.05 4.01 .051 -0.14 .270 
Group 0.47 0.43 0.11 9.76 .003 0.38 .003 
        
Age &      -0.30 .040 
NART 0.34 0,31 0.34 12.65 <.001 0.41 .002 
CPT tau 0.36 0.32 0.02 1.58 .214 -0.18 .214 
        
Age      -0.23 .067 
NART 0.31 0.28 0.31 11.03 < .001 0.14 .264 
SRT tau 0.36 0.32 0.05 4.01 .051 -0.12 .901 
DSST 0.49 0.44 0.12 11.33 .002 0.51 .002 
        
Age      -0.23 .067 
NART 0.28 0.26 0.31 11.03 < .001 0.14 .264 
DSST 0.49 0.46 0.18 16.53 <.001 0.51 .002 
SRT tau 0.49 0.44 0.00 0.02 .901 -0.02 .901 
 
visuospatial composite scores is completely accounted for by DSST if it is entered in 
the second step. 
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Table 40 Predicting MCI-LB Probable and control global cognitive (Addenbrooke’s Cognitive 
Examination [ACE-R] scores with group, DSST and tau (Simple Reaction Time and 
Continuous Performance Test-AX). 
 R2 Adjusted 
R2 
ΔR2 F Change Sig. F 
Change 
Std. Beta 
Coefficients 
Std. Beta 
Sig 
Age       -0.25  .020 
NART 0.39 0.37 0.39 18.37 < .001 0.60 <.001 
        
Age      -0.21 .028 
NART 0.39 0.37 0.39 18.37 < .001 0.44 <.001 
Group 0.52 0.49 0.13 14.64 < .001 0.39  <.001 
        
Age      -0.06 .528 
NART 0.39 0.37 0.39 18.37 < .001 0.31 .003 
DSST 0.59 0.57 0.20 27.30 < .001 0.55 < .001 
        
Age      -0.08 .425 
NART 0.39 0.37 0.39 18.37 < .001 0.31 .004 
DSST 0.59 0.57 0.20 27.30 < .001 0.47 .002 
Group 0.60 0.57 0.01 0.72 .400 0.11 .400 
        
Age &      -0.19 .125 
NART 0.34 0.32 0.34 12.87 < .001 0.49 < .001 
SRT tau 0.40 0.37 0.06 4.62 .037 -0.27 .037 
        
Age      -0.18 .130 
NART 0.34 0.32 0.34 12.87 < .001 0.39 .002 
SRT tau 0.40 0.37 0.06 4.62 .037 -0.17 .168 
Group 0.47 0.42 0.07 5.98 .018 0.30 .018 
        
Age &      -0.15 .252 
NART 0.41 0.39 0.41 17.56 < .001 0.56 <.001 
CPT-AX tau 0.43 0,40 0.02 1.64 .206 -0.18 .206 
        
Age      -0.06 .602 
NART 0.34 0.32 0.34 12.87 < .001 0.29 .014 
SRT tau 0.40 0.37 0.06 4.62 .037 -0.02 .896 
DSST 0.54 0.50 0.14 13.66 .001 0.54 .001 
        
Age      -0.06 .602 
NART 0.34 0.32 0.34 12.87 < .001 0.29 .014 
DSST 0.54 0.51 0.19 19.89 <.001 0.54 .001 
SRT tau 0.54 0.50 0.00 0.02 .896 -0.02 .896 
 
 
Multiple regressions were lastly run to consider the prediction of global 
cognitive scores from core processes (see Table 40). In the MCI-LB Probable and 
control sample, group accounted for 13.0% of ACE-R score variance after entry of 
age and NART IQ in step one (p < .001). The relationship between CPT-AX and 
ACE-R was not significant (p = .206). Both DSST (20.0%) and SRT tau (6.0%) 
predicted ACE-R scores (both ps < .001). Entering Group at step three after DSST 
showed that DSST fully explained group-associated variance in ACE-R, while SRT 
tau entered at step two only decreased the group-associated variance by 46.15%. 
Order of entry confirmed that DSST predicts additional unique variance above and 
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beyond entry of age, NART IQ, and SRT tau. SRT tau, conversely does not add any 
additional variance if entered after DSST (p = .896). 
 
8.4 Discussion 
The present chapter employed reaction time tests (SRT, CRT and CPT-AX) to 
consider how sustained attention and reaction time components vary with increasing 
executive demands. Tasks with executive function weighting have been previously 
shown to best reveal differences in IIV in the context of both ageing and 
neuropathology. It was anticipated that the increased executive function demands of 
CPT-AX in particular would be effective at demonstrating increased IIV in the MCI 
stage of LB disease. Its use may be particularly advantageous for use in the MCI 
stage, in which parkinsonism may be less pronounced and confounding to the 
response modality.  
Firstly, analysis of the reaction time data using Vincentile plots indicated that 
MCI-LB Probable participants were significantly slower than controls across much of 
the RT distribution in the SRT and CRT tasks. This suggests that MCI-LB diagnosis 
is associated with longer response latencies, particularly in the slower Vincentiles. In 
the case of CRT, these slower trials should signal increased burden on attentional 
and decision-making resources (Jackson & Balota, 2013). However, mean response 
latency did not differ significantly between the MCI-LB Probable and either the control 
or MCI-AD groups in most of the distribution of CPT-AX results This emphasizes the 
need to consider modelling reaction time data from such tests in ways other than the 
typical Gaussian distribution. While not substantially slower than controls, MCI-LB 
Probable were significantly impaired in response accuracy in the CPT-AX. Overall, 
they demonstrated reduced hit rate, increased error rate and poorer target 
discrimination, relative to both MCI-AD and control groups (with large effect sizes). 
This suggests sustained attention may serve as a discriminating deficit, specific to 
MCI-LB. However, increased misses could be due to various causes, including 
slowed cognitive processing speed, slowed psychomotor speed, or lapses in 
attention. Ex-Gaussian modelling was therefore used to decompose the 
subcomponents of reaction time that are linked to specific cognitive processes.  
 
Ex-Gaussian results 
On the SRT, groups did not differ in the mean (mu) or SD (sigma) of the 
Gaussian component of the ex-Gaussian model. There was likewise no difference in 
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groups in terms of CRT mu or CPT mu or sigma. CRT sigma was greater in MCI-LB 
Probable versus controls, reflecting a greater variation in the Gaussian portion of the 
distribution. However, the results from the CRT overall must be interpreted cautiously 
as there were a high number of participants whose data could not be fitted by the ex-
Gaussian model. Overall, these results indicate no difference between the groups in 
terms of mu and sigma. As suggested by Luce (1986), mu and sigma represent the 
transduction components, i.e. the sensory processing and motor response (Luce, 
1986). 
Tau, on the other hand, quantifies the mean of the exponential portion of the 
ex-Gaussian curve. It is increasingly understood to represent the decision component 
of reaction times and is suggested to relate more specifically to attentional control 
(Schmiedek, Oberauer, Wilhelm, Süß, & Wittmann, 2007; Tse, Balota, Yap, Duchek, 
& McCabe, 2010). Increasing tau values indicates a greater right skew in the 
distribution due to increased variability in response latencies. Thus, tau is indicative 
of greater fluctuations in cognitive decision-making time (Lacouture & Cousineau, 
2008; Luce, 1986). Despite entering age as a covariate, which has a strong 
established relationship with IIV, MCI subtypes differed from controls in tau. 
Moreover, the subtypes emerged with different profiles of increased variability. In the 
more executive weighted-tasks (CRT and CPT-AX), MCI-LB Probable has greater 
IIV. In contrast, MCI-AD is associated with increased IIV in SRT. As stated above, it 
is difficult to interpret CRT results because of the frequent failure of data fitting the 
ex-Gaussian model. This was generally due to a high number of errors by a number 
of participants. However, if we consider only the SRT and CPT-AX, results suggest 
that more cognitively demanding tasks reveal increased IIV in MCI-LB Probable. This 
is in line with previous chapters’ findings of executive dysfunction in MCI-LB, 
suggesting that the common deficits in established DLB (Calderon et al., 2001; 
Collerton et al., 2003; Mori et al., 2000; Mosimann et al., 2004) are observable in this 
pre-dementia stage. The CPT-AX task specifically requires sustained attention 
through both its length of completion (approximately eight minutes) and required 
vigilance (Cohen et al., 1993). These results are in line with previous work 
suggesting that poor sustained attention is a hallmark of DLB. In contrast, MCI-AD 
has pronounced IIV in the simpler SRT task, and therefore may be associated with a 
more basic psychomotor slowing. The format of the CPT-AX is faster paced than 
SRT, with a regular and short interstimulus interval. While both measure sustained 
attention, the SRT only requires focus on a single stimulus and requires only one 
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appropriate type of response, which can be preplanned. Therefore, it is a more pure 
measure of processing speed (Gentier et al., 2013). CRT and CPT-AX, in contrast, 
involve executive control and decision-making processes (Gentier et al., 2013; Magill 
& Anderson, 2007). 
Clinical motor impairment was included in initial analyses as a potential 
confound. However, it was not a significant covariate in any of the models. This is in 
line with previous work in DLB that stresses that increased IIV in DLB is independent 
of motor and parkinsonism symptoms (Ballard, O'Brien, et al., 2001; Ballard et al., 
2002; Walker, Ayre, Cummings, Wesnes, McKeith, O’Brien, et al., 2000). For 
example, Gorus et al. (2008) reports that variability (tau) is primarily related to the 
cognitive subprocess of reaction time. Longer latencies (mu and sigma) instead 
reflect both motor and cognitive task demands (Gorus et al., 2008). Chapter 9 will 
also consider how UPDRS scores may covary with these measures using HLRs. 
 
CPT errors and detection indices 
The role of executive dysfunction in sustained attention was explored through 
the examination of error types in the CPT-AX. The version used was optimized for 
high response competition through the use of a high target frequency. Intact inhibition 
is required to avoid AY errors. Neither MCI group differed from controls in committing 
AY False Alarms, suggesting that both groups have intact inhibition relative to 
controls. This does not fit with the findings in Stroop CW and Stroop Difference, 
which captures inhibitory control, and in which both MCI-AD and MCI-LB performed 
more poorly than controls (Chapter 3). However, controls also made substantial AY 
errors in the CPT-AX: 18.8% versus 25.0% and 26.2% frequency in MCI-AD and 
MCI-LB Probable, respectively. This perhaps indicates that the task itself is quite 
difficult for older populations. In the CPT-AX, the high target frequency creates a 
bias, even in cognitive heathy participants, to respond with a keypress after seeing 
an “A” as it is the appropriate response the majority of the time. The speed and high 
frequency of response targets may mask true differences in inhibition between the 
groups.  
Similarly, while MCI-AD did commit more “other-A” errors than controls, they 
did not differ from controls in terms of signal detection or any other errors types. 
Intact sustained attention in MCI-AD is in line with previous work in the construct 
(Calderon et al., 2001). However, previous work specifically in CPT-AX by Braver et 
al. (2005) showed AD participants made more BX errors than age-matched healthy 
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controls. This did not occur in the present sample. This may be due to the small 
sample size. MCI-LB Probable, on the other hand, did have higher rates of BX errors 
than controls. BX errors are most likely related to updating and context processing 
abilities (Robinson et al., 2013). To avoid BX errors, participants must update and 
monitor a representation of the previous stimulus in their working memory so that an 
incorrect response will be inhibited (Robinson et al., 2013). Such “context 
processing” is an important factor in general executive functioning and cognitive 
control, particularly in response-competition scenarios such as the CPT-AX (Rush, 
Barch, & Braver, 2006). Whether based on task instructions or on prior processing of 
stimuli, these internal context representations must be continually maintained and 
updated based on changing exogenous cues (Braver & Barch, 2002; Braver & 
Cohen, 2000). The present results may therefore indicate that MCI-LB Probable is 
associated with impaired updating or context processing. However, there was no 
difference between MCI subtypes, interpreting these deficits as specific to MCI-LB 
remains speculative. 
If, with replication, higher rates of BX errors in MCI-LB are confirmed, this 
would introduce the possibility of an Inhibitory Deficit (ID) account of cognitive decline 
(Hasher & Zacks, 1988). In this model, inhibition is proposed as the explanatory 
mechanism across declines in various cognitive abilities with age (Hasher & Zacks, 
1988). In pathologies such as AD, reports of inhibitory failure have been mixed, with 
evidence that some inhibitory mechanisms remain intact as well as arguments for a 
generalized breakdown in inhibition above and beyond age-associated impairments 
(Amieva et al., 2002; Balota & Ferraro, 1996; see Collette, Van der Linden, & 
Salmon, 1999 for a review). Little work has focused on inhibition specifically in DLB, 
but the ID account of cognitive decline offers a possible alternative to the similarly 
parsimonious processing speed account of Salthouse (1996). As mentioned in 
Chapter 3, my battery of neuropsychological tasks did not include a pen-and-paper 
updating task (such as an N-back test), so we are unable to determine if BX errors 
successfully correlate with more established measures of inhibition. This emphasizes 
the need to include updating tasks in future studies.  
Consideration of the pattern of error rates allows some inferences to be made 
about differentiated executive functions in MCI-LB. However, the combined false 
alarm rate was also significantly higher in MCI-LB than controls. Moreover, the MCI-
LB Probable group committed significantly more BY-errors than controls. BY-errors 
are made in the absence of any response competition (Robinson et al., 2013). The 
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erroneous keypress is neither preceded by an “A” that would cue the participant nor 
based on presentation of an “X” that warrants a keypress in correct contexts. Instead, 
BY errors may suggest that there may be a generalized impairment in the population 
(MacDonald, Pogue-Geile, Johnson, & Carter, 2003; Robinson et al., 2013). Indeed, 
the MCI-LB Probable group demonstrated poorer signal detection accuracies overall. 
Taken together, this suggests there may be a non-specific attentional impairment in 
MCI-LB Probable, related specifically to the cognitive, decision making component as 
evidenced by the increased tau parameter. MCI-AD, in contrast to MCI-LB, appears 
to be associated with intact sustained attention in terms of signal detection and errors 
generally, in line with previous work in the construct (Calderon et al., 2001).  
There are several limitations to the present analyses. Firstly, MCI subtypes did 
not differ significantly with each other in most measures including CPT-AX errors and 
tau. It is possible that the CPT-AX task is too difficult for not only MCI patients but 
also healthy older adults to complete, as suggested by their substantial commission 
of AY False Alarms. The task is quite long by necessity: ex-Gaussian modelling 
requires at least 40 and ideally a greater number of correct reaction times. Longer 
interstimulus intervals would further lengthen the test, but could help ameliorate the 
potential issues caused by high task difficulty. Other technical adjustments to the 
analysis pipeline could be advantageous. For example, no practice trials were 
included in the CPT-AX. Therefore, the first seconds of the task might be considered 
“learning” periods and could be excluded. While a very conservative approach was 
taken in trimming outliers in the reaction time data prior to ex-Gaussian analysis, 
scripts are also available to determine a data-driven, optimal SD cutoff. 
Further work could consider programming and subsequent analysis of CPT-
AX tasks in blocks, such as pursued in Robinson et al. (2013). The high rate of target 
stimuli in this version of the CPT-AX means that over time it would be increasingly 
difficult for participants to inhibit a response following an “A” cue in AY error 
scenarios. Increased AY errors over the time course of the task was demonstrated to 
occur in Bipolar Disorder, consistent with an expectancy cue (Robinson et al., 2013). 
However, in MCI-LB, it is unclear whether such a pattern would emerge or whether 
potential fluctuations over the testing period with lead to a “phasic loss of context 
maintenance over the course of the task” (Robinson et al., 2013, p. 461). In this latter 
scenario, AY errors would not increase with time.  
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Conclusions and future work 
In conclusion, MCI-LB shows increased IIV using tau, but only in tasks with 
greater complexity and executive loading, particularly context maintenance. MCI-AD, 
on the other hand, has higher IIV in simpler psychomotor response tasks (SRT). In 
contrast, groups did not differ in the Gaussian components of the model (mu and 
sigma), emphasizing the benefits of using ex-Gaussian modeling and tau rather than 
mean latencies in reaction time analyses. As with IIV in healthy ageing, increased 
variability in MCI is associated with a number of negative outcomes for patients 
including impaired activities of daily living, lower performance on other cognitive tests 
and “proximity to death” (see Hultsch et al., 2008 for a review). As such, IIV may be a 
relevant and consequential predictive marker of MCI-LB. The presence of multiple 
types of high error rates relative to controls suggests that there may be a generalized 
impairment, either in executive functions or sustained attention per se, that may 
facilitate or explain this increased variability. However, overall, the analyses did not 
provide evidence that IIV is a more useful construct than speed of processing in the 
neuropsychology of MCI-LB. While increased IIV was predictive of the poorer global 
cognitive assessment and visuospatial ability of MCI-LB Probable relative to controls, 
the DSST captured greater variance. Indeed, speed of completion of the DSST was a 
stronger predictor of visuospatial ability and ACE-R total score than an MCI-LB 
Probable diagnosis itself. Accordingly, IIV does not appear to add unique explanatory 
power above and beyond DSST in predicting these broader cognitive abilities. 
Chapters 4 and 5 aimed to consider the hierarchical organisation of cognition.  
  
178 
 
Chapter Nine: Exploratory analysis of the relationship between 
cognitive performance, white matter integrity and clinical 
measures 
 
9.1 Introduction 
This thesis has focused on determining the neuropsychological profile of 
clinically-defined MCI-LB, in comparison to both healthy age-matched controls and 
MCI-AD patients, and with consideration of the hierarchical structure of such deficits. 
The larger SUPErB study is extremely comprehensive, and includes a range of other 
assessments including bloodwork, olfactory testing, carer questionnaires, and MRI. 
The final empirical chapter will briefly explore how the salient neuropsychological 
findings of the primary PhD analyses relate to selected elements of the wider cohort 
data. Firstly, and as explained in more detail below, the potential relationship 
between processing speed and white matter integrity will be explored, given that the 
former emerged as a substantially impaired resource in MCI-LB that explains 
significant variance in higher-order task performance in that group only. Secondly, 
because MCI-LB Probable showed increased IIV, tau will be analysed in association 
with clinical measures of cognitive fluctuations, one of the most prominent symptoms 
of DLB.  
 
White matter integrity in MCI-LB 
 Fast transmission in the central nervous systems is facilitated by the myelin of 
white matter pathways; as such, the myelin integrity of white matter tracts is posited 
as the primary determinant of speed of processing (Manoach et al., 2007). Work in 
normal ageing, neurodegenerative dementias such as DLB, and other neurological 
conditions have utilized various imaging techniques, such as magnetic resonance 
imaging (MRI), to explore the neural correlates of processing speed and, to a lesser 
extent, IIV, in vivo. DTI is a relatively recently-developed MRI technique that enables 
visualization and quantification of the integrity of white matter microstructure using 
principles of water diffusion (Assaf & Pasternak, 2008). As diffusion along white 
matter tracts is faster than perpendicularly, the normalized SD of the diffusivities, 
known as fractional anisotropy (FA), provides a measure of white matter 
microstructure integrity in vivo (Assaf & Pasternak, 2008). Decreased FA indicates 
less directionally-oriented diffusion along tracts and less intact white matter integrity. 
Mean diffusivity (MD), the other primary DTI measure, represents the perpendicular 
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diffusivity along tracts. Decreased integrity of structural barriers (i.e. the myelin) 
would be reflected by lower MD values. Existing studies in DLB report decreases in 
FA (Firbank et al., 2007; Kantarci et al., 2010), with some reporting particularly 
widespread abnormalities (Bozzali et al., 2005; Lee et al., 2010; Watson et al., 2012).  
DTI has been used in a plethora of studies to link white matter integrity to 
speed of processing (for example: Madden et al., 2004; Shimony et al., 2009; Turken 
et al., 2008), including specifically in MCI (Christensen et al., 2005). DTI may be 
especially useful in MCI as it can quantify changes in white matter at the subvoxel 
level prior to the gross structural changes that are targeted in conventional MRI 
(Bozzali et al., 2005). DTI measures have been reported as an earlier imaging 
biomarker than grey matter atrophy in predicting progression from intact cognition to 
amnestic AD (Zhuang et al., 2013). DTI should thus be particularly relevant to DLB 
given that early stages of disease are not typified by neuronal loss but by neuronal 
dysfunction, in contrast to AD (Bamberger & Landreth, 2002; Katsuse, Iseki, Marui, & 
Kosaka, 2003; Molina et al., 2002).  
As mentioned, the relationship between white matter integrity and elevated IIV 
has also been demonstrated (Britton, Meyer, & Benecke, 1991; Tamnes, Fjell, 
Westlye, Østby, & Walhovd, 2012). Tamnes et al. (2012), for example, found lower 
IIV to be associated with increased white matter integrity (both FA and MD), 
independent of sex, age and median response time in a sample of children and 
adolescents. The rapid, moment-to-moment nature of IIV in processing speed, unlike 
other behavioural measures, is suited to capture endogenous sources of variability. 
Exogenous changes such as affective states and somatic complaints would show 
fluctuations over longer timespans, for example with test-re-testing over a period of 
days or weeks. The fluctuations encapsulated by IIV measures are alternatively more 
likely to relate to neural network and neurotransmitter efficiency (Phillips et al., 2013). 
However, research into white matter connectivity, processing speed and IIV in 
DLB is sparse, particularly in early stages of the condition (see Mak et al., 2014 for a 
review). The CPT, in particular, may be a useful tool to link gross cognitive 
fluctuations to IIV and white matter integrity as it is suggested as a sensitive and valid 
measure of brain and physiological function. For example, CPT performance deficits 
are present in a number of neuropathological conditions, including conditions 
impacting subcortical and white brain matter, including Multiple Sclerosis (MS; Wilken 
et al., 2003), human immunodeficiency virus (HIV; Karlsen, Reinvang, & Frøland, 
1992), and cerebrovascular disease (Jerskey et al., 2009). To the author’s 
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knowledge, only one study to date has used a CPT task and MRI analyses in DLB. 
Although Sanchez‐Castaneda et al. (2010) investigated grey matter atrophy they 
found decreased anterior cingulate and prefrontal volume correlated with worse 
performance on the CPT in DLB. The atrophy was also significantly correlated to 
visual hallucination severity as measured by NPI (Sanchez‐Castaneda et al., 2010). 
However, no studies have utilised CPT-AX and an ex-Gaussian approach in linking 
cognition to white matter integrity in DLB.  
 
Cognitive fluctuations 
Cognitive fluctuations are one of the core symptoms of DLB and involve 
spontaneous and pronounced variations in attention, alertness and arousal (McKeith 
et al., 2017). Episodes may resemble delirium, with fluctuations as profound “such 
that at times she was able to hold a conversation, albeit with some expressive 
dysphasia, whilst on other occasions she was mute and unable to stand without 
assistance” (Byrne, Lennox, Lowe, & Godwin-Austen, 1989, p. 713). Mini-Mental 
State Examination scores may change by more than 50% day-to-day in DLB (Byrne 
et al., 1989). While a common symptom in other causes of dementia such as AD 
(20%; Escandon, Al-Hammadi, & Galvin, 2010; Kolbeinsson & Jonsson, 1993) and 
vascular dementia (35-50%; Hachinski et al., 1975; Román et al., 1993), cognitive 
fluctuations are especially prevalent in DLB, reported in nine out of ten patients 
(Byrne et al., 1989; Walker, Ayre, Cummings, Wesnes, McKeith, O’Brien, et al., 
2000), as well as in PDD. Lee et al. (2012) suggest that cognitive fluctuations are 
aetiologically related to the presence of LB pathology in the LBDs. 
Cognitive fluctuation severity has been operationalized using various methods. 
A systematic review on the identification of cognitive fluctuations in dementia by Lee 
et al. (2012) concluded that there is a dearth of empirical evidence on how 
fluctuations are clinically assessed. Their search found that only two published 
studies reported on scale utility in clinical settings (Ferman et al., 2004; Walker, Ayre, 
Cummings, Wesnes, McKeith, O'Brien, et al., 2000). Standard methods of quantifying 
fluctuations, primarily caregiver or clinician observation, can be problematic. 
Informant questioning, for example, is used regularly but is most reliable in 
discriminating DLB from AD when “fluctuations” concern daytime sleepiness, 
lethargy, staring into space or disorganized speech, rather than cognition per se 
(McKeith et al., 2017). Clinician assessment is typically only sensitive to extreme 
manifestations in DLB and are vulnerable to poor inter-rater reliability, with reports as 
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low as 58% (Mega et al., 1996). Reaction time testing has been promoted as an 
alternative to informant-based assessment scales that provides greater objectivity; 
however, such tests are not routinely utilised in clinical practice. Given the limitations 
of assessment, the severity and prevalence of cognitive fluctuations in DLB may be 
grossly underestimated (Walker, Ayre, Cummings, Wesnes, McKeith, O’Brien, et al., 
2000). Fluctuations have also been independently associated with additional 
negative downstream effects in DLB, such as impaired activities of daily living 
(Ballard, Walker, O'Brien, Rowan, & McKeith, 2001). As such, a valid and reliable 
means of quantifying fluctuating attention, which is suited to the clinical setting, is 
needed. 
“Microfluctuations” are proposed as rapidly-occurring, transient changes in 
performance at a second-to-second level, but which are linked to the broader 
cognitive, behavioural and functional changes of fluctuations in DLB (Bradshaw et al., 
2006; Walker, Ayre, Cummings, Wesnes, McKeith, O’Brien, et al., 2000; Walker, 
Ayre, Perry, et al., 2000). Bradshaw et al. (2006) suggests that while not clearly 
evident at a clinical level, these microfluctuations are demonstrable and correlate 
with the more protracted fluctuating pattern. Bradshaw et al. (2006) summarize the 
proposal that, “this fluctuating attentional profile may represent a quantifiable 
measure of the gross fluctuations in cognition and global performance that have long 
been regarded as a cardinal clinical feature of DLB but paradoxically have been 
problematic to identify in a reliable manner” (p. 1130). Could elevated IIV, a measure 
of intermittent long response latencies, serve to capture these “microfluctuations” in 
attention? Microfluctuations have been targeted primarily by looking at fluctuations in 
attention using computerised reaction time-based tests. As discussed in Chapter 8, 
while there has been some success, few studies have utilised advance modelling 
techniques or targeted MCI-LB specifically. Tau, as derived from attentional tasks 
such as CPT-AX and SRT, could be argued conceptually analogous to 
“microfluctuations,” and might therefore capture fluctuating cognition over a shorter 
time interval (Nesselroade, 1991). As such, we suggest that reaction time tasks might 
have additional utility as proxies for the gross clinical fluctuations within a relatively 
concise, laboratory task setting.   
 
Hypotheses and aims 
Because the larger SUPErB study collected DTI images and clinical measures 
of cognitive fluctuations, the decision was made to explore the relationship of the 
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neuropsychological findings with these variables in an exploratory chapter.  Whether 
white matter integrity relates to processing speed (DSST) or IIV (tau) will be 
investigated. Secondly, it is posited that IIV (tau) may be correlated with clinical 
measures of cognitive fluctuations, which would suggest tau as representative of 
microfluctuations in cognition.  
 
9.2 Methods 
 
Participants and materials 
The MRI sequence was administered to 80 participants, but 13 MCI-LB 
Possible participants were excluded from analysis in the present chapter. Three 
participants’ MRI data were removed due to excessive head movement during the 
scan that could not be corrected. This resulted in analysis of 28 healthy control 
participants (mean age = 72.96, SD = 7.04, range 61-89), 14 MCI-AD (mean age = 
75.14, SD = 8.44, range 62-89) and 25 MCI-LB (mean age = 73.92, SD = 7.04, range 
60-87) patients. The groups did not differ significantly in age (F(2,64)=23.11, p 
= .657). Bivariate Pearson correlations were run between variables of interest. 
Multiple regressions were carried out using a stepwise procedure to predict 
visuospatial composite scores, with age and NART IQ entered in the first step of the 
model. 
 
MRI acquisition and procedure 
All MRI data were acquired at the Newcastle Magnetic Resonance Centre by 
experienced radiographers and with direction from Dr Michael Firbank who set the 
acquisition protocol (see Appendix N). DTI data pre-processing steps and analyses 
were completed by the author. MRI used a 3-Tesla Phillips Achieva clinical system 
with an 8-channel head coil. Scan data were transferred to a Linux-based workstation 
and analysed using the Functional MRI of the Brain software library (FSL, v 5.0). 
Distortion effects were corrected for following an adaptation of the technique of Shen 
et al. (2004) and affline registration in FMRIB’s Linear Image Registration Tool 
matched pairs of diffusion weighted images together. The eddy-corrected DT images 
were visually inspected for indications of severe motion. A brain mask corrected for 
high signal dropout using Statistical Parametric Mapping (SPM). 
FA and MD can be reliably analysed voxelwise to determine between-group 
differences (Smith et al., 2007; Wen, Steffens, Chen, & Zainal, 2014). Following 
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image pre-processing, voxel-wise analysis of the data was performed by FSL’s Tract 
Based Spatial Statistics (TBSS; Smith et al., 2006). FA images were created by fitting 
a tensor model to the raw diffusion data and then brain-extracted using BET (Smith, 
2002). All subjects' FA data were aligned to the pre-defined FSL FMRIB58 FA map 
using a resolution of 1 mm in the standard Montreal Neurological Institute 152 adult 
brain template space. Data was visually inspected for issues with the nonlinear 
transformation (Smith et al., 2006). Next, the mean FA image was created and 
thinned to create a mean FA skeleton which represents the centres of all tracts 
common to the group. Each subject's aligned FA data was then projected onto this 
skeleton. 
 The resulting data was used in two ways. Firstly, a global FA (gFA) and global 
MD (gMD) value was calculated per participant for analysis with neuropsychological 
domains. gFA and gMD reflect the average FA and MD, respectively, across the 
entire white matter skeleton. Secondly, pre-processed data was fed into voxelwise 
cross-subject statistics using Randomise (Winkler, Ridgway, Webster, Smith, & 
Nichols, 2014), a permutation method for non-parametric t-tests. Randomise utilised 
500 permutations and the threshold-free cluster enhancement (TFCE) test statistic, 
resulting in TFCE corrected statistical maps. Three contrasts were run with 
randomise: (1) between-group differences in FA, MCI-LB Probable versus controls, 
(2) voxelwise correlations with demeaned age, and (3) voxelwise correlations with 
DSST scores. The JHU White-Matter Tractography Atlas was utilised with FSLeyes 
to determine the white matter tracts showing any significant correlations. 
 
9.3 Results 
 
Group differences in global DTI measures and fluctuation scales 
 Means and SD for global white matter integrity measures and fluctuation 
scales were computed by group (see Table 41). One-way ANOVA indicated that 
groups did not differ significantly in gFA (F(2,64) = 0.68, p = .511) or gMD (F(2,64) = 
0.95, p = .393). Independent-samples T tests showed MCI-LB Probable had 
significantly higher DCFS scores than MCI-AD (t(40) = -2.89, p = .006, d = 0.97). The 
difference in CAF was nonsignificant (p = .159).  
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Table 41 Means (standard deviations) of global fractional anisotropy (gFA) and mean 
diffusivity (gMD), and two measures of clinical fluctuations (DCFS, CAF). 
*Pre-transformed values. gMD values in 10 - 4  
 
Using TBSS, no between-group differences were found in FA after correcting 
for age (see Appendix O for complete brain images). Figure 16 shows the axial, 
sagittal and coronal views of the brain standard superimposed with the FA skeleton 
(in yellow; aligned at voxel 72x139x103) and TFCE corrected t-statistical map with 
significant voxels associated with age in red, indicating the lowest p-values. The 
contrast with demeaned age showed significant negative correlations with FA in 
regions in the right hemisphere, including (proceeding ventrally) areas around the 
anterior corpus callosum and the anterior corona radiata, Anterior thalamic radiation, 
Forceps minor and the inferior fronto-occipital fasciculus.  
 
 
Figure 16 TFCE corrected statistical map of significant voxelwise correlations with age in red 
over the mean FA skeleton in yellow (all participants). 
  
 gFA* gMD* DCFS CAF 
Controls  
n = 28 
0.46 (0.02) 7.72 (0.28) - - 
MCI-LB Probable 
n = 25 (27 with 
DCFS, CAF) 
0.46 (0.03) 7.85 (0.38) 9.07 (3.45) 4.26 (4.18) 
MCI-AD 
n = 14 (15 with 
DCFS, CAF) 
0.46 (0.2) 7.79 (0.39) 6.13 (2.53) 2.47 (3.27) 
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Figure 17 TFCE corrected statistical map of significant voxelwise correlations with DSST (all 
participants; significant voxels in blue). 
 
Inspection of the statistical maps indicates that substantially more white matter 
regions are significantly associated with DSST after TFCE correction than are 
associated with age Figure 17. In particular, voxels in the corpus callosum (genu and 
body), the right cingulum (connecting to the hippocampus), the left superior corona 
radiata, the right posterior thalamic radiation (including optic radiation) and 
unclassified areas of the left posterior occipital lobe (see Appendix M). This 
emphasizes the close association between DSST and white matter integrity, with a 
stronger relationship in the present sample than even with age. 
 
Relationship between DTI measures and demographics, clinical measures and 
cognitive processes 
gFA and gMD correlated significantly with age in both controls (gFA, r(27) = -
0.42, p = .027; gMD, r(27) = 0.58, p = .001) and MCI-AD (gFA, r(13) = -0.60, p = 
.024; gMD, r(13) = 0.68, p = .008). There was no significant relationship in MCI-LB 
Probable. The relationship between NART IQ and the DTI indices was not significant 
in any group. There was no significant correlations between the DTI indices, DSST or 
IIV and the clinical fluctuation scales (DCFS and CAF; see Appendix P) in MCI-LB 
Probable. Excluding MCI-LB Probable patients without clinical symptoms of 
fluctuations yielded the same results.  
The relationship between DTI indices and the primary neuropsychological 
processes of interest (SRT and CPT-AX tau, DSST, visuospatial composite) were 
also considered in the group overall (Table 42). Both gFA and gMD weakly 
significantly correlated with DSST and the visuospatial composite, with higher white 
matter integrity values associated with higher neuropsychological scores. The  
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Table 42 Whole group Pearson correlations between DTI indices and neuropsychological 
processes. 
 gFA gMD SRT tau CPT-AX tau DSST 
gMD 
n = 67 
-0.90**     
SRT tau 
n = 62 
-0.22 0.20    
CPT-AX tau 
n = 63 
-0.10 0.16 0.51**   
DSST 
n = 67 
0.34** -0.31* -0.55** -0.48**  
Visuospatial 
composite 
n = 67 
0.26* -0.31* -0.38** -0.36** 0.65** 
*Correlation  significant at the p =  .05 level, **p = .01 level. 
 
correlation with tau was not significant in the group overall; however, within controls, 
there were moderately strong, significant negative relationships between gFA and 
SRT tau (r(25) = -0.42, p = .033) and gFA and CPT-AX tau (r(27) = -0.49, p = .008). 
Similarly, gMD was moderately positively associated with CPT-AX tau values, (r(27) 
= 0.46, p = .014), indicating greater IIV is associated with lower measures of global 
white matter integrity. Greater IIV as measured by SRT and CPT-AX taus was also 
weakly-to-moderately associated with slower DSST times and lower visuospatial 
composite scores. The relationship between cognitive fluctuation ratings, IIV and DTI 
indices was also considered only in those MCI-LB Probable with cognitive 
fluctuations identified in their clinical examination. However, no correlation between 
these variables was significant. 
  
9.4 Discussion 
 
This exploratory chapter aimed to consider how two of the most important 
processes in the neuropsychology of MCI-LB Probable emerging from previous 
chapters (speed of processing and intra-individual variability) relate to DTI and 
clinical fluctuation severity, measures collected as part of the larger SUPErB study. 
 
Differences in white matter integrity between groups 
The results showed no differences in white matter integrity between groups; 
that is, healthy controls and patients with clinically defined MCI-LB Probable or MCI-
AD had similar global and voxelwise measure of FA and MD across the entire white 
matter skeleton, after controlling for age 
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Between-group differences were expected given the existing literature 
demonstrating decreased white matter integrity in advanced DLB and different areas 
of damage in DLB versus AD. In particular, a predominance of posterior FA changes 
and relatively intact frontal white matter has been previously shown in DLB. Watson 
et al. (2012), for example, investigated the relationship between white matter integrity 
and general neuropsychological functioning using DTI in DLB, AD and healthy 
controls. They found DLB patients had decreased FA particularly in parieto-occipital 
white matter tracts as well as the left thalamus and pons, while frontal lobes white 
matter was relatively intact. Posterior white matter damage been demonstrated 
elsewhere in this population (Colloby et al., 2002; Firbank, Colloby, Burn, McKeith, & 
O'Brien, 2003; Ishii et al., 1999; Pasquier et al., 2002), and data from Watson et al. 
(2012) emphasize this predominance by the proportion of voxels showing 
significantly lower FA that healthy controls: 21% in posterior regions versus only 
3.2% in frontal regions. FA was also decreased in AD patients, but in a much more 
general pattern (Watson et al., 2012). Both Watson et al. (2012) and Bozzali et al. 
(2005) suggest that the demonstrated occipital white matter damage may be a 
pathophysiological explanation for the prominent visuospatial and visual hallucinatory 
symptoms of DLB, with the former going so far as to suggest it as a potential tool for 
differential diagnosis. The corpus callosum, strongly associated with speed of 
processing, has also been shown to have lower ratings of white matter integrity in 
DLB (Bozzali et al., 2005).  
The lack of significant difference in the integrity of the white matter skeleton 
between groups precluded localization of where tract damage may relate specifically 
to DSST completion. However, the DSST was significantly associated with white 
matter integrity in a voxelwise analysis, including in the corpus callosum, the right 
cingulum, the left superior corona radiata, the right posterior thalamic radiation 
(including optic radiation) and the posterior occipital lobe. A number of these areas 
(the corpus callosum, thalamic radiation and occipital lobes) were cited by Watson et 
al. (2012) and Bozzali et al. (2005) as impacted in DLB. It is possible that between-
group differences in the MCI stage are subtle and escape capture by the rather basic 
DTI methods employed in the present study. However, given that DSST emerged as 
critical to MCI-LB neuropsychology, it is noteworthy that in MCI-LB it is closely 
associated with white matter areas affected in advanced DLB. Indeed, inspection of 
the statistical maps indicate a more substantial association of white matter with the 
DSST than with age. This is particularly striking given the long-standing and 
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extensive evidence of increasing age’s close relationship with white matter. White 
matter volume decreases with age, reaching peak volume in the mid-30s before 
losing 3% to 20% of volume (Lebel et al., 2012; Park & Reuter-Lorenz, 2009). 
Clearly, the DSST is a powerful neuropsychological tool with strong associations with 
white matter. It may perhaps hint at white matter tracts that will show increasing 
damage with disease progression. 
Replication of these analyses would also be useful to rule out Type II error. 
Less conservative TFCE corrections in the voxelwise analysis, or simply a larger 
cohort, could be used to confirm equivalence in white matter structure between the 
patient groups. Future work should also continue to consider how neuropsychological 
deficits relate to white or grey matter structural damage; however, such efforts may 
be undermined by the likely involvement of multiple regions, mechanisms or 
association cortices in DLB-related neurodegeneration (Bozzali et al., 2005). In 
addition to structural analyses, DTI data could use tractography methods to segment 
and analyse specific white matter tracts. Tractography algorithms automatically 
delineate tracts by assuming that the principal direction of axonal diffusion in a voxel 
is parallel to the main diffusion direction, the largest eigenvalue associated with that 
voxel. Such a method will allow consideration of connectivity issues in more depth 
and perhaps reveal significant correlations with processing speed measures.  
 
Variability, cognitive fluctuations and white matter integrity 
As hypothesized, less variable healthy controls have better measures of white 
matter integrity (global FA and MD). However, there was little evidence that tau 
serves as a proxy measure of microfluctuations in MCI-LB. As expected, fluctuation 
rating scale (DCFS) scores were higher in MCI-LB Probable than MCI-AD; however, 
we did not see the anticipated associations between attentional impairment 
(increased variability) and clinical cognitive fluctuations. This is in contrast to reports 
that attention is the most impacted cognitive domain in patients with fluctuations 
(Ballard, Walker, et al., 2001; Ballard et al., 2002; Walker et al., 1999). 
While IIV has strong conceptual links to fluctuating cognition, these results do 
not suggest it is related to clinically-assessed fluctuation severity. How to best assess 
cognitive fluctuations in DLB will remain an important challenge for clinical research 
studies going forward (Lee et al., 2012). One of the cited difficulties for clinicians in 
this regard is the variability of tests and the similarity between DLB and AD in later 
stages (Mega et al., 1996). For example, the CAF, used in the present study, 
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consists of open-ended questions and its accurate completion is highly dependent on 
the skills of the administering clinician. MCI-LB is an advantageous stage in disease 
progression to conduct research on fluctuations as participants are more able to 
tolerate sustained attention tasks and are generally less burdened by motor 
symptoms. Therefore, effort to develop a neuropsychological measure of fluctuations 
in the MCI phase remains justified.  
Future research could also consider variability and MCI-LB symptomology in 
terms of visual hallucinations. There have been similar efforts to link occipital white 
matter damage to hallucinations in DLB as with cognitive fluctuations. Fluctuations in 
sustained attentional are likewise associated with a high prevalence of visual 
hallucinations (Calderon et al., 2001; Lee et al., 2012). In DLB, visual hallucinations 
are typically complex, fully-formed, and varying in terms of patients’ emotional 
reaction and degree of insight into them (McKeith et al., 2017). Varanese et al. 
(2010) reports visual hallucinations are more common in individuals with dementia 
who also have cognitive fluctuations. A model proposed by Collerton, Perry, and 
McKeith (2005) argues that recurrent complex visual hallucinations are due to a 
combination of dysfunction in attentional binding and visuoperception. When 
attention to visual stimuli is reduced, proto-objects, units of bound visual information 
accessed as a coherent object, are experienced in the visual field and result in the 
phenomenology of a visual hallucination (Collerton et al., 2005; Rensink, 2000; 
Rensink, O'Regan, & Clark, 1997). A study in DLB by O'Brien, Firbank, Mosimann, 
Burn, and McKeith (2005) in DLB provides further evidence for attentional 
dysfunction’s contribution to visual hallucinations by demonstrating that patients with 
a decreased frequency of hallucinations at follow up showed increased perfusion in 
the posterior cingulate and precuneus. These neuronal regions are associated with 
attentional activation, suggesting improved attention was responsible for mitigation of 
hallucination symptoms (O'Brien et al., 2005). Given such evidence and the finding of 
an association between IIV and visuospatial ability, it suggested that IIV be 
considered in relation to visual hallucinations in MCI-LB in future work. However, as 
with cognitive fluctuations, few unproblematic clinical measures of visual hallucination 
severity are in use. 
 
Limitations 
The present chapter utilised data collected for the larger SUPErB study rather 
than my PhD per se. It is thus limited in scope and was not intended to be a 
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comprehensive evaluation of neither white matter integrity nor cognitive fluctuation 
symptoms.  
In addition, the other ex-Gaussian components of the reaction time tests were 
not considered. Tau was anticipated as the best index for the likely association 
between IIV and white matter. This assumption was made given past work showing 
increased tau in MCI-AD versus controls and a strong negative relationship between 
IIV and white matter volume (Jackson et al., 2012). In that study, smaller tau 
composite scores were associated with greater volumes of cerebral white matter and 
more regions of interest than sigma (Jackson et al., 2012). Tau has also been 
demonstrated as the ex-Gaussian subcomponent most closely related to working 
memory and executive functions measures, which in turn are hypothesized as 
strongly dependent on underlying white matter integrity (Balota et al., 2010; Gunning‐
Dixon, Brickman, Cheng, & Alexopoulos, 2009; Schmiedek et al., 2007; Tse et al., 
2010). However, Jackson et al. (2012) did find that smaller mu composite scores 
were also associated with larger volumes of cerebral white matter and the inferior 
parietal lobule. Therefore, future work could also consider whether sigma or mu in 
relationship to white matter integrity.  
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Chapter Ten: General discussion 
 
This concluding chapter will provide a summary of the results of the 
proceeding empirical results (section 9.1), a discussion of their implications (section 
9.2), comments on the strengths and limitations of the work more broadly (section 
9.3) and recommendations for future research (section 10.4).  
 
10.1 Summary of results 
The objective of this PhD was to establish the neuropsychological profile of 
MCI with Lewy bodies following the most recently published clinical criteria for this 
emergent diagnostic category (McKeith et al., 2017). Recruitment and baseline 
testing of MCI patients and healthy age- and sex-matched controls led to the creation 
of four clinically-defined participant groups: controls, MCI-LB Probable, MCI-LB 
Possible and MCI-AD. In comparing MCI-LB (Possible and Probable), equivalence 
was found in demographic factors and global cognitive measures, although groups 
differed in premorbid IQ and sex distribution. 
Results of univariate analysis of neuropsychological scores indicated that MCI-
LB and MCI-AD display cognitive impairments in line with the advanced stages of 
DLB and AD, respectively. The MCI-LB groups in particular were characterised by 
poor abilities in attention, visuospatial and executive function tasks. MCI-AD, 
conversely, demonstrated an amnestic profile of verbal learning and memory deficits. 
However, MCI-AD also scored poorly in executive function measures and had slowed 
speed of processing relative to controls. In addition to univariate group comparisons, 
percentile standings and discriminant analysis were used to quantify impairments in 
MCI-LB and MCI-AD. Overall, MCI-LB Probable was best discriminated and typified 
by slow processing speed. Processing speed, and not executive function, was 
associated with higher-order cognitive activities such as visuospatial function, long 
term visual memory, and verbal learning and memory. 
PCA analyses served as a data reduction technique to preserve the richness 
within the dataset in preparation for multivariate analyses. Attempts to use PCA 
within the MCI-LB subset failed due to multiple loadings of the DSST and other 
processing speed/ attentional tasks. Control-informed composites helped to 
reconfirm theoretical assumptions about grouping of processing speed and 
visuospatial measures.  
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Multivariate analyses demonstrated that processing speed accounted for the 
group-associated variance in visuospatial and verbal ability. In MCI-LB Probable, 
processing speed was associated with visuospatial working and long term memory, 
visuoconstruction, and verbal learning and memory. In contrast, processing speed 
did not correlate with visuospatial or verbal learning ability in controls or MCI-AD. The 
processes involved in the processing speed task DSST were then investigated using 
hierarchical linear regressions. Results showed that cognitive processing speed time 
was the most important contributor to DSST and that MCI-LB associated variance in 
the DSST is independent of motor impairment (UPDRS). 
Chapter 8 considered the role of variability in speeded reaction time tests. 
Elevated IIV occurred in MCI-LB in tasks with executive function weighting (CRT) or 
requiring sustained attention (CPT-AX). MCI-LB also had higher error rates relative to 
controls suggesting generalized impairment, either in executive functions or 
sustained attention per se, that may facilitate or explain this increased variability. 
Alternatively, the simple motor reaction time task (SRT) elicited higher IIV in MCI-AD. 
In Chapter 4, no differences between MCI patients and controls was found in SRT 
nor CRT mean reaction time. This emphasizes the benefits of using ex-Gaussian 
modeling and considering tau, rather than simply mean response latencies, in 
reaction time task analyses. Tau was also associated with group-related variance in 
visuospatial ability and global cognitive scores, but it explained less variance than 
DSST in those domains. Chapter 9, an exploratory chapter, considered the 
relationship between clinical symptoms, white matter integrity as measured by DTI, 
and IIV and DSST, the neuropsychological variables that emerged as most important 
in the previous chapters. Contrary to expectations, groups did not differ in white 
matter integrity. Moreover, tau did not relate to measures of white matter integrity nor 
to clinical measures of cognitive fluctuation severity. 
10.2  Interpretation and implications of results 
 
This study is a crucial step towards better understanding of cognitive 
dysfunction in the emergent diagnostic classification of MCI-LB. Based on my results, 
it can be expected that clinically-defined MCI-LB patients will present with cognitive 
impairments in the same domains as advanced DLB. That is, MCI-LB was impaired 
relative to both controls and MCI-AD in visuospatial ability, executive function, 
attention and processing speed. Verbal learning and memory dysfunction was also 
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observed relative to controls in MCI-LB, although deficits were significantly smaller 
than those in the MCI-AD group.  
Similarly, MCI-AD and MCI-LB were similar in showing executive dysfunction 
(set-shifting and inhibition) but intact working memory capacity and maintenance 
relative to controls (Miyake et al., 2000). While MCI-LB did also show evidence of 
impaired updating, which was not observed in MCI-AD, these results suggest 
executive dysfunction may be a less useful differentiating factor in the MCI stage. 
This is surprising, given its acceptance as a hallmark of DLB and associated 
neuropathologies. A profile of non-amnestic decline with executive and attentional 
dysfunction has been repeatedly linked to the nigrostriatal dopamine depletion 
observed in LB diseases (Foltynie et al., 2004; Goldman et al., 2014a; Muslimovic, 
Post, Speelman, & Schmand, 2005). Auning et al. (2011), using 123I-FP-CIT SPECT, 
reports 79% of DLB cases show striatal dopamine transporter loss, while reduced 
caudate nucleus uptake is associated with executive impairment in both DLB and PD 
(Aarsland, 2016). Experimentally, studies have also succeeded in inducing executive 
dysfunction through the manipulation of dopaminergic (levodopa) medication in PD 
patients (Cools, Barker, Sahakian, & Robbins, 2001; Kehagia et al., 2012). However, 
it is important to note that it has been suggested that PD as a dysexecutive 
syndrome is an oversimplification. There may alternatively be two subgroups of PD-
MCI: (1) an executive dysfunction/ frontostriatal subtype that shows less association 
with the development of PDD, and (2) a posterior-cortical type more likely to progress 
to PDD and characterized by poor visuospatial and semantic skills (Williams-Gray et 
al., 2009; Williams-Gray et al., 2013; Wu et al., 2012). In a review, Goldman et al. 
(2014a) argues that this distinction would have important clinical and therapeutic 
implications. Clarification, perhaps through longitudinal studies, could be made as to 
whether similar subtypes can be demonstrated in MCI-LB, which may explain my 
equivocal findings. 
One of the most salient findings in the present project was the importance of 
processing speed to the neuropsychological performance of MCI-LB. Processing 
speed accounted for substantial variance in scores on higher-order tasks in the 
group, including visuospatial working and long term memory, visuospatial 
construction (drawing), verbal learning, and global cognition. The differences 
between groups in visuospatial and verbal learning scores were also fully statistically 
explained by processing speed. One of the most commonly used measures of 
processing speed is the DSST, although there are many other tasks employed in 
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various studies. This project provides evidence of the task’s utility as a valid measure 
of processing speed in MCI-LB. This is particularly notable given that MCI-LB is a 
synucleinopathy with substantial overlap with PD. Clinical diagnosis of these 
conditions includes motor impairments, which might obviously call into question 
interpretation of any impairments on motor-dependent cognitive tasks. It would be 
easy to dismiss a trend of slowed psychomotor or cognitive speed as dependent on 
motor function. Performance on the DSST is indeed related motor speed; however, 
my analyses show that it also succeeds in capturing cognitive processing speed 
independent of both fine motor speed and gross motor symptoms. As such, the 
DSST quantifies cognitive speed as intended in this population.  
In MCI-AD, findings of impaired long-term episodic verbal memory offer further 
evidence that a typical AD profile can be expected in the early MCI phases of 
disease as well. It is also of note that the MCI-AD group was identified from an initial 
MCI patient cohort recruited on the basis of suspected Lewy body disease. In this 
way, demonstrable significant differences in cognitive scores between groups are 
even more impressive than if the MCI-AD group had been sourced from individuals 
presenting to their physicians as a more typical, “pure” AD participant. 
10.3 Thesis overall strengths and limitations 
Major strengths of this thesis include the comprehensive neuropsychological 
assessment administered and the robust, clinical classification of the cohort. 
Participants underwent clinical examination, bloodwork, and multiple neuroimaging 
modalities, including two of the three indicative biomarkers in the new consensus 
criteria (FP-CIT and MIBG; McKeith et al., 2017). MCI diagnoses were determined by 
consensus of expert Old Age Psychiatrists, blind to previous diagnoses and following 
separate MIBG analysis and panel-rated FP-CIT (see Chapter 3). Many of the 
healthy control volunteers were family members of MCI volunteers, ensuring some 
overlap between the groups in education and socioeconomic background. The 
groups nevertheless differed significantly in premorbid IQ estimates overall. Age and 
premorbid IQ were thus included in regression analyses in Chapters 6-7 and the 
ANCOVAs in Chapter 8, due to their strong association with many of the 
neuropsychological task employed. As such, SUPErB benefits from a rigorous 
diagnostic protocol and clear, reliable clinical diagnosis of MCI participants, with 
statistical consideration of their demographics. 
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Secondly, the thesis has presented the neuropsychological profile of these 
clinically defined MCI groups, in particular the novel MCI-LB Probable category. Not 
only were cognitive deficits relative to controls considered in each task, but domain-
level scores and percentiles were utilised. The data-reduction technique served to 
combine the extensive range of tasks into composites that were determined to best 
capture the variability in the data. Using these composites in the multivariate 
analyses facilitated interpretation of the results, better captured the breadth of each 
domain, and minimised the risk of Type I error.  
Thirdly, a cognitive psychological approach was employed to demonstrate a 
hierarchical structure in the neuropsychology of MCI-LB Probable. This technique 
allowed us to reach the conclusion that higher-order deficits in global cognitive ability, 
visuospatial and verbal abilities were fully statistically explained by processing-speed. 
As discussed above, this has implications to the larger field of psychology by positing 
a processing speed-mediated model of decline, rather than an executive function 
mediated decline. 
Fourthly, speed of processing was investigated in greater detail by analysing 
the subcomponents of completion of the DSST, which indicated that the DSST 
successfully captures cognitive speed of processing in addition to simpler motor 
speed in this population. This is an important finding due to the frequent motor 
slowing observed in LB disease. An ex-Gaussian modelling technique was employed 
to consider variability in reaction time in addition to mean response latency. Lastly, 
the thesis briefly addressed the potential relationship between (1) the 
neuropsychological processes that emerged as most important in MCI-LB and (2) 
white matter integrity, a potential neurobiological source of such deficits, both globally 
and through voxelwise analysis. 
However, there are several limitations to the thesis that should be 
acknowledged, in addition to the specific critiques addressed in each empirical 
chapter. The MCI-LB Probable group had a predominance of men, as expected by 
previous studies (Nelson et al., 2010), and the potential of neuropsychological 
differences related to sex was not considered. Females, for example, generally 
perform better on verbal memory tasks, as well as some visuospatial memory tasks 
(Herlitz, Airaksinen, & Nordström, 1999). In terms of ageing, older women tend to 
outperform older men in verbal memory, although gender differences in speeded or 
non-verbal working memory were not observed (Aartsen, Martin, & Zimprich, 2004). 
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More specifically, females over 60 years of age complete the DSST more quickly 
than their male counterparts.  
Similarly, medication was not taken into consideration. Cholinesterase 
inhibitors, in particular, are regularly prescribed to improve cognition in DLB (McKeith 
et al., 2017). Their action can substantially improve attention and executive function 
performance in MCI (Carter, Caine, Burns, Herholz, & Lambon Ralph, 2012; Herholz, 
2008). Their use in the cohort was not investigated, although volunteers must have 
been pharmacologically stable for one month prior to commencing participation. 
Future studies (and analyses of this dataset) could benefit from including sex and 
educational level in their analyses and accounting for anticholinesterase use. 
Alternatively, MCI participants and controls could be matched on educational level 
during recruitment, and the sample could be limited to drug-naïve MCI volunteers. It 
is unlikely, however, that such a study design would be achievable. 
Another potential limitation is the exclusion of MCI-LB Possible from analyses 
in Chapters 5-9. As discussed previously, this decision was made in order to isolate 
the most “Lewy” MCI patients within the cohort. Doing so allows us to most assuredly 
draw inferences about the neuropsychology of the emergent MCI-LB diagnostic 
category, the main purpose of this thesis. However, loss of the MCI-LB Possible 
participants does decrease the statistical power of analyses. Future analyses of this 
dataset could consider inclusion of those MCI-LB Possible, particularly those patients 
with a positive FP-CIT scan. 
  
10.4 Future directions 
 
As described in Chapter 3, the larger SUPErB study will follow volunteers for 
up to five years after baseline assessments. This will offer a wealth of longitudinal 
data and, critically, indicate the characteristics of participants that go on to convert 
dementia within that time frame. Such information may reposition the findings in the 
present cross-sectional work. For example, Breitve et al. (2018) found worse 
visuoconstructional ability in DLB than AD at baseline, but no association between 
visuospatial function and the rate of cognitive decline or dementia severity. 
Longitudinal follow-ups will determine whether the deficits identified in MCI-LB in the 
present study, particularly processing speed, is informative in terms of conversion to 
dementia or functional or cognitive decline. Moreover, MCI studies are at risk of the 
inclusion of “contamination” by healthy individuals (Petersen et al., 1999, p. 307). For 
example, a substantial proportion of individuals receiving an MCI diagnosis are “false 
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positives” who will revert to normal cognition or have long-standing, non-progressive 
poor performance (see Brooks et al., 2008 for a review). De Jager and Budge (2005) 
and Koepsell and Monsell (2012), for example, found 13% and 16% of participants 
with baseline cognitive impairment showed normal cognitive status at four- and one-
year follow up, respectively. Higher figures (38% and 31%, respectively) have been 
reported in other incidence studies (Manly et al., 2008; Roberts et al., 2014). Indeed, 
the temporal instability of the concept of MCI is one of the major concerns in its use, 
which is most relevant to clinical settings but could also remain a challenge in 
research. Various sources of MCI’s diagnostic instability have been identified, 
including fluctuations in mood and somatic comorbidities and practice effects. 
Cognitive profiles in MCI can range broadly and with disease progression, and may 
reflect mixed pathologies that may have differential trajectories of decline and 
potential remission of cognitive deficits (Goldman, Williams-Gray, Barker, Duda, & 
Galvin, 2014b; Mosimann et al., 2004). Indeed, the high prevalence of multiple 
pathologies in dementia makes attempts to delineate a clear, etiologically-orientated 
neuropsychological profile challenging. However, Roberts et al. (2014) and Koepsell 
and Monsell (2012) both found that those with MCI that revert to normal cognition still 
had a higher risk of later converting to dementia. This suggests that MCI has 
“prognostic value” regardless of its temporal instability. Other concerns and 
controversies surrounding the concept of MCI include whether classification should 
be clinical or algorithmic, such as using neuropsychological data as discussed in 
Chapter 2, the applicability to different populations, and the reliability of putative 
biomarkers (Gauthier & Touchon, 2005; Petersen et al., 2014). Longitudinal data will 
be critical in determining whether MCI remains a useful concept and diagnostic 
category despite these limitations. 
Statistically, several alternative methods may improve future work using the 
tasks employed herein. Firstly, staircase methods may offer a means to determine 
optimal interstimulus interval in an MCI sample on computerized tasks such as the 
SRT, CRT and CPT-AX. Staircasing is a rather simple adaptive method used in 
psychophysics that estimates the perceptual threshold for 50% correct detection of a 
stimulus using an “up-down” procedure (Cornsweet, 1962; Leek, 2001). Stimulus 
presentation is adjusted based on the accuracy of the previous response or 
responses until the threshold is reached. Secondly, in interpreting the results of a 
large battery of neuropsychological tasks, a more advanced perspective can be 
taken to understand what constitutes abnormally low performance. Within a healthy 
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population, a certain proportion will be expected to exhibit at least one abnormally 
low test score. The extent of patient impairment, based on the control group, could 
thus be overestimated. Crawford et al. (2007), for example, recommend a Monte 
Carlo method that can be applied to any test batteries to help account for variance in 
control and patient populations. This method also facilitates for comparison between 
studies without relying on normative data (Crawford et al., 2007).  
Thirdly, better measures of processing speed may be developed from a task 
perspective or alternative statistical analyses. Task-based improvements could 
include staircasing, as described above, or further manipulation of executive 
weighting in the CPT-AX. For example, the present study used a target frequency of 
70%. This was in order to increase the cognitive demands of the task, specifically 
executive function: a high proportion of targets creates a strong response tendency, 
increases response competition during the non-target stimuli, and increases the error 
rate (Conners, Epstein, Angold, & Klaric, 2003; MacDonald, Pogue-Geile, et al., 
2003; Silverstein, Weinstein, & Turnbull, 2004). This allowed me to consider how 
error types would differ between groups. However, low target frequencies have been 
argued to be purer measures of sustained attention, by clearly requiring sustained 
“vigilance” to respond to the occurrence of an infrequent event (Carter, Russell, & 
Helton, 2013). Indeed, lower frequencies may place less demand on the motor 
control of participants (Carter et al., 2013). While my DSST analyses suggest that 
motor and cognitive processing speed components can be measured separately in 
MCI-LB, it might be nevertheless advantageous to minimize motor determinants of 
performance in future reaction time tests. 
Furthermore, while these results suggest a processing speed, rather than 
executive, mediated model of decline in MCI-LB, executive function is a broad class 
of cognitive processes that may not have been fully captured by the present study’s 
battery (see Chapter 6). Future work should aim to capture the multifaceted nature of 
the construct of executive function, and this may be possible while simultaneously 
measuring processing speed. An alternative to the cognitive psychological framework 
taken in the present PhD, which presumes overlap or hierarchy in cognitive 
processes (Baddeley, 1996b; Logie, 1995), could be taken in this regard. For 
example, the Attention Network Test (ANT; Fan, McCandliss, Fossella, Flombaum, & 
Posner, 2005) is based on the spotlight-theory of attention (Posner, Snyder, & 
Davidson, 1980) and conceptualises attention as consisting of interrelated systems of 
executive control, orienting, and alerting (Posner & Petersen, 1990). Cromarty et al. 
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(2018) used the ANT test to demonstrate slowed mean reaction time in a combined 
DLB and PDD group, relative to controls and AD. In terms of attention, however, the 
LBD and AD groups did not differ in executive control or orienting efficiency 
(Cromarty et al., 2018), suggesting that the ANT may not be useful in identifying 
differences in attention between dementia subtypes. The ANT has also been shown 
to have questionable psychometric properties, including poor reliability and 
substantial interrelatedness of the purportedly independent networks (MacLeod et al., 
2010). As such, there remains an unmet need to develop or adopt a task that can 
simultaneously deconstruct attention and quantify processing speed.  
Other advanced techniques for modelling IIV may also be useful in MCI. The 
ex-Gaussian approach utilized in Chapter 8 was successful in demonstrating that 
intra-individual variability was elevated in MCI subtypes differently, depending on the 
executive weighting of the reaction time test. However, the ex-Gaussian model, while 
commonly used, has been criticized for linking subcomponents of reaction time to 
specific cognitive processes. For example, the present study assumed tau as 
indicative of periodic attentional lapses or “microfluctuations” (Kieffaber et al., 2006; 
Matzke & Wagenmakers, 2009). Some argue that this link is tenuous and not 
sufficiently supported by theory (Osmon, Kazakov, Santos, & Kassel, 2018). 
Alternatively, a number of other models have been argued to have more theoretical 
support for interpreting parameters as representative of specific cognitive processes 
(see Osmon et al., 2018 for a review). For example, Drift Diffusion Modelling (Ratcliff, 
1978; Ratcliff & McKoon, 2008) is predicated on a model of reaction time in which the 
cognitive components (sensory-perceptual encoding, response execution duration, 
etc.) vary randomly from trial to trial. Of course, models may differ in their usefulness 
depending on both the tasks and populations, and some authors suggest that the 
same data should be examined using multiple models to determine the optimal 
approach (Osmon et al., 2018).  
Further work is also needed to determine the clinical relevance of these 
findings. For example, evidence from Chapter 6 that cognitive de-differentiation 
occurs in MCI-LB may suggest a rehabilitative pathway. Analyses using the VPT 
showed that MCI-LB’s verbal ability is related to their visuospatial memory 
performance, even when remembering stimuli that are validated as least-susceptible 
to verbal coding. It is possible that MCI-LB may be recruiting intact 
neuropsychological processes, like verbal recoding, in order to compensate for, or 
“scaffold”, the significant deficits in the visuospatial store. Compensatory scaffolding 
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is expected across development including in normal ageing, during which 
complementary neural pathways are recruited in order to complete cognitive tasks 
that rely on declining neural circuits (see Park & Reuter-Lorenz, 2009 for a review). A 
number of correlational studies have established that cognitive engagement across 
the lifespan, such as educational attainment and cognitive effort, is associated with 
better intellectual function in later life (Schooler, Mulatu, & Oates, 1999, for example). 
Moreover, declines associated with AD are less severe or delayed in individuals with 
high cognitive stimulation (Bennett et al., 2003; Stern et al., 1994).  
More direct measures of semantic ability or a dual-task framework could be 
used in future studies to confirm whether cognitive scaffolding truly occurs differently 
in MCI-LB during completion of the VPT. Articulatory suppression tasks, for example, 
can be used to interfere with verbal rehearsal, and thus confirm whether such 
phonological engagement modulates visuospatial memory (Baddeley, 2000b; 
Vandierendonck et al., 2004). For example, during the VPT retention interval, 
participants could be required to repeat the word “the,” which impedes the operation 
of the phonological loop, in one condition of the task. Such a paradigm is challenging 
for patients but may be possible in MCI, when cognitive decline is not too advanced. 
Evidence of cognitive scaffolding using the VPT could have consequential 
implications for cognitive rehabilitation, for example through training in verbal 
recoding strategy use. In a randomized controlled trial, Kinsella et al. (2009) found 
significant improvements in prospective memory scores and increased knowledge 
and implementation of memory strategies after five weeks of training in amnestic 
MCI. Using semantic strategy training, Miotto et al. (2013) similarly demonstrated 
improvements in word list recall in patients with acquired prefrontal cortex lesions. 
Unfortunately, if speed of processing is confirmed to be the critical factor in predicting 
visuospatial memory success, efforts to increase this core resource have previously 
failed in MCI (Barnes et al., 2009).  
The evidence of differential performance by aetiology in MCI in the present 
thesis is also relevant to clinical trials for dementia. Indeed, neuropsychology remains 
crucially important in the development of any breakthrough pharmaceutical 
treatment. With the highest fail rate in the industry and a 30% greater cost per 
successful development than in other specialties, there is decreasing investment in 
research and development in neurodegeneration and a number of major 
pharmaceutical companies recently either downsized (Pfizer, Sanofi and Janssen) or 
closed (GSK, AstraZeneca and Novartis) their departments. A major barrier to 
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successful drug development in dementia is failure to detect subtle changes in 
cognition during the trials. These incredibly expensive and lengthy trials require early 
evidence of success (often improvements in cognitive performance) to justify their 
continuation, yet may use bulky global cognitive measures or clinical measures such 
as CDR to track changes over time. Burdick et al. (2014), for example, found the 
MMSE was only 45% successful in identifying PD patients with dementia. Investment 
in developing valid and reliable neuropsychological measures that can detect small 
effect sizes across shorter time spans will be essential. As such, it is suggested that 
processing speed tasks and advanced modelling techniques are further developed to 
ensure that any positive changes to cognition are recognised before a trial is forced 
to cease.  
Any intervention will need to be administered early in disease course, and thus 
reliable identification of suitable patients for (firstly) clinical trials and (subsequently) 
treatment implementation is needed. Differences in the profiles of MCI-LB and MCI-
AD that emerged in the present study suggest promising directions in early diagnosis 
and the identification of differential cognitive processes between the causes of 
dementia. The significant differences found between MCI-LB and MCI-AD are 
especially noteworthy given the recruitment process of SUPErB (as discussed in 
section 4.4). Future work, including ongoing analyses within the longitudinal SUPErB 
study, will help to elucidate how processing speed functions as a core mechanism of 
cognitive performance in MCI-LB. 
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Appendix B. Graphical comparison of equivalent tasks using data 
extracted in the structured review. 
 
 
 
 
 
Fig.BA1 and B2. Bias-corrected effect sizes of Digit Span Forwards and Backwards in PD-MCI (black 
points) and early PD (white points) relative to controls, showing both individual studies (circles) and 
summary effect sizes by group (diamonds).  
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Fig.s B3 and B4. Bias-corrected effect sizes of semantic verbal fluency scores in (a) PD-MCI (black 
points) and (b) early PD (white points) relative to controls in individual studies (circles) and as a 
summary effect size by group (diamonds).  
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Fig. B5. Bias-corrected effect sizes of semantic verbal fluency scores in PD-MCI (black points) and 
early PD (white points) relative to controls in individual studies (circles) and as a summary effect size 
by group (diamonds).  
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Fig. B6. Bias-corrected effect sizes of visuospatial copying and recall tasks in PD-MCI (black points) 
and early PD (white points) relative to controls in both individual studies (circles) and as a summary 
effect size by group (diamonds). (BVMT = Brief Visuospatial Memory Test; ROCF = Rey-Osterrieth 
Complex Figure). 
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Fig. B7. Bias-corrected effect sizes of word list verbal learning and memory tasks in PD-MCI (black points) and early PD (white points) relative to controls in both 
individual studies (circles) and as a summary effect size by group (diamonds). (CVLT = California Verbal Learning Test; FCRST = Free and Cued Selective 
Reminding Test; HVLT = Hopkins Verbal Learning Test; RAVLT = Rey Auditory Verbal Learning Test). 
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Fig. B8. Bias-corrected effect sizes of naming tests in PD-MCI (black points) and early PD (white 
points) relative to controls in both individual studies (circles) and as a summary effect size by 
group (diamonds).  
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Figure B9. Bias-corrected effect sizes of tasks measuring psychomotor speed in PD-MCI (black) and 
early PD (white) relative to controls in individual studies. 
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Figure B10 and B11. Bias-corrected effect sizes of Trail Making Tests A and B in PD-MCI (black 
points) and early PD (white points) relative to controls, showing both individual studies (circles) and 
summary effect sizes by group (diamonds).  
 
 
Figure B12. Bias-corrected effect sizes of card sorting tasks in PD-MCI (black points) and early PD 
(white points) relative to controls, showing both individual studies (circles) and summary effect sizes 
by group (diamonds). 
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Figure B13. Bias-corrected effect sizes of additional executive function tasks in PD-MCI (black 
points) and early PD (white points) relative to controls, showing both individual studies (circles) and 
summary effect sizes by group (diamonds).  
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Appendix C. Reasons for removal from PhD Analyses of SUPErB Study 
data. 
 
No Consent, n = 1 
SUP001ES 
Voluntary Removal, n = 1 
SUP170BR 
Too Impaired at V2, n = 5 
SUP110GH, SUP135AL, SUP139RC, SUP142RJ, SUP173GO 
Insufficient Impair., n = 1 
SUP081MB  
Medical delay, n = 2 
SUP168JD, SUP171MM 
Before imaging, n = 4 
SUP146BN (voluntary/vision), SUP108CV (pain, partial neuropsychological 
assessment), 
SUP125PS: no clinic, scans or computer (voluntarily withdrawn), 
SUP101RH: no clinic, scans or computer (voluntarily withdrawn) 
                              
Participants with partial clinical/ scan data:                           
Partial Clinical or Scan Data 
SUP010PH: no clinic or scans (voluntarily withdrawn) 
SUP015PT: no MIBG or DaT (clinic in LewyPro) 
SUP055PJ: no MRI/ MIBG  
SUP107AB: no DaTSCAN  
SUP144RD: no MRI (deceased) 
SUP156HF: no scans (deceased) 
SUP085MS: no MRI 
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Appendix D. Outliers removed and transformations performed, by 
neuropsychological task 
Table A-1. Outliers removed by individual task. 
 
Variable Name Participant Raw score z-score 
F (FAS) SUP088PS 33 3.81 
A (FAS) SUP161ED 27 3.31 
Trails A  SUP117PE 253.58 5.85 
Trails B     
Stroop_CW_items SUP055PJ 97 5.16 
RAVLT_Percent_Forgetting SUP089DK -2.0 -5.58409 
RAVLT_Percent_T5_recalled SUP089DK 300 5.58409 
DSST Error Check SUP034RS 84.00 3.19281 
 
 
Table A-2. Transformations performed by neuropsychological task. 
 
Variable Skew 
+/- 
Dir. 
Δ? 
Orig. 
Skew 
Orig. 
Kurt. 
Trans used New 
Skew 
New 
Kurt. 
Stroop Classical 
Interference 
 Y   Changed 
direction only 
  
Stroop Ratio 
Interference 
    Changed 
direction only 
  
RAVLT Percent 
Forgetting 
 Y .374 -.580 Changed 
direction only 
  
RAVLT “Miss” List 
B 
 Y   Changed 
direction only 
  
RAVLT Forgetting  Y   Changed 
direction only 
  
RAVLT Proactive 
interference (B-A1) 
 Y   Changed 
direction only 
  
Pareidolia + Y 2.63 7.42 -1*SQRT(X) -1.15 .534 
Trail Making Test A ++ Y 3.112 13.82 -1*Lg10(X) -.824 .893 
Trail Making Test B + Y 1.71 2.68 -1*SQRT(X) -1.11 .704 
Trails Making Test 
Difference (B-A) 
+ Y 2.12 5.44 -1*SQRT(X) -1.11 1.26 
Trail Making Test 
Ration (B/A) 
+ Y 1.71 3.10 -1*SQRT(X) -1.22 1.49 
Coding Time (DSST) ++ Y 2.68 9.65 -1*LG10(X) -.474 .772 
Simple Reaction 
Time  
++ Y 3.50 13.83 -1*LG10(X) -2.06 5.13 
Choice Reaction 
Time 
+ Y 2.56 11.10 -1*SQRT(X) -.675 7.90 
Corsi Blocks + N .871 2.27 SQRT(X) -.312 .881 
VPT Ratio (high/ 
low) 
+ Y 1.20 .720 -1*SQRT(X) .889 .272 
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Appendix E. Charts of univariate analysis between-groups 
Table A-3. Comparison of the four subgroups on measures of verbal learning and memory, with t-tests between MCI-AD and MCI-LB 
Probable and one-way ANOVAs between all four groups. 
 
Task Controls  
(n = 31) 
MCI-LB 
Probable  
(n = 30) 
MCI-LB 
Possible  
(n = 14) 
MCI-AD  
(n = 18) 
MCI-LB 
Probable vs. 
MCI-AD 
All group 
one-way 
ANOVA 
Graded 
Naming Test 
23.58(4.18) 21.24(3.95) 20.86(4.85) 21.00(4.98) t(45)=-0.18, 
p = .855 
F(3,88) = 
2.26, p 
= .087 
 
ACE-
Language 
24.87(1.18) 23.73(1.78) 22.64(2.65) 
 
24.06(2.10) t(46)=0.57,  
p = .573 
F(3,89) = 
5.10, p 
= .003 
Control > 
MCI-LB 
Probable, 
p = .002 
Control > 
MCI-LB 
Possible, 
p = .080 
RAVLT Max 
T1:T5 
11.39(2.23) 8.63(2.58) 8.14(2.77) 
 
8.17(3.05) t(46)=-0.57,  
p = .574 
F(3,89) = 
9.36, p 
< .001 
Control > 
MCI-LB 
Probable, 
p < .001, 
MCI-LB 
Possible, 
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p = .001, 
& MCI-
AD p 
< .001 
RAVLT: 
“Learning” 
5.58(2.13) 4.30(2.68) 3.79(1.97) 
 
3.22(3.08) t(46)=-1.28, 
p = .208 
F(3,89) = 
3.93, p 
= .011 
Control > 
MCI-AD 
p = .011 
RAVLT Short 
Delay 
8.94(2.78) 5.83(3.36) 4.36(3.18) 
 
3.72(3.64) t(46)=-2.04,  
p = .047, 
g = 0.60 
F(3,89) = 
12.75, p 
< .001 
Control > 
MCI-LB 
Probable, 
p = .002, 
MCI-LB 
Possible, 
p < .001, 
& MCI-
AD p 
< .001 
RAVLT Long 
Delay 
8.35(3.27) 5.66(3.46) 3.86(3.18) 4.00(4.62) t(43)=-1.36,  
p = .180 
F(3,86) = 
7.86, p 
< .001 
Control > 
MCI-LB 
Probable, 
p = .023, 
MCI-LB 
Possible, 
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p = .001, 
& MCI-
AD p 
= .001 
RAVLT 
Percent 
Remembered 
at Long 
Delay (from 
max T1:T5) 
71.59(19.52) 65.02(37.61) 42.55(31.91) 
 
38.23(35.67) t(43)=-2.33,  
p = .025, 
g = 0.73 
F(3,86) = 
5.73, p 
= .001 
Control > 
MCI-LB 
Possible, 
p = .024, 
MCI-AD, 
p = .004 
RAVLT: 
Retroactive 
Interference 
(A6-A5) 
-2.00(2.25) -2.13(2.60) -3.36(1.86) 
 
-3.72(1.90) t(46)=-2.25,  
p = .029, 
g = 0.70 
F(3,89) = 
3.16, p 
= .029 
Control > 
MCI-AD, 
p = .056 
RAVLT: 
Proactive 
Interference 
(B-A1) 
-0.94(1.63) -0.30(1.75) -0.50(1.40) -0.83(1.54) t(46)=-1.07,  
p = .291 
F(3,89) = 
0.90, p 
= .444 
Rey 
Recognition 
False B* 
-0.98(0.84) -1.73(0.80) -1.83(1.00) -1.57(1.20) t(20.71)=0.47, 
p = .642 
F(3,82) = 
4.30, p 
= .007 
Control > 
MCI-LB 
Probable, 
p = .012, 
Control > 
MCI-LB 
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Possible, 
p = .049 
* Direction change transformation.  
 
Table A-4. Comparison of the four subgroups on measures of visuospatial learning and memory, with t-tests between MCI-AD and MCI-
LB Probable and one-way ANOVAs between all four groups. 
 
Task Controls  
(n = 31) 
MCI-LB 
Probable  
(n = 30) 
MCI-LB 
Possible  
(n = 14) 
MCI-AD  
(n = 18) 
MCI-LB 
Probable 
versus MCI-
AD 
All group 
one-way 
ANOVA 
ACE-
Visuospatial 
15.52(0.85) 13.70(2.15) 14.00(1.84) 14.44(1.50) t(46)=1.29,  
p = .204 
F(3,89) = 
6.81, p 
< .001 
Control > 
MCI-
Probable, 
p < .001, 
& MCI-LB 
Possible, 
p = .025 
Corsi 
blocks* 
6.09(1.17) 4.57(1.37) 5.08(1.52) 5.12(1.37) t(44)=1.33,  
p = .191 
F(3,82) = 
6.44, p 
= .001 
Control > 
MCI-
Probable, 
p < .001 
MTCF Copy 34.37(1.59) 33.32(3.92) 31.21(4.82) 30.75(7.54) t(38)=1.19,  
p = .242 
F(3,78) = 
2.84, p 
= .043 
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Control > 
MCI-
Probable, 
p = .041 
MTCF 
Recall 
16.67(5.77) 
 
 
11.90(5.14) 9.50(3.89) 9.92(6.42) t(36)=-1.02,  
p = .313 
F(3,76) = 
7.85, p 
< .001 
Control > 
MCI-LB 
Probable, 
p = .009, 
MCI-LB 
Possible, 
p = .001, 
& MCI-AD 
p = .003 
MTCF % 
Retained 
48.52(16.96) 39.10(14.08) 30.23(11.32) 29.81(18.48) t(36)=-1.71,  
p = .096 
F(3,76) = 
6.30, p 
= .001 
Control > 
MCI-LB 
Possible, 
p = .005, 
& MCI-AD 
p = .004 
Visual 
Patterns 
(high) 
13.38(3.26) 8.08(3.59) 8.50(3.06) 10.80(2.93) t(37)=2.46,  
p = .019, 
g = 0.28 
F(3,76) = 
13.33, p 
< .001 
Control > 
MCI-LB 
Probable, 
p < .001 & 
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MCI-LB 
Possible, 
p < .001. 
Controls > 
MCI-AD p 
= .072  
MCI-AD > 
MCI-LB 
Probable, 
p = .065 
Visual 
Patterns 
(low) 
10.04(3.02) 6.00(3.80) 4.83(2.69) 8.13(2.64) t(37)=1.90,  
p = .065, 
 
F(3,76) = 
10.90, p 
< .001 
Control > 
MCI-LB 
Probable 
& MCI-LB 
Possible, 
ps < .001 
MCI-AD > 
MCI-LB 
Possible, 
p = .043 
VPT Ratio 0.76(0.17) 0.70(0.33) 0.54(0.27) 0.76(0.17) t(36.1)=0.72,  
p = .476 
F(3,76) = 
2.61, p 
= .057 
Control > 
MCI-LB 
Possible, 
p = .047 
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Pareidola: 
pareidolias* 
0.56(0.25) 0.96(0.41) 0.68(0.34) 0.66(0.22) t(40.20)=2.69, 
p = .010, 
g = 0.79 
F(3,82) = 
4.68, p 
= .005 
Control < 
MCI-LB 
Probable, 
p = .020 
MTCF % Retained = (recall/copy)*100) 
*Transformed variable with means and standard deviations taken post-transformation. 
 
Table A-5. Comparison of the four subgroups on measures of executive function, with t-tests between MCI-AD and MCI-LB Probable and 
one-way ANOVAs between all four groups. 
 
Task Controls  
(n = 31) 
MCI-LB 
Probable  
(n = 30) 
MCI-LB 
Possible  
(n = 14) 
MCI-AD  
(n = 18) 
MCI-LB 
Probable 
versus 
MCI-AD 
All group 
one-way 
ANOVA 
Verbal 
Fluency 
(FAS) 
43.77(9.84) 30.10(15.47) 25.93(12.24) 39.89(12.22) t(46)=2.29,  
p = .027, 
g = 0.70 
F(3,89) = 
9.54, p 
< .001 
Control > 
MCI-LB 
Probable 
& MCI-LB 
Possible, 
ps < .001,  
MCI-AD > 
MCI-LB 
Probable, 
p = .054 
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MCI-AD > 
MCI-LB 
Possible, 
p = .014 
Stroop CW 
(items) 
34.04(8.82) 22.58(7.79) 19.09(6.56) 25.13(9.12) t(38)=0.95,  
p = .351 
F(3,76) = 
12.76, p 
< .001 
Control > 
MCI-LB 
Probable, 
p < .001, 
MCI-LB 
Possible, 
p < .001, & 
MCI-AD, p 
= .005 
Stroop 
Classical 
Interference* 
-
51.95(12.77) 
-
41.42(13.38) 
-
43.82(15.27) 
-
56.94(12.38) 
t(38)=3.70,  
p = .001, 
g = 1.20 
F(3,76) = 
5.57, p 
= .002 
MCI-LB 
Probable > 
Control , p 
= .026 
MCI-LB > 
MCI-AD  
Probable, 
p = .003 
MCI-LB 
Possible > 
MCI-AD, p 
= .063 
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Stroop Ratio 
Interference* 
-0.60(0.09) -0.64(0.09) -0.68(0.14) -0.70(0.10) t(38)=1.66,  
p = .106 
F(3,76) = 
3.60, p 
= .018 
Control > 
MCI-AD, p 
= .020 
 
Trails B* -8.02(1.46) -12.23(3.73) -12.16(3.71) -10.77(2.36) t(44)=1.48,  
p = .146 
F(3,86) = 
12.83, p 
< .001 
Control > 
MCI-LB 
Probable 
& MCI-LB 
Possible, 
ps < .001, 
MCI-AD, p 
= .008 
Trails 
Difference* 
-5.61(1.63) -9.28(3.38) -9.50(3.58) -8.40(2.30) t(43)=0.97, 
p = .339 
F(3,85) = 
11.50, p 
< .001 
Control > 
MCI-LB 
Probable 
& MCI-LB 
Possible, 
ps < .001, 
MCI-AD, p 
= .004  
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Trails Ratio* -1.44(0.21) -1.65(0.34) -1.66(0.34) -1.63(0.24) t(43)=0.24,  
p = .812 
F(3,85) = 
3.50, p 
= .019 
Control > 
MCI-LB 
Probable, 
p = .034 
Digit Span 
Forwards 
8.81(2.54) 7.93(2.00) 7.29(2.02) 8.50(2.26) t(46)=0.91,  
p = .370 
F(3,89) = 
1.77, p 
= .159 
Digit Span 
Backwards 
7.03(2.58) 5.50(1.85) 4.86(1.75) 5.56(2.28) t(46)=0.09,  
p = .927 
F(3,89) = 
4.30, p 
= .007 
Control > 
MCI-LB 
Probable, 
p = .037, & 
MCI-LB 
Possible, 
p = .014 
* Transformed variables with means and standard deviations taken post-transformation. 
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Table A-6. Comparison of the four subgroups on measures of processing speed, with t-tests between MCI-AD and MCI-LB Probable and 
one-way ANOVAs between all four groups. 
 
Task Controls  
(n = 31) 
MCI-LB 
Probable  
(n = 30) 
MCI-LB 
Possible  
(n = 14) 
MCI-AD  
(n = 18) 
MCI-LB 
Probable 
versus MCI-
AD 
All group 
one-way 
ANOVA 
DSST 46.07(10.73) 25.53(9.55) 31.23(15.31) 32.61(7.42) t(43)=2.65,  
p = .011, 
g = 0.83 
F(3,85) = 
19.25, p 
< .001 
Control > 
MCI-LB 
Probable, 
MCI-LB 
Possible 
& MCI-
AD, all ps 
< .001 
DSST 
Symbol 
Copy 
95.86(18.01) 60.28(22.16) 69.81(26.36) 71.66(18.88) t(43)=1.79,  
p = .081 
F(3,85) = 
15.15, p 
< .001 
Control > 
MCI-LB 
Probable, 
p < .001, 
MCI-LB 
Possible, 
p = .002, 
& MCI-
AD, p 
= .001 
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DSST 
Error 
Check 
48.68(9.61) 31.34(11.49) 33.33(20.41) 41.73(9.04) t(31.92)=3.30, 
p = .002,  
g = 1.09 
F(3,71) = 
10.75, p 
< .001 
Control > 
MCI-LB 
Probable, 
p < .001, 
& MCI-
LB 
Possible, 
p = .004 
MCI-
AD > 
MCI-LB 
Probable, 
p = .047 
DSST 
Coding 
Time* 
-0.01(0.16) -0.33(0.23) -0.24(0.26) -0.17(0.13) t(43)=2.58, 
p = .013, 
g = 0.83 
F(3,85) = 
13.11, p 
< .001 
Control > 
MCI-LB 
Probable, 
p < .001, 
MCI-LB 
Possible, 
p = .004, 
& MCI-
AD, p 
= .030 
MCI-
AD > 
MCI-LB 
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Probable, 
p = .058 
Trails A* -1.49(0.14) -1.74(0.25) -1.71(-.24) -1.63(0.16) t(46)=1.64,  
p = .107 
F(3,88) = 
8.89, p 
< .001 
Control > 
MCI-LB 
Probable, 
p < .001, 
& MCI-
LB 
Possible, 
p = .007 
Stroop C 
(items) 
85.98(14.87) 64.40(18.04) 62.91(15.91) 78.88(19.37) t(40)=2.54,  
p = .015. 
g = 0.94 
F(3,78) = 
9.68, p 
< .001 
Control > 
MCI-LB 
Probable, 
p < .001, 
MCI-LB 
Possible, 
p = .001 
MCI-
AD > 
MCI-LB 
Probable, 
p = .037 
Simple 
Reaction 
Time* 
-2.52(0.08) -2.60(0.15) -2.61(0.23) -2.57(0.14) t(44)=0.69,  
p = .495 
F(3,85) = 
19.25, p 
= .163 
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Choice 
Reaction 
Time* 
-22.13(3.82) -25.32(3.60) -26.14(5.95) -24.55(2.11) t(43)=0.81,  
p = .425 
F(3,80) = 
4.22, p 
= .008 
Control > 
MCI-LB 
Probable, 
p = .021, 
& MCI-
LB 
Possible, 
p = .016 
*Transformed variables with mean and standard deviation taken post-transformation. 
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Appendix F. Principle components analysis performed on entire sample (including controls, MCI-LB and MCI-AD) 
PCA #1 – Whole group 
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Table A7 Pearson bivariate correlations of neuropsychological outcome measures (whole group) 
 
Table A-7 Pearson bivariate correlations of neuropsychological outcome measures (whole group) 
ACE 
Lang.
RAVLT 
Max 
T1:T6
RAVLT 
Learning
Rey 
Short 
Delay
Rey Long 
Delay
RAVLT 
% Max at 
Long 
Delay
RAVLT 
% 
"Forgettin
g"
RAVLT 
Retro. 
Int.
RAVLT 
Proact. 
Int.
RAVLT 
Recog. B
ACE 
Visuospa
tial
-0.218 -0.187 -0.196 -0.053 0.050 -0.218 -0.187 -0.161 -0.218 -0.215 -0.205
-0.206 -0.179 -0.161 0.130 0.056 -0.181 -0.155 -0.098 -0.215 -0.208 -0.186
-0.106 -0.075 -0.113 0.132 0.071 -0.113 -0.141 -0.082 -0.184 -0.138 -0.141
0.022 0.065 -0.030 0.177 0.163 -0.068 -0.117 -0.029 -0.179 -0.069 0.008
0.076 0.140 -0.009 1 0.190 -0.068 -0.095 -0.024 -0.173 0.005 0.131
0.090 0.174 0.031 0.275 0.191 -0.054 -0.094 -0.016 -0.156 0.014 0.149
0.114 1 0.075 0.277 1 0.021 -0.081 -0.010 -0.143 0.046 0.201
0.130 0.233 0.094 -0.284 0.234 0.045 -0.059 -0.005 -0.118 0.076 0.213
0.141 0.275 0.108 -0.285 -0.252 0.056 -0.044 -0.002 -0.112 0.083 1
0.164 -0.282 0.184 -0.291 0.258 0.063 -0.037 0.003 -0.112 0.084 0.242
0.194 0.295 0.211 0.305 0.267 0.064 -0.025 0.008 -0.102 0.145 0.264
1 0.3 1 -0.365 -0.267 0.066 -0.023 0.010 -0.089 0.201 0.28
0.223 0.341 0.226 0.376 0.28 0.102 -0.009 0.012 -0.083 0.211 0.281
0.226 -0.355 0.241 0.382 -0.284 0.107 -0.003 0.025 -0.075 0.213 0.3
0.242 0.356 0.242 0.394 0.314 0.122 -0.002 0.027 -0.064 1 0.304
0.264 0.376 0.254 0.401 -0.325 0.130 0.000 0.033 -0.052 0.235 -0.338
0.266 0.382 0.262 0.416 0.332 0.131 0.004 0.048 -0.048 0.238 0.351
0.267 0.413 0.269 0.421 0.35 0.149 0.019 0.065 -0.047 0.241 -0.367
0.287 0.43 0.28 0.422 0.352 0.160 0.022 0.084 -0.047 0.25 0.379
0.307 -0.432 0.281 0.432 0.37 0.162 0.027 0.090 -0.033 0.254 0.387
0.312 0.441 0.285 0.439 0.386 0.181 0.037 0.113 -0.015 0.274 0.394
0.32 0.481 0.287 -0.453 0.4 0.201 0.039 0.116 0.008 0.291 0.412
0.322 0.489 -0.289 0.469 0.4 1 0.147 0.145 0.025 0.298 0.443
0.324 0.491 0.31 0.47 0.411 0.227 0.185 0.149 0.102 0.306 0.483
0.328 0.497 0.351 0.471 0.413 0.242 1 0.158 0.105 0.309 0.49
0.341 0.515 0.358 0.486 0.446 0.392 0.247 1 0.120 -0.312 0.511
0.346 0.537 0.363 0.487 0.469 0.413 -0.33 0.258 0.141 0.316 0.52
0.369 0.538 0.38 0.517 0.503 0.425 -0.351 -0.279 1 -0.422 0.528
0.376 0.578 0.385 0.518 0.587 0.454 -0.422 0.31 0.247 0.43 0.534
0.385 0.593 0.437 0.542 -0.624 0.519 -0.453 0.328 0.269 0.469 0.591
0.4 0.709 0.503 0.635 0.819 0.635 -0.464 0.392 -0.279 0.519 0.639
0.4 0.821 0.542 0.838 0.821 0.819 -0.624 -0.464 -0.284 0.528 0.645
-0.401 0.838 0.709 0.855 0.855 -0.902 -0.902 0.487 -0.284 0.587 0.645
M all corr 0.221 0.327 0.238 0.319 0.280 0.160 -0.088 0.082 -0.033 0.190 0.306
M sig corr 
only 0.319333333 0.461461538 0.345428571 0.446642857 0.423807692 0.3224 0.474125 0.359714286 0.26975 0.348833333 0.430333333
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Table A-7 Pearson bivariate correlations of neuropsychological outcome measures (whole group) 
Corsi
MTCF 
Recall
MTCF % 
Retain VPT High VPT Low
VPT 
Ratio FAS Stroop C
Stroop 
CW
Stroop 
Ratio Int. Trails B
-0.095 -0.147 -0.180 -0.047 -0.118 -0.214 -0.219 -0.184 -0.199 -0.219 -0.203
-0.048 -0.091 -0.055 -0.037 -0.081 -0.203 -0.181 -0.083 -0.102 -0.206 -0.112
-0.009 -0.075 -0.047 0.048 0.107 -0.199 -0.161 -0.003 -0.059 -0.205 0.012
0.025 0.171 0.026 0.149 0.113 -0.194 -0.082 -0.002 0.003 -0.196 0.037
0.185 0.187 0.085 1 0.181 -0.186 -0.015 0.021 0.160 -0.147 0.064
0.207 0.217 0.206 0.235 1 -0.184 0.014 0.084 0.211 -0.138 1
0.211 1 1 0.243 0.264 -0.161 0.056 0.113 1 -0.113 0.258
0.216 0.25 0.226 0.306 0.285 -0.160 0.085 0.120 0.266 -0.091 0.306
1 -0.262 0.23 -0.312 0.291 -0.152 0.108 0.161 0.305 -0.055 0.306
0.223 0.266 0.232 -0.342 0.331 -0.106 0.132 0.190 0.317 -0.022 0.352
0.227 0.28 0.241 -0.352 0.336 -0.097 0.171 0.194 0.322 0.008 0.358
0.236 0.328 0.241 0.385 -0.348 -0.094 0.171 0.216 0.38 0.019 0.366
-0.268 -0.33 0.246 0.41 0.352 -0.091 0.185 1 0.39 0.120 -0.371
0.28 0.343 0.257 0.411 -0.354 -0.088 0.219 0.226 0.4 0.134 0.4
-0.327 0.347 0.26 0.423 0.366 -0.075 1 0.232 0.404 0.161 0.417
0.37 0.358 0.264 0.431 0.373 -0.053 0.236 0.275 0.448 1 0.418
0.382 0.398 0.266 0.437 -0.378 -0.030 0.245 0.347 0.468 -0.247 0.422
0.382 0.404 0.284 0.442 0.4 -0.010 0.264 0.356 0.481 -0.252 0.466
0.394 -0.413 0.297 0.476 0.446 -0.009 0.275 0.373 0.486 0.269 -0.487
0.402 0.425 0.306 0.483 0.47 0.011 0.312 0.387 0.49 0.276 0.497
0.423 0.438 0.306 0.518 0.489 0.025 0.336 0.409 0.538 -0.282 0.509
0.424 0.441 0.31 -0.531 -0.493 0.050 0.365 0.412 0.545 -0.285 0.534
0.443 0.441 -0.325 0.565 0.499 0.063 -0.401 0.423 -0.553 -0.312 0.557
0.446 0.456 0.331 0.576 0.545 0.083 0.431 0.443 -0.56 -0.327 0.577
0.448 0.46 0.351 0.578 0.55 0.090 -0.436 -0.452 0.565 -0.333 0.661
0.459 0.466 -0.351 0.645 0.613 0.131 0.443 -0.469 -0.604 -0.355 0.673
0.475 0.469 0.376 0.66 0.626 0.134 0.481 0.568 0.644 -0.357 0.704
0.483 0.475 0.394 0.666 0.645 0.206 0.502 0.577 0.691 -0.364 0.713
0.484 0.517 0.439 0.667 0.645 1 0.508 0.585 0.704 -0.371 0.768
0.528 0.591 0.442 0.672 0.647 -0.253 0.509 0.634 0.75 -0.378 0.78
-0.541 0.613 0.446 0.673 0.661 -0.291 0.556 0.644 0.762 -0.402 0.806
0.557 0.666 0.454 0.716 0.726 -0.342 0.611 0.66 0.771 -0.484 -0.923
0.558 0.909 0.909 0.871 0.871 -0.354 0.636 0.678 0.791 -0.604 0.999
M all corr 0.278 0.321 0.257 0.366 0.335 -0.053 0.223 0.277 0.340 -0.144 0.359
M sig corr 
only 0.312 0.359076923 0.337846154 0.391142857 0.365111111 0.31 0.326277778 0.3654 0.392346154 0.346941176 0.473407407
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Trails 
Diff.
Trails 
Ratio
Digit 
Forward
Digit 
Backward
s DSST
Symbol 
Copy
Error 
Check
Coding 
Time 
(DSST) Trails A SRT CRT
-0.194 -0.068 -0.156 -0.151 -0.214 -0.156 -0.184 -0.218 -0.089 -0.160 -0.155
-0.112 -0.044 -0.098 -0.088 -0.173 -0.152 -0.005 -0.208 -0.002 -0.117 -0.143
0.010 -0.016 -0.069 -0.033 -0.024 -0.029 0.027 -0.180 0.033 -0.064 -0.097
0.039 0.090 -0.054 0.000 -0.023 0.004 0.045 -0.156 0.066 -0.022 -0.091
0.063 0.105 -0.052 0.005 0.122 0.107 1 -0.151 0.201 0.026 0.075
1 1 0.011 0.056 1 1 -0.253 -0.113 1 0.031 0.158
0.256 -0.248 0.071 0.084 0.254 0.232 0.26 -0.068 0.233 0.046 0.162
0.306 -0.274 0.085 0.114 0.284 0.262 0.274 -0.025 0.246 0.085 0.164
0.309 0.276 0.094 0.120 0.316 0.264 0.298 0.027 -0.291 0.102 0.171
0.35 -0.289 0.107 0.184 0.346 0.298 0.31 0.063 0.307 0.114 0.207
0.351 -0.312 0.113 0.191 -0.355 0.32 0.328 0.102 0.314 0.114 0.215
0.359 -0.325 0.130 0.207 0.363 0.353 0.332 1 0.385 0.116 1
-0.364 -0.325 0.131 0.215 0.413 -0.357 -0.333 -0.262 0.385 0.140 0.233
0.4 -0.339 0.147 1 0.428 0.386 0.358 -0.267 -0.402 0.163 0.234
0.411 -0.365 0.174 0.295 0.441 0.398 0.401 -0.268 0.413 0.177 0.238
0.412 -0.367 0.207 0.297 0.471 0.424 0.402 0.269 0.421 0.185 0.257
0.416 -0.367 0.217 0.304 0.477 0.432 -0.42 -0.291 0.423 0.187 0.277
0.46 0.383 1 0.305 -0.48 0.483 0.433 -0.338 0.423 0.219 -0.339
-0.481 -0.401 0.23 0.343 0.484 0.491 0.438 -0.348 0.456 1 0.358
0.491 -0.401 0.232 0.353 0.489 0.509 0.459 -0.352 -0.48 -0.274 0.379
0.502 -0.413 0.233 0.365 0.511 0.537 0.515 -0.355 0.481 0.306 -0.379
0.52 -0.432 0.243 0.366 0.593 0.55 0.528 -0.379 0.508 0.317 0.39
0.558 -0.469 0.245 -0.367 -0.622 -0.57 0.556 0.383 -0.526 0.352 0.402
0.568 -0.493 -0.247 0.369 0.626 0.576 -0.617 -0.42 0.585 0.358 0.409
0.647 -0.526 -0.248 0.402 0.636 0.611 0.645 -0.436 0.639 0.359 0.41
0.66 -0.531 0.254 0.411 0.66 0.634 0.667 -0.447 0.716 0.366 0.412
0.691 -0.541 0.256 0.413 0.672 0.702 0.678 -0.452 0.724 0.385 0.418
0.702 -0.553 0.258 0.417 0.755 0.713 0.739 -0.48 0.726 0.387 0.423
0.755 -0.57 0.28 0.445 0.768 0.724 0.762 -0.48 0.75 0.387 0.433
0.766 -0.617 0.298 0.468 0.791 0.739 0.766 -0.481 0.781 0.428 0.477
0.781 -0.622 0.305 0.476 0.799 0.771 0.78 -0.487 0.799 -0.447 0.491
-0.937 -0.923 0.324 -0.484 0.83 0.83 0.814 -0.56 0.806 0.509 0.499
0.999 -0.937 0.445 0.489 0.899 -0.888 0.899 -0.888 0.814 0.699 0.699
M all corr 0.354 -0.300 0.157 0.229 0.380 0.339 0.361 -0.220 0.359 0.196 0.254
M sig corr 
only 0.535259259 0.455518519 0.2732 0.387842105 0.438851852 0.386074074 0.393535714 -0.34947619 0.393925926 0.334285714 0.320047619
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Appendix G. Correlation matrix for entire sample (including controls, 
MCI-LB and MCI-AD) 
 
Table A-8 PCA 1 - Component Correlation Matrix (whole group; initial model) 
Component 1 2 3 4 5 
      
1 1.000 -.139 -.132 -.268 .515 
2 -.139 1.000 .153 .165 -.156 
3 -.132 .153 1.000 .015 -.070 
4 -.268 .165 .015 1.000 -.349 
5 .515 -.156 -.070 -.349 1.000 
Extraction Method: Principal Component Analysis.   
Rotation Method: Oblimin with Kaiser Normalization. 
 
Tables A 8-9: Removal of SRT 
Removed Simple Reaction time (not loading above threshold in either matrix): 
KMO = .846 
Pattern Matrixa 
 
Component 
1 2 3 4 5 
RAVLT Max T1:T5 .201 .829 -.008 -.137 -.010 
RAVLT “Learning” .027 .874 .026 .096 .027 
RAVLT Short Delay -.036 .723 -.050 -.215 .202 
RAVLT Recognition 
B 
-.029 .246 .031 -.855 -.130 
ACE Visuospatial .108 -.003 -.009 -.012 .777 
Corsi .091 -.075 -.187 -.683 .276 
MTCF Recall -.136 .168 .006 -.043 .865 
VPT High .230 .236 -.127 .045 .623 
FAS .840 -.071 -.120 .142 -.143 
Stroop C .837 .084 .506 .095 .115 
Stroop CW .703 .164 -.263 -.078 .023 
Stroop Ratio Int. -.122 -.041 .887 .165 .096 
Trails Difference .621 .067 -.115 -.184 .191 
Digit Backwards .153 .041 -.624 .245 .348 
DSST .802 .136 -.076 -.119 .070 
Symbol Copy .811 .065 -.039 -.181 -.003 
Error Check .784 .072 -.031 -.095 .126 
Trails A .645 .099 -.117 .007 .283 
CRT .294 -.239 .136 -.365 .400 
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Extraction Method: Principal Component Analysis.  
Rotation Method: Oblimin with Kaiser Normalization. 
Rotation converged in 12 iterations. 
 
Structure Matrix 
 
Component 
1 2 3 4 5 
RAVLT Max T1:T5 .467 .918 -.200 -.374 .376 
RAVLT “Learning” .267 .863 -.129 -.124 .267 
RAVLT Short Delay .329 .832 -.208 -.442 .470 
RAVLT Recognition 
B 
.156 .396 -.034 -.866 .179 
ACE Visuospatial .489 .263 -.144 -.266 .833 
Corsi .390 .228 -.270 -.778 .529 
MTCF Recall .341 .395 -.121 -.311 .861 
VPT High .618 .498 -.304 -.253 .810 
FAS .745 .117 -.258 .014 .219 
Stroop C .789 .251 .302 -.112 .445 
Stroop CW .835 .439 -.448 -.289 .474 
Stroop Ratio Int. -.311 -.241 .915 .221 -.153 
Trails Difference .797 .367 -.296 -.396 .584 
Digit Backwards .413 .238 -.700 .065 .451 
DSST .917 .430 -.286 -.349 .546 
Symbol Copy .876 .349 -.232 -.372 .470 
Error Check .893 .365 -.234 -.320 .561 
Trails A .835 .389 -.312 -.246 .641 
CRT .469 .029 .037 -.483 .561 
Extraction Method: Principal Component Analysis.  
Rotation Method: Oblimin with Kaiser Normalization. 
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Tables A 10-11: Removal of CRT 
Removed CRT: KMO = .845 
 
Pattern Matrixa 
 
Component 
1 2 3 4 5 
RAVLT Max T1:T5 .165 .860 -.022 -.044 -.110 
RAVLT “Learning” -.022 .900 .006 -.011 .106 
RAVLT Short Delay -.057 .756 -.060 .165 -.178 
RAVLT Recognition 
B 
.004 .200 .075 -.076 -.859 
ACE Visuospatial .134 -.067 .020 .804 -.042 
Corsi .136 -.141 -.137 .334 -.700 
MTCF Recall -.115 .122 .030 .875 -.057 
VPT High .230 .212 -.119 .618 .038 
FAS .831 -.108 -.112 -.117 .105 
Stroop C .847 .081 .501 .113 .102 
Stroop CW .692 .181 -.270 .007 -.059 
Stroop Ratio Int. -.099 -.062 .890 .111 .152 
Trails Difference .632 .030 -.095 .215 -.199 
Digit Backwards .127 .087 -.650 .294 .276 
DSST .802 .139 -.077 .065 -.106 
Symbol Copy .815 .079 -.042 -.011 -.157 
Error Check .790 .051 -.021 .139 -.101 
Trails A .646 .080 -.111 .286 .001 
Extraction Method: Principal Component Analysis.  
 Rotation Method: Oblimin with Kaiser Normalization. 
a. Rotation converged in 9 iterations. 
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Structure Matrix 
 
Component 
1 2 3 4 5 
RAVLT Max T1:T5 .470 .936 -.207 .395 -.374 
RAVLT “Learning” .269 .857 -.124 .296 -.143 
RAVLT Short Delay .330 .859 -.220 .483 -.430 
RAVLT Recognition 
B 
.163 .404 -.031 .198 -.890 
ACE Visuospatial .493 .296 -.159 .848 -.239 
Corsi .395 .257 -.282 .542 -.778 
MTCF Recall .344 .428 -.135 .876 -.284 
VPT High .619 .538 -.324 .821 -.223 
FAS .748 .128 -.263 .230 .015 
Stroop C .790 .310 .271 .424 -.040 
Stroop CW .835 .488 -.475 .470 -.255 
Stroop Ratio Int. -.310 -.244 .919 -.167 .249 
Trails Difference .801 .406 -.315 .592 -.374 
Digit Backwards .409 .273 -.723 .444 .093 
DSST .917 .488 -.318 .538 -.302 
Symbol Copy .874 .413 -.268 .451 -.317 
Error Check .895 .413 -.259 .560 -.283 
Trails A .836 .435 -.336 .643 -.211 
Extraction Method: Principal Component Analysis.  
Rotation Method: Oblimin with Kaiser Normalization. 
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BRANCH 1: remove VPT High first. 
Tables A12-13: Following removal of Digit Backwards from Branch #1. 
 
Pattern Matrixa 
 
Component 
1 2 3 
Rey_max_A1_A5 .171 .831 .087 
RAVLT_Learning .007 .911 -.146 
Rey_T6 .036 .777 .212 
Rey_recog_false_B_
TRANSDIR_replaced 
-.132 .164 .849 
Corsi_TotalScore_TR
ANS_replaced 
.254 -.106 .813 
FASTotal_replaced .821 -.180 -.110 
stroop_C_items_repl
aced 
.811 .052 -.189 
stroop_CW_items_re
placed 
.778 .187 .029 
Trails_difference_repl
aced 
.745 .035 .251 
DSST_orig_replaced .853 .108 .120 
DSST_copy_replaced .825 .048 .115 
DSST_error_replaced .863 .039 .109 
Trails_A_TRANS_rep
laced 
.814 .119 .037 
Extraction Method: Principal Component Analysis.  
 Rotation Method: Oblimin with Kaiser 
Normalization. 
a. Rotation converged in 6 iterations. 
 
Structure Matrix 
 
Component 
1 2 3 
Rey_max_A1_A5 .505 .925 .428 
RAVLT_Learning .303 .862 .175 
Rey_T6 .386 .865 .495 
Rey_recog_false_B_
TRANSDIR_replaced 
.175 .413 .869 
Corsi_TotalScore_TR
ANS_replaced 
.449 .273 .849 
FASTotal_replaced .722 .086 .064 
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stroop_C_items_repl
aced 
.776 .287 .063 
stroop_CW_items_re
placed 
.856 .486 .319 
Trails_difference_repl
aced 
.831 .400 .478 
DSST_orig_replaced .927 .466 .404 
DSST_copy_replaced .876 .394 .370 
DSST_error_replaced .909 .397 .371 
Trails_A_TRANS_rep
laced 
.869 .434 .314 
Extraction Method: Principal Component Analysis.  
 Rotation Method: Oblimin with Kaiser 
Normalization. 
 
BRANCH 2: remove Trails Difference first. 
 
Tables A14-15: Following removal of Digit Backwards. 
Pattern Matrixa 
 
Component 
1 2 3 
Rey_max_A1_A5 .240 .089 -.793 
RAVLT_Learning .076 -.084 -.915 
Rey_recog_false_B_
TRANSDIR_replaced 
-.241 .669 -.305 
ACE_VisSpat .364 .609 .159 
Corsi_TotalScore_TR
ANS_replaced 
.055 .832 .040 
MTCF_Recall_replac
ed 
.152 .689 .014 
FASTotal_replaced .830 -.180 .079 
stroop_C_items_repl
aced 
.810 -.062 -.016 
stroop_CW_items_re
placed 
.762 .100 -.178 
DSST_orig_replaced .815 .145 -.157 
DSST_copy_replaced .795 .129 -.087 
DSST_error_replaced .804 .173 -.074 
Trails_A_TRANS_rep
laced 
.756 .197 -.081 
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Extraction Method: Principal Component Analysis.  
 Rotation Method: Oblimin with Kaiser 
Normalization. 
a. Rotation converged in 8 iterations. 
 
Structure Matrix 
 
Component 
1 2 3 
Rey_max_A1_A5 .476 .472 -.887 
RAVLT_Learning .276 .281 -.903 
Rey_recog_false_B_
TRANSDIR_replaced 
.097 .687 -.488 
ACE_VisSpat .561 .693 -.157 
Corsi_TotalScore_TR
ANS_replaced 
.369 .839 -.278 
MTCF_Recall_replac
ed 
.416 .743 -.277 
FASTotal_replaced .740 .114 -.066 
stroop_C_items_repl
aced 
.790 .259 -.200 
stroop_CW_items_re
placed 
.847 .462 -.408 
DSST_orig_replaced .912 .520 -.417 
DSST_copy_replaced .867 .470 -.336 
DSST_error_replaced .890 .513 -.342 
Trails_A_TRANS_rep
laced 
.853 .521 -.346 
Extraction Method: Principal Component Analysis.  
 Rotation Method: Oblimin with Kaiser 
Normalization. 
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Tables A16-17: Final matching matrices of Branch 2. 
KMO = .882, 3 components 74.61% cumulative, #1 explains 54.86% 
 
Pattern Matrixa 
 
Component 
1 2 3 
Rey_max_A1_A5 .164 .899 -.033 
RAVLT_Learning -.008 .899 -.104 
Rey_T6 -.057 .797 .213 
ACE_VisSpat .136 -.120 .820 
Corsi_TotalScore_TR
ANS_replaced 
.042 .001 .697 
MTCF_Recall_replac
ed 
-.120 .089 .875 
VPT_High_correct_re
placed 
.262 .184 .594 
FASTotal_replaced .877 -.128 -.148 
stroop_C_items_repl
aced 
.789 -.002 -.018 
stroop_CW_items_re
placed 
.723 .199 .089 
DSST_orig_replaced .815 .147 .112 
DSST_copy_replaced .812 .092 .071 
DSST_error_replaced .787 .049 .184 
Trails_A_TRANS_rep
laced 
.661 .063 .303 
Extraction Method: Principal Component Analysis.  
 Rotation Method: Oblimin with Kaiser 
Normalization. 
a. Rotation converged in 6 iterations. 
 
 
 
 
 
 
 
 
 
 
275 
 
Structure Matrix 
 
Component 
1 2 3 
Rey_max_A1_A5 .485 .946 .463 
RAVLT_Learning .276 .847 .305 
Rey_T6 .348 .874 .551 
ACE_VisSpat .500 .308 .833 
Corsi_TotalScore_TR
ANS_replaced 
.390 .337 .719 
MTCF_Recall_replac
ed 
.350 .447 .856 
VPT_High_correct_re
placed 
.627 .555 .809 
FASTotal_replaced .756 .133 .230 
stroop_C_items_repl
aced 
.779 .285 .374 
stroop_CW_items_re
placed 
.842 .511 .541 
DSST_orig_replaced .926 .504 .586 
DSST_copy_replaced .882 .429 .518 
DSST_error_replaced .897 .428 .599 
Trails_A_TRANS_rep
laced 
.836 .450 .661 
Extraction Method: Principal Component Analysis.  
 Rotation Method: Oblimin with Kaiser 
Normalization. 
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BRANCH 3: Trails A removed first. 
 
Tables A18-19: Final matching matrices of Branch 3. 
 
Pattern Matrixa 
 
Component 
1 2 3 4 
Rey_max_A1_A5 .186 .863 -.032 -.086 
RAVLT_Learning -.016 .895 -.056 .078 
Rey_T6 -.036 .769 .192 -.153 
Rey_recog_false_B_
TRANSDIR_replaced 
.032 .251 -.013 -.800 
ACE_VisSpat .141 -.080 .745 -.088 
Corsi_TotalScore_TR
ANS_replaced 
.171 -.091 .459 -.608 
MTCF_Recall_replac
ed 
-.103 .107 .838 -.085 
VPT_High_correct_re
placed 
.235 .210 .638 .056 
FASTotal_replaced .837 -.121 -.049 .183 
stroop_C_items_repl
aced 
.850 -.003 -.130 -.029 
stroop_CW_items_re
placed 
.730 .188 .093 .010 
Trails_difference_repl
aced 
.648 .038 .256 -.154 
digitBack_replaced .130 .134 .576 .467 
DSST_orig_replaced .819 .134 .104 -.052 
DSST_copy_replaced .841 .071 .012 -.116 
DSST_error_replaced .805 .040 .138 -.079 
Extraction Method: Principal Component Analysis.  
 Rotation Method: Oblimin with Kaiser Normalization. 
a. Rotation converged in 16 iterations. 
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Structure Matrix 
 
Component 
1 2 3 4 
Rey_max_A1_A5 .500 .937 .419 -.270 
RAVLT_Learning .282 .852 .280 -.089 
Rey_T6 .362 .863 .506 -.335 
Rey_recog_false_B_
TRANSDIR_replaced 
.195 .416 .236 -.851 
ACE_VisSpat .494 .286 .799 -.210 
Corsi_TotalScore_TR
ANS_replaced 
.425 .276 .610 -.683 
MTCF_Recall_replac
ed 
.366 .420 .843 -.237 
VPT_High_correct_re
placed 
.629 .540 .830 -.114 
FASTotal_replaced .750 .135 .293 .135 
stroop_C_items_repl
aced 
.787 .268 .301 -.088 
stroop_CW_items_re
placed 
.846 .495 .533 -.113 
Trails_difference_repl
aced 
.806 .412 .623 -.266 
digitBack_replaced .424 .319 .616 .332 
DSST_orig_replaced .927 .491 .578 -.175 
DSST_copy_replaced .885 .411 .482 -.212 
DSST_error_replaced .897 .410 .572 -.187 
Extraction Method: Principal Component Analysis.  
 Rotation Method: Oblimin with Kaiser Normalization. 
 
 
TABLE A-20 Component Transformation Matrix of PCA#1 – Whole group optimised 
model 
 
Component 1 2 3 
1 .835 .439 .331 
2 -.548 .707 .447 
3 -.038 -.555 .831 
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Extraction Method: Principal Component 
Analysis.   
Rotation Method: Varimax with Kaiser 
Normalization. 
 
 
Table 1 PCA 1: Optimised Model Total Variance explained by component (whole 
group) 
 
Initial Eigenvalues 
Rotation Sums of Squared 
Loadings 
Total 
% of 
Variance 
Cumulative 
% Total 
% of 
Variance Cumulative % 
1 7.13 54.84 54.842 5.52 42.48 42.48 
2 1.81 13.94 68.777 2.61 20.05 62.52 
3 1.07 8.21 76.988 1.88 14.47 76.99 
4 0.59 4.53 81.519    
5 0.55 4.22 85.738    
6 0.42 3.20 88.936    
7 0.37 2.82 91.752    
8 0.29 2.26 94.010    
9 0.25 1.93 95.938    
10 0.19 1.49 97.431    
11 0.17 1.32 98.752    
12 0.09 0.70 99.447    
13 0.07 0.55 100.000    
Extraction Method: Principal Component Analysis. 
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Appendix H Principle Components Analysis conducted on control 
subsample only. 
PCA #2 – Controls 
Table A-21  PCA 2 - Pearson bivariate correlations of neuropsychological outcome 
measures (controls) 
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Table A-22 PCA 2 Varimax initial model total variance explained by component 
(controls) 
 
Initial Eigenvalues 
Rotation Sums of Squared 
Loadings 
Total 
% of 
Variance 
Cumulative 
% Total % of Variance 
Cumulative 
% 
1 5.21 47.35 47.35 3.42 31.06 31.06 
2 1.65 15.01 62.36 2.66 24.16 55.22 
3 1.02 9.29 71.65 1.81 16.43 71.65 
4 0.81 7.39 79.03    
5 0.61 5.57 84.60    
6 0.45 4.10 88.70    
7 0.40 3.60 92.31    
8 0.30 2.70 95.00    
9 0.24 2.15 97.15    
10 0.17 1.51 98.66    
11 0.15 1.34 100.00    
Extraction Method: Principal Component Analysis. 
 
Table A-23. PCA #2 (controls) – Initial Varimax rotation Component Transformation 
Matrix 
 
Component 1 2 3 
1 .736 .532 .419 
2 -.449 .846 -.286 
3 -.506 .022 .862 
Extraction Method: Principal Component 
Analysis.   
 Rotation Method: Varimax with Kaiser 
Normalization. 
 
Table A-24 PCA 2 - Varimax initial model communalities (controls) 
 Initial Extraction 
RAVLT Max T1:T5 1.000 .648 
MTCF Recall 1.000 .620 
VPT High 1.000 .796 
VPT Low 1.000 .651 
FAS 1.000 .845 
Stroop CW 1.000 .821 
Trails B 1.000 .766 
Digit Backwards 1.000 .580 
DSST 1.000 .824 
Symbol Copy 1.000 .706 
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Trails A 1.000 .624 
Extraction Method: Principal Component 
Analysis. 
 
 
Table A-25 PCA 2 - Varimax rotated component matrix (controls; initial model) 
 
Component 
1 2 3 
RAVLT Max T1:T5 .745 .237 -.192 
MTCF Recall -.024 .732 .290 
VPT High .161 .878 -.013 
VPT Low .210 .776 -.065 
FAS .177 .043 .901 
Stroop CW .872 .053 .239 
Trails B .500 .490 .526 
Digit Backwards .432 .573 .257 
DSST .719 .167 .529 
Symbol Copy .803 .114 .220 
Trails A .633 .283 .378 
Extraction Method: Principal Component Analysis.  
Rotation Method: Varimax with Kaiser 
Normalization, converged in 4 iterations. 
 
Table A-26 PCA 2 – Initial Oblimin Rotation Component Correlation Matrix (controls) 
Component 1 2 3 
1 1.000 .368 .250 
2 .368 1.000 .161 
3 .250 .161 1.000 
Extraction Method: Principal Component 
Analysis.   
Rotation Method: Oblimin with Kaiser 
Normalization. 
 
Table A-27 PCA 2 – Initial Oblimin Rotation Pattern Matrix (controls) 
 
Component 
1 2 3 
RAVLT Max T1:T5 .770 .113 -.362 
MTCF Recall -.178 .776 .227 
VPT High .008 .901 -.130 
VPT Low .083 .785 -.182 
FAS .142 -.005 .874 
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Stroop CW .923 -.114 .068 
Trails B .425 .415 .388 
Digit Backwards .348 .521 .120 
DSST .722 .031 .380 
Symbol Copy .837 -.036 .056 
Trails A .615 .172 .233 
Extraction Method: Principal Component Analysis.  
Rotation Method: Oblimin with Kaiser Normalization, 
converged in 11 iterations. 
 
Table A-28 PCA 2 – Initial Oblimin Rotation Structure Matrix (controls) 
 
Component 
1 2 3 
RAVLT Max T1:T5 .721 .338 -.151 
MTCF Recall .164 .747 .307 
VPT High .307 .883 .017 
VPT Low .326 .786 -.035 
FAS .359 .188 .909 
Stroop CW .898 .236 .281 
Trails B .674 .633 .561 
Digit Backwards .569 .668 .291 
DSST .828 .357 .565 
Symbol Copy .838 .281 .259 
Trails A .736 .436 .414 
Extraction Method: Principal Component Analysis.  
Rotation Method: Oblimin with Kaiser Normalization. 
 
Table A-29 PCA 2 - Oblimin final model pattern matrix (controls). 
 
Component 
1 2 
MTCF Recall -.048 .763 
VPT High .003 .872 
VPT Low .074 .819 
Stroop CW .935 -.110 
DSST .873 .001 
Symbol Copy .865 -.005 
Trails A .771 .176 
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Extraction Method: Principal Component 
Analysis.  
Rotation Method: Oblimin with Kaiser 
Normalization, converging in 4 
iterations. 
 
Given that neither Trails B nor Digit Backwards loaded above the threshold in 
either model (although Trails B in particular loaded moderately on the three 
components), each was iteratively removed. If Digit Backwards is first removed, 
Trails B remains loading similarly moderately but below the conservative threshold. 
Therefore, Trails B was removed first, followed by Digit Backwards. In the resulting 
model, two components were retained. Neither components loaded onto FAS nor 
RAVLT Max T1:T5 above the threshold. Removal of these variables results in the 
same model regardless of which is removed first. 
 
Table A-30. PCA #2: Control (Oblimin) final model structure matrix. 
 
Component 
1 2 
MTCF Recall .203 .747 
VPT High .291 .873 
VPT Low .344 .844 
Stroop CW .899 .199 
DSST .873 .289 
Symbol Copy .863 .281 
Trails A .829 .430 
Extraction Method: Principal Component 
Analysis.  
 Rotation Method: Oblimin with Kaiser 
Normalization. 
 
Table A-31. PCA #2: Control (Oblimin) final model component correlation matrix. 
 
Component 1 2 
1 1.000 .330 
2 .330 1.000 
Extraction Method: Principal 
Component Analysis.   
 Rotation Method: Oblimin with 
Kaiser Normalization. 
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Table A-32 PCA 2 - Final Varimax model rotated component matrix (controls) 
 
Component 
1 2 
MTCF Recall .079 .744 
VPT High .147 .860 
VPT Low .209 .821 
Stroop CW .903 .050 
DSST .861 .149 
Symbol Copy .851 .141 
Trails A .789 .303 
Extraction Method: Principal Component 
Analysis.  
 Rotation Method: Varimax with Kaiser 
Normalization, converged in 3 iterations. 
 
Table A-33 PCA 2 - Final optimised model communalities (controls) 
 Initial Extraction 
MTCF Recall 1.000 .560 
VPT High 1.000 .762 
VPT Low 1.000 .717 
Stroop CW 1.000 .818 
DSST 1.000 .763 
Symbol Copy 1.000 .745 
Trails A 1.000 .715 
Extraction Method: Principal Component 
Analysis. 
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Table A-34 PCA 2  – final model’s total variance explained (controls). 
 
Component 
Initial Eigenvalues Extraction Sums of Squared Loadings 
Rotation 
Sums of 
Squared 
Loadingsa 
Total 
% of 
Variance Cumulative % Total 
% of 
Variance Cumulative % Total 
1 3.531 50.441 50.441 3.531 50.441 50.441 3.247 
2 1.549 22.129 72.569 1.549 22.129 72.569 2.419 
3 .630 8.993 81.563     
4 .481 6.871 88.433     
5 .374 5.337 93.770     
6 .268 3.828 97.598     
7 .168 2.402 100.000     
Extraction Method: Principal Component Analysis. 
a. When components are correlated, sums of squared loadings cannot be added to obtain a total 
variance. 
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Appendix I. Principle Components Analysis conducted on MCI-LB 
subsample only. 
MCI-LB Probable had higher mean significant Pearson correlation values than 
controls and the group overall (0.529). The significant loadings were all above 0.300. 
Variables were moved for having very few significant correlations: ACE Language 
(2), RAVLT Percent Forgetting (3), RAVLT Proactive Interference (2), RAVLT B 
Recognition (2), Digit Forward (2), Digit Backwards (2), MTCF Percent Retained (4), 
VPT Ratio (4). After removal of these variable, RAVLT Retroactive only had three 
significant correlations and was remove. Of the remaining variables, very high 
correlations (r > .8) were observed between thirteen pairs of outcome measures (see 
Appendices). In order to remove these high correlations while minimizing removal of 
variables, RAVLT Learning, VPT Low, Trails Ratio, Trails Difference, Error Check, 
DSST Coding Time, and SRT were removed. The remaining high correlations 
between Stroop C-TrailsA, Trails A-DSST, and Stroop C-DSST were retained due to 
the variables’ high number of correlations with other variables that were within the 
target range. This resulted in 17 variables for entry into the PCA.  
After removal of these variable, RAVLT Retroactive only had three significant 
correlations and was remove. Of the remaining variables, very high correlations 
(r > .8) were observed between thirteen pairs of outcome measures (see 
Appendices).  
RAVLT Max and Learning 
VPT High and VPT Low 
Stroop CW and DSST Original 
Stroop CW and Error Check 
Stroop CW and Trails A 
Trails A and DSST 
Trails A and Error Check 
Trails B and Trails Ratio 
Trails B and Trails Difference 
Trails Ratio and Trails Difference 
DSST and Error Check 
Symbol Copy and DSST Coding Time 
Simple Reaction Time and Choice 
Reaction Time 
 
Deletion of RAVLT Learning, VPT Low, Trails Ratio, Trails Difference, Error 
Check, DSST Coding Time, and SRT. The remaining high correlations, between 
Stroop C-TrailsA, Trails A-DSST, and Stroop C-DSST were retained due to the high 
number of correlations in the target range with other variables. This resulted in 17 
variables for entry into the PCA. The  
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Table A-35 PCA 3 - Pearson bivariate correlations of neuropsychological outcome 
measures (MCI-LB Probable) 
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Table A-35 PCA 3 - Pearson bivariate correlations of neuropsychological outcome 
measures (MCI-LB Probable) 
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Table A-35 PCA 3 - Pearson bivariate correlations of neuropsychological outcome 
measures (MCI-LB Probable) 
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PCA #3 - Removal steps 
 
Table A-36 PCA 3 - Varimax initial model, total variance explained (MCI-LB 
Probable) 
 
Initial Eigenvalues Rotation Sums of Squared Loadings 
Total 
% of 
Variance Cumulative % Total 
% of 
Variance Cumulative % 
1 7.13 47.52 47.52 3.91 26.07 26.07 
2 2.16 14.43 61.94 3.01 20.06 46.13 
3 1.48 9.87 71.82 2.83 18.87 64.99 
4 1.13 7.50 79.32 2.15 14.33 79.32 
5 0.78 5.22 84.54    
6 0.57 3.81 88.35    
7 0.43 2.87 91.22    
8 0.33 2.21 93.43    
9 0.25 1.68 95.11    
10 0.23 1.56 96.67    
11 0.15 0.99 97.66    
12 0.12 0.82 98.48    
13 0.10 0.64 99.12    
14 0.09 0.62 99.74    
15 0.04 0.26 100.00    
Extraction Method: Principal Component Analysis. 
 
Table A-37PCA 3 - Varimax rotated component matrix (MCI-LB Probable; initial 
model) 
 
Component 
1 2 3 4 
RAVLT Max T1:T5 .374 .031 .856 -.064 
RAVLT Short Delay .052 .151 .909 .180 
RAVLT Long Delay -.051 .176 .881 .071 
ACE Visuospatial .148 .742 .086 .389 
Corsi .302 .763 -.025 -.213 
MTCF Recall -.092 .780 .309 .320 
VPT High .379 .626 .432 .182 
FAS .815 -.142 -.066 -.044 
Stroop C .473 .208 .179 .718 
Stroop CW .710 .463 .208 .256 
Trails B .694 .411 .176 .132 
DSST .787 .282 .251 .388 
Symbol Copy .759 .174 .075 .413 
Trails A .634 .502 .153 .362 
CRT .174 .117 .032 .851 
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Extraction Method: Principal Component Analysis.  
Rotation Method: Varimax with Kaiser Normalization, 
converging in 6 iterations. 
 
Table A-38 PCA 3 - Oblimin Component Correlation Matrix (MCI-LB; initial model) 
Component 1 2 3 4 
1 1.000 .161 -.259 -.238 
2 .161 1.000 -.307 -.262 
3 -.259 -.307 1.000 .343 
4 -.238 -.262 .343 1.000 
Extraction Method: Principal Component Analysis.   
Rotation Method: Oblimin with Kaiser 
Normalization. 
 
 
Table A-39 PCA 3 - Oblimin rotation pattern matrix (MCI-LB Probable; initial model) 
 
Component 
1 2 3 4 
RAVLT Max T1:T5 .302 .906 .093 .168 
RAVLT Short Delay -.094 .931 .023 -.093 
RAVLT Long Delay -.184 .910 -.032 .022 
ACE Visuospatial -.091 -.023 -.705 -.346 
Corsi .163 -.092 -.874 .303 
MTCF Recall -.352 .218 -.725 -.255 
VPT High .170 .372 -.566 -.090 
FAS .868 -.060 .135 .057 
Stroop C .301 .099 -.041 -.729 
Stroop CW .551 .141 -.410 -.195 
Trails B .569 .124 -.385 -.068 
DSST .646 .194 -.179 -.346 
Symbol Copy .656 .016 -.086 -.400 
Trails A .454 .070 -.438 -.315 
CRT .014 -.056 .061 -.905 
Extraction Method: Principal Component Analysis.  
Rotation Method: Oblimin with Kaiser Normalization. 
Converged in 20 iterations. 
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Table A-40 PCA 3 - Oblimin rotation structure matrix (MCI-LB Probable; initial model) 
 
Component 
1 2 3 4 
RAVLT Max T1:T5 .384 .883 -.206 -.109 
RAVLT Short Delay .072 .933 -.271 -.306 
RAVLT Long Delay -.034 .884 -.256 -.183 
ACE Visuospatial .170 .269 -.793 -.560 
Corsi .303 .124 -.784 -.011 
MTCF Recall -.069 .450 -.788 -.477 
VPT High .398 .597 -.755 -.422 
FAS .810 .024 -.052 -.087 
Stroop C .501 .350 -.399 -.840 
Stroop CW .726 .407 -.663 -.504 
Trails B .705 .352 -.594 -.368 
DSST .806 .443 -.524 -.612 
Symbol Copy .776 .253 -.398 -.590 
Trails A .653 .360 -.685 -.592 
CRT .204 .164 -.235 -.872 
 
Upon removal of DSST, Symbol Copy, a measure of psychomotor speed, 
then emerged as loading strongly but below the .722 threshold on two components 
in both the matrices. Removing Symbol Copy, FAS (executive function) dropped 
below the acceptable threshold (0.500) in the anti-image correlation matrix diagonal. 
At this point, the two matrices match; however, two variables are not loaded above 
the pre-set threshold in the pattern matrix (ACE Visuospatial, 0.675; MTCF Recall, 
0.697). Component 1 (43.28% variance explained) can be interpreted again as 
visuospatial (ACE Visuospatial, Corsi, MTCF Recall), component 2 (21.01% total 
variance explained) as verbal learning and memory (RAVLT Max A1:A5, Short and 
Long Delay), and component 3 as a processing speed factor (Stroop C and CRT). 
The cumulative variance explained by the model is 77.77%. All anti-image 
correlation diagonals are above 0.500 and Bartlett’s test of sphericity was significant, 
X2(28)=102.5, p < .001. However, the KMO remains acceptable but mediocre 
(0.664). 
However, if VPT High is removed first instead of DSST, Corsi must then be 
removed (anti-image correlation matrix diagonal < 0.500). At this stage, we again 
see processing speed measures (Stroop C and DSST) loading strongly/ moderately 
onto two components. The model then again matches if we accept 0.716 for Choice 
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Reaction Time threshold. These extracted factors differ from the previous, with 
component 1 as loading both on visuospatial and processing speed variables (ACE 
Visuospatial, MTCF Recall Stroop C and Choice Reaction Time). Component 2 
remains a verbal learning and memory component (RAVLT Max A1:A5, short and 
long delay). Component 3 is similarly difficult to interpret, with only two variables: 
FAS and Symbol Copy, relating to executive and psychomotor speed. 
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Appendix J. Correlation matrices MCI-AD subsample only (Principle 
Components Analysis not conduced due to small sample size). 
 
Pink shading indicates moderate significant correlations at p < .05, but dark 
grey shading notes significant correlations that are very high (r > .8). ACE 
Visuospatial and Stroop C items did not correlation significantly with any variables 
and were removed. As in controls and MCI-LB, Trails B and Trails Difference 
correlated very highly (r = .956) and the latter was removed. High loadings were 
shown between RAVLT outcome variables, and as such RAVLT Max and Long 
Delay were removed. Other pairs of highly correlated variables were identified and 
the latter was removed: DSST Original and DSST Coding Time, MTCF Recall and 
MTCF Percent retained, and Stroop Ratio Interference and Stroop CW items. The 
following variables were also removed for low numbers of significant correlations: 
Simple Reaction Time, DSST Copy, Corsi Blocks and Choice Reaction Time. 
297 
 
Table A-41 Correlation matrix of MCI-AD subsample only. 
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Appendix K. Digit Symbol Substitution Test, Symbol Copy and Error 
Check
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Appendix L. Hierarchical multiple regressions to predict DSST scores 
from its variants in the whole group. 
Table A-42 Hierarchical multiple regressions to predict DSST scores from its variants 
(Symbol Copy, Error Check), Coding Time Index, and demographics (age and 
premorbid IQ [NART]). 
 R2 Adjuste
d R2 
ΔR2 F 
Change 
Sig. F 
Change 
Std. Β 
Coefficien
ts 
Std. Β 
Sig 
Age &      -0.36 <.001 
NART IQ .281 .262 .281 14.64 <.001 0.45 <.001 
Age &      -0.30 .001 
NART IQ .281 .262 .281 14.64 <.001 0.39 < .001 
Group .421 .398 .141 17.97 < .001 -0.38 < .001 
Age &      -0.10 .147 
NART IQ .281 .262 .281 14.64 <.001 0.09 .214 
Symbol 
Copy 
.698 .686 .418 102.41 <.001 0.70 <.001 
Group .714 .698 .016 4.02 .049 -0.14 .049 
Age &      -0.03 .530 
NART IQ .281 .262 .281 14.64 <.001 0.04 .433 
Error 
Check 
.823 .816 .543 227.16 <.001 0.82 <.001 
Group .860 .852 .037 19.11 <.001 -0.20 <.001 
Age &      -0.12 .035 
NART IQ .281 .262 .281 14.64 <.001 0.20 .001 
Coding 
Time 
.739 .728 .446 124.91 <.001 0.67 <.001 
Group .801 .790 .062 22.47 <.001 -0.26 <.001 
        
Age &      -0.01 .912 
NART IQ .281 .262 .281 14.64 <.001 -0.01 .857 
Error 
Check 
.823 .816 .543 227.16 <.001 0.65 <.001 
Symbol 
Copy 
.873 .866 .049 28.23 <.001 0.28 <.001 
Group .889 .881 .016 10.47 .002 -0.14 .002 
Age &      -0.05 .286 
NART IQ .281 .262 .281 14.64 <.001 0.08 .126 
Coding 
Time 
.739 .728 .446 124.91 <.001 0.51 <.001 
Symbol 
Copy 
.858 .850 .119 60.42 <.001 0.40 <.001 
Group .876 .868 .018 10.39 .002 -0.15 .002 
        
Age &      -0.01 .912 
NART IQ .281 .262 .281 14.64 <.001 -0.01 .857 
Symbol 
Copy 
.698 .686 .418 102.41 <.001 0.28 <.001 
304 
 
Error 
Check 
.873 .866 .174 99.80 <.001 0.65 <.001 
Group .889 .881 .016 10.47 .002 -0.14 .002 
        
Age &      -0.05 .286 
NART IQ .281 .262 .281 14.64 <.001 0.08 .126 
Symbol 
Copy 
.693 .681 .401 95.40 <.001 0.40 < .001 
Coding 
Time 
.858 .850 .165 83.62 <.001 0.51 < .001 
Group .876 .868 .018 10.39 .002 -0.15 .002 
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Appendix M. Data cleaning for ex-Gaussian investigation of 
intraindividual variability in Simple Reaction Time, Choice Reaction 
Time and Continuous Performance Test-AX tests. 
SRT: Across the total group, 39 anticipated responses and 10 non-responses 
were removed. These anticipated responses came from 19 participants (n = number 
of anticipated responses per person): 11 (n = 1), 3 (n = 2), 2 (n = 3), 1 (n = 4), 1 (n = 
5) and 1 (n = 7). Non-responses came from 6 different participants, with 4 
participants with one non-response each, 1 participant with 2 non-responses, and 1 
participants with 4 non-responses. Whole-group z-scores were computed from the 
remaining reaction times. While the ex-Gaussian approach is utilized in order to 
retain long response latencies, 21 data points were removed for being over 4.0 SD 
above the mean. 
CRT: There were seven “anticipated” responses that all occurred prior to 
stimulus presentation by four participants: three participants made one anticipatory 
keypress each and one participant made four anticipatory keypresses. Four non-
responses made by four different participants. In addition, there were 38 multiple 
keypresses and 88 wrong keypresses, the latter made by 45 participants. Twenty 
data points were removed as they were greater than 4.0 SDs from the mean of the 
whole sample. 
CPT-AX: One-hundred and thirty-nine data points were above 3.0 z-scores 
above the mean; however, no z-scores were over 4.36 and Inspection of a histogram 
suggests that this dataset is appropriate for ex-Gaussian analysis. It was therefore 
entered into the algorithm without removal of any outliers. 
 
  
306 
 
Appendix N. Magnetic resonance imaging (MRI) acquisition protocol 
(created by Dr Michael Firbank) 
 
T1-weighted whole brain magnetization-prepared 180 degrees radio-frequency 
pulses and rapid gradient-echo (MPRAGE) images were acquired in the sagittal 
plane (TR=8.3ms, TE=4.6ms, flip angle=8°, inversion delay=1250ms, 216x208 
matrix; slice thickness=1.0 mm) yielding 180 slices through the brain.  A fluid 
attenuated inversion recovery (FLAIR) sequence (TR=11000ms, TE=125ms, 
IR=2800ms, Turbo SE factor = 27; refocus angle=120°, slice thickness=3mm) 
yielded 50 slices. Diffusion tensor acquisition parameters were: repetition time (TR) = 
6103, echo time (TE) = 70 ms, SENSE factor = 2, field of view 270x270 mm, 
acquisition matrix = 124x120, 59 2.11 mm thick slices, echo-planar imaging factor 
(EPI-SE) = 63, foldover = AP b = 0 (6 averages), b = 1000 (64 directions), acquisition 
time = 7 minutes, 20 seconds. 
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Appendix O. Additional FMRIB Software Library (FSL) brain images to 
complement Chapter 9’s exploratory analyses. 
 
Group differences MCI-LB Probable versus Controls after controlling for age 
(lightbox view; no significant voxels) 
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TFCE-corrected significant associations between voxelwise FA and age with all 
participants (in red; lightbox view): 
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TFCE-corrected voxelwise differences in FA between MCI-LB Probable and controls 
without controlling for age associations (ortho view [72x139x103]; significant 
voxels in red). 
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TFCE-corrected statistical map showing significant correlations between FA and 
DSST for MCI-LB Probable and controls only (significant voxels in blue; ortho 
view aligned at voxel 62x50x87) 
 
 
 
TFCE-corrected statistical map showing significant correlations between FA and 
DSST for MCI-LB Probable and controls only (significant voxels in blue; ortho 
view aligned to show “unclassified area” of the posterior occipital lobe). 
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TFCE-corrected statistical map showing significant correlations between FA and 
DSST for MCI-LB Probable and controls only (significant voxels in blue; 
lightbox view) 
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Appendix P. Correlation matrix between global white matter 
measures (gFA and gMD) and clinical fluctuation scales (DCFS, 
CAF) in patients. 
 
Table A-45. Correlation matrix between global white matter measures (global 
Fractional Anisotropy and global Mean Diffusivity) and clinical fluctuation 
scales (Dementia Cognitive Fluctuation Scale [DCFS], Clinical Assessment of 
Fluctuation [CAF]) in MCI-LB Probable and MCI-AD. 
 
 
 MCI-LB Probable MCI-AD 
 DCFS CAF DCFS CAF 
gFA 0.09 
(p = .682) 
 -0.07 
(p = .757) 
0.07 
(p = .822) 
-0.06 
(p = .850) 
gMD   -0.07 
(p = .757) 
 0.12 
(p = .585n) 
-0.18 
(p = .564) 
-0.01 
(p = .978) 
